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Voor Kim 
 
We think that we will have pleasure 
or delight if we fulfil a certain plan, 
if a certain dream comes true, 
if someone we care for likes us, 
if we take a wonderful trip. 
This attitude is an insult to who we truly are. 
We are the pleasure, we are the joy! 
Why would you want your happiness 
to depend on something 
other than your own nature? 
  
(vrij naar) A.H. Almaas 
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CHAPTER 1: INTRODUCTION 
 
1.1 Introduction 
 
This thesis deals with research performance in the academic medical and health sector. Ideas 
about research performance are usually conceived in terms that allow for some form of 
comparison of a particular work with other research in the same field. Typically, these 
comparisons are conducted by experienced colleagues, i.e. peers. The evaluation of research, 
including medical and health research, by peer review is becoming increasingly problematic. It is, 
for instance, difficult to find non-affiliated, independent peers because of the concentration of 
research facilities in fewer and larger centres (King, 1987). In evaluating basic or fundamental 
research and strategic research1 characterised by a high level of uncertainty compared to applied 
research and experimental development, it is important to recognize the various expected but also 
unexpected applications of this research to different areas. Medical and health research is based 
on the translation of biological and medical research into clinical practice, also called ‘from 
bench to bedside’ (Horton, 1999). In an increasing number of laboratories this translation can be 
observed literally: basic scientists and clinical scientists are working side by side, often on the 
same problems. Some scientists argue that in evaluating medical and health research the 
translational character must be taken into account, for example: ‘…the scoring system used by 
organizations giving grants for health-related research needs to have two components: one for 
the scientific merits of the application, and a second for its applicability to human disease. This 
should receive equal recognition’…(Horton, 1999, p. 213). 
Other medical and health scientists emphasise that scientific knowledge is, after all, created to be 
used by clients such as doctors, social workers, patients and managers. Researchers are 
responsible for both knowing their target group and directly communicating their research results 
to the target group. For example: ‘An indicator of societal relevance of research could be an 
article that is written in the language and medium that is used by the target group. Others are 
direct actions of the researcher(s) to communicate with the users2’ (Klazinga and van 
Everdingen, 2001, p. 35-36). 
                                                           
1
 The basic research category has been subdivided into ‘pure or curiosity-driven research’ and ‘strategic 
research’. Pure research corresponds to the traditional notion of academic research carried out with the aim 
of producing new knowledge primarily for its own sake. Strategic research differs from pure or curiosity-
driven research in the rationale of its support, there being at least some expectation that it will contribute 
background knowledge required in the development of new technologies (Irvine & Martin, 1984).  
2
 This quotation was translated into English (by the author of this thesis) as literally as possible. 
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As stated in the quotations above, the demands for the evaluation of research have changed 
considerably over the past three decades. This has resulted in, what some call, a morbid growth in 
evaluation3 methods, procedures and indicators. Evaluation of research and research institutions 
is seen as an important element in quality control of the R&D infrastructure (e.g. Rip and van der 
Meulen, 1995). However, some think that all this measurement has become an obsession 
(Harvey, Pettigrew and Ferlie, 2002). Others consider it as a new disease, the quality disease, that 
has affected the whole world (Vroeijensteijn, 1995). Therefore, the general objective of this thesis 
is to gain more insight into the evaluations organised to assess performance4 and manage 
academic research in the Netherlands and their impact. It concentrates on the research work level, 
the research groups consisting of a head (mainly a professor) and scientific, technical, analytical 
and administrative staff in universities and research institutes. The focus is on medical and health 
research carried out in an academic setting. The medical and health sector has a long tradition of 
research evaluation and quality assurance. The next sections (1.2 and 1.3) briefly introduce the 
trends emerging in research production and evaluation. In section 1.4, health research is defined 
and its funding structure in the Netherlands explained. Section 1.5 addresses the research 
objectives and questions of this thesis. Finally, the last section, 1.6, gives an overview of this 
thesis. 
 
 
1.2 Increased organisation and the use of research evaluations 
 
1.2.1 Externally organised research evaluations 
 
From the end of the 1980s5, the government, intermediary organisations (defined as organisations 
or parts of organisations that have a dual alliance with both the government and the scientific 
                                                           
3
 The term ‘research evaluation’ is defined in this thesis by adopting the definition of Vroeijensteijn (1995): 
‘every structured activity that leads to judgement of the teaching/learning process and/or research, 
whether self-assessment or assessment by external experts’. The words ‘assessment’ and ‘evaluation’ are 
interchangeable and used in this thesis as synonyms. There may be some difference in connotation 
(evaluation more than assessment seems to refer to ex-post judgements), but neither in the literature nor in 
practice does a strict division exist between the two (see for example Spaapen, 1995 and Vroeijensteijn, 
1995). 
4
 The concept of quality refers intuitively only to the scientific quality of research and to publication 
measures. The concept of performance was introduced in the 1970s. It is a broader concept and contains 
elements that are also used in the quantitative part of this thesis.  
5For an overview of historical developments in science policy in the Netherlands and the introduction and 
creation of the Dutch evaluation system from the 1970s, see Rip and van der Meulen (1995) and Spaapen 
(1995).  
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community) and social groupings in the Netherlands have been putting strong emphasis on the 
evaluation of research. This has resulted in the development of a large number of research 
evaluations. From the literature, four different goals of externally organised research evaluations 
can be derived:   
(1) To gain insight into the scientific quality of research in order to stimulate or retain (in the case 
of excellence) research. On the macro level, for example, the Ministry of Education, Culture and 
Science emphasised in the Science Budget of 1997 the view of the Dutch government on the 
importance of research quality in The Netherlands: …’For the cabinet, making choices also 
entails choosing quality, both of institutions and individual researchers. Academic research is 
after all first and foremost concerned with people. The cabinet aims to retain top talent and to 
create the conditions for eminent research’2 (Ministerie van Onderwijs, Cultuur en 
Wetenschappen, 1996).  
 (2) To gain insight into the efficiency and effectiveness of public spending in order to optimise 
resource allocation (e.g. OECD, 1999). The budgets for scientific research in the Netherlands as a 
percentage of the Gross Domestic Product (GDP) have been declining, compared to the 
prosperity, for years. In 1987, the share in the GDP was 2.3%. In the last decade the GDP share 
decreased from 2.1% in 1996 to 1.89% in 2001. The Heads of State and Government of the 
European Union launched in 2000 a series of ambitious reforms at national and European level 
(the so-called Lisbon strategy). By establishing an effective internal market, by boosting research 
and innovation and by improving education they aimed to make the European Union “the most 
dynamic and competitive knowledge-based economy in the world” by 2010 
(www.europa.eu.int.). A year later in Barcelona it was decided to reserve 3% of the GNP for 
R&D. In 2005 -half-way through the process- results were not very satisfactory. By reviewing the 
process Kok concluded that the implementation of reform in Member States had been quite poor 
(Unknown, 2004). Responsibility and commitment are the major problems. An obligatory 
allocation of tasks between the EU and member states must overcome this problem (Unknown, 
2005) because the EU cannot boost productivity and employment if Member States do not do 
their part.  
 (3) To account to research organisations, funding agencies, government and society at large for 
the spending of public money. Various factors have resulted in a need for greater accountability 
and selectivity in the allocation of funds. In a review, King (1987) reported some of these factors, 
for example: an increase in the capital intensity of research; expanding objectives and 
opportunities, with many new fields emerging; an increase in collaborative, often 
   14 
multidisciplinary, research projects which require coordination; a coalescence of basic and 
applied research, with much research being now of a strategic nature; economic constraints 
requiring choices to be made between different disciplines, fields and research proposals. 
(4) To demonstrate the relevance of research for users. Governmental science policy in the 
Netherlands and most other Western countries includes making academic research not only more 
‘efficient’ and ‘accountable’ but also more ‘relevant’. As far as medical and health research is  
concerned, the public ultimately supports and provides money to generate improvements in 
patient care. The general public is also interested in the ‘cultural’ aspects of medical and health 
research, as appears from the interest in medical television programmes such as for example 
surgeries, the working of the brain, and information about DNA. However, Horrobin (1990) 
showed that if improved medical care is not delivered, support for medical research (and hence 
for medical journals) will dwindle and atrophy. The public, represented by patient organisations, 
also want to be involved in medical and research policy and management. Wagner (1999, p. 14-
15), for example, reported that ‘patients are no longer willing to be passive participants in the 
care process, but want to choose who treats them and where they are treated, and they also want 
to be involved in clinical and policy decision-making’. These expectations and pressures have led 
to changes in criteria or indicators, methodologies and procedures traditionally used in externally 
organised research (including medical and health research) evaluations. For example, the need to 
evaluate the utility of the outcomes of research has led to the development of methods and tools 
for assessing the societal quality6 of research (see 2.3). 
So far the goals of externally organised research evaluations have been presented as being only 
important for governmental agencies, intermediary organisations, funding agencies and society at 
large. However, externally organised research evaluations are also important for research groups 
and individual scientists. For example, research grants are transformed into resources (researchers 
and equipment), which produce data used in knowledge claims. Papers are written and published. 
These papers are read and cited by the international scientific community. In this way, individual 
scientists and research groups accumulate credibility – credit and acknowledgement of 
knowledge claims – which is transformed into reputation and the chance of having subsequent 
proposals funded (e.g. the credibility cycle of Latour and Woolgar in Rip 1999b). Furthermore, 
funding agencies ask researchers to peer-review research proposals and external evaluating 
authorities ask researchers to participate in their external review committees to evaluate research 
output. Researchers are questioned in these peer review processes on the basis of their so-called 
                                                           
6
 The concept of the ‘societal quality’ of research was first introduced in Dutch discussions in the early 
1990s, by for example Spaapen (1995) and van der Meulen and Rip (1995).  
   15
credibility. But, these peer review activities also increase the reputation of individual researchers. 
In this way, the credibility cycle for scientists is linked with credibility cycles for external 
authorities (including funding agencies).  
 
 
1.2.2 Internally organised research evaluations 
 
The goals of externally organised research evaluations, as described above, lead to complex 
evaluations at various levels, depending on organisational resource dependence. All these 
evaluations and resource distribution mechanisms result in a varied environment of evaluations in 
which we are interested. At the same time, research organisations, departments and groups have 
also developed and introduced internal procedures and systems themselves. These research 
evaluations are called internally organised research evaluations.  
 
Various social, economic and political factors have changed the working environment for 
scientific research (Morris, 2002) and resulted in a need for internally organised research 
evaluations:   
(1) Increased pressure caused by externally organised research evaluations. The number and 
variety of external evaluations, occurring in all phases of the scientific process (as described in 
1.2.1), have increased. Internally organised research evaluations are often developed in response 
to the increased attention and importance of evaluations organised by actors in the environment of 
research groups. In general, the goals of both externally and internally organised research 
evaluations are similar. Improving research in order to gain a better competitive position and to 
obtain a leading position within the research field, e.g. van Erp Taalman Kip (1993), are stressed 
as the most important objectives of internally organised research evaluations.  
(2) Political changes, including the new government policies for science. In the Netherlands, the 
focus of science policy has recently changed. Before 1998, science policy in the Netherlands 
focused strongly on the process of decision making by the government with respect to the 
development of scientific disciplines and research needed for societal areas. After 1998, the role 
of the government changed, giving the primary responsibility for these choices to the various 
research organisations (Van Steen, 2000). Today, the autonomy of research organisations 
(including universities) is almost complete (Meijerink, 1999).  
(3) Process evaluations. Quality management in the (pharmaceutical) industry has led in the past 
two decades to the formulation of elaborate quality systems. Some examples of this are the rules 
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for Good Laboratory Practice (GLP) and Good Clinical Practice (GCP). For the production of 
pharmaceutical drugs, the rules for Good Manufacturing Practice (GMP) should be mentioned. A 
combination of these rules and standards can result in an efficient system of Total Quality 
Management (TQM). There is a trend to use these systems more and more in conducting 
scientific research in order to promote reliability and efficiency. Furthermore, these systems are 
sometimes required under government regulation or by customers (van der Weijden, 1999a and 
1999b). 
(4) To handle scientific dishonesty. The recognition of the need for systems to handle the problem 
of scientific misconduct has increased over recent years (e.g. Klasen and Overbeke, 2002; 
Koenen, 2000; Nyelenna et al., 1999). These systems may include guidelines for good scientific 
practice and the promotion of scientific integrity, the definition of dishonesty, procedures and 
bodies to prevent, detect, investigate and punish misconduct whenever it occurs, and even 
research into this field. In the Netherlands, the Amsterdam Medical Centre (AMC) recently 
developed a research code, an internal guideline (‘How to act scientifically with care and 
integrity’) for desirable behaviour (Vermeulen, 2002).  
To summarise, the increasing development and involvement in externally as well as internally 
organised evaluations in different phases of the research process indicate that researchers and 
research groups are experiencing to a greater extent control over their work. 
 
 
1.3 The changing context of science 
 
As a result of the governmental cuts in public funding, as described in 1.2.1, and the 
governmental rethinking of the rationale for the public support of research in general, universities 
have reformulated their missions and management to demonstrate economic and social benefits 
(Morris, 2000). Various steps have been taken to exploit the results of research conducted in 
universities and to encourage more entrepreneurial activities (Etzkowitz, 2002; Louis et al., 
1989). One way to utilise academic research in a commercial manner is to set up university spin-
off companies (Meyer, 2003). Also industrial firms have increasingly attempted to develop direct 
connections with universities to gain access to new ideas, to encourage ‘relevant’ research and to 
promote the transfer of knowledge and technology from university centres to their own more 
development-oriented laboratories (Clark, 1995). These changes in universities were in keeping 
with broader socio-political trends, including changes in the production of scientific knowledge.  
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In the remaining part of this subsection some changes now unfolding in the area of knowledge 
production and in science systems will be introduced and the outline of discussions between 
scholars will be presented. These discussions will be presented because they form a relevant 
background for this thesis. A study that has attracted a lot of attention is that of Gibbons, 
Limoges, Nowotny, Schwartzman, Scott and Trow, who argued that a new kind of production of 
knowledge is emerging in the dynamics of science and research (Gibbons et al., 1994). This has 
been labelled Mode 2 knowledge production, and is emerging alongside the more traditional 
Mode 1. Mode 1 is discipline-based and a distinction is made between what is fundamental and 
what is applied. This implies an operational distinction between a theoretical core and other areas 
of knowledge production where theoretical insights are translated into applications. This contrasts 
with Mode 2 production, which does not cast research problems within a single disciplinary 
framework but is transdisciplinary. It is characterised by a constant flow back and forth between 
fundamental and applied research, between theory and the practice. In Mode 1, research groups 
tend towards homogeneity in terms of skill and experience. Mode 2 knowledge production is 
heterogeneous in terms of the skills experienced people bring to it. Mode 2 research groups are 
less firmly institutionalised than Mode 1 research groups. People come together in temporary 
working teams and networks that dissolve when a problem is solved or redefined. As compared 
with Mode 1, Mode 2 is more socially accountable; sensitivity to the impact of research is built in 
from the start. Finally, operating in Mode 2 makes all the participants more reflexive. This is 
because the issue on which the research is based cannot be answered in scientific and technical 
terms alone (Gibbons et al., 1994). Another concept describing changes in the research system is 
the Triple Helix Model (Etzkowitz and Leydesdorgg, 1995). These changes are expressed in 
terms of the relations between institutes of science, government and industry. The authors 
propose to model this complex system as a triple-helix DNA-like structure of university-industry-
government relations (Etzkowitz and Leydesdorgg, 1995) and to present it as a methodological 
tool. The three strands intertwine and are cross-linked. It generates a knowledge infrastructure in 
terms of overlapping institutional spheres, with each taking the role of the other and with hybrid 
organisations emerging at the interfaces. Morris (2002) suggests that the dynamics in the model 
contribute to a new way of making science policy and fostering innovation. According to 
Etzkowitz and Leydesdorff (2000), the triple-helix thesis implies that the university can play an 
enhanced role in innovation in an increasingly knowledge-based society. From these two views it 
can be concluded that changes are occurring in the relation between science in general and its 
context. These changes have consequences for evaluating practices of research; the attention to 
societal quality is one example. The different views on changes in knowledge production and 
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research systems, as presented above, have also raised some criticism in the academic world. For 
example, Rip (1999a) argues that phrases like ‘Mode 2 knowledge production’ and ‘the triple 
helix’ posit a dichotomous history, which emphasises the fact that a new phase has been entered 
which is very different from the former pattern. He shows that when stable configurations 
threaten to break down, actors as well as analysts have opportunities to outline ‘a brave new 
world’. According to Rip (1999), this explains the fashionable interest in Mode 2 and other labels 
that attempt to capture a transformation that is becoming more evident. In a comment by Shinn 
(2002) the impact of the concepts ‘triple helix’ and ‘the new production of knowledge’ are 
discussed. Shinn stresses the point that changes in cognitive, artefactual and social factors are 
happening on such a grand scale that proof is elusive. It results in simplification and dealing in 
headline-grabbing metaphors where the utmost care must be taken, for example, to base concepts 
and conclusions on empirical studies. Especially in the medical and health-care field one wonders 
whether the practice of science is really changing (e.g. Blume and Geesink, 2000). The 
knowledge produced in the medical and health sector will, after all, be used by clients including 
patients. Furthermore, in order to generate improvement in patient care, users provide money to 
fund medical and health research (see Figure 1). The medical and health research areas are 
characterised by the strong relationships between researchers (in universities, non-university 
institutes and industrial R&D laboratories), users and funding (agencies, including 
pharmaceutical industries). It can be concluded that there are no grounds for arguing that there are 
no significant changes in the production of knowledge (Mode 2) and in the research system 
(Triple Helix) within the medical and health sector. 
 
 
 
 
 
 
 
 
 
Figure 1: Relationships between science, funding (agencies) and users in the medical and health 
research field 
 
SCIENCE 
 
 
 
 
 
 
 
 
 
FUNDING    USERS 
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1.4 Brief characterisation of Dutch medical and health research 
 
1.4.1 Classification of medical and health research 
 
The average life expectancy of the world population is increasing due to growing prosperity. In 
Western Europe also the effects of the ‘babyboom’ after the second world war are becoming 
visible. The mean age of the population is increasing which results in a corresponding increase of 
the demand for health care and health research and consequently puts pressure on the health care 
expenditure. The concept of medical and health research is broad. It covers research into the 
prevention, development and identification of diseases, the relief of illness and the function of the 
system of health care (Klasen, 2000). Two trends can be distinguished7: (1) scientific health 
research in which not only prevention and recovery from diseases are important, but also the 
reduction of inconvenience; (2) health care research in which the health-care system matters 
greatly.  
The term ‘health research’ covers many activities, and it has been shown that it is not easy to 
make a straightforward classification of all these activities (Omta, 1995; Rigter, 1986). In this 
study, the degree to which research is related to potential patients is used to distinguish between 
three categories of health research: para-clinical, pre-clinical and clinical research (see Table 1). 
Para-clinical research emphasises both health-care research and diagnostic testing. The 
relationship with patients is of an advisory nature. In pre-clinical research no direct contact with 
patients exists. Research has a fundamental orientation and is often carried out by medical 
biologists and biochemists. In clinical research a direct relation exists with clinical practice. 
Dutch medical and health research is conducted in several academic medical centres 
(formalisation of cooperation in medical faculties and university hospitals) and non-university 
research institutes8. The tasks of Dutch academic medical centres are patient care, research (both 
biomedical, translational and clinical research), education of students (pre-doctoral), specialist 
medical training and additional training (both post-doctoral and post-vocational) (Buruma, 1997; 
NFU, 2004).  
                                                           
7
 The Advisory Council on Health Research, the Medical Committee of the Royal Netherlands Academy of 
Arts and Sciences and the Dutch Council for Medical and Health Research set up definitions of health 
research in October 1994. An early version of the definitions was published in 1993 by NWO Medische 
Wetenschappen  (1993, p. 9). 
8
 It should be remembered that the large variation in research quality, funding and orientation found, for 
example, in the USA, does not exist in the Netherlands (see Omta, 1995). Dutch universities are publicly 
financed and operate under the same conditions. Dutch universities as well as the Dutch non-university 
research institutes have, within limits, the same access to funding.  
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PARA-CLINICAL 
RESEARCH GROUPS 
PRE-CLINICAL RESEARCH 
GROUPS 
CLINICAL RESEARCH 
GROUPS 
Pharmacology and toxicology Cell and developmental biology Bioinformatics and epidemiology 
Medical psychology Genetics Neurology 
Public health medical technology Oncology 
Social medicine Endocrinology Psychiatry 
Environment, work and health Immunology Cardiovascular system 
Youth and health Microbiology Nephrology 
 Virology Gerontology and Geriatrics 
 Metabolism Respiration 
 Neurosciences Dermatology 
 Haematology Musculoskeletal disorders 
  General practice 
  Gastroenterology and Hepatology 
 
Table 1: Sub-disciplines of para-clinical, pre-clinical and clinical research groups  
 
 
1.4.2 Dutch science expenditure on medical and health research 
 
In the Netherlands, the government, charity funds and private industry fund academic medical 
and health research. In 1997, the Netherlands spent about 680 million Euros. This was about 10% 
of all national R&D expenditure (Ellenbroek, van Ark and Klasen, 2002; Klasen, 2000). Pro 
capita expenditure in terms of the budget for medical and health research in the Netherlands, as 
measured in a different manner, were relatively low (USD 55), compared to the main OECD 
countries. Pro capita expenditure in Germany, the UK, the USA, Denmark and Sweden was 
between USD 104 and USD 156 (see Table 2). A recent study by van Ark et al. (2005) showed 
that the total national expenditure for medical and health research in European countries remained 
at the same level (around 4‰ of the GDP) during the years 1997-2001. However, in the USA the 
expenditure increased steadily from 4‰ to almost 5‰ of the GDP for the same period (van Ark 
et al., 2005).  
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The allocation of resources to medical and health research in the Netherlands is complex. 
Responsibility for the allocation of resources is fragmented over several agencies (see Table 3). 
36.5% of the total research budget flows directly to the eight medical faculties and medical 
clusters of the Dutch universities. The Ministry of Education, Culture and Science allocates it 
through the general budgeting mechanisms for universities. Governmental funds also flow from 
the Ministry of Education, Culture and Science and the Ministry of Health, Welfare and Sports to 
the Medical and Health Research Councils. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: International comparison of pro capita medical and health research expenditure in USD. 
Data are from Ellenbroek, van Ark and Klasen (2002). 
 
This agency distributes 7.0% of the budget. The remaining governmental funds account for 7.8% 
of the total research budget, mainly through the funding of: 
– (parts of) the Royal Netherlands Academy of Arts and Sciences (KNAW) project grants; 
– (parts of) the Netherlands Organization for Applied Scientific Research (TNO); 
– (parts of) the National Institute of Public Health and the Environment (RIVM); 
– (parts of) the Netherlands Institute for Health Services Research (NIVEL).  
The charity funds which together donate about 9.1% of the funds, form an important flow of 
money. The pharmaceutical industry is the second most important contributor, responsible for 
39.5% of the spending on health and medical R&D. 
 
                                                           
9
 Please note that in 2002 most medical faculties were co-operating to some degree with university 
hospitals at that time. However, this was only formalised in Leiden (Leiden University Medical Center, 
LUMC), Utrecht (Utrecht Medical Center, UMC) and Amsterdam (Amsterdam Medical Center, AMC). 
10
 In 2001 the Health Research and Development Council (ZON) and the Medical Sciences of the 
Netherlands Organisation for Scientific Research (MW-NWO) were merged.  
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Medical faculties9 20 33 53 6 4 20 16 
Medical and health research councils10 4 5 3 16 46 5 5 
Other governmental agencies 4 11 10 6 9 20 20 
Industry 22 35 37 74 58 82 103 
Charities 5 4 1 12 4 8 13 
Total expenditure 55 87 104 113 120 135 156 
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 BUDGET IN MILLION 
DOLLARS 
% OF TOTAL 
Medical faculties and academic hospitals 312 36.5 
Medical and health research councils 60 7.0 
Other governmental agencies 67 7.8 
Industry 338 39.5 
Charities 78 9.1 
Total 855 100 
 
Table 3: Dutch expenditure for medical and health research in 1997. Data are from Ellenbroek, 
van Ark and Klasen, 2002. 
 
In conducting health research, academic groups in the Netherlands depend to a large extent on 
external financial resources. Table 3 shows that only 36.5% of the expenditure on health research 
is allocated by the employment organisation. Van der Weijden et al. (2002) computed, by using 
DAG 1998 data, the average number of PhD students and staff (in full-time equivalents, fte) per 
year who were paid in the period 1992–1996. They found that medical and health research, 
subdivided into 12 clusters, is dependent on different external financial sources (see Table 4). 
Dependence on the various external sources is weak in a number of clusters. For example, only 
8.6% of the PhD students and staff (55.75 fte) who were working in Oncology were funded in the 
period 1992–1996 through the second flow of funds. The most important source of money for 
oncology research seems to be charity funds (third flow). These funds were responsible for 
funding, on average, 35.3% of the PhD positions and staff. Furthermore, in the clusters Genetics 
and Neuroscience a relatively high proportion of PhD students and staff (20.7% and 18.6% 
respectively on average) were paid via the second flow. Compared to other disciplines, research 
focusing on endocrinology obtained, on average, a considerable amount of money from the 
second and third flows of money (30.5%). Only 6.6% of the researchers were paid by 
pharmaceutical industries and firms (fourth flow). Finally, immunology research is mostly 
(58.5%) dependent on the various external resources. 
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Nutrition, digestive system, kidney and 
biologically active substances 
60.8 10.6 20.0 8.6 539.8 
Geriatrics 60.4 13.3 4.9 21.4 40.7 
medical technology and biomechanics 57.4 8.9 16.9 16.8 84.5 
Neurosciences 54.4 18.6 19.1 7..9 540.8 
Public health 51.7 8.7 29.3 10.3 531.3 
Cardiovascular disease 48.7 11.8 31.3 8.2 685 
Development, Growth and differentation 47.4 15.4 24.2 13.0 261.4 
Endocrinology 46.1 16.8 30.5 6.6 233.8 
Genetics 43.5 20.7 24.9 10.9 328.9 
Oncology 42.4 8.6 35.3 13.7 648.3 
Respiratory system 42.2 3.6 26.3 27.9 52.8 
Immunology 41.5 12.7 34.4 11.4 813.9 
 
Table 4: Percentage of staff and PhD students per year who have been paid from the first, second, 
third and fourth flow of money11 per discipline in the period 1992–199612.  
 
 
1.5 Research questions 
 
In the preceding sections, the goals, the increased interest and the use of research evaluations 
were described, including the changing demands for evaluation coming from different actors in 
the research system. The governmental cuts in the public funding of health research are 
reinforcing these developments. As a result, choices about research have to be made again and 
again. Studies such as for example (Obbink, 2000) have shown that researchers are complaining 
about the large number of different internally and externally organised research evaluations they 
are experiencing. Researchers are confronted with research evaluations at two different levels. On 
                                                           
11
 Financial resources are subdivided into 4 flows of money. The first flow of money is obtained from the 
university budget. The second flow of money is obtained from intermediary governmental research 
organisations such as CMHR, KNAW and the European Union (EU) research programme. The third flow 
of money is obtained from charitable funds. Finally, the fourth flow of money comes from industrial 
resources. 
12
 The disciplines ‘Geriatrics’ and ‘Respiratory system’ are relative small, so it is difficult to make a 
statement. 
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the micro level, researchers are, for example, involved in the evaluation of research input. They 
have to submit research proposals in order to get enough research funding. Furthermore, funding 
agencies, in their turn, ask researchers (peers) to review proposals. On the macro level, 
researchers are, for instance, involved in the evaluation of research output. They are asked to 
collect and gather input and output data, and present it to the evaluating authority. In addition, 
these authorities are asking researchers (peers) to evaluate research output. Relatively little is 
known about the experiences of research groups with both internal and external pressures. The 
question arises of how research groups react to evaluation pressure and if (and in what way) this 
affects their behaviour. Therefore three general questions are central in this thesis. 
  
1. What different research evaluations have been organised to assess Dutch medical and 
health research? 
To gain more insight into externally organised evaluations used to assess academic medical and 
health research in the Netherlands, six intermediary organisations responsible for these 
evaluations were mapped. Intermediary organisations are organisations or parts of organisations 
(for example, research councils) mediating between the interests of the government on the one 
hand and the ongoing scientific work and its institutional arrangements on the other. The 
intermediaries have an important function within the environment of medical and health research 
groups: they are able to fund, steer, control and facilitate research. These processes could be 
strengthened by using the outcome of evaluations of one intermediary organisation as input into 
the evaluation process of other intermediaries. Intermediary organisations that primarily focus on 
health care, such as the Council for Public Health and Health Care (Gezondheidsraad) and the 
Health Care Insurance Board (College voor Zorgverzekeraars), have not been analysed. 
Furthermore, the evaluation practices of charities have not been considered here because the rise 
of their research evaluations is mainly the result of the evaluations developed and used by 
medical and health research councils. Consequently, the overlap between both evaluation 
practices is considerable. 
As presented in section 1.2.2, research groups themselves recently have developed and introduced 
procedures and systems to assess the quality of their research. Very little is known yet about these 
so-called internally organised research evaluations. These evaluations could be interpreted as part 
of the internal management of the research organisation. It was pointed out by van der Meulen 
and Rip (1994, p. 41) that ‘…internal management has to do with using external processes for 
internal policies, set up internal policies to meet external objectives and develop relations with 
others. The other aspect is to organize internal processes and communication optimal with 
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regard to the mission of the institute’… In this thesis, research evaluations organised by 
universities, non-university medical research institutes, medical faculties and research groups 
themselves were analysed. Universities, non-university research institutes and medical faculties 
are also important actors in the environment of medical and health research groups. Just like 
intermediaries, they fund, steer, control and facilitate research. In order to answer this first 
research question, which is of a descriptive, comparative and explorative character, semi-
structured interviews were held. Personal interviews with eight representatives of intermediary 
organisations and eleven personal interviews with research managers of medical faculties and 
non-university research institutes were held. Questions were asked about topics such as the 
concept of ‘research quality’, features of evaluation procedures (for example, goals, criteria and 
methods), the distinction between the scientific and societal qualities of research, and recent 
developments in evaluation procedures. The results of this study are discussed in Chapter 4 
(externally organised medical and health research evaluations and their implications) and Chapter 
5 (internally organised medical and health research evaluations and their implications).  
 
2. What is the impact of both externally and internally organised research evaluations? 
After outlining the evaluation practices of the most frequently used research evaluations in 
medical and health research, the question arises of what implications these evaluations have for 
the research groups concerned. A few studies have focused on the implications of evaluation 
outcomes. Westerheijden (1997), for example, studied the impact of the national discipline-based 
research evaluations co-ordinated by the Associations of Universities in the Netherlands (VSNU), 
on the faculties and universities concerned. He demonstrated that these evaluations have gained a 
place in the management of Dutch universities. It seemed that the VSNU evaluations provided 
managers or administrators of Dutch universities with a solid basis of legitimate arguments on 
which to base strategic decisions. In this thesis two types of effects are identified: (1) the effect of 
the evaluation procedures and methods, and (2) the effect of the evaluation outcomes. An 
explorative research approach was chosen because no clear definition of the possible effects was 
determined beforehand. Therefore, the empirical work consisted of open unstructured interviews 
conducted with eight representatives of intermediary organisations and eleven personal interviews 
with research managers of medical faculties and research institutes. Results are discussed in 
Chapter 4 (externally organised medical and health research evaluations and their implications) 
and Chapter 5 (internally organised medical and health research evaluations and their 
implications).  
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3. Do research management activities and positive views or judgements on research 
management enhance the performance of Dutch para-clinical, pre-clinical and clinical 
research groups? 
The developments and changes in research evaluations of medical and health research (as sorted 
out in the first research question) and the implications of these evaluations (as stated in research 
question 2) are the stimulus for investigating whether (and what) factors really enhance research 
performance. Previous studies have investigated the personal characteristics of productive 
researchers. These include personal motivation, research training, mentors, early scholars’ habits, 
socialisation to academic values, a network of productive colleagues, resources and substantial 
uninterrupted time (Cole and Cole, 1967; Pelz and Andrews, 1966). It is now clear that the 
research performance of groups is not only affected by personal characteristics but also by 
environmental ones. For a selected overview see for example, Bland and Ruffin (1992). The 
characteristics of a productive environment investigated in this thesis are divided into (1) research 
management items, a composite of internal and external control and (2) contingencies such as 
size of the group, time allocation and age. A couple of articles have been published on different 
managerial aspects that improve the performance of industrial R&D (e.g. Drongelen and 
Bilderbeek, 1999; Efferth, 2001 and Omta, 1995). Comparably less, but still considerable, 
attention has been paid to the different managerial aspects of academic research. A number of 
papers and studies have shown that the quality of academic research groups and their group 
members is affected by management activities (see Chapter 2 for a detailed description). Most of 
these studies concentrate on only one or a few management activities. In this study a large 
number of management activities have been distinguished. Internally organised research 
evaluations are interpreted in this study as a management activity. This choice can be supported, 
for example, by the study of van der Meulen and Rip (1994). They showed that internally 
organised research evaluation in institutes is interwoven with planning and internal 
communication (e.g. conferences, colloquia) and concluded that internal evaluations are one of 
the management instruments that enhance the quality of research. Unfortunately, empirical data 
that could corroborate their statement are lacking. As far as is known, empirical studies that have 
described the relationship between different research management activities and research 
performance exclude internal research evaluations from the scope of research. In order to answer 
this third research question, a comparative study was conducted in Dutch medical and health 
research groups in an academic setting. Also the impact of the disciplinary setting was taken into 
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account13. The heads of the medical and health research groups received a postal survey. They 
were asked to answer a total of 48 questions regarding their management activities and situation-
dependent items (contingencies). Two input and five output measures were used to indicate 
research group performance. These measures are further explained in chapter 3. 
 
 
1.6 Structure of the thesis 
 
The next chapter is a theoretical chapter about performance indicators and research groups. In the 
first part, the most important evaluation methods and indicators relevant to public research that 
were found in the literature are outlined. The second part of the theoretical chapter discusses the 
literature about characteristics and activities that stimulate and maintain the performance of 
research groups. Chapter 3 presents a number of methodological issues. Chapters 4, 5 and 6 
constitute the empirical part of this study. In Chapter 4 externally organised evaluations of Dutch 
medical and health research are presented and analysed (research question 1). Also the 
implications of these evaluation procedures and outcomes are presented (research question 2). 
Internally organised evaluations of Dutch medical and health research and their implications are 
presented and analysed in Chapter 5. The third research question is quantitatively discussed in 
Chapter 6. The first part of Chapter 6 describes the response rate and analyses the non-response. 
The second part gives an overview of the results. The relationships between research 
management, contingencies and performance found in Dutch medical and health research groups 
are presented and discussed. Finally, in Chapter 7 the results are summarised, conclusions are 
drawn and a general discussion of the thesis is presented.  
                                                           
13
 In the case of published empirical medical and health research studies, differences between several kinds 
of health research (para-clinical, pre-clinical and clinical health research) are frequently disregarded. 
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CHAPTER 2: RESEARCH GROUPS: CONTEXT AND PERFORMANCE 
INDICATORS 
 
2.1 Introduction 
 
A substantial part of academic research is carried out in research groups14 (or also called research 
teams). For researchers, this research group provides the most important environment for day-to-
day work and the primary focus of orientation for the research of individual scientists (Andrews, 
1979b). In the past it was almost axiomatic to consider science – especially fundamental science – 
as the province of individuals (Stankiewicz, 1979). Over the years the prevalence of the 
team/group organisation in science has become widely recognised. Also, institutes and research 
centres were mushrooming in many parts of the world (Pelz and Andrews, 1966). Since then, 
most individual scientists depend on such organisational forms for funding, equipment and 
support. In medical and health research the necessity to: (a) share expensive research 
infrastructure, (b) collaborate with different disciplines and (c) share various proceedings have 
stimulated scientists to work together in groups.     
Interestingly, Stanckiewicz (1976a) found that the prevalence of research groups, units or teams15 
(composed of scientists and supporting personnel) among Swedish academic scientists (in natural 
sciences and technology) was strongly related to their research field. The frequency of group 
membership was highest in rapidly developing fields characterised by a high degree of theoretical 
consensus (for example, chemistry and molecular biology). In these fields, more than 90% of 
scientists worked in research groups. The lowest frequencies were found in descriptive and/or 
theoretically less crystallised fields. In a later study, Stanckiewicz (1980) suggested that the 
advantage of working in a group derives from the fact that groups create the socio-psychological 
environment (for example, interactions in terms of communication and collaboration), which is 
conducive to creativity and productivity. The formation of research groups may be regarded as 
the means to promoting intellectual synergy by achieving a high level of interaction among 
scientists. Nowadays, academic research groups operate in a complex environment, consisting of 
                                                           
14
 Cohen, Kruse and Anbar (1982) empirically investigated the social structure of scientific research 
groups. They created a typology of groups as well as of leadership roles, derived from organisational and 
social-psychological theories. Group type or type of leadership role or both were associated with other 
structural features of research groups (e.g. size, disciplinary composition, whether the team had co-
principal investigators and included prestigious senior scientists). It can be suggested, although this was not 
tested in their study, that group social structure influences team interaction in ways that can affect a group’s 
chances of successfully reaching its research objectives.  
15
 In this thesis the terms ‘research groups’, ‘research units’ and ‘research teams’ are used as synonyms. 
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scientific opportunities, constraints and resources. The environment influences the manner and 
direction in which scientific knowledge develops (Groenewegen, 1988). The environment of 
academic research groups comprises various actors, which are the key elements of the national 
innovation system. The research groups have interactions and exchange relations with all actors 
in their environment. The nature of the exchange relations between a research group and its 
environment varies and could change over time. From the environment, research groups draw 
resources (for instance, funds, legitimacy, information, instruments and know-how) in exchange 
for research products such as research problems, outcomes and credibility. From the environment 
they also exchange demands and needs that research problems may address (Zeldenrust, 1988). In 
order to receive resources and to define demands and needs, both actors and the research groups 
themselves use methods to evaluate the performance of research. In this way, each actor to some 
extent adds weight to the direction and quality of research conducted by the research group. The 
first part of this theoretical chapter gives an overview of the most important research performance 
measures found in the literature. In section 2.2 both qualitative (peer review process) and 
quantitative (number of publications and citations and more advanced bibliometric indicators) 
methods used in the evaluation processes of scientific research are presented and discussed. But, 
what factors stimulate research group performance? Some conditions for public scientific 
research – increased demand for accountability of public funds, increasing emphasis on both the 
scientific and the societal quality of research, and the redirection and reduction of funding (see 
Chapter 1) – increase the urgency to find answers to this question. The second part of this chapter 
highlights empirical contributions that help to provide insight into the capabilities of individual 
members as well as the environment in which the group is embedded. During 1960-1980 
important contributions to research on the personal characteristics of researchers and their 
relationship with (both individual and group) performance were made by Pelz and Andrews (Pelz 
and Andrews, 1966; Andrews, 1979b). Personal motivation, confidence in one’s own ideas, 
diversity in professional activities and skills, a moderate level of autonomy and creative ability 
are some examples. After 1980 this type of research was seldom continued or improved upon by 
other researchers. It can be argued that research organisations and research groups provide more 
than facilities for their members (e.g. Andrews, 1979). They also provide an environment that 
may either stimulate or inhibit the performance of their members. For example, Paolillo and 
Brown (1979) state that R&D managers should not assume they can simply hire good people and 
let the system run by itself. The literature strongly indicates that environmental elements of 
managerial control such as communication, a reward system, coordination, leadership, climate 
and culture, which are largely the result of the institutional setting in which the scientists are 
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employed, can have a substantial positive impact on the research performance of both individuals 
and groups. In fact, several studies suggest that environmental characteristics are the most 
powerful predictors of the research productivity of both researchers and research groups (e.g. 
Allison and Long, 1990; Long, 1978; Long and McGinnis, 1981; Thamhain and Wilemon, 1987). 
Compared to studies on the personal characteristics of researchers, that have been done by only a 
few researchers (mainly Pelz and Andrews), the environmental characteristics of researchers and 
groups have been studied more extensively and by a diverse set of authors. However, it should be 
kept in mind that elements of managerial control do not operate in research groups as isolated 
characteristics. ‘Rather, they are like delicate threads of a whole fabric: individual, yet when 
interwoven, providing a strong, supportive and stimulating backdrop for the researcher’ (Bland 
and Ruffin, 1992; p. 387). Environmental factors of research groups that are related to individual 
and group performance are presented and discussed in section 2.3.1 and 2.3.2. Section 2.3.3 
describes the personal characteristics of ‘productive’ scientists. The objective of these sections is 
not to give an exhaustive review of the literature but rather to highlight some issues. In both 
sections results of studies performed in R&D settings have been selected.  
 
 
2.2 Research evaluation methods  
 
The evaluation of research plays an important role in both science and society today. For 
researchers these evaluations are important, for example in competition and decisions about 
appointments, promotions, tenure positions, allocation of research funding and the publication of 
papers. Evaluations (organised either internally or externally) are not only crucial throughout a 
scientist’s career but also in the survival of research groups, research departments and faculties, 
and research institutes. In this section the most important qualitative and quantitative research 
evaluation methods are presented and discussed. This gives some insight into the relevant 
dimensions of research and presents useful indicators for research group performance. Most of 
these performance indicators are also used by scholars in studying the relationship between 
managerial control, contingencies and the performance of research groups (see section 2.3.1 and 
2.3.2). Also, a number of these performance indicators are used to measure the individual 
performance of scientists and to describe the personal characteristics of productive and effective 
scientists (see section 2.3.3). In addition, performance indicators were used in the empirical 
studies reported in this thesis (Chapters 4–6).  
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2.2.1 Peer review 
 
Peer review is the predominant method for making actual evaluations of research performance in 
several important areas. Peer review can be defined as: …the judgement by scientists (or other 
professionals identified as having the appropriate expertise) on the research (either completed or 
proposed) of other scientists… (Wood, 1997, p. 9). Peer review may be confined to questions of 
scientific excellence or be extended to include broader socio-economic considerations. Most 
authors of articles on the subject assume that the purpose of peer review is quality control. 
According to Horrobin (1990, p.1438), in medical and health research, an additional goal of peer 
review is to facilitate the introduction into medicine of improvements in cure, relief and comfort. 
Even in those many fields of medical research that are remote from clinical practice, the peer 
reviewer should always be asking the question: ‘Is this a possible innovation that should be 
encouraged because at some time it could lead to improvements in the treatment of patients?’. 
The first precursors of the peer review process started in the scientific societies and academies of 
the late seventeenth century. They were crucial to the social development of the scientific 
journals. From the earlier practice of merely putting manuscripts into print, without competent 
evaluation of their content by anyone except the author, the practice of having the substance of 
manuscripts appraised there slowly developed. This was carried out principally before publication 
although sometimes after, through evaluation by institutionally assigned and ostensibly 
competent reviewers (Merton, 1973)16. At present, the referee system has been widely adopted in 
the academic journals of all disciplines. Most medical journals have similar practices (see Table 
5). In fact, peer review has become an integral part of the social institution of science17. Besides 
for the appraisal of the quality of papers before publication in scientific journals, peer review has 
been introduced in many other contexts and on different aggregation levels. Peers who evaluate 
academic performance for career decisions, such as hiring and promotion (Creswell, 1985), are 
one example. Peer review has also been introduced into the evaluation of research output. 
 
 
 
 
                                                           
16
 For a detailed (historical) analysis of the introduction and development of peer review in science, see, for 
example, the chapter ‘Institutionalized patterns of evaluation in science’ by Merton and Zuckerman, 
published in The Sociology of Science: theoretical and empirical investigations. 
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Table 5: Conventional peer review in medical journals, after Fletcher and Fletcher (1999) 
 
The evaluation of research programmes of universities and institutes, research schools and 
disciplinary evaluation practices (see for an example of evaluation of health research in the 
Netherlands in 1988, 1994 and 1999) are based on peer review. Furthermore, the peer review 
process is common practice in research councils and other funding agencies (e.g. (Bazeley, 1998; 
Cole, Rubin and Cole, 1978; Wood, 1997). Peers evaluate research proposals and have positions 
in advisory committees. According to Rip (1999b), research councils became legitimate to 
scientists in this way. Effects of this can be seen on reward and reputation systems. Grants 
received from the national research councils and international funding organisations became 
indicators of performance and credit. For example, in job applications, tenure decisions and even 
in the allocation process of external funds (through peer review of the research proposals), it is 
important to show that grants have been awarded.  
 
New forms of peer review within medical and health research 
The most important recent change in the publication processes, electronic publication, is affecting 
peer review of articles (Rennie, 1999). One example is open peer review, where the names of 
reviewers (in contrast with formal peer review) are known to the author. In medical and health 
sciences, the British Medical Journal has, after completing a randomised controlled trial (Van 
Rooyen, 1999), introduced open peer review and is experimenting with an open electronic system 
(for more detailed information, see http://bmj.bmjjournals.com/advice/peer_review.shtml).  
                                                                                                                                                                             
17
 Since 1990, even international congresses have been organised to discuss the process of medical peer 
review, the most recent insights into what has been achieved by peer review and how it might be improved 
(Goldbeck-Wood, 1999).  
• One to three reviewers 
• Reviewers selected from senior academics 
• Reviewers know author’s name and institutions 
• Reviewers do not sign their reviews 
• Authors do not know reviewers’ names and institutions (blind review) 
• Simple, general instructions to reviewers 
• Ask reviewers to provide: comments for authors, comments for editors, grades on 
individual components and overall quality of the manuscript 
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Another type of peer review is a refereeing structure with review comments made public and all 
comments, responses, and changes becoming part of the final publication. In the medical and 
health sector a system of this kind is already in practice in the journal, Behavioral & Brain 
Sciences, where, after formal review, articles are circulated to as many as one hundred potential 
commentators, across specialities and around the world. Then, each article is co-published with 
the 20 to 30 (accepted) peer commentaries it elicits, plus the author’s response to the 
commentaries (Harnad, 1996). The last type mentioned here is post-publication. The Medical 
Journal of Australia, for instance, performed an Internet peer review study of electronically 
published articles (Bingham, 1999). After electronic publication the authors could revise the 
publication in response to comments from readers. Afterwards, the articles were published in 
print.  
 
Problems with peer review 
In an ideal world, there would seem to be only advantages involved in any well-run, smoothly 
functioning peer review system. Decision makers (e.g. editors, funding agencies) feel more 
comfortable in their decisions when they are informed by expert opinions. Peers appreciate being 
recognised as experts. Scientists who are evaluated (e.g. applicants, authors) realise that the only 
hurdles worth jumping are those they respect: the hurdle erected by experts (Rennie, 1999). Over 
the years a lot of articles have been published that criticise (by giving their opinion and/or by 
collecting empirical data) the use of peer review in assessing research performance (e.g. 
Horrobin, 1990; Moxham and Anderson, 1992). Reviewers may, for instance, be partially biased, 
jealous, ignorant, incompetent, malicious, corrupt or incapacitated by conflicts of interest 
(Rennie, 1999). Of the many criticisms directed at peer review prominent ones are highlighted in 
this section. 
(1) Selection of peers on the basis of their point of view  
Peers need to be specialists in the relevant research field, but peers who are too closely involved 
with the subject may be influenced by jealousy or cronyism (e.g. Fuhrer and Grabois, 1985; 
Wenneras and Wold, 1997), whereas more distant referees may not have the required expertise. 
The use of international referees is frequently proposed as a way to reduce conflict of interest and 
jealousy. However, Wessely (1998) found that they tend to produce more favourable and less 
rigorous evaluations.  
(2) Biases in the peer review process 
In the peer review process several examples of bias can be found. Bias against personal 
characteristics of scientists, such as sex (female scientists) and research experience (young 
   34 
scientists), is well known. Cognitive bias, when a referee gives a negative review because the 
theoretical approach or methodological approach of the author is not the same as that of the 
referee, is described by several authors including Cole (1998) and Wood (1997). Institutional 
bias, when a referee gives a negative review because the researcher works in an institute that is 
less known to the referee (Wood, 1997), is another example of bias in the peer review process. 
Finally, the Matthew effect in science is probably the best known example of the consequences of 
bias in psychological processes. It was originally construed in terms of ‘the enhancement of the 
position of already eminent scientists who are given disproportionate credit in cases of 
collaboration or of independent multiple discoveries’ (Merton, 1973, p. 458). The Matthew 
effect18 may heighten the visibility of contributions by more highly ranking scholars. For 
example, they are more likely to have their papers or proposals accepted, because their names are 
recognised by peers, than authors with lower academic qualifications.  
(3) Low reliability of peer review ratings 
The extent to which independent reviewers (of the same proposal/paper, etc.) agree on the quality 
of a paper is one indicator of peer review reliability. However, studies have shown a low level of 
consensus or agreement of assessor scores among peers. For example, Cicchetti (1991) reported 
in a review about agreement between peers in academic journals a low reviewer agreement in 
both medicine and behavioural sciences. Also, Rothwell and Martyn (2000) showed that 
agreement between independent reviewers on whether manuscripts in the field of clinical 
neuroscience should be published, or their priority for publication, was low. In fact, agreement 
was not greater than what would have been expected by chance alone. 
(4) Time-consuming and costly process  
Researchers spend much time on writing and reviewing research papers and grant applications. 
The resource input into the review process, both in terms of administrative costs and of scientists’ 
time, is considerable but, according to King (1987), usually ignored. Not only awarding bodies 
but also editors of scientific journals encounter difficulties in persuading scientists to give up time 
to review grant applications or papers (e.g. Cole, 1998; Wessely, 1998). The Australian Research 
Council, for example, now makes agreements to undertake reviewing duties a condition for 
awarding a grant (Wessely, 1998). Another example is the former Dutch medical research council 
MW-NWO. In order to attract more reviewers, this council carried out an experiment in 
2001,where they paid international researchers who were willing to review a research grant 
proposal. However, the results showed that the (extra) amount of money invested did not 
                                                           
18
 In the literature there is some dispute about the amount of variance explained by the Matthew effect (e.g. 
Cole, 1998; Daniel, 1998). 
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compensate for the increased number and quality of review reports (MWO-MW, 2000). After 
internal evaluation of this experiment, it was decided not to continue paying reviewers. 
(5) Lack of transparency  
Some authors argue that the peer review process has the characteristics of a black box. It does 
produce judgements, but one does not know how they come about. In order to get some insight 
into the thought processes of peers when they pass their judgements, Sonnert (1995) explored the 
criteria by which (in this case US biology) scientists evaluate the performance of their colleagues. 
He found, among a variety of productivity measures, three significant predictors – annual 
productivity rate, solo-authored publications and graduate school expertise – that together 
explained 59% of the variance in the judgements of biologists.   
In response to the criticism many alternatives and additions to peer review have been suggested 
for measuring research performance. The most common ones are quantitative indicators based on 
the use of characteristics of scientific publications that in general publications are considered the 
most important output of scientific research. As Chubin and Hackett (1990; p. 83) stated:  
…‘Publication is the lifeblood of science, conveying the symbolic nutrients of new theories, 
research findings, credit and critical scrutiny’…  
 
 
2.2.2 Quantitative methods 
 
In this section the commonest quantitative measures and indicators of research performance19 
found in the literature are discussed: publication counts, impact factors, citation counts and more 
advanced bibliometric methods.  
 
 
2.2.2.1 Number of publications 
 
The number of publications is considered to be an indicator of the quantity of scientific output. It 
is obtained by simply counting the number of publications or by counting the number of 
publications while using a weighted scale for each type of publication (Creswell, 1985). It may 
                                                           
19
 Indicators other than described in this section can measure research performance. Examples are the 
number of research grants obtained, the number of appointments to editorial boards, the number of 
improved processes, the number of new products and the number of new analytical methods (e.g. Creswell, 
1985). In medical and health sciences also other experimental methods based on the evaluation of scientific 
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include journal articles, (chapters in) books, papers presented at professional meetings and book 
reviews (e.g. Patrick and Stanley, 1996). Most scientists believe that the quantity of output is not 
the equivalent of output quality. According to Smith and Fiedler (1971), the main problem in 
using publication counts as a measure of research performance is that they may give equal credit 
to poorly conceived papers appearing in poorly edited journals and to well-written papers in high-
quality journals.  
 
 
2.2.2.2 Number of citations 
 
Until 1961, there seemed to be no practical way of measuring the impact of publications. Cole 
and Cole (1973) reported that the problem of assessing the quality of scientific publications has 
long been a major impediment to progress in the sociology of science. The invention of the 
Science Citation Index (SCI)20 in 1961 by Eugene Garfield and the publication of the first volume 
of SCI in 1963 provided, for the first time, a tool for measuring the significance of the 
contributions of individual scientists21. The Citation Indices (CI) claim to cover the most 
important ‘leading’ international journals and serials with a well-functioning referee system. 
More ‘peripheral’ journals, often national in scope, are usually not covered by the CI. By using 
references in publications, researchers show how they have built on previous work by others. The 
quality of a publication and its influence on academic knowledge are reflected in the number of 
times others cite it (Cole and Zuckerman, 1984). In this way, citations seem to have universal 
quality because any article can be compared with any other, independently of the subjects 
involved (e.g. Egghe and Rousseau, 1990; Wouters, 1999).  
 
Problems with the use of citations 
The use of citations, in the years after the construction of the SCI as a science performance 
indicator, ran into some problems regarding the gathering and handling of data. A distinction was 
                                                                                                                                                                             
papers are developed, presented and discussed by scholars; see, for instance, the study of Ugolini, Parodi 
and Sant (1997) in the field of oncology.    
20
 The SCI claims to cover the central and most important journals in the natural and life sciences. It fully 
indexes 5900 major journals across 150 scientific disciplines. The Social Science Citation Index (SSCI, a 
multidisciplinary index of 1725 journals across 50 social science disciplines), the Arts and Humanities 
Citation Index (AHCI, a multidisciplinary index of 1144 of the world's leading arts and humanities 
journals), the Materials Science Citation Index (MSCI) and the Neuroscience Citation Index (NCI)are 
related indices published by the Institute for Scientific Information (ISI).  
21
 For a detailed analysis of the creation and building of the SCI, see the thesis of Wouters (1999), chapters 
2 and 3.  
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made between technical and methodological problems. Technical difficulties created by the 
production process of citations include:  
• deficiency or errors in references, caused by spelling mistakes (estimated at 10% by Moed, 
Burger and van Raan, 1983), leading to non-existent texts;  
• regular occurrence of identical names for different entities; 
• incompleteness of the ISI database. See, for example, Lewison (2002), who studied this 
problem in the medical field; and 
• self-citations22. 
These problems have been frequently noted in the literature, e.g. (Egghe and Rousseau, 990; 
King, 1987; Moed et al., 1983; van Raan, 1999c). In addition, some methodological problems 
have been experienced, e.g. Cole and Cole, 1973; Egghe and Rousseau, 1990; Smith, 1981; van 
Raan, 1999c): 
• (sub)field dependence: the chance of being cited varies greatly among scientific specialties or 
disciplines, depending on the size (number of journals covered), publication culture 
(importance of journals as a communication medium)23 and citing culture of the field 
concerned (number of citations to a publication)24;   
• time delays for citations: the amount of time it will take to elicit citations varies greatly 
among (sub)fields25; 
• critical citations: citations may refer to papers that are being criticised and rejected rather than 
utilised;  
• dominance of English as the scientific language. 
Besides these technical and methodological problems, also some concern about the impact of 
citation counts has been raised, as is illustrated by a quote from Cole and Zuckerman (1984, 
p.240): ‘Does a work cited an average of 55 times over 12 years have a greater impact than a 
work cited an average of 32 times over 12 years? Or, have two scientists who have each been 
cited 50 times in a given year had the same impact as one who has published 25 papers, each of 
which has been cited twice, and the other has also published 25 papers but has two papers which 
received 25 citations each, while the others 23 received none at all’?  
                                                           
22
 According to Moed et al. (1983) about 10% of all citations appear to be self-citations.  
23
 According to van Leeuwen (1996) books, proceedings and reports play an important role in the 
communication of results in application- and problem-oriented scientific fields . 
24
 Van Raan (1999c) compared an average publication in biology and an average publication in 
mathematics. He found that a biological publication received an average of 20 citations while an average 
mathematical publication received only 5 citations. 
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2.2.2.3 Bibliometric methods 
 
Over the years, more sophisticated bibliometric indicators have been developed, constructed and 
used in research evaluations. In fact, a new profession has been created, scientometrics, with a 
core journal and an international conference. The more sophisticated indicators are too numerous 
to discuss in detail individually. According to Wouters (1999, p. 115), there is a pattern in the 
construction of these indicators: ‘First, all are built on the basis of varying combinations of the 
signs reference and citation. The way these two dimensions (the citing and the cited) are 
combined determines important characteristics of the resulting indicator network. Second, they 
all aim to represent reality in a more reliable way than competing indicators, or qualitative 
descriptions. Third, they build upon one another’. 
 
Impact factor  
The impact factor (IF), introduced by Eugene Garfield and regularly published in the Journal 
Citation Report, is a purely citation-based measure for the significance and performance of 
journals. The impact factor is calculated from the number of citations to a scientific journal in a 
certain period divided by the number of publications in that journal during the same period 
(mostly 2 years). According to Glänzel and Moed (2002), it is the most popular bibliometric 
product used in bibliometrics as well as outside the scientific community26. Although the use of 
journal citation impact factors as a performance indicator has been practised for many years, it 
has not been without criticism. See, for instance, the critical letters and reviews of Boor (1982, p. 
976): ‘…recognize characteristics of the citation impact factor that render it of dubious validity 
and potentially deleterious to the research and publication enterprises’; Edwards, van 
Steirteghem and Richardson (1993, p. 983):‘we have discovered a major inconsistency in the 
compilation of citation data for journals that are included in Current Contents, but not covered in 
the Science Citation Index’; Hansson (1995, p. 906): ‘impact factor as a misleading tool: there is 
virtually no correlation between the citation frequency and IF of the journal in which it is 
published; Moed and van Leeuwen (1996, p. 186): ‘…the IFs of many journals included in the 
Science Citation Index (SCI) are inaccurate because of an inappropriate definition of citable 
documents’ and Smith (1998, p. 1079): ‘…impact factors are meaningless as a measure of the 
                                                                                                                                                                             
25
 Van Raan (Van Raan, 1999c) found that publications in more fundamental sciences (e.g. natural and 
medical fields) cite recently published work (a maximum of three years after publication). In applied 
scientific (sub)fields citations are made to much older publications. 
26
 For a (historical) overview of the most important attempts to improve or to complement the impact 
factor, see Glänzel and Moed (Glänzel & Moed, 2002). 
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performance of individual scientists or research groups for the simple reason that there is little 
correlation between the number of times that individual articles may be cited and the impact 
factor of a journal. This is because impact factors depend on a few articles that are highly cited’. 
The impact factor and other bibliometric indicators are mainly used to assess the scientific quality 
of research. Lewison (2002) suggested that, for example, journal-specific indicators can also be 
used to assess some societal aspects of (in his case medical) research. For instance, the frequency 
with which journals are cited in clinical guidelines, in patents and in newspapers can be measures 
that can be used to analyse the societal aspects of research quality. 
 
Two-dimensional indicators  
In the above section only one-dimensional quantitative research performance indicators are 
discussed, based on direct counts of specific bibliographic items (e.g. publications) or particular 
data elements in these items such as citations (Van Raan and Tijssen, 1993). Box 1 and box 2 
introduce two-dimensional indicators constructed from the co-occurrence of specific information 
elements: co-citation and co-word analysis. With the help of special data analytical techniques27 
based on matrix algebra, it is possible to convert the information in such a co-occurrence matrix 
into a spatial configuration of elements (keywords or references) in a two-dimensional space. In 
this way a map is made of a scientific field. These maps can be interpreted by scientists, science 
managers and science policy officials, see, for instance, Noyons (1999) and Wouters (1999). 
Despite the promising introduction of bibliometric maps of science in a science policy context in 
the 1970s, they have not been very successful yet. According to Noyons (2001), it seems, 
however, that only recently they are becoming acknowledged as useful tools, mainly by virtue of 
the developments and integration of hypertext and graphical interfaces, which makes the strength 
of such navigation tools more visible. 
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27
 For details about the sophisticated combination of clustering techniques and multi-dimensional scaling 
used in these two-dimensional bibliometric techniques, see the studies of Peters and van Raan (1993a; 
1993b).  
Box 1: Co-citation analysis  
The first two-dimensional technique is based on the number of times citations are mentioned 
together in publications. The co-citation technique was introduced in 1973 (Small, 1973). The co-
citation frequency is the number of times a certain pair of cited articles is cited together in the 
same papers1. Co-citation analysis is, in fact, an attempt to identify so-called ‘high-density areas’ 
in a citation network by clustering highly co-cited documents and it thereby indicates the 
existence of ‘research fronts’1 (Braam, Moed and van Raan, 1991). However, the validity, the 
interpretation of results and the practical usefulness of co-citation analyses for science policy 
purposes are often subjects of debate (e.g. Hicks, 1987; King, 1987; Rip, 1988). 
 
Box 2: Co-word analysis  
The second two-dimensional technique, co-word analysis, is not based on citations and references 
but on the number of times keywords mentioned together in publications. In 1983, co-word 
analysis was introduced to a wider audience by Callon and his colleagues (1983). In short, for 
each scientific field all keywords of publications can be collected, and for each keyword in the 
compiled set one may analyse how many times each keyword occurs together with any other 
keyword in the publications involved (Callon, 1983). Examples of bibliometric maps based on co-
word analysis can be found in van Raan and Tijssen (1993: map of neural network research) and 
Noyons, Buter and van Raan (1999: map of neurosciences). Maps of science can be seen as tools 
for searching, identifying and analysing structures of scientific activities as reflected by 
publications. They may point to emerging fields of science and emerging new activities, and they 
offer insight into the position of countries, research organisations or institutes in a field of science 
(van Raan and Tijssen, 1993). Just like all measures or techniques, co-word analysis has its limits 
and potentials. According to van Raan (1999a), an advantage is that, when maps are made for a 
series of years, it becomes possible to observe trends and changes in the structure of fields. 
According to Hinze (1997), the most important disadvantage is the time delay caused by the slow 
actualisation of thesauri and classification schemes.  
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2.2.2.4 Application of bibliometric methods in the research evaluation process 
 
In spite of the criticism of peer review processes, as discussed in section 2.3.1, peer review is still 
the most accepted way to evaluate research. Compared to some decades ago, the main difference 
is that peer review is no more the one and only way to evaluate research. Increasingly, 
quantitative methods and indicators allow the measurement of the response of the international 
scientific community to the published work (expressed in references in scientific literature) in the 
evaluation processes of science. Currently, bibliometric indicators are frequently used – often in 
combination with peer review – not only in externally organised research evaluations (see box 3 
for some examples in the Netherlands) but also by scientists themselves. The impact factor is the 
most commonly used bibliometric indicator because it contributes to solving problems by 
comparing the output of the various scientific (sub)fields. In section 2.3.2.2 it is shown that 
scientific (sub)fields differ in publication and citation patterns. Therefore, it is usually not 
meaningful to compare the raw impact of publications in one field with those in another field 
(Nederhof, van Leeuwen and Visser, 1998a). In solving this problem, two international 
benchmark indicators were developed by van Raan (1996): (1) the mean journal citation score 
based on all publications of the group or institute evaluated), (2) the mean field citation score 
based on all publications in SCI journals in one field. In order to get information about the impact 
of research publications, the mean impact scores per publication are compared with the 
benchmark indicators. Furthermore, Noyons and Moed (1999) recently demonstrated that the 
combination of mapping and citation analysis can be a powerful tool in the evaluation of research 
activities. This combined approach was applied to support a governmental audit of research 
activities of the Inter-university Centre for Micro-Electronics in Leuven, Belgium. On the basis of 
the comments of an international panel of experts in micro-electronics, the method was discussed 
in detail. The panel concluded that the method provided a detailed and useful picture of the 
position of the institute from an international perspective. Moreover, they found that the results of 
each of the two parts had added value for the other one.  
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AGGREGATION 
LEVEL 
EXAMPLE EVALUATION GOAL 
Individual 
researcher 
None  
Research 
departments  
or research groups 
Bibliometric analysis of economic 
research groups (Nederhof and van 
Raan, 1993)  
Research performance of research 
units in economics has been 
evaluated by simultaneous efforts 
of peers and bibliometricians 
Research institute Bibliometric analysis of the Cardio-
vascular Research Institute Maastricht 
(Nederhof and Visser, 1997)  
Bibliometric analysis of the 
research institute CARIM (part of 
the medical faculty of Maastricht 
University) organised by CARIM 
Bibliometric analysis of the Faculty of 
Medicine of the University of 
Groningen (Nederhof, van Leeuwen 
and Visser, 1998a) 
Bibliometric analysis of the 
Faculty of Medicine (Universitiy 
of Groningen), as part of the 
internal evaluation of research 
output 
Faculty 
 
 
 
 
UMC Bibliometric analysis of eight UMCs 
(NFU, 2004) 
External goals: transparency and 
justification to Dutch society and 
funding agencies. 
Internal (UMC) goals: results can 
be used to make policy and 
improve research  
Research school Bibliometric analysis of the Netherlands 
School of Primary Care Research 
(Nederhof, van Leeuwen and Visser, 
1998b) 
External research evaluation of 
research school CaRe based on 
bibliometric indicators only 
Quantitative assessment of Dutch soil 
biological research (NRLO, 1997)  
Explorative study of the use of 
bibliometric indicators in strength-
weakness analyses of soil 
biological research 
Research field 
Bibliometric profile of Dutch physical 
research (van Leeuwen, 1996) 
Evaluation of Dutch physical 
research. Bibliometric profile is 
used in combination with a report 
of the peer review committee. 
 
Box 3: Examples of bibliometric methods in Dutch (externally organised) output evaluations 
 
 
2.2.3 Societal performance indicators 
 
Over the past years externally organised research evaluations have focused on indicators 
measuring the scientific quality of research, including the role of bibliometric analysis on 
scientific impact (see sections 2.3.1–2.3.2.4). The scientific quality of research is based on the 
view of Merton (1973), who argues that the contribution to the growth of the scientific knowledge 
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is the final objective of science. In addition to scientific quality, the societal quality28 of research 
is also important. It refers to the increased pressure on researchers to demonstrate user relevance, 
the relationship to industry or the utility of the research, e.g. van der Meulen and Rip (2000). In 
medical and health research the final objective is to improve the health outcome for each 
individual. Therefore, societal quality can be divided into: (1) relevance for health care providers 
and the process of health care delivery (KNAW, 2002), (2) relevance for policy makers and the 
process of designing, implementing and monitoring policy decisions (Council for Medical 
Sciences, 2002) and (3) the relationship to the pharmaceutical industry. Besides societal quality, 
the societal impact of medical and health research – which can be described as the 
implementation of research output by executive professionals and the policy field – is also an 
important element to evaluate. It addresses the systematic and planned process of integrating new 
research findings or valuable procedures and techniques within normal practice routines. 
 
Societal indicators in externally organised research input evaluations 
In selecting research projects there is traditionally a peer evaluation of scientific quality. In 
society-inspired research programmes, an important criterion in the assessment of research 
proposals is their merit in relation to the defined targets of the particular programme. To obtain 
research grants, proposals have to score above a certain threshold on both scientific and societal 
indicators.  
 
Societal indicators in externally organised research output evaluations  
Over the past few years, some experimental evaluations have been carried out which tried to 
develop methodologies to evaluate the societal quality and impact of research output. Most of 
these developed and tested methodologies are quantitative evaluation tools (see Table 6) that can 
be used in qualitative peer practices such as self-evaluations and external audits. The criteria and 
indicators used in this kind of evaluations always depend on the mission of the group or institute 
evaluated (Council for Medical Sciences, 2002). Therefore, evaluation outcomes must always be 
interpreted in relation to the research mission. 
 
 
 
                                                           
28
 See for example van der Meulen and Rip (2000) who identified (in a case study approach) dimensions of 
societal quality in environmental as well as in neuromuscular research and indicators linked to them. They 
found that the expectation that the research would contribute to socio-economic developments (relevance), 
the interaction with (possible) users and the actual use of results were the dimensions mainly used. 
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Table 6:  Examples of recently developed ex-post societal quality methods and indicators 
 
Concluding remarks: The use of multiple indicators in research evaluations 
In the preceding sections the most important qualitative (peer review process) and quantitative 
(number of publications and citations and more advanced bibliometric indicators) methods used 
in evaluation processes of scientific research are presented and discussed29. Of all these different 
methods, the qualitative peer review process is still the most accepted one. According to Chubin 
and Hackett (1990), the refereeing effort is even seen as ‘a good citizen chore that comes with 
membership in the scientific community’. In contrast, quantification and weighting of research 
output have been most difficult, problematic and debated tasks for years, e.g. Cole and Cole 
(1971) and Endler (1978). According to Sonnert (1995), a major strength of the quantitative 
methods is their reliability. Their weakness lies in the area of validity: do they really measure 
what they intend to measure? For instance, researchers may also tend to cite what they consider to 
be poor or flawed studies to contrast them with their own work. Finally, with regard to the 
interpretation of results of bibliometric studies, it should be clear that the results of bibliometric 
                                                           
29
 It has been noted in the literature that performance indicators are inter-correlated. Cole and Zuckerman 
(1984), for example, reported positive correlations between citations and publication counts, ranging from r 
= 0.50 to r = 0.75. Citation counts also correlate strongly with other performance indicators, such as 
employment in a prestigious university, listing in important bibliographies of scientists, and receiving 
scientific awards (for instance Nobel Prize winners and fellowships awarded (Creager, 1967 in Smith and 
Fiedler, 1971). Furthermore, citations correlate positively with peer review ratings. Cole and Cole (1971) 
found that visibility with peers correlates positively with publishing productivity rates (r = 0.56) and 
citation counts (r = 0.68). No research has been done yet on the correlation between different societal 
indicators because this field is relatively new and still developing. 
 
• Societal quality research profile (SQRP) in health research (Spaapen, 1995)  
• Research embedment and performance profile (REPP) in agricultural sciences (Wamelink and 
Spaapen, 1999) and pharmaceutical research (Callon, Law and Rip, 1986; Dijkstelbloem, 
Spaapen and Wamelink, 2002)  
• Stakeholder analysis of agricultural sciences (Wamelink and Spaapen, 1999) and 
pharmaceutical research (Dijstelbloem, Spaapen and Wamelink, 2002)  
• End-user relevance in agricultural and biological research organizations (Lyall et al., 2004)  
• Methodology for the (ex-post) evaluation of the societal impact of applied health research 
(Council for Medical Sciences, 2002) in which communication to health professional workers, 
quality improvements, implementation activities and the relevance of health care for policy are 
evaluated. 
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studies could not be interpreted properly without background knowledge. Some knowledge of 
specific internal circumstances and the international subfield is required (van Leeuwen, 1996). It 
is currently a common belief, especially among bibliometric experts, that the combination of 
advanced bibliometric methods and peer review is the best approach in evaluating research, e.g. 
van Raan (1996). Furthermore, bibliometric experts emphasise that bibliometric indicators are not 
meant to replace peer evaluation, e.g. Nederhof and Visser (1997), van Leeuwen (1996) and van 
Raan (1999c), but: ‘…they can offer crucial information about research performance that can be 
seen as complementary to peer opinion’… (van Leeuwen, 1996, p. 3).  
The research evaluation methods as presented and discussed in the preceding section present a 
brief overview of the environmental complexity of research groups.  
 
 
2.3 Environmental and personal characteristics and research performance  
Factors in the environment of research groups (both in an organisational and social context) are 
divided in this section into contingencies (2.3.1) and managerial control factors (2.3.2). Each of 
the environmental factors is discussed separately. However, it should be remembered that 
environmental factors do not operate in research groups as isolated characteristics. ‘Rather, they 
are like delicate threads of a whole fabric: individual, yet when interwoven, providing a strong, 
supportive and stimulating backdrop for the researcher’ (Bland and Ruffin, 1992, p. 387). 2.3.3 
finally presents important contributions to research on the personal characteristics of researchers 
and their relationship with both individual and group performance. 
 
 
2.3.1 Contingencies and performance 
 
In the literature group size, age, resources and research goals are the most important 
contingencies that are related to research performance. In this section an overview of the 
literature is presented. 
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2.3.1.1 Group size and performance  
 
There have been several pioneering studies on the effects of group size on research performance, 
for example Wallmark and Sellerberg (1966), Blume and Sinclair (1973a; 1973b) and Wallmark 
et al. (1973). Wallmark and colleagues (1966, 1973) investigated the relationship between the 
size of 60 research teams in applied physics and their performance (measured as the number of 
citations that the team’s papers received divided by the number of citations, excluding self-
citations). They found that: (1) there is a positive effect of group size on performance; (2) there is 
no optimum team size; (3) the improvement in performance is exponential with the size of the 
research team, and (4) other factors such as material resources, selection of productive group 
members and personal characteristics could contribute to research performance of groups. Blume 
and Sinclair (1973a, 1973b) investigated the relationship between group size and effectiveness 
(measured as the number of articles) in a large sample of British academic chemists. They 
concluded that neither critical nor optimum size effects exist. They also found that the 
relationship between size and productivity varied considerably among areas of the chemistry 
discipline. They speculated on the multiplicity of skills required for some types of research and 
on the degree of mechanisation and typification of the research procedure influencing this 
relationship. However, in studying 200 Swedish academic groups in natural and technology 
sciences, Stanckiewicz (1980) found that group size affected both the quality and quantity of 
research output. The relationship was curvilinear with the optimum corresponding to the average 
size of 6–7 scientists. More recently, for example, Jordan, Meador and Walter (1988), who 
studied economic departments, Pineau and Levy-Leboyer (1983), who studied medical 
laboratories, and Baird (1986), who studied chemistry, history and psychology, showed that 
research performance increases with the increasing size of the research group. These findings 
suggest that, as one would expect, there are, for example, more opportunities for contact, 
stimulation, and resources in larger research groups (see also the review by Bland and Ruffin, 
published in 1992). 
 
 
2.3.1.2 Age and performance  
 
The first studies investigating the effect of group age on the performance of research groups were 
published by Wells (1962) and Wells and Pelz (1966). They studied in 83 industrial and 
governmental research groups the relationship between the age of groups and their performance. 
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Age was measured as the average number of years the members belonged to the group. 
Performance was measured as the rating of the scientists’ scientific contribution and their overall 
usefulness to the organisation. They found that (1) the general scientific contribution of the 
groups tended to decline with increasing group age and (2) the group’s overall usefulness to the 
organisation tended to increase during the first four to five years, after which it declined. Wells 
and Pelz (1966) found that these effects could be linked to decreasing cohesion and 
competitiveness and to increasing specialisation in ‘ageing’ groups. Smith (1971) found similar 
results by studying 52 R&D groups.  
A few scholars studied age as the amount of research experience in relation to performance. Dill 
(1985), for instance, suggested that the leader’s professional expertise as a scientist significantly 
affected the unit’s productivity. Dill also contended that the professional experience of leaders 
enables them to influence members’ knowledge and values, to facilitate contacts and networks, to 
attract other competent researchers, to help colleagues, and so on. Stanckiewicz (1980) found that 
the level of a leader’s R&D experience bears a fairly strong, largely linear relationship to the 
index of recognition of the research groups, but seems to be unrelated to the groups’ quantitative 
performance. Recently, Omta (1995) found that the research and management experience of 
research leaders correlates inversely with the annual growth rates of medical research groups. 
 
 
2.3.1.3 Age, size and performance  
 
Knorr et al. (1979) studied, with data drawn from the International Comparative Study on 
Organizational and Performance of Research Units, the relation between different organisation 
characteristics and the productivity of academic (natural science and technological science) 
research groups. They showed that, in addition to individual productivity, three contingency 
factors positively influence the published output of research groups. These are:  
(a) size of the research group, measured as the average number of man-years of scientists;  
(b) age of the research group, measured as the number of years a group has existed formally 
under its present name and goal structure;  
(c) scientific exchange maintained by the research group. 
By using the same data, Stanckiewicz (1979) found that given a high level of cohesiveness, the 
effectiveness of research tends to increase with group size. This result is in line with other studies, 
including those of Blume and Sinclair (1973a; 1973b) and Wallmark et al. (1973). But, when 
cohesiveness is low, there seems to be a strong decline in performance for research groups larger 
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than 7 scientific members. Stanckiewicz (1979; 1980) also reported that the relationship between 
size and output per scientist is strong within groups headed by leaders with long research 
experience (more than 14 years), but it is weak within groups headed by younger researchers. In 
fact, within groups headed by younger leaders, there is a negative relationship between 
productivity and group size. Finally, it was found that groups characterised by high levels of 
cohesiveness and/or directed by experienced leaders, group age has little effect on research 
performance. In contrast, within groups characterised by low cohesiveness and/or directed by 
highly involved leaders, the importance of group age is considerable (see Stanckiewicz, 1979). 
 
 
2.3.1.4 Resources and performance  
 
Resources to accomplish a task or to achieve a goal are essential for any activity, including 
research. Stolte-Heiskanen (1979) investigated the impact of material resources (such as 
workspace and equipment), human resources (such as size of the unit, contacts of the unit, 
competence of the unit head, unit scientists and technicians), and information resources (such as 
international library services and science information service) on administrative and social 
effectiveness of research units. The satisfaction of the unit’s members with these resources was 
defined as subjective resources. Data were collected in 1222 research units from six countries. 
The relationships of material and information resources to effectiveness was generally very weak. 
On the whole, human resources seem to play a more important role in the effectiveness of 
research units. The possibilities for interaction with other scientists and the competence of the 
unit head are the most important (objective) human resources. The satisfaction with human 
resources explains most of the variance in the unit’s performance (about 5% of the variance in 
administrative effectiveness).  
Pineau and Levy-Leboyer (1983) highlighted the importance of support staff. They found that, 
among 155 medical teams, the least productive teams had either no or only a few full-time 
laboratory technicians, and the most productive teams had ten or more full-time technicians. 
Culpepper and Franks (1984) studied the common major impediments to research reported by 
353 family medicine university units. They found that lack of time (78%) and lack of funding 
(61%) seemed to be the two most important impediments to research. Other studies, as for 
example Creswell (1985), Meltzer (1956) and Pruthi et al. (1993) also reported the inadequate 
availability of money as a barrier to performing research. Finally, Stanckiewicz (1980) studied the 
relation between the amount of time a research leader (n = 200) spends with the group and 
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performance and found that performance improved as the percentage of time allocated to the 
group increased up to 35%. If more than 35% of the leader’s time is allocated to the group, the 
performance stabilised or even decreased.  
 
 
2.3.1.5 Research emphasis and performance  
 
In 1986, Baird showed that departments with clear, dominant goals of research were more 
productive than departments that emphasised the training of practitioners. Similarly, other 
departments that place high priority on practitioner training and service, such as family medicine 
and nursing, generally have low research productivity (Perkoff, 1986). Omta (1995) found that 
scientific staff of pre-clinical and para-clinical units can spend twice as much time on research as 
staff in clinical units. Interestingly, this extra time was not translated to higher research and user 
effectiveness. The researchers in clinical units published, on average, a similar number of 
scientific papers. 
 
 
2.3.2 Managerial control and performance 
 
2.3.2.1 Communication and performance  
 
Giving or exchanging information, supportive and sympathetic relationships, physical 
connections and access to a large network of colleagues define communication. Communication 
processes can occur within research groups (between the leader and group members or/and 
among group members), between research groups (between external networks of colleagues), and 
between group members and their clientele. In 1956, Pelz studied a large government 
organisation that conducted basic medical research. He found that the performance of researchers 
was higher when they had: (1) daily contact with several scientific colleagues who, on average, 
had been employed in settings different from their own, who stressed values different from their 
own, and who tended to work in scientific fields different from their own; (2) frequent contact 
with at least one important colleague who had similar professional values; (3) a supervisor and a 
major colleague, where one was in the same scientific discipline and the other in a different one, 
rather than both similar or both dissimilar. A decade later, Pelz and Andrews (1966) reported that 
the average frequency of contact (conversations, memoranda, seminars) between researchers 
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working in a laboratory setting and their most important colleagues correlated positively to their 
performance. Scientists who performed at the highest level spent considerably more time on 
communicating with their colleagues (optimum 6–10 hours per week). Furthermore, high 
performance was shown by scientists who had contacts with a large number of colleagues 
working in their own group as well as outside their research group (but within their ‘own’ 
organisation). The positive relationships found between colleague contact and the performance of 
researchers appeared even after differences in experience, in supervisory status and in who 
initiated the contact, were taken into account. Also, Allen (1970) found that high performers 
(working in R&D laboratories) communicated to a larger extent with organisation colleagues, 
spent more time on their discussions with colleagues, and relied on more people both within their 
own speciality and in other specialities. By interviewing successful scientists, Sinderman (1985) 
found extensive references to communication and networking. It seemed that successful 
researchers usually have long-term cordial relationships with peers and colleagues. Relationships 
with peers usually begin early in the scientist’s career with discussions about methodology or 
design of an experiment or with enquiries about poorly understood concepts. This mutual testing 
process continues with, for example: office or seminar discussions with colleagues; requests for 
informal evaluations of research proposals and draft manuscripts; and the development of co-
operative research projects (Sinderman, 1985). A large quantitative study about communication 
and research performance has been conducted by Visart (1979). Data were collected from 10,000 
individual researchers from six countries. She found that both the between- and the within-unit 
communication indices explained as much as 22% of the variance in recognition, 21% in 
applications effectiveness, 19% in R&D effectiveness, and 31% in the number of published 
written products. After controlling for unit size, age and experience of staff, it was shown that the 
percentage of variance explained in the recognition by communication predictors tended to be 
lower in larger research units, units with older scientific staff and units where scientific staff had 
more years of R&D experience. Just the opposite was found for applications effectiveness. A few 
years later, in another quantitative study approach, Saxberg and Newell (1983) reported that it 
was the unanimous opinion among directors and members of interdisciplinary research teams that 
communication and interaction among team members form the most critical ingredients in 
keeping the group and its work on course. A wide range of reporting events was suggested 
ranging from the most informal team discussion to a formal seminar to which interested 
colleagues from elsewhere may be invited. Finally, Cole and Cole (1973) used the concepts 
‘awareness’ and ‘visibility’ to analyse the process of scientific communication (exchange of 
information between producers and audience, consisting of other scientists working in the field). 
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They concluded that awareness (in this case of physicists) is not greatly influenced by the 
individual or contextual characteristics of physicists and that communication is relatively open. 
Visibility, on the other hand, is strongly influenced by individual or contextual characteristics, 
such as scientific achievements and the location in the research system. 
 
 
2.3.2.2 Rewards and performance  
 
According to Omta and de Leeuw (1997), the challenge of research management is to create the 
conditions conducive to meeting the corporate goals of scientific performance as well as the 
scientists’ need for satisfaction and motivation. Rewards used and given by local, national and 
international research management can motivate employees, including scientists, to perform at 
higher levels, and the proper use of rewards culminates in improved performance at the 
organisation and group levels. Figure 2 shows the path from rewards to organisation performance. 
Latham and Wexley (1981) tried to identify outcomes engineers and scientists would value as 
rewards for doing a good job. By interviewing 242 engineers and scientists they found that the 
five most valued rewards were: (1) seeing one’s work applied, (2) receiving a salary increase, (3) 
having one’s work put to commercial use, (4) praise from a supervisor, and (5) a monetary bonus.   
 
 
 
Figure 2: Rewards’ influence on performance according to Allen and Helms (2001)  
 
In the literature several examples of effective reward systems for R&D researchers have been 
reported. In 1981, Latham and Wexley conducted an experimental study in which they assessed 
the effectiveness of various rewards on the performance of R&D scientists. The rank ordering in 
terms of impact on performance was: (1) money, (2) praise and (3) public recognition. However, 
they reported that the lead in performance due to the money over praise was so small as to be 
practically insignificant. As early as in 1960, Gustad had concluded that money seems to be a 
motivating factor for researchers only under limited circumstances, for example when the salary 
of the researcher is very low compared to others. Beyond a certain level of subsistence or 
comfort, salary is not rated as an important reward element (Lewis and Becker, 1979). 
McKeachie (1979) argued that praise, prestige, salary and promotion are important, but not so 
much for the material gains they provide but for their ability to grant recognition of the 
Reward practices -> Motivation -> Individual performance -> Organisational performance 
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researchers’ special expertise, intellectual ability and value vis-à-vis their colleagues. For 
example, being promoted indicates that one has achieved competence in the eyes of respected 
peers. Furthermore, McKeachie suggested that motives important for a particular researcher at 
one particular time may not be important at another time (also called ‘life-span development 
theory’). In this way the indicators salary and promotion are supposed to be of particular 
importance in the early years of one’s career. By using a meta-analytic study design Jenskins et 
al. (1998) studied the effects of financial incentives on the performance of employees (in general, 
not only employees working in a R&D setting). Interestingly, they concluded that financial 
incentives were not related to performance quality (r = 0.08, n.s.). A positive correlation was 
found between financial incentives and performance quantity, in which setting consistently 
moderated the strength of the relationship (ranging from r = 0.23 in a laboratory setting to r = 
0.46 in field experiments). Fairweather (1993) demonstrated the dominance of the research and 
scholarship-oriented reward structure for faculties in four-year colleges and universities. He 
found that, regardless of the type or mission of the institution, staff in faculties that spend more 
time on research and publishing were paid more than their teaching-oriented counterparts. In a 
study among academic medical research groups, Omta and de Leeuw (1997) found that the use of 
material and immaterial incentives (for example, career possibilities and planning, training 
facilities and recognition) together explained about 10% of the variance in performance. 
Stimulation of international contacts can also be seen as a form of reward. Contact with 
colleagues in other countries gives access to new information and is important for exchanging 
results and ideas. Kyvik and Marheim Larsen (1994) studied the internal contacts and 
performance of faculty members of the rank of assistant professor or higher. A clear correlation (r 
= 0.44) was found in the medical sciences between the number of international contacts 
(measured as international conference attendance, long-term research stays abroad, guest lectures 
abroad, evaluation work abroad and research collaboration with foreign scientists) and the 
number of international publications. Omta and de Leeuw (1997) reported that the frequency of 
international contacts with scientists (for instance, in international congresses and workshops) 
accounted for 4% of the explained variance in research performance in academic medical groups. 
Finally, in 1998 Badawy provided an overview of the management of human resources in R&D 
during the past fifty years. He reported that effective reward systems for scientists consist of 
several elements including: a dual ladder system, a professional award system, a career planning 
system, a creative climate, mentoring and effective communication. 
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2.3.2.3 Coordination and performance  
 
Pelz already found in 1956 that researchers in very tightly coordinated situations were so 
constrained that it decreased their ability to be productive. A decade later, Pelz and Andrews 
examined the relationship between motivation and performance and between autonomy and 
performance in research units (data were obtained from 500 R&D scientists in industrial, 
governmental and university units) that differed in levels of coordination. They found that 
productive scientists working in loosely coordinated groups could be characterised as: (1) highly 
involved and having inner motivation, (2) had a desire for self-actualisation, (3) communicated 
frequently with colleagues, (4) worked closely with colleagues, (5) experienced a strong 
competition between groups, (6) experienced a tight competition among individuals, (7) were 
specialised in various areas and (8) had various R&D functions. However, they also found that a 
relatively high level of individual autonomy was effective mainly in the middle range of 
situations: those who were neither very tightly nor loosely coordinated. Pineay and Levy-Leboyer 
(1983) compared successful medical laboratories with less successful ones (n = 155) and found 
that the best laboratories were those managed by supervisors whose approach was moderately 
free but who did formally control their researchers’ work.  
 
 
2.3.3 Personal characteristics of researchers and performance 
 
Pelz and Andrews (1966) found that personal motivation has a moderately positive relationship 
with individual performance (ratings as well as actual scientific outputs). Interestingly, they 
concluded that the critical element in the relation between motivation and performance is not the 
specific source of motivation but an underlying factor of intellectual self-reliance – confidence in 
one’s own ideas. A cross-national replication was undertaken by Andrews a few years later. He 
reported a positive relationship between the motivation of scientists and group performance 
(Andrews, 1979a). Pelz and Andrews (1966) also found that diversity in professional activities 
and skills of American scientists seem to be positively related to their individual performance. 
More than a decade later, Andrews (1979a) showed in an international comparative study of 
research units that diversity, as a general phenomenon, explained roughly 10% of the variance in 
recognition, R&D effectiveness and number of publications. The relationship between the 
autonomy of scientists and individual performance was also studied by Pelz and Andrews (1966). 
They found that PhDs in research labs with moderate autonomy performed somewhat better if 
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their interest in breadth was weak. The reverse occurred at high levels of autonomy: PhDs who 
maintained a broad interest in new areas performed quite well indeed, and those who were 
interested in detail performed poorly. Furthermore, Pelz and Andrews (1966) argued that the 
creative ability of scientists alone is not enough to elicit good performance. They found that the 
environment in which scientists work might affect the likelihood of their making good use of 
whatever creative ability they have. Working on a project or specialising in an area for a 
relatively short time, being part of a team in which coordination was not too high and where one 
had the ability to influence important decision-makers, and having reasonably good facilities for 
communicating new ideas to others were three situations that seemed to enhance the pay-off from 
the creative ability of the scientist (Pelz and Andrews, 1966). Finally, the relationships of 
personal traits of scientists (including sex, race, age and class), academic origin and job histories 
with the performance of scientists were studied mainly in the period 1966–1979. Pelz and 
Andrews (1966), for example, reported a continuing increase in performance (scientific 
contribution, overall usefulness, number of published papers and unpublished reports) with age of 
the researcher up to the early or late forties. These measures dropped sharply in the researcher’s 
early fifties and recovered in the later fifties30.  
Cole and Cole (1967) found that the more scientists’ work is recognised and used by colleagues 
(also called early recognition), the more often they continue to be productive. In addition, they 
showed that when scientists are ignored, their productivity will tail off. Several studies (Crane, 
1965; Reskin, 1979) showed that being trained by an eminent sponsor is associated with higher 
productivity in scientists. By studying career contacts in obtaining a position, Granovetter (1973) 
pointed out weak ties as important resources for utilising possible mobility opportunities and 
indispensable for the integration of individuals into communities. Strong ties, in contrast, led to 
overall fragmentation. Furthermore, the prestige of departments seemed to be important for 
research productivity at the middle and end of their first postdoctoral decade and for the number 
of citations scientists received from early first-authored work (Reskin, 1979). 
  
 
2.4 Conclusion 
 
Chapter 2 describes research groups and performance. Both the actors in the environment of 
research groups and employing organisations or institutes frequently evaluate research during 
                                                           
30
 A search for factors that might account for these differences led to a set of motivational items indicating 
inner motivation or self-reliance (Pelz and Andrews, 1966). 
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different phases in the research process. One can assess research input (also called ex-ante 
evaluation), research throughput and research output (also called ex-post evaluation). It can be 
concluded that an adequate research evaluation requires several methods, criteria and indicators. 
As early as in 1971, Smith and Fiedler (p. 232) stated that …‘no criterion or measure currently 
available is sufficiently well established to stand alone’… In addition, research quality is a broad 
and complex concept with different aspects (e.g. van Leeuwen, 1996; van Raan, 1985; 
Vroeijensteijn, 1995) that cannot be easily applied operationally in an unambiguous way. For 
example, one can distinguish between cognitive and methodological quality (van Leeuwen, 
1996). Cognitive quality is concerned with the importance and, often, the originality of scientific 
findings. Methodological quality refers primarily to the accuracy with which specific methods are 
applied. Another example is the difference between scientific and societal quality. The concept of 
the scientific quality of research is based on the view of Merton (1973), who argues that the 
contribution to the growth of scientific knowledge is the final objective of science. Societal 
quality refers to the increased pressure on researchers to demonstrate user relevance and 
relationships with industry or utility (e.g. van der Meulen and Rip, 2000).  
Chapter two also presents empirical studies concerning group environment and research 
performance. It can be concluded that personal characteristics of group members, managerial 
control and contingencies affect research performance. To be productive, research groups must 
employ researchers with certain personal characteristics and researchers must also work in 
environments conducive to research. The empirical studies show both differences and similarities.  
The most important differences concern the study sample and the methodological approaches. 
First, a number of studies used a sample composed of excellent researchers and/or research 
groups, while other studies used a randomly selected sample of researchers and/or research 
groups. Another difference was the size of the sample, ranging from about 20 to 1300. Second, 
the methodological basis of the studies was different: some studies employed qualitative 
interviews, while other studies used a questionnaire-based collection procedure. Furthermore, the 
underlying theories and constructs used were different. Many personal characteristics and 
managerial control items identified in these empirical studies are also important in the general 
context of organisational behaviour and management theory. This observation was also noted by 
Bland and Ruffin in 1992 and just recently by Ryan (2003). There is a substantial body of 
management and organisation-development literature that points to the importance and influence 
of factors such as leadership, motivation, communication, culture and diversity in achieving 
performance (e.g. Martin, 1998; Moorhead and Griffin, 1998). However, since1980 these newer 
insights have hardly ever been applied to research management. Despite the identification of 
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personal and managerial factors related to research performance and the observation of the 
similarity to organisational variables (which are related to organisational performance), a general 
theoretical model explaining the relationship is still lacking. On the basis of the literature as 
described in section 2.3, the different factors, which influence research performance, can be 
grouped in three layers (see figure 3). The outermost layer shows contingency items. The second 
layer consists of managerial control items. The centre represents the individual level. Within this 
level, the personal characteristics of scientists that can contribute to research performance are 
placed. The variables, on both the individual and organisational levels, in determining research 
performance are numerous and complex. As observed by Ryan (2003), the possible 
interrelationships and interdependencies between them are yet to be examined. Most empirical 
studies that examined research performance concentrated on only one or a few research 
management activities, contingencies or personal scientist characteristics. Studies that have taken 
into account multiple research management activities in combination with a number of 
contingency variables are scarce. In the quantitative part of this thesis (chapter 6) an attempt has 
been made to clarify and provide some order for the many and complex variables presented in 
this chapter. 
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Figure 3: An overview of the variables at different levels influencing the research performance of 
groups. Please note that items marked with * are known in the literature as related to research 
performance but were not empirically investigated in this study. 
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CHAPTER 3: RESEARCH DESIGN 
 
The research reported in this thesis is both qualitative and quantitative and has been developed in 
various stages (see figure 8). The purpose of this chapter is to elaborate on and to account for the 
research design of the empirical study. It starts by outlining the overall design of the project. This 
is followed by a discussion of the various steps in the process and by an explanation of the 
methodology used for each of them. In sections 3.2 and 3.3 the series of semi-structured 
interviews and the survey are described in more detail. The instruments of data collection and 
methods of data analysis are described for each of the separate steps in both the qualitative and 
quantitative part of the study. The results of the empirical studies are presented in Chapters 4–6.  
 
 
3.1 Overall research design 
 
The purpose of this study was to gain more insight into evaluations used to assess academic 
medical and health research in the Netherlands and their effects. In more detail, five research 
questions have been formulated (see 1.4):  
 
 
 
 
 
 
 
 
 
 
 
 
 
On the basis of an analysis of the literature (see Chapter 2) and a preliminary investigation31 
consisting of fifteen open interviews with experts (Dutch professors in health and management 
research), research administrators of pharmaceutical industries, semi-government research 
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 The preliminary investigation was conducted in 1999 in order to explore the central topics of this study. 
1a. What different research evaluations are organised externally to assess Dutch medical and 
health research? 
1b. What different research evaluations are organised internally to assess Dutch medical and 
health research? 
2a. What is the impact of externally organised research evaluations on Dutch medical and health 
research? 
2b. What is the impact of internally organised research evaluations on Dutch medical and health 
research? 
3. Do research management activities and positive views or judgments about research 
management enhance the performance of Dutch para-clinical, pre-clinical and clinical research 
groups? 
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institutes and research schools, it was possible to formulate a research model (see Figure 4). This 
model represents the lines of reasoning most prominently formulated or found in earlier research. 
The model shows that both the environment and the internal organisation of research groups steer 
health research. Intermediary organisations, universities, research organisations and medical 
faculties fund, steer, control and, finally, enhance the performance of health research groups by 
using research evaluations in all phases of the research process. This ranges from the granting of 
research resources to the evaluation of research products and outcomes. In Figure 4 the 
relationship between the university and the medical faculty is presented as a dotted line. This does 
not mean that this relationship does not exist. The research model concentrates on the possible 
relations that are empirically investigated in this thesis, for example international research policy 
is not taken into account. 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Research model32 
 
From Chapter 2 the hypothesis can be made that the arrangement and use of management 
activities, such as rewards, research communication and research policy planning, by research 
leaders enhance the research performance of their groups (see Figure 5). Also the subjective 
views and judgements of research leaders about research management (for example, about such 
items as the importance of externally organised research evaluations) may enhance research 
group performance.  
                                                           
32
 Please note that the qualitative interviews were conducted in the period 2000-2001. Although most 
medical faculties were co-operating with university hospitals at that time, this arrangement was only 
formalised in Leiden (Leiden University Medical Center, LUMC), Utrecht (Utrecht Medical Center, UMC) 
and Amsterdam (Amsterdam Medical Centre, AMC). In this chapter the research evaluations that are 
internally organised on the level of the faculty and the medical centre (organisation level B) are only 
indicated, for convenience, by medical faculties. 
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Contingencies are factors that influence the previously mentioned elements and relationships 
among the elements. The size and the age of the research group are examples of contingencies. 
Contingencies may influence, for example, the choice of management activities and the extent to 
which they are implemented within research groups. Furthermore, contingencies may have a 
direct relationship with performance. The possible relationships among contingencies, managerial 
control and research performance are presented in Figure 5. 
 
 
 
                                                    
 
 
 
 
 
Figure 5: The internal organisation of research groups 
 
To answer the research questions, a mixed research design was used, i.e. a combination of 
qualitative and quantitative techniques. The qualitative part of the study consists of three series of 
semi-structured interviews with successive representatives of intermediary organisations, research 
administrators and research leaders of academic groups who are all active in the field of health 
research. In total, 30 semi-structured interviews were conducted. The quantitative study consists 
of a survey among 412 leaders (mainly senior researchers) of academic health research groups. 
Also, documents were analysed during all phases of the research project. For example, 
organisational documents such as annual reports, strategic plans and research policy plans 
provide a rich source of information. They include information about mission, organisation and 
operation, and research management including quality control. These documents usefully 
complemented the interviews with background information.  
Because the research was of an exploratory character, the study was organised in such a way that 
the first stages led to defining the research area further by finding out what is known about the 
topic and then developing more detailed questions about the topic for the main part of the 
empirical work. Two examples are given below to illustrate this further. The construction of the 
interview design of the series of semi-structured interviews (see Table 7), which started as early 
as 1999, is one example. As part of the development of the central research questions and the 
overall design, open interviews were held with experts (Dutch professors in health and 
management research), research administrators of pharmaceutical industries, semi-government 
research institutes and research schools. In the summer of 1999, the results of the preliminary 
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investigation were presented and discussed in a self-organised expert workshop in the 
Netherlands. Comments and suggestions from both interviewees and participants in the workshop 
were incorporated into the interview protocol that was eventually used in the series of semi-
structured interviews. Another example is the construction of the questionnaire (see Table 7). The 
second part of the interview protocol used in interviews with research leaders was unstructured. 
The material resulting from these interviews were used to develop and to design survey questions 
and their possible answer categories. In addition, the survey was pre-tested by a sample of eight 
health research group leaders. The next sections will describe the interviews and the survey in 
more detail.  
 
RESEARCH 
QUESTION 
METHOD EXPLANATION 
Preliminary investigation 15 open interviews with Dutch professors in health and 
management research, research administrators of 
pharmaceutical industries, semi-government research 
institutes and research schools 
Expert workshop Presentation and discussion of results of preliminary 
investigation  
7 semi-structured interview with representatives of 
intermediary organisations 
11 semi-structured research administrators of the eight 
medical faculties 
1a, 1b, 2a, 2b 
Semi-structured 
interviews 
12 semi-structured interviews with leaders of health 
research groups 
Open interviews 12 open interviews with leaders of health research groups 
Pre-tested on a sample of eight health research group 
leaders  
3 
Survey (questionnaire) 
Sent to 412 medical research groups  
 
Table 7: Steps in the research process 
 
 
3.2 Semi-structured interviews 
 
The main purposes of the interviews were to describe external and internal research evaluations 
(research question 1) that are commonly used in Dutch medical and health research and to 
explore their impact on research (research question 2). This section elaborates on the content of 
the interviews in relation to these purposes, selection of interviewees and the way in which the 
interviews were constructed, conducted and analysed.  
 
 
 
   62 
3.2.1 Intermediary organisations and research administrators 
 
In the period between February 2000 and May 2000, the first series of interviews were conducted. 
Seven representatives of intermediary organisations in health research, listed below, were 
interviewed (see appendix 3 for a detailed list of the actors interviewed): 
• Advisory Council on Health Research (RGO) 
• Netherlands Organisation for Health Care Research and Development Council (ZON) 
• Medical Sciences-Netherlands Organization for Scientific Research (NWO-MW) 
• Commission for the recognition of research schools (KNAW ECOS)  
• Association of Universities in the Netherlands, Council of Medical Faculties in the 
Netherlands (DMW-VSNU) 
• Royal Netherlands Academy of Arts and Sciences, Council for Medical Sciences (RMW) 
Klasen (2000) showed that these six intermediary organisations are the most important ones for 
funding and steering health research in the Netherlands. These organisations regularly meet each 
other in both formal and informal settings to gear their activities to each other, to discuss the 
strategies pursued and to make work appointments. The most important starting-point of these 
meetings is that the missions of the various intermediaries are both respected and monitored. 
When needed, these intermediaries will make further adjustments together with the Council for 
Public Health and Health Care, the Health Care Insurance Board and the Dutch Society of 
University Hospitals.  
Health research is conducted in the medical faculties of eight universities and in research 
institutes. The research administrators of the eight medical faculties were selected as interview 
partners33. Research administrators are not only involved in implementation processes of 
externally organised evaluations but also in the development and organisation of internal research 
evaluations. Research administrators of four research institutes active in health research were also 
interviewed. These research institutes were selected because they have clear similarities with 
medical faculties: not-for-profit organisations, participation in graduate health schools and strong 
connections with universities (for example, part-time appointments at universities). Between 
October 2000 and May 2001, a second series of 11 semi-structured interviews was conducted 
with research administrators working in medical faculties or research institutes (see Appendix D 
for a detailed list of interviewees).  
                                                           
33
 The research administrators were all willing to cooperate except for one. The internal evaluation protocol 
was reconsidered at the moment of investigation. Therefore, this medical centre decided not to participate 
in this study because the reconsideration processes had to be treated confidentially. 
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Both representatives of intermediary organisations and research administrators were questioned 
about their background, the mission of their organisation and the definition of the concept 
‘research quality’ used by their organisation. They were also questioned about the characteristics 
of the evaluation procedures internally used at that time, developments that had recently been 
implemented in evaluation procedures and alterations to the evaluation procedures that will take 
place in the near future. Finally, they were asked to reflect on the impact of the research 
evaluations used on medical and health groups. Annex 1 gives a detailed list of interview 
questions. 
 
 
3.2.2 Research leaders 
 
The semi-structured interviews with research managers showed that internal research evaluations 
are not only executed at the level of the faculty or research institute but also at the level of the 
research group. Therefore, leaders of health research groups were interviewed. Between January 
2001 and June 2001, twelve interviews with leaders of health research groups were conducted. 
The interviews consisted of two parts. The first part was semi-structured and conducted to gain 
insight, from the researchers’ point of view, into the use of internal research evaluations and the 
effects of both internal and external research evaluations (research questions 1 and 2). The second 
part of the interview was unstructured and was used in the preparation of the development and 
design of survey questions and their possible answer categories (research question 3).  
The interview partners were all experienced leaders of health research groups. In this thesis the 
definition of Andrews (Andrews, 1979b, p. 19) was used to define research groups. ‘For a group 
of individuals to be regarded as a research unit, it had to meet three criteria: (1) The group had 
to have at least one recognised leader who was significantly involved in its work. (2) The group 
had to include a total of at least three people (including the leader) who were significantly 
involved in its work, and each of these people had to have been a member of the group for at least 
half a year. (3) The group had to have an expected life span of at least one year’. 
To select a small subset of the total population of medical and health research groups in the 
Netherlands that are fairly representative of the whole population, three criteria were used. First 
of all, the organisational setting of the research groups was taken into account. The groups 
interviewed were all linked to a research institute or university. In each of the medical faculties 
and research institutes only one research leader was interviewed. Second, the various 
(sub)disciplines of health research were considered. The selected research groups represented the 
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following disciplines in health research: genetics, (public) health research, cardiovascular disease, 
neurosciences and oncology. Third, the variation in research quality of health groups was taken 
into account to make sure that not only good groups were reached but also less successful ones. 
For this purpose, the results of a national external research evaluation were taken into 
consideration. An international assessment committee (IAC) performed this national evaluation in 
1998. The IAC rated all health research on a 5-point scale, ranging from poor to excellent. The 
results of the evaluation were published in 1999. Annex 3 shows a detailed list of the persons 
interviewed. 
In the first part, the interview partners were asked about their background and about the mission 
and size of their research group. They were also asked about the characteristics of their research 
evaluation procedures used at that time and about the effects that these evaluations could have on 
their health research group. In the second part, they were asked to reflect on a list of management 
activities that could contribute to a group’s research quality. Annex 1 lists the interview questions 
and topics. 
 
 
3.2.3 Data collecting and processing 
 
The average length of the three series of semi-structured interviews was 90 min, ranging roughly 
from 45 to 200 min. The principal investigator interviewed all interview partners. The interview 
partners were invited by a letter containing a request to participate in the study, signed by both the 
researcher and her supervisors, and a background document to inform the interview partners 
about this PhD project and the aims of the interview. After a week the interview partners selected 
were called and interview appointments were made. A letter that contained an endorsement of the 
appointment and a review of the topics covered in the interviews were sent to the interview 
partners.  
It is important to note that the choice to conduct semi-structured interviews implies that 
interviews differ from each other. The actual interview depends heavily on the specific expertise 
of the interview partner. Although, in general, all interview partners were asked the same 
questions (except in the interviews with research leaders, the question about management 
activities was added), the order of the questions and the importance of the topics differed. The 
interviews were not transcribed literally. A factual representation of the statements was sent to the 
respondents to correct possible misunderstandings. Finally, for each interview any 
misunderstandings were corrected and extremely confidential information was excluded. Some of 
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the conclusions drawn in this thesis are illustrated by interview quotes. All interviews were 
originally in Dutch. The quotations in this thesis were translated as literally as possible. 
 
 
3.3 Survey study 
 
The third research question I would like to answer is: ‘Do research management activities and 
positive views or judgments about research management enhance the performance of Dutch para-
clinical, pre-clinical and clinical research groups?’ In order to investigate this research question a 
questionnaire was developed. This section first elaborates on the content of the questionnaire and 
then focuses on the way it was constructed, conducted and analysed. 
 
 
3.3.1 Content 
 
The survey comprised 49 questions, some of which were subdivided into a number of separate 
statements. It was divided into six parts (see Annex 4 for the complete list of survey questions). It 
concentrated successively on general questions about the respondent (part I), general questions 
about the research group (part II), research funding (part III), research management activities 
(part IV), internal research evaluations (part V) and external research evaluations (part VI).  
 
 
3.3.1.1 Contingency factors 
 
Parts I and II of the questionnaire form operational measures for the contingency factors such as 
‘size’, time allocation’ and ‘age’ (see Table 8).  
- ‘Size’ of a research group was measured as the number of scientific and technical staff 
working in the research group in 2002, in full-time equivalents.  
- ‘Work setting’ was measured by asking whether the research leaders worked in a university 
setting or in a non-university research institute. 
- ‘Time allocation’ was measured on a 6-point response format (1 = 1–10%; 2 = 11–20%; 3 = 
21–30%, 4 = 31–40%; 5 = 41–50%; 6 = 51–100). Time was measured as percentage of the 
total working time allocated by research group leaders in 2002 to research, education, patient 
care and supervision.  
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- ‘Age’ was measured in four different ways: ‘research experience’ measured as the number of 
years of research experience of the research group leader; ‘management experience’ 
measured as the number of years during which the research group leader had a management 
function; ‘foreign experience’ measured as the number of years the research group leader had 
worked in foreign research groups; ‘supervising experience’ measured as the number of years 
the current research group leader had been supervising the research group. 
 
DEFINED CONCEPTS EMPIRICAL CONCEPTS SURVEY 
Size Staff under leadership of research leader Question 6b 
Work Setting Working in a university or non-
university research institute 
Question 3 
Time allocation Research 
Education 
Patient care/clinical practice 
Supervision of PhD students 
Question 10ba 
Question 10bb 
Question 10bc 
Question 10bd 
Age Research experience 
Management experience 
Foreign experience 
Supervising experience 
Question 2b 
Question 2d 
Question 2c 
Question 4d 
 
Table 8: Overview of the operational measures for contingencies 
 
 
3.3.1.2 Managerial control  
 
In this study managerial control of medical and health research groups is considered to be a 
composite of internal and external control. The focus is on internal control, which refers to 
control over personnel, resources and research processes. However, some elements of external 
control, such as communication with research group and environment, are included. In this study 
the subjective views and judgements of research leaders about research management (for 
example, about such items as the perceived importance of externally organised research 
evaluations) are combined with more objective measures such as the organisation of research 
evaluations. Operational measures for research management were developed from the fourth and 
fifth parts of the survey (see Table 9).  
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DEFINED CONCEPTS 
LEVEL 1 
DEFINED CONCEPTS  
LEVEL 2 
Resource control 
Research commitment 
Time spent on internal managerial control 
Communication 
Rewards 
Research policy planning 
Internal organisation of research evaluations 
Effectiveness of pre-evaluation of research proposals 
Internal control 
Importance of internally organised research evaluations 
Time spent on external research activities 
Time spent on external managerial control 
Importance of externally organised research evaluations 
External control 
Importance of collaboration 
 
Table 9: Defined concepts that together constitute the construct of research management  
 
Internal control 
- ‘Resource control’ was measured on a 5-point response format (ranging from ‘1 = always 
short of resources’ to ‘5 = never short of resources’). It refers to the subjective assessment of 
the adequacy of personnel resources (laboratory technicians, PhD students and research staff 
with a PhD degree) in 2002 to reach the goals and objectives of the research group. 
- ‘Research commitment’ was measured on a 5-point response format (ranging from ‘1 = 
disagree entirely’ to ‘5 = agree entirely’). It refers to the subjective assessment of the research 
group leaders’ commitment to research conducted by their research group (12 items). One 
example is ‘I’m intensively involved in at least one research project conducted within my 
research group’.    
-  ‘Time spent on internal managerial control’ was measured on a 6-point response format (1 = 
1–10%; 2 = 11–20%; 3 = 21–30%, 4 = 31–40%; 5 = 41–50%; 6 = 51–100). It refers to the 
amount of time (measured as percentage of total working time) research group leaders 
allocated in 2002 to internal management activities. 
- Communication 
‘Research process communication’ was measured by the frequency of research meetings 
within the research group. Four different research meetings were distinguished: (1) progress 
meetings of current research projects; (2) research presentations; (3) discussions about 
(conference) papers; and (4) discussions about research proposals. The scale items used a 5-
point scale with anchors of 1 = never and 5 = once a week. 
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‘Direct communication’ was measured as a percentage of total communication. It relates to 
the frequency with which research group leaders used e-mail, telephone and personal talks to 
communicate with their research staff. 
- ‘Rewards’ were measured on 3-point response formats (1 = not used; 2 = used to a minor 
degree; 3 = used to a larger degree). This is a subjective assessment of the extent to which 
rewards are used to motivate staff. Four different kinds of rewards were measured:  
-‘development of research skills’ (= possibility to take national and international courses, 
to attend national and international conferences, to gain experience in foreign research 
groups, to supervise MSc and PhD students);  
-‘flexibility’ (= possibility to have flexible working hours and to work at home); 
-‘special commendations’; 
-‘financial bonus system’. 
- ‘Research policy planning’ was measured on a dichotomous response format with categories 
‘no’ (coded 0) and ‘yes’ (coded 1). Research group leaders were asked to indicate if they 
organised discussion meetings about the research policy of their own research groups.  
- ‘Internal organisation of research evaluations’ was measured on a dichotomous response 
format with categories ‘no’ (coded 0) and ‘yes’ (coded 1). Internally organised research 
evaluations could take place on different levels. In the survey three levels were distinguished: 
research group/department, medical faculty, and university/non-university research institute. 
Research group leaders were asked to indicate whether ‘job evaluations’, ‘pre-evaluation of 
research proposals’ (evaluation before proposals are submitted to external funding agencies) 
and ‘evaluation of research output’ were internally organised on different organisational 
levels. Additional questions about the goals of internally organised evaluations, the frequency 
with which these evaluations take place, criteria used and the staff who carry out the internal 
evaluations were asked. These questions were analysed and are described in Chapter 5 
because they form a part of the first research question. 
- ‘Importance of internally organised research evaluations’ was measured on a 5-point 
response format (ranging from 1 = worthless to 5 = very useful). This is a subjective 
assessment of the usefulness of evaluation results and recommendations as well as the 
incorporation of evaluation results and recommendations.  
 
Table 10 gives an overview of the defined and the empirical concepts that together constitute the 
construct of internal control. 
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DEFINED CONCEPTS EMPIRICAL CONCEPTS SURVEY 
Resource control Personnel 
Equipment 
Research material 
Data processing 
Library service 
Laboratory space 
Question 20  
Question 30 (1) 
Question 30 (2) 
Question 30 (3) 
Question 30 (4) 
Question 30 (5) 
Research commitment Research commitment Question 11 
Time spent on internal managerial 
control 
Time allocated to internal management 
activities 
Question 10b 
Communication Research process communication 
Direct communication 
Question 26 
Questions 28a, 28b, 
28e and 28f 
Rewards Development of research skills 
Flexibility 
Special commendations 
Financial bonus system 
Question 22a (1-4) 
Question 22a (6-7) 
Question 22a (8) 
Question 22a (5) 
Research policy planning Research policy planning Question 29a 
Job evaluation Question 23 
Pre-evaluation of research proposals 
Level of research group/department 
Level of medical faculty 
Level of university/non-university institute 
Question 33a 
Question 33a 
Question 33a 
Question 33a 
Internal organisation of research 
evaluations 
Evaluation of research output 
Level of research group/department 
Level of medical faculty 
Level of university/non-university institute 
Question 36 
Question 36 
Question 36 
Question 36 
Effectiveness of pre-evaluation of 
research proposals 
Effectiveness of pre-evaluation of research 
proposals 
Question 35 
Importance of internally organised 
research evaluations 
Internally organised research evaluations Questions 41 and 42 
 
Table 10: Overview of the defined and the empirical concepts that together constitute the 
construct of internal control 
 
External control 
- ‘Time spent on external research activities’ was measured on a 6-point scale (1 = none; 2 = 
1–10 days; 3 = 11–20 days; 4 = 21–30 days; 5 = 31–40 days; 5 = 41–50 days; 6 = more than 
50 days). It refers to the amount of time that research group leaders allocated (in 2002) to: (1) 
presentation of lectures, (2) attendance of conferences, (3) organisation of conferences, (4) 
participation in editorial boards of journals, (5) participation in audit committees, and (6) 
participation in assessment committees. 
- ‘Time spent on external managerial control’ was measured on a 6-point response format (1 = 
1–10%; 2 = 11–20%; 3 = 21–30%, 4 = 31–40%; 5 = 41–50%; 6 = 51–100. It refers to the 
amount of time (measured as a percentage of total working time) research group leaders 
allocated in 2002 to external management activities. 
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- ‘Importance of externally organised research evaluations’ was measured on a 5-point 
response format (ranging from 1 = worthless to 5 = very useful). This is a subjective 
assessment of the usefulness of evaluation results and recommendations as well as the 
incorporation of evaluation results and recommendations. ‘DAG 1998 evaluation’ and 
‘research school evaluations’ were distinguished.   
- ‘Importance of collaboration’ is a subjective assessment. The importance of collaboration 
with ‘international and national research groups’, ‘ministries and semi-governmental 
organisations’, ‘pharmaceutical industries and firms’, ‘medical clinics’ and  ‘family doctors’ 
was specified. For all items a 10-point scale was used with marks ranging from 1 to 10. 
Table 11 gives an overview of defined and empirical concepts that together constitute the 
construct of external control. 
 
DEFINED CONCEPTS EMPIRICAL CONCEPTS SURVEY 
Time spent on external research 
activities  
Time allocated to external research activities Question 31 
Time spent on external managerial 
control 
Time allocated to external management 
activities 
Question 10be 
Question 10bf 
Importance of externally organised 
research evaluations 
DAG evaluation 1998 
Research school evaluations 
Questions 47a , 47c 
Questions 47b, 47d 
Importance of collaboration Research groups 
Ministries and semi-government 
organisations 
Pharmaceutical industries and firms 
Medical clinics 
Family doctors 
Question 32a 1-3 
Question 32a 4+9 
 
Question 32a 5+6 
Question 32a 7 
Question 32a 8 
 
Table 11: Overview of the defined and empirical concepts that together constitute the construct of 
external control 
 
 
3.3.1.3 Research performance 
 
In the survey study six measures were used to indicate research group performance. Although 
there are technical and methodological problems in using an indicator for gathering and handling 
data, the simultaneous use of various measures gives a good description of research group 
performance. Two operational measures for research performance were developed from part III 
and part IV of the survey. The remaining performance measures were derived from public 
sources. The performance measures can be divided into two broad groups: input and output 
measures (see Table 12 for an overview).  
   71
Research output measurements 
- ‘Number of SCI publications‘ 
A computer search was carried out to count the numbers of publications attributed to each of 
the (371) research group leaders on the basis of the ISI database (Web of Science). To avoid 
misinterpretation, the family name and the initials of the research group leader were 
combined with the name of the city where the research group was located. The number of 
papers (normal articles, letters to the editors, notes, reviews) was counted in which the 
research group leader was a (co-) author and which were published in international scientific 
journals entered in the SCI in 1999, 2000 and 2001. 
A problem with publication counts is that publication traditions vary among medical sub-
disciplines, e.g. Omta (1995). Whereas in some disciplines a publication in international SCI 
journals is the most common way of transferring scientific knowledge, in other disciplines 
this is often thought to be a publication in Dutch or in non-SCI journals or books. Another 
problem is the difference in publication strategy between different research groups within a 
medical sub-discipline. Whereas in some groups the research strategy is to get articles 
published only in prestigious international SCI journals (journals with a high impact factor, 
the average number of citations in the journal, depending on the discipline), in other groups 
the strategy is to get as many articles published as possible.   
- ‘DAG score 1998’  
The primary purpose of the Discipline Report on medical and Health Sciences Research 1998 
(called DAG 1998) is to provide quality judgements of medical and health sciences in the 
Netherlands. Research at all Faculties of Medicine and/or Health Sciences and most non-
university research institutes in this field in the Netherlands during the years 1992–1996 was 
evaluated. An IAC evaluated health research on the level of main research themes. An overall 
quality assessment was given for each main research theme, on a five-point scale, ranging 
from 1 (poor) to 5 (excellent). In the survey respondents were asked to write down the overall 
quality score of the research theme to which their group belonged. 
 
Research input measurement 
- ‘External research funding’ 
To obtain comparable data about research funding that groups received from external sources, 
research group leaders were asked to give an estimate of the percentage of research funding 
(in 2002) obtained from:  
- The Netherlands Organization for Scientific Research (NWO); 
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- The Netherlands Organization for Health Research and Development; 
- The Royal Academy of Arts and Sciences; 
- Dutch ministries; 
- Charity funds 
- Pharmaceutical industries and firms; 
- International funds. 
- ‘Number of research proposals submitted for NWO grants’ 
The NWO promotes scientific research at Dutch universities and research institutes and seeks 
to raise the quality of that research. The NWO is committed to ensuring that the level of the 
research carried out in the Netherlands is and remains among the highest in the world. NWO 
research funding is allocated through a stringent selection process based on the quality of the 
research proposals submitted, as well as through the provision of support to individual 
researchers (www.nwo.nl). In this study, the number of research proposals submitted and 
accepted in competition for NWO grants in the period 1999–2001 was counted for each of the 
respondents. A submitted research proposal was rated as valid when:  
(1) the name of the research group leader was mentioned in the research proposal as the 
main applicant, fellow applicant, research leader or researcher; 
(2) the research proposal was entered in Delphi, the electronic database of the NWO. 
- ‘Number of research proposals submitted for MW-NWO grants’   
- ‘Number of MW-NWO grants received’ 
Medical Sciences34 is one of the research departments of the NWO. The number of research 
proposals submitted and accepted in competition for MW-NWO grants over the period 1999–
2001 was counted for every respondent. Also the number of MW-NWO grants received in 
that period was counted for every respondent. Both the research proposals submitted and the 
research grants received were rated as valid if:  
(1) the name of the research group leader was mentioned in the research proposal as 
‘main applicant’, ‘fellow applicant’, ‘research leader’ or ‘researcher’; 
(2) the requested or received grant belonged to one of the following research 
programmes that are supported by the MW-NWO: fellowships, research supports, 
research programmes, clinical research training grants, PIONIER grants (a Dutch 
                                                           
34
 In 2001 the Health Research and Development Council (ZON) and the Medical Sciences of the 
Netherlands Organization for Scientific Research (MW-NWO) merged. In this study the number of 
proposals submitted for ZON grants and the number of ZON grants received are not taken into account. 
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abbreviation for Personal Impulse for Research Groups with New Ideas for Excellent 
Research), equipment grants, clinical research, and programmed research (e.g. 
nutrition and chronic diseases, memory and dementia)  
(3) the grant received was entered in Delfi, the electronic database of the NWO. 
- ‘NWO rating’ 
The rating of the research group leaders approached was measured by means of the electronic 
database of the NWO, called Delfi. Rating was expressed on a 4-point scale; higher values 
indicate a more positive judgement (higher rating). Research leaders obtained the highest 
rating (score 4) when they were registered both as reviewer and receiver of grants from MW-
NWO and/or NWO. Score 3 was given to research leaders who were registered as a reviewer 
as well as an applicant for a research proposal(s). Score 2 was given to research leaders who 
were registered as a reviewer but never had submitted a research proposal to the NWO. The 
lowest rating (score 1) was given to research leaders whose name was not recognised in the 
Delfi database. 
 
DEFINED 
CONCEPTS 
EMPERICAL CONCEPTS SURVEY 
 
Research output  Number of SCI publications (period 1999–2001) 
DAG score1998 
Not self-reported 
Question 44 
Research input Percentage of external research funding  
Number of submitted research proposals for NWO grants 
Number of submitted research proposals for MW-NWO 
grants (period 1999–2001) 
Number of MW-NWO grants received (period 1999–2001) 
NWO rating 
Question 14 
Not self-reported 
Not self-reported 
 
Not self-reported 
Not self-reported 
 
Table 12: Overview of operational measures for research performance 
 
Most of the questions were closed. Closed questions can be answered by simple checking a box 
or circling the proper response from a set provided by the researcher (Fowler, 1993). An 
advantage of closed questions is that they facilitate the efficient comparison of respondents.  
For most of the items a 5-point response format was used. A limited number of items were 
assessed with 2- and 3-point response formats (with the options ‘yes’, ‘no’ or ‘do not know’). 
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3.3.2 Process 
 
The survey was conducted in the winter of 2002. As described in section 3.1, it was constructed 
on the basis of interviews with twelve experienced research leaders and on a literature review. 
The questionnaire was composed with the assistance of survey experts and was pre-tested on a 
sample of eight health research group leaders from five different universities and three research 
institutes. According to Converse and Presser (1986), pre-tests can be used to test the variation, 
meaning, task difficulty as well as respondents’ interest and attention of specific questions. Pre-
testing can also be used to improve the questionnaire as a whole, for example, testing the ‘flow’ 
and naturalness of the sections, the order of questions, skip patterns and timing (Converse and 
Presser, 1986). The comments and suggestions of the pre-testers, on both individual questions and 
the questionnaire as a whole, were used to construct the final version of the questionnaire. 
The questionnaire was sent to research groups in medical faculties of the eight Dutch universities 
and four health research institutes. These medical faculties and health research institutes were 
selected because, on an organisational level, these faculties and institutes were already 
participating in this study (by participating in the semi-structured interviews). Names and 
addresses of research groups and their leaders were obtained from research managers of the 
medical faculties and health research institutes after the semi-structured interviews had been 
conducted. The lists of names and addresses were checked in the Dutch Research Database 
(Nederlandse Onderzoek Databank, NOD) and in PUBMED. NOD contains information on 
current research projects, researchers and research institutes. PUBMED is the National Library of 
Medicine’s search service. A total of 412 medical and health research groups were approached.  
The respondents answered self-administered questions. Fowler (1993) argues that the choice of a 
self-administered questionnaire means the choice of closed questions. With no interviewer 
present to probe incomplete answers for clarity and for meeting consistent question objectives, 
the answers to open questions will not be comparable across respondents, and they will be 
difficult to code. There are some questions in the survey that ask about events and behaviours that 
are difficult to report with accuracy. In that case, self-administered procedures have an advantage 
over interviews because they provide more time for thought, for checking records (Fowler, 1993) 
and for discussions with research group members.  
The questionnaire was mailed to the research leaders of the groups (mainly professors). A mail 
strategy was chosen to collect the data because of the relatively low costs (time and money). 
Furthermore, it provides access to widely dispersed samples and samples that are difficult to 
reach by phone or in person (Fowler, 1993). 
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In order to achieve a response rate as high as possible, Dillman’s tailored design method 
(Dillmas, 2000) was used. Dillman points out that five elements are needed for achieving a high 
response rate:  
1. a response-friendly questionnaire; 
2. up to five contacts with the questionnaire recipient; 
3. inclusion of stamped return envelopes; 
4. personalised correspondence; 
5. a token financial incentive that is sent with the survey. 
During pre-testing the eight pre-testers were asked to indicate whether the questionnaire was 
sufficiently response-friendly. This resulted in adaptations to the format and physical size of the 
questionnaire. The questionnaire was sent together with a personalised cover letter (explaining 
research goals and approach) and a stamped return envelope. In most cases (263, 64%) a letter of 
recommendation, advising the research leader to participate in this study, written and signed by 
research administrators of the medical faculties and research institutes, was sent together with the 
initial mailing. After the initial mailing, three series of follow-up mailings were sent to the 
research leaders. Two weeks after the initial mailing the entire sample received a reminder. A 
new questionnaire and a covering letter were sent to all non-respondents four weeks after the 
initial mailing. The remaining non-respondents received, seven weeks after the initial mailing, a 
personal e-mail containing a reminder and the questionnaire.  
Due to budgetary restraints it was decided not to give financial incentives to the respondents.  
 
 
3.3.3 Methods of data analysis 
 
The survey data were entered in SPSS version 10. The quantitative data were subjected to 
different statistical analyses, such as descriptive statistics, bivariate and multivariate analysis. The 
bivariate procedures included t-tests, one-way analysis of variance (ANOVA), Kruskal-Wallis 
tests and Pearson correlations. The multivariate procedures included factor analysis and multiple 
regression analysis. The results as well as the specific operations on the data are described in 
Chapters 4, 5 and 6. 
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3.3.4 Reliability of the instruments 
 
Cronbach’s α was calculated for the individual subscales in order to find out whether they 
corresponded with the variables defined and to check the homogeneity, which were supposed to 
measure a single concept. Table 13 shows that in most of the cases (90%), Cronbach’s α is 
sufficiently high (>0.60) to warrant confidence in the internal consistency of the scales. It should 
be noted that the variable ‘research process communication’ did not reach the threshold of 
α>0.60. However, every item of the scale had item-total correlations higher than 0.30, so it was 
decided to include this variable in the analysis of the results. In 1980, Nunnally recommended a 
standard of 0.70 as a satisfactory level of internal consistency.  
It can be concluded that the level of Cronbach’s α is sufficient to provide confidence in the 
reliability of the operationalisation of research management activities and subjective views and 
judgements about research management. 
 
 
RESEARCH MANAGEMENT 
ACTIVITIES 
NUMBER OF ITEMS CRONBACH’S α 
Research commitment 9 0.81 
Reward system: development of skills 4 0.60 
Reward system: flexibility 2 0.65 
Adequacy of human resources 3 0.78 
Research process communication 4 0.53 
Direct communication 3 0.63 
Time allocation of external research activities 6 0.73 
Importance of DAG assessment 7 0.85 
Importance of research school assessment 2 0.83 
Importance of internal research assessments 2 0.79 
 
Table 13: Consistency of the empirical concepts of management activities 
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CHAPTER 4: EXTERNALLY ORGANISED MEDICAL AND HEALTH 
RESEARCH EVALUATIONS AND IMPLICATIONS 
 
In competition and decisions about appointments, promotion, tenure positions, allocation of 
research funding and publication of papers, evaluation of research is crucial throughout the 
scientific career of researchers and for the survival of research groups, departments, faculties and 
institutes. The purpose of this chapter is twofold. First, it gives an overview of externally 
organized evaluations that are frequently used to assess medical and health research quality in the 
Netherlands. Second, this chapter explores the possible effects of these externally organised 
evaluations on research groups35. The evaluation practices organised by intermediary 
organisations to assess Dutch medical and health research are described in section 4.1. Next, the 
most important recent changes in the Dutch externally organised evaluation system are described 
and discussed in section 4.2. The last section (4.3) describes the implications of these externally 
organised evaluation procedures and evaluation outcomes on research groups and research leaders. 
This chapter is mainly based on semi-structured interviews. Representatives of intermediary 
organisations, research managers in medical faculties and non-university research institutes and 
medical and health research leaders were interviewed. Also, official policy documents and 
discussion papers are accounted for in this chapter. In a few subsections statements are supported 
by survey data.  
 
 
4.1 Intermediary organisations 
 
Intermediary organisations are part of the research system that mediates between the interests of 
the government and the public on the one hand and the ongoing scientific work and its 
institutional arrangements on the other (e.g. Rip, 1990; van der Meulen and Rip, 1994). Examples 
of this are: research funding organisations, advisory bodies, standing review panels and 
associations of research-performing institutes. These intermediaries are also called ‘buffer 
organisations’ or ‘buffers’ (Fenger, 1992). The intermediary level has grown in size and 
                                                           
35
 Parts of this chapter have been published in Dutch (van der Weijden, Groenewegen and Klasen, 2001; 
2002). See the research article ‘Van beoordelingslast naar beoordelingslust? Vermindering belasting voor 
gezondheidsonderzoekers door externe beoordelingsystemen? [From troublesome evaluation to a 
pleasurable task? Reducing the burden for medical and health researchers by means of externally organised 
evaluation systems?] and an extensive Dutch research report ‘Intermediare organisaties in het 
gezondheidsonderzoek’ [Intermediary organisations in health research]. 
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complexity, and in importance since 1945 (van der Meulen and Rip, 1994). Rip (1999b) argues 
that the occurrence of the intermediary layer of institutions between the national state and 
research-performing institutions is an important aspect of the modern research system. The 
intermediary layer is made up, to a large extent, of research funding organizations. These 
organisations (a composite organization or a cluster of organizations) allocate public funds for 
basic and strategic research which do not go to universities immediately, and which involve the 
research communities themselves in the allocation proces (OECD, 1992; van der Meulen and Rip, 
1994). They are both ‘parliaments of the scientific community’ and ‘governmental bureaucracies’ 
(Williamson in OECD, 1992) and responsive to bottom-up and top-down pressures and policies, 
receiving and transmitting in both directions (van der Meulen and Rip, 1994). During the last few 
decades, the environment of the research funding organisations has become more complex. In the 
literature scholars speak of the ‘transition of the research system’ (Cozzens et al., 1990). As 
already touched upon in Chapter 1, research funding organisations must relate to the changing 
character of the production of knowledge (see 1.3). Furthermore, public and governments become 
more directive, and exert pressure to receive value for money. Research funding organisations are 
no longer alone in the intermediary level between the state and the researchers. Not only do new 
strategic programmes for science and technology (with increasingly frequent cross-links with 
research funding organisaitons) operate at the intermediary level, trying to attract good research. 
Universities, also, apart from influencing their own researchers, have become more active as 
institutions and have moved into the market of strategic research (Rip, 1999b). Van der Meulen 
and Rip (1994) mentioned the ongoing trends towards co-funding arrangements as an example of 
complexity and transition. In addition, international funding possibilities are gradually becoming 
more important for (national) scientific research. For example, the involvement in EU research 
programmes has been the most significant trend of internationalisation in research during the 
second half of the 1990s (Husso, Karjaleinen and Parkkari, 2000). In the Netherlands, the 
Innovation Platform is the most recent actor operating at the intermediary level of the research 
system. It all started with the European summit in Lisbon in 2000 where the European leaders 
defined a new mission for Europe: to become the most competitive and dynamic knowledge 
economy in the world. The mission of the Innovation Platform is to strengthen the innovative 
capacity of the Dutch economy and to turn the Netherlands into a leading country in the European 
knowledge economy by 2010. The Innovation Platform was installed by Royal Decree for a 
three-and-a-half year period, from 1 January 2004 to 1 July 2007. By means of the platform the 
Prime Minister works together with the Minister for Economic Affairs, the Minister for Education 
and 15 leaders from business, academia and society. Together they build bridges between the 
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different actors involved in improving the innovation climate of the Netherlands, and help them 
to take action (for more detailed information see http://www.innovatieplatform.nl).  
In their decision making about the allocation of and accountability for money to researchers and 
research groups for example, intermediaries organise evaluations. Their final decisions are based 
on the results of these evaluations. Several intermediary organisations are operating in the Dutch 
medical and health research field. In this chapter the features of evaluation procedures (goals, 
methods, criteria) organised by five intermediary organisations are described:   
• Governmental research advice and recommendations given by the Advisory Council on 
Health Research (4.1.1) 
• Evaluation of research proposals organised by the Netherlands Organization for Health 
Research and Development (4.1.2) 
• National evaluation of research output organised by the Council for Medical Sciences of the 
Royal Netherlands Academy of Arts and Sciences (4.1.3) and the Disciplinary Board of 
Medical Sciences of the Association of Universities (4.1.4) 
• Evaluation of research schools organised by the Research School Accreditation Committee 
(4.1.5) 
Prior to the description of each evaluation procedure, the goals and roles of intermediary 
organisation(s) involved in the evaluation procedure are presented. 
 
 
4.1.1 Advisory Council on Health Research  
 
The Advisory Council on Health Research, established in 1987 by law, is a sector council and a 
part of the so-called cooperating sector councils (COS). The RGO advises the government, 
especially the Ministry of Education, Culture and Science, the Ministry of Economic Affairs, and 
the Ministry of Health, Welfare and Sports, on setting priorities for health research and 
technology development in the health sector36. Also recommendations are given in infrastructural 
matters. The task is to gear health research to social needs by means of a close interaction 
between government, scientists and end-users of health research. To prepare its advice, the RGO 
appoints committees in which members of the scientific community (the suppliers) and the end-
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 For more information see http://www.rgo.nl/en/ 
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users of health research (patients and industry) are represented. Usually members of the RGO37 as 
well as non-member experts (researchers and representatives of both patient organisations and 
National Health Services) participate in these committees. The advice of the RGO, presented in 
report, is formulated after an exploration of the field of interest. The analysis of a social health 
problem, the needs and the scientific research requirements and possibilities are listed after 
studying the specific research by reading relevant literature and interviewing researchers. In 
addition, the RGO frequently organises symposia to keep in touch with researchers and 
physicians and to identify issues that are important for both parties. As part of the exploration of 
the field, the committee also studies the outcomes of external input and output research 
evaluations based on peer-reviewed papers and/or bibliometric analyses reports). The results of 
such an exploration are discussed in the committee, after which an advisory report is formulated. 
The recommendations are discussed by the board of the RGO and presented to the government. 
The government decides whether and how recommendations are adopted. In general, the advisory 
reports result in the development of specific research programmes or infrastructural support38, 
which should be commissioned by other intermediary organisations (for example, the Netherlands 
Organization for Health Research and Development). One example, mentioned by one of the 
respondents, is research in the area of chronic diseases: ‘In the beginning of the 1990s, RGO 
investigated the area of chronic diseases, such as rheumatoid arthritis, chronic non-specific lung 
disease and diabetes, and recommended the stimulation of scientific research of chronic diseases. 
This resulted in liquid capital of 40 million Dutch guilders’. Another example are the 'Brede 
analyse gezondheidsonderzoek (BAGO) advices in 1994 that have had great impact on the 
steering and funding of Dutch medical and health research. The establishment of ZonMw, in 
order to improve and strengthen the relationship between research and clinical practice, is a direct 
implication of the BAGO advices.  
The work load for individual medical and health researchers is restricted. Occasionally  when an 
advisory report is being prepared in their research area, researchers may be asked to deliver data 
(to respond to a questionnaire or to participate in a symposium) and/or to participate in the 
advisory committee. The RGO has influence in the field structure and conditions, and sometimes 
also on the distribution between specialties. Of the various intermediaries studied, it is the most 
distant organisation from the perspective of research groups and scientists. 
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 The RGO has 15 advisory members with a wide range of expertise, including representatives of research 
organisations, ministries and intermediary organisations (Raad voor gezondheidsonderzoek, unknown). 
38
 For an overview of the advisory reports and their impact on the medical research field, see (Raad voor 
gezondheidsonderzoek, 2000a; 2000b)  
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4.1.2 The Netherlands Organization for Health Research and Development  
The Netherlands Organization for Health Research and Development 39 is the national funding 
body responsible for promotion and innovation of health research, ranging from basic, strategic 
and applied research to health care (the ‘knowledge continuum’). ZonMw also supports the 
transfer and implementation of knowledge, ensuring that knowledge is exchanged between all 
relevant stakeholders (researchers, professionals, patients/consumers and the general public). 
ZonMw is responsible for the allocation of resources to health research and development coming 
from the Ministry of Health, Welfare and Sports and from the Netherlands Organization for 
Scientific Research. 
Resources are distributed in two categories of national programmes40. Science-driven research is 
stimulated by open research programmes, which are open to applications involving health 
research irrespective of medical discipline. The approach is mainly tailored to talented individual 
researchers or high-ranking research groups. The main indicator in the evaluation procedure is 
scientific quality of both the applicant(s) (individual researcher or research group) and the 
proposal. Restricted programmes provide financial resources for research on specific issues, 
where the interaction between research, policy and/or practice is needed to address health and 
health care questions in order to improve and provide innovation in health care practices 
(http://www.zonmw.nl). This approach is oriented towards trans-disciplinary collaboration 
between scientists and practitioners. Indicators used in the evaluation procedure are scientific 
quality and the relevance of research proposals (their merit in relation to defined targets of the 
particular programme). Both indicators are of equal importance. The programmes use the 
responsive mode, the managed mode, or a mix of both (http://www.zonmw.nl). In the responsive 
mode, researchers themselves define topics, which, in their opinion, are relevant to the general 
objectives of the programme. By publishing a call for proposals (for example in Mediator, the 
magazine of ZonMw and Federation of Biomedical Scientific Societies -FMWV-). ZonMw 
invites researchers and organisations to submit proposals. In the managed mode, researchers 
regarded as the most capable of achieving the programme objectives are approached, for example 
by sending out a restricted call for proposals to a selected group or giving a direct research 
assignment.  
An evaluation of the brief outline of the research proposal (also called pre-evaluation) is often the 
first step in both the open and the restricted programme (see box 4). The pre-evaluation of the 
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 ZonMw was established in 2001 from a merger between ZorgOnderzoek Nederland and the Medical 
Sciences of the Netherlands Organization for Scientific Research.  
40
 For more information see http://www.zonmw.nl 
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outline of proposals as well as the final evaluation of detailed proposals are done by peer review 
(individuals and panels being members of the division board). Individual peers write down their 
comments and rate specific aspects (criteria) on a scale. Peers evaluate anonymously, with their 
names being only available to members of the division board or programme committee. The 
applicants have the opportunity to react to the judgements of reviewers. The peer evaluations and 
the reply of the applicant result in priority-setting and the selection of proposals that should 
receive grants. ZonMw-funded research projects are further evaluated twice: halfway into (mid-
term evaluation) and at the end of the funding period (final evaluation). Box 4 presents more 
detailed information about the evaluation objects, criteria, peers and evaluation outcomes in 
different phases of research projects. In addition, ZonMw (both open and restricted) programmes 
are evaluated. A mid-term evaluation, which is organised by the programme secretary, is focused 
on the processes within a programme. The scientific results of the programme are assessed within 
a final evaluation of the entire programme. International evaluation committees sometimes 
organise these final evaluations. 
 
 
4.1.3 Association of Universities  
 
The Association of Universities promotes the interests of the fourteen Dutch universities to 
political, governmental and community organisations. The principal goal is to strengthen the 
position of university education and research in society. Furthermore, the VSNU is an employers’ 
association and develops service activities for universities (http://www.vsnu.nl). Since 1993, 
VSNU has been organising external quality assurance41. Review committees set up by VSNU 
screen all study programmes at all Dutch universities, make a public report of their findings and 
submit recommendations. With regard to evaluation of medical and health research42, the 
Disciplinary Board of the Medical Sciences of VSNU has been cooperating closely, particularly 
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 The activities of the Quality Assurance department of the VSNU were taken over by Quality Assurance 
Netherlands Universities (QANU) in 2004. QANU works independently of universities, within the 
statutory framework set up for the assessment, accreditation and funding of university education and 
research in the Netherlands. 
42
 Since autumn 2004, the Netherlands Federation of University Medical Centers (NFU) has been 
responsible for the mutual collaboration and policy tuning among the eight medical centres. In that respect 
a bibliometric analysis of Dutch medical and health research was made in 2004 by the Centre for Science 
and Technology Studies (CWTS). Results have also been compared (‘benchmark’) with international 
standards for medical and health research. In addition, an international committee evaluated research 
management of the medical centres in 2005.   
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in the evaluation of 1998, with the KNAW Council for medical sciences (see 4.1.4). Recently, 
DMW-VSNU became a member of Netherlands Federation of University Medical Centers. 
 
Box 4: Phases in the ZonMw evaluation procedure of research projects43 
 
 OPEN PROGRAMME RESTRICTED PROGRAMME 
PH
A
SE
 
1 
Pr
e-
ev
al
u
at
io
n
 
 
Evaluation object: applicant + research proposal 
Criteria: originality, innovation and scientific relevance 
Peers: members of the division board 
Evaluation outcome: yes or no  
Evaluation object: research proposal 
Criteria: relevance of the proposal for the programme 
Peers: members of the programme committee or the 
study group 
Evaluation outcome: yes or no 
Evaluation object: applicant  
Criteria: education/training, work experience, research 
management, grants and awards received,  number of 
publications 
Peers: at least three external reviewers 
Evaluation outcome: 1 (poor) to 5 (excellent) 
Evaluation object: research proposal 
Criteria: scientific quality by parameters: research 
question, originality, approach, quality research group 
and feasibility 
Peers: at least three external reviewers  
Evaluation outcome: I (poor) to V (excellent) 
PH
A
SE
 
II
 
Ev
al
u
at
io
n
 
Evaluation object: research proposal 
Criteria: scientific quality by indicators: research question, 
originality, approach, quality research group and feasibility 
Peers: at least three external reviewers 
Evaluation outcome: I (poor) to V (excellent) 
 
Evaluation: research proposal 
Criteria: relevance by parameters: importance of 
proposal for the programme, innovative character, 
contribution to meeting the central goals of the 
programme, value-for-money, extent of anticipation of 
knowledge transfer, and implementation (possibility of 
and focus on application of results in health care)  
Peers: at least three external reviewers 
Evaluation outcome: very relevant, relevant or not 
relevant 
PH
A
SE
 
IV
 
M
id
-
te
rm
 
ev
al
u
at
io
n
 
Evaluation object: completed research 
Peers: programme committee and programme secretary 
Criteria: research activities (e.g. presentations and visits), 
publications and other research products (e.g. dissertations, 
handbooks, protocols, patents, website, folders, films, videos 
and CD-ROMs), future plans, collaboration with intermediary 
target groups or end-users, knowledge transfer and 
implementation, and career development of funded 
researchers 
Evaluation outcome: go/no-go decision  
 
Evaluation object: completed research 
Peers: programme committee and programme secretary 
Criteria: research activities (e.g. presentations and 
visits), publications and other research products (e.g. 
dissertations, handbooks, protocol, patents, website, 
folders, films, videos and CD-ROMs), future plans,    
collaboration with intermediary target groups or end-
users, knowledge transfer and implementation, and 
career development of funded researchers 
Evaluation outcome: go/no-go decision 
PH
A
SE
 
V
 
Fi
n
al
 
ev
al
u
at
io
n
 
Evaluation object:completed research 
Peers: programme committee and programme secretary     
Criteria: obtained research goals, research activities (e.g. 
presentations and visits), publications and other research 
products (e.g. dissertations, handbooks, protocols, patents, 
website, folders, films, videos and CD-ROMs,  collaboration 
with intermediary target groups or end-users, knowledge 
transfer and implementation, future research activities and 
career development of funded researchers 
Evaluation outcome: approval of final evaluation report 
Evaluation object: completed research 
Peers: programme committee and programme secretary    
Criteria: obtained research goals, research activities (e.g. 
presentations and visits), publications and other research 
products (e.g. dissertations, handbooks, protocols, 
patents, website, folders, films, videos and CD-ROMs),  
collaboration with intermediary target groups or end-
users, knowledge transfer and implementation, future 
research activities and career development of funded 
researchers 
Evaluation outcome: approval of final evaluation report  
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 This box was formulated according to a description of ZON, NWO-MW and ZonMw evaluation 
procedures published in NWO-MW (1998); ZON (1999); NWO (2001) and ZonMw (2002). The midterm 
and final evaluation criteria were published in May 2004 on the ZonMw intranet. 
PH
A
SE
 
II
I 
Pr
io
rit
y 
se
tti
n
g 
  
Evaluation object: research proposal  
Peers: programme committee 
Criteria: emphasis on outcomes scientific quality research 
proposal 
Evaluation outcome: grant or reject  
Evaluation object: research proposal  
Peers: programme committee  
Criteria: emphasis on outcomes, relevance research 
proposal. Scientific quality has also to be sufficient 
Evaluation outcome: grant or reject 
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 4.1.4 Council for Medical Sciences of the Royal Netherlands Academy of Arts and 
Sciences  
 
In 2001, the Royal Netherlands Academy of Arts and Sciences appointed the Council for Medical 
Sciences (RMW)44, to give advice on a solicited or unsolicited basis from a scientific perspective 
on medical sciences45 and to promote medical research and organisation. For these purposes, the 
RMW has organised, in cooperation with the Disciplinary Board of the Medical Sciences, three 
national evaluations of medical and health research (1988, 1992 and 1998). 
The most complete evaluation took place in 1998 (KNAW, 1999) and consisted of two parts. 
Output of research conducted at all faculties of Medicine and/or Health Sciences and most non-
university research institutes in the Netherlands in the period 1992–1996 was evaluated by peer 
review. First, a total of 107 research themes and 556 research programmes were evaluated by an 
International Assessment Committee. Experts from outside the Netherlands were selected by the 
IAC to pre-evaluate research within each of the main research themes. These pre-evaluations, 
compiled by the Dutch Committee for the Disciplinary Report (cDAG), served as input for the 
IAC members who performed the final evaluation. Research was finally evaluated according to 
four criteria: scientific quality, scientific productivity, scientific relevance and long-term viability 
(see Table 14 which also presents the parameters). In addition, an overall quality assessment was 
given for each main research theme. Second, health research was evaluated at the level of sub-
disciplines by cDAG, which was composed of Dutch researchers. Each sub-discipline was 
evaluated by two external peers on the basis of scientific quality, scientific relevance and future 
aspects, thereby taking into account the publication tradition of the individual sub-disciplines and 
the assessment of the IAC at the level of the main research themes. The outcomes of both 
evaluations were expressed on a 5-point scale, ranging from 1 (poor) to 5 (excellent). In addition, 
strong and weak points in research were indicated and recommendations were provided for 
maintaining or improving research. Finally, the IAC evaluated in 1998 for the first time the 
research management of participating faculties and non-university institutes.  
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 The Council of Medical Sciences was appointed in 2001 as a continuation of the Medical Committee 
which had the same tasks. 
45
 including dentistry, veterinary science and pharmacy 
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CRITERIA PARAMETERS 
Scientific quality 
 
– What is the quality of the scientific output of the main research theme? 
– What is the international position of the main research theme? 
– Scientific publication in refereed journals 
– PhD theses  
– Professional results 
– Originality and coherence of research projects 
– International recognition of the members of the research group 
Scientific productivity – What is the extent of the scientific output in relation to the input in human and 
material resources? 
Scientific relevance 
 
– What is the significance of the research for the development of the scientific 
field? 
 Long-term viability 
 
– What is the long-term viability of selected problem areas and the  approaches 
followed? 
– What are the potential prospects of the  research theme, bearing in mind   
national and international competition? 
  
Table 14: Criteria used in the IAC assessment of research themes. Source: Discipline report on 
medical and health sciences research in the Netherlands 1998 (KNAW, 1999)  
 
The workload for individual researchers is substantial. Participants need to submit (written) 
information about their research such as research objectives, research results such as a list of 
publications, input of scientific and support staff (in fte), a comparative analysis of output 
between programmes partly based on impact factors, indicators of esteem and future plans. 
 
 
4.1.5 Research School Accreditation Committee 
 
A Research School Accreditation Committee, established at the request of the government in 
199146, is tied as an independent committee to the KNAW. ECOS is responsible for the 
accreditation of research schools. A research school has to concentrate on ‘top-level research in 
the area of knowledge, often through inter-university co-operation, and needs to create a sizeable 
centre of excellence’ (interview with a representative of ECOS). In addition, it has to focus on 
post-graduate education for the next generation of researchers that should be passed on by the 
leading researchers in the national sub-field. In 2000, 20–25 research schools in the medical field 
received an accreditation. An application for accreditation of a research school has to be 
submitted by the Board of Governors of the responsible university. Assessment rounds are 
organised on an annual basis. An application subcommittee, consisting of Dutch and foreign 
                                                           
46
 For a historical overview of the rise of Dutch research schools, see Chapter 6 of Bartelse (1999)  
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researchers (mainly members of KNAW), evaluates47 the applications and advises ECOS about 
accreditation. ECOS decides autonomously on accreditation for a period of six years. The 
evaluation is based on the performance of (1) research training, (2) scientific mission, (3) 
independent organisation, (4) collaboration, (5) size, (6) selection of PhDs and approval of 
projects, (7) PhD training, (8) post-doc policy, (9) involvement in first-phase education, (10) 
annual evaluation of output and accountability (KNAW, 1995; 2002). After the (first) 
accreditation period of six years, research schools are allowed to submit an application for 
follow-up accreditation. In the evaluation of a follow-up accreditation, in addition to the criteria 
described above, the performance of research output is also important. The research school must 
present the results of an external evaluation of their output by an independent committee of 
experts (KNAW, 2001). Within the accreditation procedure as well as the follow-up accreditation 
procedure specific criteria are emphasised. These criteria could differ among disciplines. In 
medical sciences, for example, the emphasis is on scientific quality of research groups. 
Nevertheless, researchers are of the opinion that the performance of the education programme is 
more important in the follow-up accreditation procedure than scientific research performance 
(including cooperation). 
According to one of the respondents there is a logical explanation for this feeling: …‘it is difficult 
to measure the quality of researchers on the level of the research school. Moreover, this is 
evaluated within the first accreditation. The results of education or training are much easier to 
measure: it is not difficult to retrieve the number of PhD theses and, as part of the follow-up 
accreditation procedure, PhD students are interviewed about their experiences with the training 
programme. Furthermore, it is easier to influence education than research. After all, when you 
try to influence research you always have to deal with the difficult and autonomous researcher’… 
The development and evaluation of research schools received much attention in the 1990s. 
Nowadays, almost all medical and health research conducted in the Netherlands is embedded 
within a research school. This development does not create distinctions anymore. Among 
researchers doubt is raised about the quality mark of ECOS recognition and the derivation of 
prestige from participation in a research school.  
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 A subcommittee can call in the help of external peers in the evaluation process of application for 
accreditation of a research school.   
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4.1.6 Other external research-oriented funding agencies 
 
medical and health researchers are also able to obtain research funding from other intermediaries 
which are not connected to the government (so-called private research funding agencies). 
Examples of this are charity organisations, special funds and pharmaceutical industries. The 
extent to which and the form in which these funding agencies use evaluations in their awarding 
process of grants differs. In general, the evaluation practices of the research funding agencies that 
have been awarded the official quality mark of the Dutch Central Bureau for Fundraising (CBF)48 
are comparable with the ZonMw evaluation practice as described in 4.1.2. The use of peers and 
the establishment of a scientific committee are some examples of similarity (Cheung, 2003). 
 
 
4.2 In search of a new national research evaluation system 
 
4.2.1 Tensions in externally organised research evaluations  
 
In the previous section, some of the externally organised evaluation procedures49 pose a 
substantial administrative burden for medical and health researchers. In practice, it seems that the 
various research evaluations are not in tune with one another. For example, researchers receive 
multiple requests to present and provide information about their research in many different ways, 
e.g. Obbink (2000). This increases the workload for researchers. In addition, certain externally 
organised evaluation practices raise some questions about the reliability of outcomes (van der 
Weijden, Groenewegen and Klasen, 2002). In 1996, a tripartite study group under the 
chairmanship of Prof. van de Kaa pointed out these problems. This study group was established 
under the authority of the three main Dutch organisations responsible for publicly funded 
research: KNAW, VSNU and NWO. Because of the high quality of research in general it was 
suggested that the frequency and depth of externally organised research evaluations be reduced 
and that, for instance, planning, requests for information and implementation of outcomes should 
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 This official quality mark is given only to charity organisations that raise and spend funds in a 
responsible way. One of the key conditions is that at least 75% of the money raised goes to the charity’s 
beneficiaries. For more information, visit the CBF website (www.cbf-keur.nl) or that of the Dutch 
Association of Fundraising Organizations, VFI (www.goededoelen.nl). Note that both these sites are in 
Dutch only. 
49
 Note that the interviews with representatives of intermediaries and the study of documents were mainly 
conducted in the period 2000-2001. Therefore, section 4.1 presents the features of evaluation of external 
research for evaluations that were used around this period of time.    
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be geared to one another (VSNU, 1996). In spite of these recommendations, externally organised 
research evaluation procedures did not change at all until recently. In 1999, the working group 
‘Quality Assurance of Scientific Research’ (KWO) was established by the boards of KNAW, 
NWO and VSNU to develop a new national evaluation system for publicly funded research in the 
Netherlands, which will serve all regular public evaluation goals. In 2000, the working group 
published the report ‘Quality Obliges’, in which the new evaluation system is outlined 
(Werkgroep Kwaliteitszorg Wetenschappelijk Onderzoek, 2000). In 2001, KNAW, NWO and 
VSNU defined their position on the proposed system50. This was elaborated further and resulted 
in 2003 in the publication of the standard evaluation protocol developed for practical use in all 
forthcoming research evaluations conducted under their auspices (VSNU, NWO and KNAW, 
2003). In short, the evaluation protocol comprises both an external and an internal research 
evaluation at regular intervals. At present, this evaluation protocol has been introduced in just a 
few institutes51. The features of this new national research evaluation procedure are presented 
below. 
 
 
4.2.2 A new national research evaluation system: self-evaluation and external 
evaluation 
 
The new system aims at operating with the lowest possible burden for the researchers in such a 
way that researchers can spend most of their time conducting research. The main objectives of the 
new evaluation system are to improve the quality of research and research management 
(including leadership) and to contribute to higher levels of research organisations and funding 
agencies, government and society at large. The new evaluation system links external quality 
assurance to internal quality assurance. This implies that research groups initiate self-evaluations, 
which should give research institutes an incentive to improve the internal steering of research. 
The research units will produce self-evaluation once every three years. The self-evaluation 
alternates with preparations for the external evaluation and serves as an internal mid-term 
evaluation (VSNU, KNAW and NWO, 2003). It serves as a starting point for external evaluation 
by an evaluation committee. Research institutes and research groups evaluate their research by 
                                                           
50
 The report ‘Quality Obliges’ and the viewpoints of the KNAW, NWO and VSNU are only available in 
Dutch. 
51
 An institute is defined in the standard evaluation protocol for public research organisations as ‘a group of 
researchers with an articulate shared mission operating under the same management’ (VSNU, NOW and 
KNAW, 2003). 
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means of a SWOT analysis. It comprises an analysis of the internal strengths and weaknesses of 
the research institute/group as well as analysis of the external opportunities and threats that affect 
the research institute/group (see Table 15 for more detailed information). From the SWOT 
analysis conclusions are drawn as to the necessity of change in research objectives and strategy. 
In accordance with the results and conclusions of the SWOT analysis, medium and long-term 
goals can be set and strategy adjusted.  
 
CRITERIA EXPLANATION 
Strengths Recapitulation of the strongest aspects that emerge from documentation 
Weaknesses Recapitulation of the weakest aspects that emerge from documentation 
Opportunities Analysis of developments in science and in society at large that may effect the institute’s 
or group’s research in a positive way 
Threats Analysis of developments in science and in society at large that may effect the institute’s 
or group’s research in a negative way 
 
Table 15: Criteria used in SWOT analysis. Source: Standard Evaluation Protocol 2003–2009 for 
Public Research Organisations (VSNU, KNAW and NWO, 2003) 
 
Once every six years all publicly funded research is evaluated externally. Four criteria – quality, 
productivity, relevance, and vitality and feasibility (see Table 16 for more detailed information) – 
are used to evaluate both past performance and future plans of research institutes and research 
programmes. Because of publication traditions and contextual relations, elaboration of the main 
criteria may differ across research fields. Furthermore, the use of the main criteria should always 
be reviewed in relation to the mission of the research institute or group. An evaluation committee 
visits the institute and talks to the director, research leaders, the advisory committee and 
researchers of the institute asking to be heard by the committee. The committee presents its 
judgements on a 5-point scale, ranging from excellent to unsatisfactory and writes a public 
evaluation report in which the outcomes of the evaluation are outlined. A draft report is sent to 
the board in order that they can check completeness and consistency. In addition, the committee 
can organise discussions about future plans with the scientific leaders of the institute during the 
site visit. Recommendations about personnel policy and sensitive decisions are not part of the 
public evaluation report but should be drawn up in a management letter. After discussing the final 
report with the advisory committee of the institute, the board will draw conclusions for the future 
of the institute. The outcomes of the evaluation are intended to help the research organisation, the 
management of the research units and individual researchers to arrive at better decisions about 
future research, research management and policy (VSNU, KNAW and NWO, 2003). 
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CRITERIA PARAMETER(S) METHODS 
Quality International recognition 
Innovative potential 
Qualitative: 
peer review by experts, including discussions with 
group leaders and members 
Productivity Scientific output Quantitative: 
bibliometrics, technometrics, sociometrics 
Relevance Scientific impact  
Societal impact 
Both qualitative and quantitative methods 
Vitality and feasibility Flexibility 
Management 
Leadership 
Qualitative:  
peer review by the evaluation committee, including 
discussions with the institute board 
 
Table 16: Main criteria used in the external evaluation of public research organisations. Source: 
Standard Evaluation Protocol 2003–2009 for Public Research Organisations (VSNU, KNAW and 
NWO, 2003) 
 
Most of the researchers who responded in the survey study thought that the new national 
evaluation system for publicly funded research, which will serve all regular public evaluation 
goals and consists of a self-assessment and an external evaluation, is a positive development. 
Only four respondents had a negative opinion. Nowadays, each medical centre has applied the 
new evaluation system. Furthermore, the Dutch medical and health research has also been 
evaluated at national level. Under the auspices of the NFU, the Centre for Science and 
Technology Studies made in 2004 a bibliometric analysis of all Dutch medical and health 
research conducted at medical centres. In addition, an international committee has evaluated in 
2005 the research management of the medical centres. 
 
 
4.3 Evaluation of societal quality and impact in medical and health research 
 
In health research the ultimate objective is to improve the health outcome of each individual. 
According to the Council for Medical Sciences, applied health research has a dual mission, 
namely a scientific and a societal one: ‘it is explicitly concerned not only with the acquisition of 
scientific knowledge as such but also with the usefulness and implementation of scientific 
achievements’ (Council for Medical Sciences, 2002, p. 10). Therefore, it is not enough solely to 
evaluate and stimulate the scientific quality of health research. Societal quality and the impact52 
of health research is also important. As mentioned in 4.1, societal indicators are already part of 
the ex-ante research evaluation procedures used by ZonMw and RGO. But, the externally 
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 Societal quality and societal impact are distinguished and defined in Chapter 2 (see section 2.3.4) 
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organised assessments of research output in the Netherlands do not (yet) deal with societal quality 
or the societal impact of research separately in an explicit fashion, let alone judge it by separate 
criteria especially developed for this purpose. However, both the national and international 
assessment committees that in 1998 evaluated medical and health research in Netherlands felt a 
need to evaluate the research on societal quality or impact. As described by one of the 
respondents: ‘Unfortunately, there was not enough time to evaluate both the scientific and the 
societal quality of health research. This was a pity, especially in the evaluation of public health 
research. Additional problems were the shortcomings in the evaluation methods for societal 
quality. As a consequence, some non-university research institutes did not want to participate in 
the evaluation process because in their opinion the focus on scientific quality did no justice to 
quality of their research’. 
During the last few years, some experimental assessments were made in the Netherlands to try to 
develop (disciplinary) methodologies for evaluating the societal quality of research. The health 
research field trial based on visitations (Begeleidingscommissie Experimentele Visitaties 
Gezondheidsonderzoek, 1994), which explicitly included an assessment of the societal and/or 
applied value, is the first example. Other more recent attempts that should be mentioned here are 
the development of the societal quality research profile in health research (Spaapen, 1995), the 
development of the research embedment and performance profile, and stakeholder analysis 
applied to agricultural sciences (Wamelink and Spaapen, 1999) and pharmaceutical research 
(Dijstelbloem, Spaapen and Wamelink, 2002). In these methods the importance of the 
comparative feedback is emphasised; the results of the assessment of societal quality must be 
interpreted in relation to its research mission. Interestingly, the report ‘Quality Obliges’ from the 
KWO working group did not examine at all the possibilities for evaluating the societal quality 
and impact of research. The importance of societal quality and the impact of research was 
explicitly mentioned for the first time in the standard evaluation protocol; it was elaborated 
further as part of the criterion ‘relevance’. Recently a working group established by KNAW 
developed a methodology that could measure the societal impact of health care research 
outcomes. Table 4 shows the criteria and indicators of the societal impact of research output 
developed by this KNAW working group. The KNAW working group suggests implementing the 
evaluation of the societal impact of applied health research within the new national research 
evaluation system: ‘Research institutes and groups can be asked to list and describe the indicated 
‘non-SCI research papers’ output they consider relevant in their societal mission. They can also 
be asked to present other data as to the potential societal impact of research results’ (Council for 
Medical Sciences, 2002, p. 28). The working groups emphasise that it is important that both the 
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scientific quality and societal impact are assessed together by a single external review committee. 
Also the feedback of stakeholders is important. Therefore, the working groups propose that the 
external review committee may consult a panel of stakeholders, such as professionals, patient 
organisations, health care institutions, policy makers and research clients. This proposed 
methodology was presented and discussed with international researchers, experts and 
policymakers in the field of quality assessment in an invitational meeting on 19 June 2001. In this 
meeting it was concluded that the new national research evaluation system offers ample 
possibilities for including an evaluation of the societal impact of applied research. Most criteria 
listed in Table 17 can be easily implemented as part of a self-assessment (Council for Medical 
Sciences, 2002). In the survey study medical and health researchers are asked what they think 
about the incorporation of societal indicators in external research evaluation procedures? Half of 
the responding researchers (n = 82) think that incorporation of societal indicators will stimulate 
researchers to improve their performance not only for scientific quality but also for societal 
quality. Almost one third of the responding researchers (n = 47) do not think this would be the 
case.  
The currently emphasised developments in the measurement of societal quality are expected to 
acquire a firmer position in the spectrum of evaluations methods. 
 
 
4.4 Implications of externally organised research evaluations 
 
The evaluation procedures of the most frequently used externally organised research evaluations 
in medical and health research have already been outlined above. The question arises if these 
evaluations have any impact on the research groups concerned. According to the majority of the 
research leaders interviewed, the notion that assessment of research quality is important for the 
survival of research groups is growing: ‘It is important to stress the distinctive features of your 
research and your group in order to obtain external research funding’. ‘I feel more and more that 
the competition between researchers is increasing’.  
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CRITERION INDICATOR 
Professional publications 
Treatment guidelines and protocols 
Policy documents 
Cochrane library 
Textbooks 
Teaching materials 
Lay publications 
Content analysis 
ICT and software 
Citations in scientific publications (both SCI and non-SCI) Citation analysis 
Citations in professional journals, policy documents, protocols and guidelines 
Authorship (Co)-authorship of documents mentioned above under ‘content analysis’ 
Health-care technology and services Products 
Instruments, programmes, methods for (assessments or implementation of) care 
Funding of research (Semi) governmental funding 
Presentation for a non-scientific audience 
Fact sheets 
Public media 
Publicity 
Internet 
Memberships Membership of a committee issuing a policy document or a treatment guideline 
Membership of an advisory committee 
Teaching Contributions to initial and post-initial education of health-care professionals 
based on research output 
Membership of advisory committees Implementation strategy 
Interactions between researchers and public administration 
Operationalisation of research questions 
Research methodology 
Independence 
Analysis and publication of results 
 
Table 17: Criteria and indicators of societal impact of research output. Source: The societal 
impact of applied health research: towards a quality assessment system (Council for Medical 
Sciences, 2002).  
 
This section describes the implications of externally organised research evaluations in medical 
and health research. First, the implications of the ZonMw research proposals evaluations are 
presented as an example of the impact of ex-ante evaluations. Next, the implications of ex-post 
evaluations are illustrated by studying the impact of the DAG 1998 evaluation. Finally, the 
implications of the ECOS accreditation of research schools are presented. The implications of 
these externally organised research evaluations are analysed from different viewpoints. Data were 
mainly collected through open, unstructured interviews with representatives of intermediaries, 
research managers in medical faculties and non-university research institutes, and research leaders. 
The implications of the DAG 1998 evaluation were studied most intensively. Data were collected 
in both the interview and the survey study and were analysed from three different viewpoints: (1) 
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on the intermediary level, (2) on the faculty/non-university institute level, and (3) on the level of 
the research group. 
Before the empirical results were presented, it should be noted that none of the respondents had 
conducted any research on the possible implications of procedures and outcomes of research 
evaluations on research groups in the medical and health field. The implications they report were 
based on their own observations and experiences. In addition, the implications cannot be 
considered separate from the context in which science is embedded. 
 
 
4.4.1 Implications of ZonMw ex-ante research evaluations 
 
The evaluation procedures of research proposals and the allocation of the second flow of research 
funding have large implications for health research. As early as in 1950 the precursor of NWO, 
ZWO, was established to stimulate – particularly fundamental – research in the Netherlands. The 
term ‘research quality’ was introduced and is now recognised and used in the whole Dutch 
medical and health research community. Also a few non-university research institutes, medical 
faculties and research schools copy parts of the external evaluation procedures and incorporate 
them into their own internal ex-ante research evaluation. An example of this is the allocation of 
the internal research budget to PhD proposals; this will be discussed in greater detail in 
subsection 5.1.3. According to one of the representatives of ZonMw, the use of external peers and 
a peer review committee are the most important elements that are copied from the NWO 
procedures. Also, the addition of societal criteria in the evaluation procedure of restricted 
programmes influences health care researchers. As one of the representatives of ZonMw had 
experienced: ‘…On the one hand, health care researchers are becoming positively motivated and 
enthusiastic to pay attention to the societal quality or impact of their proposals…On the other 
hand, researchers who have never performed fundamental research are, to some extent, forced by 
the evaluation procedure to pay attention to the methodological aspects of the research 
proposal…’  
Not only the procedures and methods used to evaluate research proposals, but also the evaluation 
outcomes and recommendations are affecting medical and health research. First, it seems that the 
outcomes of the evaluation of research proposals organised by ZonMw in both open research 
programmes and restricted research programmes have implications for the internal operations of 
medical faculties and non-university research institutes in the distribution of internal funding. The 
research proposals that do not receive funding in the open ZonMw research programmes are 
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generally evaluated as ‘very good’ (score 2). Because of the low external success rates (10–15%) 
the applicants have an increased chance of obtaining internal research funding. Second, one of the 
ZonMw representatives indicated that the evaluation of research proposals results in a high 
rejection rate of proposals submitted by research groups from non-university research institutes or 
medical faculties that have hardly any internal quality assurance, if at all. According to this 
representative, these research groups are improving, for example by establishing an internal pre-
evaluation of proposals and/or by asking for help from high-quality groups in the process of 
writing proposals. Finally, both representatives of ZonMw think that restricted research 
programmes stimulate and steer researchers to perform research in a particular research field. 
According to one of them, this influence is even larger than the amount of money that can be 
spent by ZonMw: ‘Experience shows that the stimulation of a research change or a new 
development is, in universities, a tardy process. It is essential for ZonMw to invest money slowly 
in order to stimulate discussion about the research change or development in university boards. 
Once the new research subject is rooted in faculties the new research activity should continue 
even when the ZonMw stimulation would be reduced’. 
In sum, the implications of research proposal evaluation extend beyond the funding process itself. 
The views on research have changed.  
 
   
4.4.2 Implications of ex-post DAG evaluation 1998 
 
This subsection explores the impact of the national evaluations of medical and health research 
that were organised in 1998 by RMW (KNAW) and DMW (VSNU). As stated in 4.1, the 
disciplinary evaluations are the most extensive external ex-post research evaluation in the medical 
and health field. It appears that both RMW and DMW have never performed research into the 
implications of the various disciplinary reports, but are highly interested in their working. The 
representatives of intermediaries emphasise that the outcomes and recommendations of DAG are 
intended for internal quality assurance of medical faculties and non-university research institutes. 
In addition, the disciplinary report is used as a reference book by the Dutch government. 
Therefore, research managers of medical faculties and non-university research institutes were 
interviewed. These eleven research managers, with one exception, were all involved in the DAG 
1998 evaluation. This makes it possible to compare their answers. In addition, the implications of 
the DAG 1998 evaluations are also described here (both qualitatively and quantitatively) from the 
researchers’ point of view. The survey study shows that the majority of research group leaders 
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who responded (74.1%, n = 119) were involved in the national disciplinary evaluation of 1998. In 
general, these research groups seemed to be of good quality. Half of them belonged to a main 
research theme that was rated as ‘very good’ or ‘excellent’. In comparison, 15% of the main 
research themes were rated as excellent, 46% as good, 36% as satisfactory and 3% as 
unsatisfactory. Table 18 gives more detailed information about the evaluation score of both the 
research themes covered by DAG 1998 and the survey respondents.  
 
 
DAG 1998 EVALUATION SCORE OF 
RESEARCH THEMES 
PERCENTAGE OF 
RESEARCH THEMES 
PERCENTAGE OF 
RESPONDENTS 
Poor (1) 0 0 (n = 0) 
Unsatisfactory (2) 3 1.7 (n = 2) 
Satisfactory (2–3)  36 10.1 (n = 12) 
Good (3) 
Good to very good (3–4)  
Very good (4) 
Very good to excellent (4–5)  
Score 3 to 4–5: 46 10.1 (n = 12) 
10.9 (n = 13) 
11.8 (n = 14) 
23.5 (n = 28) 
Excellent (5) 15  20.2 (n = 24) 
Missing data  11.8 (n = 14) 
 
Table 18: DAG 1998 scores of the main research themes compared with the DAG 1998 scores of 
survey respondents.  
 
Direct implications perceived by research managers  
In general, it seems that the outcomes and recommendations of the DAG 1998 did not have very 
much impact on the various faculties and institutes. In only two medical faculties did the DAG 
1998 results and recommendations result in some direct changes in local policy. In one internal 
research institute two divisions were evaluated as unsatisfactory. As a consequence, the two 
divisions were restructured. According to the research manager this decision was made by the 
internal research institute itself, not by the board of the medical faculty, because the board holds 
the opinion that each research division should deserve a chance of success: …the stronger 
divisions must help the weaker ones. They should not be restructured on the basis of external 
advice’… In the other medical faculty, the dean talked to the leaders of research programmes 
judged as satisfactory (score 3) or unsatisfactory (score 2). A written agreement was made for 
each research programme, which contains arrangements (‘mainly to reduce the number of 
research themes’) to ensure that research improves. After some time, the dean will evaluate the 
implementation of these plans.  
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In two other medical faculties the results of the DAG 1998 were compared with the results of an 
internal research evaluation53. In one medical faculty, a strength-weakness analysis was made as 
part of the internal evaluation of research procedure. Results were expressed on a 4-point scale: 
strong (score 1), weak (score 2), opportunity (score 3) or threat (score 4). In the other medical 
faculty, the DAG 1998 outcomes of research programmes were compared with the results of an 
extensive internal evaluation of research programmes. Further analyses were made when the 
results of both evaluations conflicted; in this comparison process the results of the internal 
research evaluation were emphasised.  
In the remaining three medical faculties and three non-university research institutes involved in 
the disciplinary evaluation, the DAG 1998 results did not have a direct effect on their internal 
research policy because of good evaluation outcomes. As some respondents argue: ‘Our research 
is of high quality and our faculty holds the opinion that such high-quality research groups are 
able to steer themselves’ 
However, the most important reasons given by research managers are problems experienced in 
the DAG evaluation procedure. Five different problems were pointed out: the evaluation units, 
time spent on research, selection of peers, communication and evaluation outcomes:  
– Evaluation units. In the past, RMW formulated fourteen clusters. medical and health research 
carried out in the Netherlands has to be subdivided into these clusters. In presenting the research 
information over 1992–1996 to the RMW and the VSNU, these research clusters had to be used. 
Interview data shows that a few clusters were not recognised or used by research managers. As a 
consequence, some research programmes were not evaluated separately. This resulted in a 
distortion of the quality of some research clusters, as the following quote illustrates: 
‘Unfortunately, genetics, which is a strong research area in our faculty (according to internal 
research evaluation outcomes), was not evaluated separately because it was presented in the 
neurosciences cluster. Our mistake: we never use the genetics cluster’.  
– Time spent on research. Research programmes can have several goals, for example to conduct 
research, to educate students and to deliver patient care. The proportional  amount of time spent 
on each of these activities differs among research programmes. According to one of the research 
managers, this has been insufficiently taken into account in the DAG 1998 evaluation procedure.  
– Selection process of peers. The second part of the disciplinary report 1998 presents the 
evaluation of sub-disciplines participating in research programmes. These disciplines were 
evaluated by a national peer committee. Due to the national character of peers, a number of 
                                                           
53
 See Chapter 5 for more information about the internal research evaluation procedures of 
medical faculties. 
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research managers have doubts about the objectiveness of this evaluation: ‘Roughly speaking, the 
sub-disciplines were evaluated by colleagues. Therefore, the outcomes should not be taken very 
seriously’. ‘ …it’s an old boys’ network…’. ‘One research programme of our faculty traced the 
name of one the peers and made some comments on the evaluation outcomes’. 
– Communication. Some failures of communication between participants and organisers of the 
DAG 1998 evaluation have been reported. As one research managers states: ‘...our faculty has set 
up a document about our research management and sent it to RMW. We never received the final 
results of the research management evaluation. We have called several times to RMW but this did 
not help. This is a pity because we have spent a lot of time on writing the document, and the 
evaluation report included some good points’.  
– Evaluation outcomes. The whole evaluation procedure took much time – almost two years – 
before the results were published. In the DAG 1998 assessment, medical and health research in 
the period 1992–1996 was evaluated. At the time of publication (winter 1999), the research 
outcomes seemed to be already outdated. Some respondents wonder whether the liabilities 
(‘amount of time and energy’) are not higher than the assets (‘results are often already known to 
the board of our faculty’).   
 
Direct implications perceived by research leaders  
The survey study shows that research leaders of medical and health groups, in their turn, hold 
different views on the usefulness of the results and recommendation of the DAG 1998 evaluation. 
28% of the research leaders considered the outcomes and recommendations as very useful for 
their own research groups. About the same proportion (29%) considered the outcomes and 
recommendations as not useful at all. In addition to views on usefulness, views on the 
possibilities of implementing the DAG 1998 results and recommendations also differed. 24% of 
the research leaders reported (very) intensive implementation of the results and recommendations. 
According to 38% of the research leaders, the DAG 1998 results and recommendations had not 
been implemented within the research policy of the medical faculty or research institute in which 
their research groups were operating. Also the twelve experienced research leaders, who were 
interviewed qualitatively, share this opinion as illustrated by the following quotes: ‘People talked 
more about the DAG disciplinary report compared to the actions that have been taken. For 
example, research groups that received a low evaluation score brought up extenuating 
circumstances‘. ‘Our faculty did too little with the results. No extra money has been invested in 
both ‘good’ groups to maintain quality and ‘poor’ groups to improve quality.’ 
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Research leaders reported various reasons to explain why, in their opinion, the DAG 1998 results 
have not been implemented very well. Five different problems were pointed out with regard to the 
evaluation units, evaluation criteria, evaluation outcomes and communication.  
– Evaluation units. Almost one third of the respondents in the survey study indicated that research 
was evaluated on the wrong level. For example, research was not evaluated at the level of the 
research group.   
– Evaluation criteria. The survey study shows that almost 25% of the respondents thought that the 
results and recommendations were not relevant due to the use of wrong evaluation criteria.  
– Evaluation outcomes. A few research leaders who were interviewed qualitatively considered the 
results as irrelevant because the evaluation procedure took so much time that the results were 
already outdated when they were published. Also, 30% of the quantitative respondents shared this 
opinion. As one of the research leaders said: ‘…evaluated research has been conducted years 
ago…’ 
Also, a few research leaders, both those qualitatively and quantitatively approached, claimed that 
the results were unreliable. As one research leader further explained: ‘…our institute decided on 
its own what parts of the research input and research output should be externally evaluated…’  
– Amount of information. Most of the research leaders who participated in the survey study 
shared a negative view of the amount of information they received from the RMW and the VSNU 
about the DAG 1998 evaluation procedure. Almost half of the research leaders received little or 
no information at all about the procedures. One third of the research leaders indicated that they 
were poorly informed about the evaluation procedure. Only a small number of the research 
leaders thought they have been informed adequately. The hypothesis can be made, although this 
was not studied, that the shortage of information has reduced the involvement of researchers and 
has contributed to some extent to the relatively low impact of the DAG 1998 results.   
 
Indirect implications perceived by research managers and research leaders 
Although most researcher leaders and research managers did not experience many direct 
implications in the internal research policy and research agenda (see Table 18 for an overview), a 
few indicated that the DAG 1998 disciplinary report had indirect implications. For example, the 
outcomes and recommendations served a political goal, as one research manager emphasised: 
‘…they are used by the board to legitimize an internally announced action…’  
Also, the outcomes are important for the public at large to stress the distinctive features of the 
research programmes or research groups. As one of the research managers argued: ‘…they may 
attract people to apply for a job at our department…’ 
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IMPLICATIONS EXAMPLES 
Direct changes in local (faculty) policy  Reorganisation of units  
Agreements to improve research  
Comparison of outcomes of internally 
organised research evaluations 
Strength-weakness analysis  
Indirect implications Legitimisation of internally announced action(s) 
Enhancing the attractiveness of the medical faculty and/or 
research group 
 
Table 18: Implications of the ex-post DAG evaluation 1998 
 
 
4.4.3 Implications of research schools 
 
Qualitative interviews with both the representative of ECOS and research leaders showed that 
accreditation of research schools has implications for Dutch medical and health research. First, 
the EOCS accreditation procedure demands that decisions about research and education made in 
the past and to be made in the future are considered carefully. Research schools are also obliged 
to consider their past and future decisions about spending money. In addition, the follow-up 
accreditation procedure requires that self-evaluation is accomplished. According to the 
representative of ECOS, this reflection can result in a more effective way of allocating resources. 
Second, to submit an application for accreditation, research schools have to make some rules 
about both the purchase and use of research equipment. Furthermore, PhD courses should be 
developed. This increased coordination between research groups seems to be an important 
positive consequence of the accreditation procedure.  
Furthermore, the accreditation itself can have implications. In the past, an accredited research 
school obtained extra research funding from the Dutch government. This benefit of accreditation 
has already faded away due to the expansive growth of the number of accredited research schools. 
According to the representative of ECOS, some research schools did not submit an application for 
follow-up accreditation because it did not yield profit.  
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4.5 Concluding remarks 
 
Externally organised evaluations of  medical and health research 
It appears that Dutch research groups in the medical and health field are experiencing a lot of 
different externally organised research evaluations. These evaluations take place in different 
phases of the research process. The goals of the external research evaluations vary widely. 
External evaluations are used to allocate funds to research (ZonMw and other external research 
funding agencies), to mark the quality of research (ECOS), to advise about research (RGO, 
RMW, VSNU), to direct research (RGO, ZonMw) and to promote research (all). All the 
intermediaries examined, with the exception of RGO54, identify themselves within the definition 
of intermediary organisations used in this study. Former studies about research systems, as 
described in Chapter 2, have shown that research systems in industrialised countries can be 
analysed in a three-level system. Figure 655 shows the relations found between intermediary 
organisations, government and research institutes in the Dutch medical and health field. ZonMw 
receives from ministries an annual budget to stimulate medical and health research (red arrow). 
Linked to this budget, ZonMw receives assignments from the ministries (blue arrow) to promote 
research focusing on a particular health care problem. The government can also ask the RGO for 
advice on priority setting for health research and technology development. The external research 
evaluations organised by ZonMw, ECOS, RMW and VSNU as well as the explorations of the 
RGO are based on research information. Information on both research input and research output 
is received on the research performance level (purple arrows). Advice and recommendations from 
the RGO are communicated to the government (green arrow). The outcomes of research proposal 
evaluations, DAG output evaluations and the evaluation of research schools are communicated to 
both the governmental and the research performance level (green arrows). In the case of the 
allocation of resources, ZonMw grants are provided to researchers. Since RGO advice often 
results in the development of research programmes, which are elaborated further by ZonMw, it 
can be suggested that RGO indirectly advises ZonMw (yellow arrow). Finally, identification of 
                                                           
54
 As one of the respondents further explains: …‘the RGO is an independent organization. It is not 
responsible for any policy, nor does it allocate any funds or manage any research’...Consequently, in figure 
7 the RGO is put on governmental level.  
55
 Throughout the empirical (interview and survey) study the interpretation of the new national research 
evaluation system (as presented in 4.2) was intensively discussed. It was not certain how the new national 
research evaluation system would fit into this figure. Therefore, it was decided not to include the new 
national research evaluation system in figure 7. 
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important scientific developments is one of the traditional goals of the RMW. For that reason, 
ZonMw also obtains indirect advice from the RMW. 
Externally organised research evaluations of medical and health research in the Netherlands are 
all based on peer review. In general, a peer evaluation protocol is used in the peer evaluation 
process, comprising a description of objectives, main criteria, planning and procedures that are 
used in the evaluation. The selection of the peer evaluators is probably one of the most important 
steps in research evaluation. A peer must not only be competent to carry the evaluation but also 
be completely independent of the evaluation object (e.g. researcher/research 
group/programme/institute) involved. In the evaluation of scientific quality of research, peers are 
invariably scientists. The question of societal relevance, which is becoming increasingly 
important in the evaluation of Dutch medical and health research, cannot be grafted onto the 
traditional peer review process. Because research activities are not only aimed at colleague 
scientists but also at other stakeholders, traditional peer review processes in science can be 
extended by including stakeholders other than scientists in the evaluation process of science. The 
Medical Committee of KNAW, for example, proposes the consultation of patient organisations, 
health care institutions, policy-makers and research clients in the new external ex-post evaluation 
(Medical Committee of the Royal Netherlands Academy of Arts and Sciences, 2002). External 
output evaluations of research schools and disciplinary output evaluation practices are conducted 
by peer committees. Also, a peer committee will be used in the new external evaluation system. 
Generally, a peer committee consists of a chair, (inter)national members (the ‘peers’) and 
supporting staff. A self-evaluation is used as an input of the externally organised ex-post 
evaluations. In general, the self-evaluation is sent together with other relevant material, such as an 
evaluation protocol, background information and a list of additional questions that need to be 
answered by the committee. In the new external evaluation system, the peer committee will visit 
the research group and institute for a few days and meet the research director, the research leader 
and researchers. Finally, externally organised ex-post evaluations are completed by publishing a 
(public) report on the evaluation outcomes and sometimes also a confidential management letter 
about (personnel) policy and sensitive decisions.    
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Figure 6: Relations among different actors operating in the Dutch health research system 
 
              Research funding                                        Information            Indirect recommendation 
             Assignments                                          Communication about research evaluation outcomes 
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research 
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RESEARCH INSTITUTES, UNIVERSITIES AND UNIVERSITY MEDICAL CENTERS 
KNAW VSNU NWO 
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Evaluation research proposals 
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of research 
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Give advice on 
priority setting in 
research and 
technology 
development 
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Implications of externally organised research evaluations  
In conclusion, it appears that none of the intermediary organisations conduct studies into the 
implications of external research evaluation. It is remarkable that, given the attention to externally 
organised evaluations as discussed in this chapter and knowledge accumulation in that area, 
intermediaries have so little information available on adjustment in internal work processes.  
This study shows that both ZonMw evaluation practices and evaluation outcomes have a direct and 
high impact on Dutch medical and health research. Parts of the ZonMw evaluations procedures are 
used in internally organised ex-ante evaluations. In addition, ZonMw outcomes are highly esteemed 
and are used as quality marks in internal processes for the allocation of resources.   
According to research managers and research leaders, the operation of the DAG 1998 evaluation was 
not flawless. As a consequence, the impact of the DAG 1998 evaluation on the internal research policy 
of medical faculties and non-university research institutes is relatively low. Both the interview and the 
survey study also reveal that DAG 1998 had little impact on medical and health researchers. Research 
managers as well as research leaders report that they experienced three main problems with the DAG 
evaluation procedure. First, the evaluations units are not recognised. Second, communication 
(frequency and intensity) between the research level and both organisers (RMW and VSNU) seems to 
be unsatisfactory. Third, the evaluation procedure took so much time that the evaluation outcomes and 
recommendations were outdated when they were published.  
It can be concluded that the impact of the accreditation of research schools on medical and health 
research is modest. In the nineties, the number of research schools that obtained accreditation strongly 
increased. Thus, accreditation is no quality feature any more. Nowadays the number of ECOS research 
schools is decreasing. In addition, financial incentives are not given any more to research schools.  
Finally, we have seen that that most of the research leaders who participated in the survey study attach 
higher value to the outcomes of ex-post evaluations that are internally organised. Internally organised 
research evaluations and their impact will be discussed in greater detail in Chapter 5 of this thesis. 
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CHAPTER 5: INTERNALLY ORGANISED MEDICAL AND HEALTH RESEARCH 
EVALUATIONS AND IMPLICATIONS 
 
In Chapter 4 the external research evaluation practices organised by intermediary organisations are 
presented and discussed. It was concluded that medical and health research groups are subject to 
various external research evaluations which take place in different phases of the research process. As 
indicated in Chapter 1, research evaluations are also internally organised as part of the local research 
policy. Four organisational entities can be specified: research organisations (universities and non-
university research institutes), medical faculties and medical centres56 and research groups. The 
procedures developed and introduced by these entities to evaluate research are called internal research 
evaluations. The first part of this chapter (section 5.1) discusses the internal evaluations of medical and 
health research procedures that are developed and used. In the first phase of research (research input), 
it is essential to attract, employ and stimulate staff and to obtain enough research funding (see Figure 
7). In that process research input evaluations are concentrated on the assessment of staff, research 
project proposals and research equipment acquisition. In the last phase of research, output is generated. 
For example, papers are published, including those in SCI journals, and/or patents are obtained. In 
output evaluations the research output generated is assessed. This chapter concentrates on the features 
of evaluation procedures (goals, methods and criteria) that are internally developed and used for 
assessing staff, research proposals and research output. The procedures that are internally developed 
and used to evaluate research throughput are not the subject of this chapter. It should be stressed at this 
point that it is remarkable that – given the attention to external research evaluations and knowledge 
accumulation in that area – so little information is available on the degree to which these evaluation 
procedures are translated within the internal organisation.  
 
 
 
 
 
Figure 7: Evaluations are internally organized in different phases of medical research 
  
The second part of this chapter (section 5.2) describes, from two different viewpoints (research 
managers and research leaders), the impact on research groups of output evaluation practices organised 
by medical faculties and non-university research institutes.  
                                                          
56
 see footnote 32 
 
INPUT 
Job evaluations (5.1.1/5.1.3) 
Evaluation of research 
proposals (5.1.2/5.1.3) 
THROUGHPUT 
 
OUTPUT 
Output evaluations (5.1.4) 
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This chapter is based on both an interview study (2000-2001) and a survey study (2002). Semi-
structured interviews were administered to research managers from medical faculties and centres and 
non-university research institutes. Also research leaders were interviewed. In addition, 160 medical 
research leaders participated in the survey study, viz. 127 respondents working in a university setting 
and 33 respondents working in a non-university research institute (see tables 40–41 in Chapter  6 for 
more details).  
 
 
5.1 Internally organised research evaluation procedures  
 
5.1.1 Job evaluation 
 
The interview study as well as the survey study shows that most research groups organise official job 
evaluations with their staff on a regular basis57. Of the twelve research leaders interviewed 
qualitatively, only one does not organise internal job evaluations. Nine research group leaders evaluate 
their members yearly. Two research group leaders report an internal job evaluation once every two 
years. These results are supported by the outcomes of the quantitative approach: 93% (n = 149) of the 
responding research group leaders indicate that they organise job evaluations to assess their staff. Most 
research leaders (72.8%, n = 110) evaluate their employees on an annual basis (see Table 19). 
 
FREQUENCY PERCENTAGE 
Every six months 4.6% (n = 7) 
Once a year 72.8% (n = 110) 
Every two years 20.5% (n = 31) 
Every five years 0.7% (n = 1) 
 
Table 19: Frequency of job evaluations. Three research leaders (1.9%) did not respond to this question. 
 
As is shown in Table 20, almost all research leaders focus on the assessment and improvement of both 
skills and output of their staff. In order to reach individual research goals, yearly agreements between 
the employee and the research leader are made in 71.3% (n = 107) of the groups. The agreements as a 
result of the previous assessment are evaluated and adjusted wherever necessary. In many research 
groups employees are allowed to reflect upon the leadership style of the supervisor. In more than half 
of the research groups the internal job evaluations are also organised to develop and/or maintain 
relations between the employees and the supervisor. No significant differences were found in the 
                                                          
57
 It must be stressed here that this question is asked independently of the current collective labour agreement. 
So, it is not known whether research leaders organise job evaluation and use human resource management 
criteria because this is a compulsory part of the collective labour agreement, or because they want to develop an 
additional recruitment policy for the benefit of their research groups.    
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objectives of job evaluations in para-clinical, pre-clinical and clinical research groups. Finally, some 
research leaders and research managers qualitatively indicate that the results of job evaluations are also 
used in decision-making about permanent research positions (for example, about the appointment of or 
admission to the position of (associate) professor) and about salary increases. 
 
GOALS PERCENTAGE 
Presence of possibilities to develop skills 90.7% (n = 136) 
Evaluation of output 81.3% (n = 122) 
Reflection upon leadership supervision 78.7% (n = 118) 
Yearly appointments 71.3% (n = 107) 
Maintenance/development of relations 59.3% (n = 89) 
 
Table 20: Goals of job evaluations58. One research leader (1.3%) did not respond to this question.  
 
Output indicators such as the number of publications (including the first authorship/co-authorship 
ratio), number of citations and the amount of research funding obtained are used by most of the 
research leaders interviewed in evaluating their staff. Other criteria reported in the interview study are: 
embeddedness in international networks, participation in internal work meetings and brainstorm 
sessions, style of leadership (if applicable), and educational contribution.  
 
 
5.1.2 Pre-evaluation of research proposals  
 
Most of the research proposals written by medical and health researchers in the Netherlands are pre-
evaluated internally before being submitted to external funding agencies. The survey study shows that 
91% of the medical and health research leaders participating in the study indicate that proposals are 
pre-evaluated on at least one level.  
 
A. Organisational level: University 
Research proposals of half of the responding research groups (53.0%) are subject to pre-evaluation 
organised by their university. Most of these research groups reports that researchers employed by their 
own faculty or institute – but not employed by their own research group – are asked to review research 
proposals (see Table 21). In 30.6% of these research groups research proposals are evaluated on this 
level by close colleagues. External researchers – who are employed outside the ‘own’ university – are 
not often approached in the evaluation procedure. Foreign researchers are rarely asked to review 
proposals. 
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PEERS PERCENTAGE 
Researchers employed in own faculty/institute 72.6% (n = 45) 
Close colleagues 30.6% (n = 19) 
Researchers employed elsewhere in the Netherlands 14.5% (n = 9) 
Foreign researchers 8.1% (n = 5) 
 
Table 21: Types of peers who pre-evaluate research proposals organised by universities  
 
B. Organisational level: Medical faculty 
The interview study shows that four medical faculties organise internal pre-evaluation of research 
proposals, depending on both the type of proposal and the funding agency (see Table 22). In one 
medical faculty, the research project, programme and equipment proposals are internally pre-evaluated 
by a research steering group before being submitted to KNAW or NWO. In another medical faculty, 
only research proposals submitted to the Dutch Cancer Society are pre-evaluated at this level. An 
evaluation committee that organises and evaluates these proposals has recently been established. 
Another medical faculty has set up an extensive internal evaluation procedure. In this medical faculty, 
three subcommittees of professors (from different disciplines) pre-evaluate personal research proposals 
(AGIKO59, KNAW fellows or NWO Aspasia60), equipment proposals (NWO) and health care 
efficiency research proposals. Subcommittees are chaired by a non-university research institute 
manager. Comments, suggestions and recommendations are sent to the applicants and the Board of 
Directors. Finally, research proposals written by medical and health researchers employed by another 
medical faculty to obtain KNAW fellowship grants, AGIKO scholarships, NWO individual support for 
research and NWO financial resources for major investments in large scientific research equipment are 
pre-evaluated. A research committee provides information to the dean on the quality of the proposal 
and funding opportunities. It is the dean who finally decides whether the research proposal may be 
submitted.  
Three medical faculties do not organise -at an institutional level- pre-evaluations of research proposals. 
This does not mean that research proposals are not reviewed before they are submitted to external 
funding agencies. For example, pre-evaluation of research proposals is organised by research groups 
or research divisions themselves, as indicated by one of the research managers interviewed. 
 
 
                                                                                                                                                                                     
58
 It should be stressed at this point that respondents are allowed to tick all suitable answers on questions about 
evaluation goals, peers and evaluation criteria. Therefore the sums of the percentages in table 2-5, 9-10, 14 and 
15 are not equal to 100%.  
59
 AGIKO grants are allocated in order to stimulate (young) doctors –who are training to become specialists - to 
combine their clinical tasks with scientific PhD research activities.   
60
 The allocation of ASPASIA grant is intended to stimulate the promotion of female assistant professors to 
associate professor positions.  
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EVALUATION TYPE NUMBER OF 
FACULTIES 
Pre-evaluation of external research proposals organised by ‘central’ committee 3 
Pre-evaluation of external research proposals organised by various subcommittees 1 
No pre-evaluation of external research proposals 4 
 
Table 22: Pre-evaluation of external research proposals internally organised by medical faculties 
 
In the survey study, 70.5% (n = 86) of the responding research groups indicated that their research 
proposals are pre-evaluated at the faculty level. As already observed in the interview study with 
research managers, internal peers are often asked to evaluate research proposals (see Table 23). 
External peers (including international researchers) are rarely approached in the evaluation procedure. 
On average, external reviewers are invited in 2% of the research groups processing research proposal 
evaluations on this level. 
 
PEERS PERCENTAGE 
Researchers employed by own faculty/institute 82.6% (n = 71) 
Close colleagues  40.7% (n = 35) 
Researchers employed elsewhere in the Netherlands 2.4% (n = 3) 
Foreign researchers 1.6% (n = 2) 
 
Table 23: Types of peers who pre-evaluate research proposals organised by medical faculties  
 
C. Organisational level: Non-university research institute 
According to the research managers, the four non-university research institutes included in the study 
(Netherlands Cancer Institute, Sanquin Blood Supply Foundation, Netherlands Institute for Health 
Services Research and TNO Prevention and Health) all organise pre-evaluations of research proposals. 
These qualitative observations contrast in part with the results of the survey study. 81.3% (n = 26) of 
the research group leaders affiliated with these non-university research institutes indicate that their 
research proposals are pre-evaluated at the institute level. In each of these research institutes, research 
proposals are evaluated regardless of potential external funding agency. In both the interview study 
and the survey study it was found that internal peers (usually two) are often asked to evaluate research 
proposals (see Table 24). A few research groups only approach external peers, including foreign 
researchers. In one of these four research institutes also customers are invited to peer review proposals. 
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PEERS PERCENTAGE 
Researchers employed by own faculty/institute 80.8% (n = 21) 
Close colleagues  21.2% (n = 7) 
Researchers employed elsewhere in the Netherlands 12.1% (n = 4) 
Foreign researchers 9.1% (n = 3) 
 
Table 24: Types of peers who pre-evaluate research proposals organised by non-university research 
institutes 
 
The management team and/or research board of the research institutes plays an important role in the 
evaluation procedure. In the following interview quotes four research managers emphasise this: 
(1)‘Research proposals are presented to the research board (RB). The RB sends research proposals to 
two internal peers who evaluate the proposal. Suggestions and recommendations for improvement are 
sent to applicants, the scientific management team and the RB. The RB discusses the peer comments of 
proposals and sets up an advice (submission yes/no), which will be sent to the scientific management. 
After correction, it is the scientific management team who finally decides if researchers are allowed to 
submit the proposal to an external funding agency’. (2)‘… budget and planning of research proposals 
are evaluated by the management team…’. (3)‘…first ideas about research proposals are discussed in 
the management team…’. (4)‘Results and outcomes of the peer review process are discussed in 
research meetings, which are attended by all researchers. The chair formulates conclusions’. 
 
D. Organisational level: Research group 
The survey study results show that most research group leaders (83.9%, n = 135) internally organise 
the pre-evaluation of research proposals. Interestingly, some research leaders who do not organise pre-
evaluations of proposals on a group level indicate that there is no need to organise such evaluations 
because they are experiencing an extensive evaluation procedure (and pressure) coming from non-
university research institutes in which the groups are embedded. Furthermore, the evaluations 
organised by the non-university research institutes have a high impact: ‘It is not allowed to submit 
proposals to external agencies without permission of two internal peers. A signature of both peers is 
required’. ‘Researchers whose proposals receive a negative evaluation are strongly recommended not 
to submit their proposals to external agencies’.  
Both survey study and interview study show that pre-evaluation of research proposals organised by the 
groups themselves is often done by close colleagues employed in the same research group. Examples 
of close colleagues are research staff and senior researchers. Interestingly, from the qualitative 
interviews it appears that, in two research groups, evaluation committees are internally established. 
These committees are responsible for both the organisation and the peer review process of the pre-
evaluation of research proposals. Table 25 shows that 81.5% (n = 110) of the research leaders who 
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indicate that they organise pre-evaluation of proposals approach direct colleagues to review the 
proposals. This is in contrast to the pre-evaluations organised by universities, institutes and medical 
faculties, which approach more often peers employed by the ‘own faculty or institute’. External peers 
are of minor importance, in accordance with the description of the evaluation procedure of proposals 
on different levels as presented in preceding sections. In the interview study it was found that only one 
research group invites external peers on a regular basis (regardless of type of research proposal) in the 
review process. Another research group invites external peers only in the pre-evaluation process of 
research programmes. 
 
PEERS 
PERCENTAGE 
Close colleagues  81.5% (n = 110) 
Researchers employed by own faculty/institute 51.9% (n = 70) 
Researchers employed elsewhere in the Netherlands 8.1% (n = 11) 
Foreign researchers 9.0% (n = 12) 
 
Table 25: Types of peers who pre-evaluate research proposals organised by research groups  
 
The interview study shows that the research quality of proposals -indicated by peers- seems to be the 
most important criterion used in the pre-evaluation procedure at a group level. In two research groups, 
the addition of a second criterion, the fit of the proposal within the research programme or research 
priorities, extends the pre-evaluation procedure. Peers give general as well as more detailed comments 
and recommendations to improve the research proposal. They also estimate the chance of success of 
the proposal. The outcomes of pre-evaluations are intended for the quality assurance of research 
groups. In most groups it is up to the applicants to decide whether the outcomes should be 
incorporated. Nevertheless, some respondents stress the importance of evaluation outcomes. The 
following quote serves as an illustration: ‘Researchers who have written a proposal that is evaluated 
negatively are strongly advised against submission to external agencies’. 
Three research leaders emphasise the high impact of pre-evaluations of proposals. In these groups, 
researchers are only permitted to submit the proposal externally after approval by the peers 
approached. In the survey study, research leaders were also asked their opinion on statements about 
pre-evaluations of research proposals. Table 26 shows that more than half of the respondents have the 
opinion that researchers should not be obliged to incorporate the comments and suggestions given by 
peers. Only a quarter of responding researcher leaders consider the incorporation of the outcomes of 
peer review compulsory. These results are in line with the results of qualitative interviews as presented 
above. According to almost half of the respondents, the final decision about submission or retraction 
of research proposals to external funding agencies should be left to the leader(s) of the research group. 
Almost a quarter of the respondents state that these decisions should be made by the researchers 
themselves. Finally, opinions differ greatly on the question of whether medical faculties or internal 
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non-university research institutes should have the authority to select and submit research proposals. A 
few researchers partly support this view. Just less than half of the responding research leaders disagree 
with this statement (see Table 26). 
 
 
 
 
DISAGREE 
FULLY  
DISAGREE 
PARTLY 
NEITHER 
AGREE 
NOR 
DISAGREE 
AGREE 
PARTLY 
AGREE 
FULLY 
Researchers should be obliged to 
incorporate comments and 
suggestions from peers  
13.5% 43.3% 19.1% 24.1% 0% 
Research leader decides whether 
external submission of research 
proposals will occur  
5.1% 19.1% 27.4% 33.8% 14.6% 
Faculties or non-university 
research institutes should have 
the authority to select and submit 
research proposals  
20.4% 26.1% 26.8% 24.8% 1.9% 
 
Table 26: Opinions of research leaders on statements about pre-evaluations of research proposals, 
measured on 5-point scale 
 
 
5.1.3 Research output evaluations 
 
Output produced by medical and health research groups in the Netherlands is internally evaluated. In 
the same way as  proposals, output is also evaluated at different levels. The evaluation procedure can, 
for example, be organised by universities, non-university research institutes, medical faculties and/or 
by research groups themselves. 98.8% (n = 158) of research leaders participating in the survey study 
report an evaluation of the output of their group at one level at least.  
 
A. Organisational level: University 
Of the 127 respondents, 85 (66.9%) are subject to research output evaluations organised by their 
university. In about half of these groups research output is evaluated at the highest level once in three 
to five years. Table 27 shows that the research output of more than one third of respondents is 
evaluated even more frequently.  
A clear difference between the evaluation of proposals and the evaluation of output organised at the 
highest organisational level can be found with regard to involvement of peers. Table 27 shows that 
external peers – researchers not employed in the same medical faculty, institute or research group as 
the respondents – are asked by one third of the groups to evaluate their research output. In the 
evaluation of research proposals external peers are less often involved (see Table 21). 
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Box 5: Evaluation of research proposals and PhD students 
In the Netherlands, PhD students are employed by universities. They are appointed for four years as an 
‘assistant in training’ (AIO) and have a distinct academic position61. The survey study shows that 
medical and health research PhD students account for one third of the research group members. The 
ratio of PhD students and senior staff members in pre-clinical research groups is 1:1.25, in clinical 
research groups 1: 1.1 and in para-clinical research groups 1:0.8.  
Qualitative interviews with research managers and research leaders show that a number of faculties 
and non-university research institutes have developed separate evaluation procedures to stimulate both 
PhD research and PhD students62. First, evaluation procedures have been developed to allocate internal 
(first-flow) money to PhD projects. PhD proposals written by senior researchers are evaluated yearly 
on the faculty level. Scientific quality is the main indicator. Also the research theme of the PhD 
proposal is important. According to a research manager, the success rate of PhD proposals increases if 
the proposed research theme is part of the faculty profile. Second, on a regular basis (mainly once a 
year), job evaluations are organised for PhD students. In some medical faculties and non-university 
research institutes job evaluations are organised and carried out by supervisors, while in other medical 
faculties and non-university research institutes PhD students are evaluated by an internal committee. 
Also the complexity of the evaluation procedure differs. For instance, one non-university research 
institute established a committee for each PhD student, which consisted of tutors/co-examiners and 
two senior researchers who were not members of the research group. The criteria are research 
planning, time schedule, publications, conference attendance, research resources, research training, 
teaching courses and content of the thesis. The outcomes of the job evaluations are reported by a 
coordinator. Negative outcomes are discussed with the head of the non-university research institute. 
According to this research manager, PhD students as well as members of the evaluation committee are 
satisfied with this evaluation procedure. In one of the medical faculties a PhD committee has been 
established in each of the six research sub-institutes. These PhD committees evaluate research progress 
and list the problems with supervisors experienced by PhD students. Third, a few research managers 
report that ‘PhD students are stimulated during the whole research process’. For example, PhD 
students are coached during the writing process of scientific articles. As one research manager explains 
further: ‘The structure of the article, statistical data analysis and the detailed content of paragraphs 
are discussed. The research leader makes comments on the draft article. The article is under 
discussion three times at most. The PhD student loses the first authorship if the research leader rejects 
the article after the third discussion’.   
 
 
                                                          
61
 The objective of this AIO system, which was introduced in 1985, is to provide advanced research training by 
way of active participation in university research and, to a limited extent, in teaching and administration. For 
more detailed information about the history of doctoral education policy in the Netherlands, see the thesis of 
Bartelse (1999), chapter 6.  
62
 This (second) part of the interviews with research managers was unstructured. Due to this open character the 
questions about evaluation procedures that are internally organised to stimulate PhD students were not asked to 
every interview partner. Thus, no general conclusions can be formulated.   
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FREQUENCY PERCENTAGE 
Every 3–5 years 51.7% (n = 44) 
Every 2–3 years 9.4% (n = 8) 
Once a year 27.0% (n = 23) 
 
Table 27: Frequency of research output evaluations organised by universities. Ten research leaders 
(11.7%) did not respond to this question. 
 
The opposite is found for involvement of peers employed in the same medical faculty or non-
university research institutes as the respondents. Table 89 shows that 43.5% of the respondents subject 
to output evaluations at this level indicate that researchers employed in their own faculty or institute, 
but not in their own research group, are asked to evaluate research output. As is shown in Table 21, 
involvement of these peers in the pre-evaluation process of research proposals on this level is much 
higher.   
 
PEERS 
 
PERCENTAGE 
Close colleagues  57.6% (n = 49) 
Researchers employed by own faculty/institute 43.5% (n = 37) 
Researchers employed elsewhere in the Netherlands 29.4% (n = 25) 
Foreign researchers 4.7% (n = 4) 
 
Table 28: Types of peers involved in evaluation of research output organised by universities 
 
Table 29 shows that publications (e.g. articles, reviews) are the most important items of research 
output to be assessed. In most cases the number of publications is used in the evaluation protocol as an 
indicator of research output. Also the impact factors of SCI scientific journals in which researchers 
have published is frequently used as a research output indicator. Furthermore, 36.5% of the research 
groups indicate that a citation analysis is part of the output evaluation procedure. In addition to the 
number of publications, it is also important to measure the number of dissertations. According to 
67.1% of the research groups, the number of dissertations is used as an indicator in output evaluations. 
The amount of external research funding obtained is a quality indicator in almost half of the research 
groups. For most universities and non-university research institutes it is not important to compare the 
research output (inter)nationally. Finally, also the number of presentations or lectures given is of minor 
importance. 
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CRITERIA PERCENTAGE 
Number of publications 75.3% (n = 64) 
SCI impact factors 68.2% (n = 58) 
Number of dissertations 67.1% (n = 57) 
External research funding 42.4% (n = 36) 
Citation analysis 36.5% (n = 31) 
Benchmarking 16.5% (n = 14) 
Number of presentations 4.7% (n = 4) 
 
Table 29: Criteria used in research output evaluations organised by universities 
 
B. Organisational level: Medical faculty 
All research managers but one report in the interview study that internal evaluations in which the 
research output of medical and health research is evaluated are organised at the faculty level. This 
finding is supported by the results of the survey study. According to 107 research groups leaders 
(84.3% of the respondents), research output evaluations are, on a regular basis, organised by their 
medical faculty. Table 30 shows that in about half of these groups (45.8%) these research output 
evaluations are organised yearly.  
  
FREQUENCY PERCENTAGE 
Every 3–5 years 36.4% (n = 39) 
Every 2–3 years 14.0% (n = 15) 
Once a year 45.8% (n = 49) 
 
Table 30: Frequency of research output evaluations organised by medical faculties. Four research 
leaders (3.7%) did not respond to this question. 
 
Table 31 shows that, roughly speaking, three types of internal output evaluation procedures are used in 
different medical faculties: (1) no evaluation, (2) a restricted evaluation, and (3) an extensive 
evaluation. Only one medical faculty does not organise research output evaluations. A restricted 
evaluation of research programmes is organised by four medical faculties. The procedure consists of a 
(yearly) evaluation in which research output is broadly evaluated by three criteria: (1) external 
research funding, (2) number of publications and (3) impact of publication by using impact factors or 
other marks63. In one medical faculty also indicators of esteem (e.g. awards, invited lectures, 
conferences or symposia organised by researchers) are also taken into account. Internal output 
evaluations are coordinated by the research sub-institutes or on faculty level by a steering committee. 
                                                          
63
 An example to illustrate these publication marks is given here. A medical subfield is divided – on the basis of 
impact factors of SCI journals – into four (equal) parts. A publication in the first part of this subfield yields 4 
points, a publication in the third part yield 3 points, etc. Furthermore, an interdisciplinary list of journals is 
formulated that consists of the most prestigious journals (Nature, Science, Cell, etc.). A bonus of 4 points is 
given for publishing in this category of journals.  
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Extensive internal output evaluations are organised by two medical faculties. The extensive internal 
evaluation procedures consist of: (1) a yearly evaluation in which research output is broadly evaluated 
and (2) a more comprehensive research output evaluation which is organised every three to five years. 
The broad analysis of the research output in these faculties is mainly made by counting the number of 
publications and citations, and by using impact factors. In one medical faculty this procedure was 
recently extended by taking parameters of esteem into account. Examples are editorial activities (chief 
editor or members of the editorial board) for journals listed in the ISI Journal Citation Reports and 
contributions to various national and international scientific councils, review committees and 
organisational committees for international congresses. In both medical faculties the extensive 
research output evaluation is organised and executed by internally established research advisory 
committees. These extensive evaluations are based on output and input figures which are mainly 
generated per research programme. Members of the internal committees evaluate the output of 
research programmes by criteria concerning publications (number, impact factor, citations, ratio of 
number of first authorships to number of co-authorships), dissertations, external funding (amount and 
the success rate in obtaining external research funding). A quantitative bibliometric analysis is 
sometimes part of the internal evaluation procedure. One faculty reports that the number of patents is 
used as an additional output criterion. The internal committees are given evaluation scores for each 
research programme evaluated. Both medical faculties use different scoring methods. In one faculty, 
four categories are used. A I notation is given to programmes of the international level; a VI notation 
is given to programmes that have the international level but are falling behind a little; a VN notation is 
given to programmes that have not achieved the international level yet but are progressing; an N 
notation is given to programmes that do not achieve the international level. Sometimes programmes 
are not evaluated because of their short duration; these programmes receive an O notation (not 
evaluated). In the other faculty, the outcomes of research programmes are expressed on a four-point 
scale ranging from excellent to unsatisfactory. In addition, one of the medical faculties performed in 
2001, as an experiment, an internal output evaluation research in which research output during the 
years 1999–2000 was evaluated by external peers. One Dutch scientist and one foreign scientist were 
selected by the dean of the medical faculty to peer-review research. In both faculties, preliminary 
evaluation outcomes are presented for comments to the programme leaders and heads of department 
who contributed to the programmes. On the basis of discussions it is possible to re-adjust the 
evaluation outcomes.  
In general, final outcomes and recommendations of restricted as well as extensive output evaluations 
are presented to the faculty board. In a few faculties an advice drawn by the internal evaluation 
committee is added. Then the final outcomes are discussed, for example between the medical faculty 
board and the board of directors of the Academic Hospital. In two medical faculties, the final internal 
evaluation outcomes are compared with the outcomes of external output evaluations (for example, 
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DAG scores). Again, this task is accomplished by (a different) internal committee; for instance, one 
faculty established the committee ‘Quality of Research’. In one faculty the results of this so-called 
strength-weakness analyses are expressed on a 4-point scale, ranging from strong to weak. The 
research programmes in this faculty are finally ranked (see Figure 8). This ranking is based on both the 
outcomes of the internal programme evaluation and the strength-weakness analysis.  
 
 
 
 
 
 
 
 
Figure 8: Ranking of research programmes 
 
 
EVALUATION TYPE NUMBER OF 
FACULTIES 
No output evaluation 1 
Restricted output evaluation:  
Step 1: Annual broad evaluation of research output 
Step 2: Presentation of evaluation outcomes to faculty board + discussion 
4 
Extensive output evaluation: 
Step 1: Annual broad evaluation of research output 
Step 2: Comprehensive research evaluation based on input and output figures once every 3–5 
years 
Step 3: Presentation of evaluation outcomes to faculty board + discussion 
Step 4: Strength-weakness analysis  
2 
 
Table 31: Summarised evaluation of research output organised by medical faculties 
 
 
C. Organisational level: Non-university research institute 
The interview study with research managers shows that non-university research institutes also organise 
output evaluations64. A restricted output evaluation is organised by one non-university research 
institute. Two non-university research institutes organise more extensive output evaluations. In both 
institutes external peers, Dutch as well as foreign researchers, evaluate research output. In one of the 
institutes these external peers actually visit the researchers, as explained further in this quote: ‘A two-
day site visit is organized in which the peers are meeting the staff. During this visit posters are 
                                                          
64
 The output evaluation of one of the non-university research institutes is not taken into account because their 
research output is not internally evaluated by a separate procedure, but as part of the ‘knowledge audit’ that is 
organised every 3–4 years. National and international peers evaluate, by the use of publication marks, the 
national and international knowledge position of this non-university research institute. 
1. Programme determines the profile of the faculty 
2. After revision the programme will probably fit into the profile 
3. Wait, maybe the programme will fit into the profile 
4. Wait, the programme will stay outside the profile 
5. Reorganise the programme 
6. Stop the programme 
7. No advice: programme is still reorganising   
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presented and oral presentations are given. The peer review committee closes the site visit by 
presenting a concluding evaluation report’. The criteria used in restricted and extensive output 
evaluations are comparable with criteria used in output evaluation organised by medical faculties (see 
above). However, one non-university research institute already takes societal impact of medical and 
health research into account. Another has recently performed a pilot study. 
In general, final evaluation outcomes and recommendations are presented to the board of the non-
university research institutes. On the basis of evaluation outcomes, two institutes formulate policy 
consequences which are written down, for example, in a list of improvements or a management letter.  
 
D. Organisational Level: Research group 
The survey study shows that most of the research group leaders (86.3%, n = 139) who participated in 
this study internally organise evaluations of research output. Table 32 shows that the frequency of 
output evaluations is high: two thirds of these research groups organise annual output evaluations.  
 
FREQUENCY PERCENTAGE 
Every 3–5 years  18.0% (n = 25) 
Every 2–3 years 8.6% (n = 12) 
Once a year 67.6% (n = 94) 
 
Table 32: Frequency of research output evaluations organised by research groups. 8 research leaders 
(5.8%) did not respond to this question. 
 
Most research groups ask researchers employed in their own faculty or non-university research 
institute to evaluate their research output (see Table 33). The involvement of close colleagues in these 
output evaluations is lower than in output evaluations organised on a higher organisational level 
(56.8% and 70.5% respectively). Interestingly, 21 research leaders (15.3%) indicate that they ask 
foreign researchers to evaluate the research output of their group. Compared to the low proportion of 
research leaders who indicate that foreign researchers are involved in the output evaluation procedures 
organised at a higher organisational level (ranging from 3.8% to 9.1%, see previous sections), the rate 
of 15.3% is high.  
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PEERS PERCENTAGE 
Researchers employed by own faculty/institute 78.1% (n = 107) 
Close colleagues  42.6% (n = 58) 
Researchers employed in the Netherlands 22.1% (n = 30) 
Foreign researchers 15.3% (n = 21) 
 
Table 33: Type of peers who evaluate research output organised by research groups. Three research 
leaders (2.1%) did not respond to this question. 
  
As is shown in Table 34, most of the research groups use the number of publications and their SCI 
impact as indicators of research quality. Not only are published papers important, but the number of 
publications that are still in the pipeline is also an output indicator. In the interview study it was found 
that some research groups make an inventory of the number of articles that are in press, accepted, 
submitted, or in preparation. In addition, a few groups report that they evaluate the future prospects by 
taking work in progress into account. Table 35 shows that the amount of research funding obtained 
from external agencies is an output indicator in almost two thirds of the research groups. Research 
groups use this indicator more often than universities or non-university research institutes to measure 
research output (60.4% compared to 44.1% and 56.2%; see Table 28). Also, the number of 
dissertations is an important output indicator, being used by some two thirds of the research groups. 
One third of the research groups use a citation analysis to evaluate their output. The number of 
presentations are important in almost 20% of the research groups. Furthermore, in the qualitative 
approach it was found that some groups make a distinction between invited lectures and unsolicited 
lectures given by their researchers during conferences. Table 34 shows that most research groups do 
not compare their research output with that of similar (inter)national research groups.  
 
INDICATOR PERCENTAGE 
Number of publications 88.4% (n = 123) 
SCI impact factors 82.0% (n = 114) 
Number of dissertation 61.2 % (n = 85) 
External research funding 60.4% (n = 84) 
Citation analysis 31.7% (n = 44) 
Number of presentations 19.4% (n = 27) 
Benchmarking 13.7% (n = 19) 
 
Table 34: Criteria used in research output evaluations organised by research groups. Two research 
leaders (1.4%) did not respond to this question. 
 
In qualitative interviews research leaders mention four additional output indicators used in internal 
evaluations organised by research groups:   
• Number of abstracts 
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• Number of published books 
• Number of conferences or symposia organised by researchers 
• Participation of researchers in committees (editorial boards of scientific journals, evaluation and 
audit committees) 
 
 
5.2 Implications of internally organised research output evaluations 
 
Research evaluation is an indispensable tool in improving research. Internal quality assurance of 
research input, throughput and output depends on the efforts of research leaders and staff. Therefore, a 
great deal of importance is attached to the use and implementation of evaluation outcomes. This 
section on the effects of internal research output evaluations is based on open unstructured interviews 
with research managers and research leaders. Some qualitative observations are supported by 
quantitative results of the survey.   
 
5.2.1 Implications perceived by research managers 
 
Research managers were asked to describe whether and how the outcomes and recommendations of 
output evaluations organised by medical faculties and non-university research institutes are 
implemented. They were also asked to assess the implications of output evaluations organised by 
medical and non-university research institutes.  
In most medical faculties and non-university research institutes the evaluation outcomes and 
recommendations have had direct implications for the local research policy65. Five different direct 
implications are reported by research  managers: 
(a) Re-adjustment of research programmes. For example, a negative evaluation outcome can 
result in a phase-out of research programmes (‘…during the past 10 years, 15 to 20 research 
programmes were finished...’) or research groups are recommended to merge (‘…the merger 
of a small research group and a big research group has enhanced the research quality as 
measured in a later evaluation...’).  On the other hand a positive evaluation can result in a 
development of new research programmes.  
(b) Contribution to the formulation (and adjustments) of the total research strategy and the profile 
of medical faculties or non-university research institutes. One example: ‘On the basis of 
                                                          
65
 It should be noted that there may be reasons, for example when a new research leader has just been 
appointed or when the research field concerned is moving rapidly, that make the board or dean decide 
not to implement the recommendations. 
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outcomes of internal output evaluations, immunology, haematology and organ transplantation 
became the main areas that should be stimulated within our faculty’. 
(c) Redistribution of financial resources. In two medical faculties the evaluation results are used 
to reallocate resources. This implies that the amount of money that is internally allocated 
(first-flow money) to research departments and research programmes is variable. As one 
research manager explains in more detail: ‘25% of the structural first budget source of 
scientific departments66 depends on the results of the internal output evaluation. Half of this 
25% is allocated on the basis of two criteria: amount of external funding (second-flow money) 
obtained and the number of theses. The other half of 25% is allocated on the basis of the 
number of publications in leading journals (defined as journals listed in the first part of the 
SCI index) 67’. This allocation of research money on the basis of performance aims to gain 
some flexibility in research budget and to stimulate research quality. 
(d) Appointment of staff. The following quotes of two research managers from non-university 
research institutes serve as examples: ‘In department X, supervision of PhD students was 
evaluated as being inadequate. The number of PhD students was too large in proportion to the 
number of staff. The research leader responded by writing a job description for a second head 
of the department. This second head will supervise the PhDs. At this moment the position is 
still a vacancy’. ‘In 1990, the faculty appointed (20 FTE) research staff to develop and to 
conduct health care research’ 
 
Two research managers pointed out that the internally organised output evaluations only have indirect 
implications for local research policy. One research manager argues that the advice, which is 
formulated in reply to the evaluation outcomes, is not binding and intended for internal quality 
assurance of university research institutes: ‘It is up to the institutes to decide whether or not the 
outcomes and recommendations are incorporated’. The other research manager explained that the 
dean offers research leaders the opportunity to clarify the evaluation outcomes and recommendations. 
Recommendations are implemented only if total agreement is reached.    
 
 
5.2.2 Implications perceived by research leaders 
 
Research leaders were asked for their opinion on the usefulness of results and recommendations of 
internal output evaluations organised by universities, research institutes and non-university research 
                                                          
66
 The first experiences with this approach will be evaluated. A positive evaluation will increase this 
percentage to maximum of 50%.  
67
 A list of leading journals is made for each medical subfield.    
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institutes. In addition, they were asked to indicate the impact of internal evaluation outcomes. The 
outcomes and recommendations of internal output evaluations are experienced as (very) useful by 
more than half of the responding research leaders. Table 35 shows that only a few research leaders (n 
= 14, 9.5%) believe that these evaluations are not (very) useful for their own research group. Some of 
them make the criticism that the evaluation criteria used do not allow for differences among medical 
disciplines. According to half of the respondents the results and recommendations of internal output 
evaluations are generally implemented intensively in the research policy of their groups. Only a small 
proportion (12.3%, n = 18) of the responding research leaders indicate that they did not (or only very 
rarely) implement outcomes and recommendations (see Table 35). One of the reasons given is the lack 
of evaluation consequences. As one of the research leaders points out:  ‘The outcomes are only of 
importance if they actually influence the extent/size of the research budget. This is currently not the 
case’. The extent to which evaluation outcomes and recommendations have already been implemented 
in the research policy of groups is often used as an indicator in the ensuing output evaluations. 
According to 12.2% of the research leaders a follow-up is a standard indicator in the evaluation 
procedure while 60.9% of the respondents indicate that a follow-up is sometimes conducted and a 
quarter of the research leaders never noticed any follow-up activities. 
 
EFFECTS PERCEIVED BY RESEARCH 
LEADERS 
PERCENTAGES 
Experiences outcomes and recommendations 57.4% (very) useful 33.1% neutral 9.5% not useful  
Implementation of outcomes and 
recommendations 
52% (very) intensive 35.6% neutral 12.3% not intensive  
 
Table 35: Implications of output evaluations that are internally organised by universities, research 
institutes and non-university research institutes as perceived by research leaders: a summary 
 
 
5.2.3 Future prospects of research output procedures developed by medical faculties and non-
university research institutes 
 
The interview study with research managers in 2000-2001 revealed that there is a great deal of internal 
discussion about the evaluation procedures used by medical faculties and non-university research 
institutes. Four research managers report that the whole internal evaluation procedure will undergo 
changes in the near future (Table 36). In one medical faculty, research output is not being evaluated 
yet. In the near future, research output indicators will be developed on a faculty level. Another 
research manager stated that new evaluation guidelines are being developed in the faculty, but that it is 
(still) not clear in how much detail the output of research will be evaluated. One non-university 
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research institute seriously considers adopting a research output procedure that is currently used by an 
inter-university research institute. Finally, the board of another non-university research institute would 
like to develop and introduce a model that would steer medical and health research in the whole 
organisation. Scientific research quality (indicators will be borrowed from the DAG protocol) and 
research management should be the most important criteria.  
In two medical faculties and one non-university research institute a few small changes in the research 
output evaluation procedure will be implemented (Table 36). According to one research manager, a 
site visit will introduce a new item in the internal procedure used by the faculty to evaluate research 
output. In another medical faculty, a steering group is just discussing the possibilities of involving 
external peers in research output evaluations. Furthermore, this faculty is developing a publication 
scoring system (‘number of points depends on type of publication’) and is discussing the extension of 
the internal output evaluation procedure by incorporating citation analysis (‘probably this will only be 
applied to top-class researchers’). Finally, the research manager from the non-university research 
institute reported that the institute is thinking about the development of societal quality indicator(s) 
and its incorporation into the internal output evaluation procedure. This institute is engaged in applied 
policy research for policy makers in public healthcare. This research is conducted for a large number 
of clients, ranging from governmental bodies and (umbrella organisations of) healthcare insurers to 
professional groups, healthcare organisations and patient and consumer organisations. Therefore, not 
only scientific quality but also societal quality is essential. 
 
CHANGES IN RESEARCH OUTPUT EVALUATION 
PROCEDURE 
NUMBER OF 
FACULTIES 
NUMBER OF NON-
UNIVERSITY RES. 
INSTITUTES 
Implementation of a whole new evaluation procedure 2 2 
Implementation of small changes in evaluation procedure 2 1 
 
Table 36: Changes in research output evaluation procedures in medical faculties and non-university 
institutes 
 
 
5.3 Concluding remarks 
 
In general, medical and health research is internally evaluated in different phases of the research 
process. According to the majority of the research leaders who participated in the survey study, both 
research input (jobs and proposals) and research output are evaluated (Table 37). These evaluations are 
organised by different organisational entities: universities, medical faculties, non-university institutes 
and research groups. The relationships of medical and health researchers with their internal 
environment, as found in the interview study and survey study, are presented in Figure 9. The 
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conclusion with respect to the features of evaluations procedures developed and used internally in 
order to assess staff, research proposals and research output are presented separately in subsequent 
sections.   
 
Research evaluation Percentage 
Job evaluation 95% 
Pre-evaluation research proposals 91% 
Research output 98% 
 
Table 37: Percentage of research leaders indicating that research evaluations are organised internally 
 
Job evaluations 
In conclusion, the interview study as well as the survey study shows that the majority of the research 
leaders evaluate staff members yearly. It appears that job evaluations serve multiple purposes. They 
are not only used to the assess staff but also to improve conditions in order to stimulate (individual) 
research quality. Furthermore, the results of job evaluation are used for the development of 
researchers’ careers.   
 
Pre-evaluation of research proposals 
In sum, it appears from both the interview study and the survey study that research proposals written 
by medical and health researchers are pre-evaluated at different organisational levels before they are 
submitted to external funding agencies. At the medical faculty and non-university institute level these 
pre-evaluations are organised by steering committees. What proposals are pre-evaluated varies among 
faculties, depending generally on the type of proposal (personal or programme grant) and the funding 
agency. Non-university research institutes pre-evaluate any research proposal written, regardless of 
external funding agency. The procedures are comparable to those used by medical faculties, but are 
more detailed. Also, both the research board and the research management team are highly involved in 
the pre-evaluation. Research groups generally organise pre-evaluations of proposals. Research quality 
of proposals seems to be the main criterion. Peers give comments and suggestions to improve research 
proposals. In most of the research groups, such advice is not binding. 
  125 
 
 UNIVERSITIES MEDICAL 
FACULTIES/MEDICAL 
CENTRES 
NON-UNIVERSITY 
RESEARCH INSTITUTE 
RESEARCH GROUPS 
RESEARCHERS 
Input 
 
Output 
Input 
Output 
Figure 9: Relations between different internal actors organising evaluation practices  
 
Pre-evaluation 
research proposals 
Output evaluations 
Pre-evaluation 
research proposals 
Output evaluations 
Pre-evaluation 
research proposals 
Output evaluations 
Job evaluations Pre-evaluation of 
research proposals 
Output evaluations 
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Finally, it can be concluded that internal peers are mainly involved in the pre-evaluations of research 
proposals organised at any organisational level. External peers are rarely involved. 
 
Research output evaluations 
To summarise, results of both the interview study and the survey study show that output evaluations 
are prevalent. However, the complexity of evaluation practices varies among medical faculties and 
non-university research institutes. Three types of output evaluation practices – none, restricted and 
extensive – can be distinguished. Figure 10 conceptualises these three types. The boundary lines 
between the different types are not clear or sharp. From the interviews with research managers it can 
be concluded that one evaluation type can gradually be converted into another over time. The 
empirical data show that the arrows should be drawn to the right. None of the medical faculties and 
non-universities that organise extensive research output evaluations are planning to switch to more 
restricted output evaluations types. 
The findings of both the interview and survey study suggest that the involvement of external Dutch 
peers is (much) higher in internal output evaluations organised at any organisational level than their 
involvement in pre-evaluation of research proposals.  
Finally, it can be concluded that the number of publications and their SCI impact are the most popular 
indicators in output evaluations organised by universities, medical faculties, non-university institutes 
and research groups alike.  
 
 
 
 
 
 
Figure 10: Conceptualisation of the three types of research output evaluations organised by medical 
faculties and non-university research institutes 
 
Implications of internally organised output evaluations 
In sum, it appears that internally organised research evaluations are frequently used by the (faculty) 
board to re-adjust, develop and stimulate local research programmes. The (faculty) board also uses 
internal evaluations outcomes to formulate and adjust their research strategy and profile. The survey 
reveals that most research leaders take positive views on the outcomes of internal research evaluations. 
Most of the research groups implement the recommendations given by peers.  
The question arises as to whether internal research evaluations and other research management items 
are positively correlated with research performance. In addition, research leaders were asked in the 
interview study whether (six) different research management items could influence (positively or 
 
NO OUTPUT 
EVALUATION 
 
RESTRICTED OUTPUT 
EVALUATION 
 
EXTENSIVE OUTPUT 
EVALUATION 
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negatively) the performance of the research group. According to para-clinical, pre-clinical and clinical 
research leaders the staffing policy internally developed to employ research staff is a very important 
precondition to performing well (Table 38). Also development of a scientific strategy and 
collaboration with other (inter)national research groups seem to be important conditions. In choosing 
new research topics, apparently no attempts have been made to maintain consistency among research 
themes. The interview study shows that the connection with previous research is no prerequisite for 
high performance. A clear difference was found with the importance attached by research schools. The 
pre-clinical and clinical research group leaders interviewed stated that it is not important to be a 
member of a research school. The two para-clinical research group leaders take more positive views. 
 
 PARA-CLINICAL 
GROUPS (N=2) 
PRE-CLINICAL 
GROUPS (N=4) 
CLINICAL GROUPS 
(N=6) 
Staffing policy ++ ++ ++ 
Scientific strategy  +/- + + 
Consistency of research themes - - - 
Member of research school +/- -- - 
Collaboration  + + + 
 
Table 38: The importance of research management items for research performance. ++ very important, 
+ important, - hardly important, -- not important.  
 
The interview study provides insufficient data to answer the question of whether research management 
items correlated positively with research performance. Therefore, a survey was developed for 
investigating this research question further. In the next chapter (Chapter 6) a series of bivariate and 
multivariate analyses are presented.   
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CHAPTER 6: RESEARCH MANAGEMENT AND PERFORMANCE 
 
This chapter presents the main results of the survey study. The survey was sent in 2002 to research 
leaders of Dutch health research groups. In the first part of this chapter the response rate and the 
analysis of non-response are examined. In the second part comparisons are made between 
contingencies, views on research management, research management activities and performance. Data 
from para-clinical, pre-clinical and clinical research groups are presented separately. To investigate 
whether views about research management and research management activities are positively related 
to research performance, bivariate and multivariate analyses of contingencies, research management 
and performance are presented.   
 
 
6.1 Data collection 
 
6.1.1 Response rate 
 
All 412 research leaders of Dutch academic health research groups (mainly chaired professors) were 
approached. A total of 31 research leaders were non-eligible. They turned out to be attached to their 
research group only for a short period of time (less than 6 months) or could not answer the questions 
because hardly any research was done in the group (focus on patient care) or had just left the research 
group (professors emeritus). The research group leaders returned 162 questionnaires, resulting in an 
individual response rate of 42.5% of the eligible population of 381. Two questionnaires could not be 
used because some parts of the survey were not filled in. Therefore, 160 questionnaires were analysed. 
Group members (junior and senior staff) were not involved in the study. Therefore, the data show the 
perspective of the research group leader. 
 
 
6.1.2 Analysis of non-response 
 
The response rate in the eight medical faculties varies from 24% to 60% (see Table 39 for an 
overview). Three research managers from medical faculties were not willing to write a letter of 
recommendation. The response rate of research leaders operating in faculties (44%, 34%, 24%) is, on 
average, lower than that of research leaders operating in faculties who did write a letter of 
recommendation (60%, 56%, 44%, 33%, 25%). In the faculties with the lowest response rates (below 
30%) the principal investigator contacted the research leaders or the secretaries of the non-responding 
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groups to list the reasons for non-response. Involvement in reorganisation, lack of time and sabbatical 
leaves were most often mentioned as reasons for non-response.  
 
 NUMBER OF GROUPS RESPONSE RATE (%) 
A 13 34 
B 28 56 
C 18 60 
D 18 44 
E 15 44 
F 9 25 
G 12 24 
H 14 33 
Total 127 39.6% 
 
Table 39: Overview of the number of participating research groups in eight medical faculties 
(indicated with A until H). During this empirical study (in 2002), most of the medical faculties were 
co-operating to some degree with an academic medical centre (see also footnote 59 in Chapter 5). 
 
The response rate in the four non-university health research institutes differed from 25% to 75% 
(Table 40). The institute with the lowest response rate was contacted. Both non-responding and 
responding research leaders indicated that there would be no differences in internal research policy 
between units because they agreed on most of these items. 
 
 NUMBER OF GROUPS RESPONSE RATE (%) 
A 21 58 
B 6 75 
C 3 25 
D 3 60 
Total 33 53.8% 
 
Table 40: Overview of the number of research groups in four non-university health research institutes 
(indicated with A until D). 
 
Of the 160 respondents, 22 were research leaders of para-clinical research groups, 75 were research 
leaders of pre-clinical groups and 63 were research leaders of clinical research groups (see Table 41). 
Para-clinical research groups accounted for 15.4% of the total population and 13.8% of the response 
sample. 34.3% of the total population and 46.8% of the response sample were classified as leaders of 
pre-clinical research groups. Clinical research groups made up 49.7% of the total population and 
39.4% of the sample of respondents. This study does not intend to draw general conclusions about the 
relation between management activities, contingencies and performance in the whole population of 
Dutch health research leaders. The classification of para-clinical, pre-clinical and clinical research is 
used in each analysis (as described in the next sections). 
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 TOTAL 
POPULATION 
NON- 
RESPONDENTS 
RESPONDENTS 
 
Para-clinical  
research groups 
N = 59 
15.4% of total population 
N = 37 N = 22 
13.8% of response sample 
Pre-clinical 
research groups 
N = 131 
34.3% of total population 
N = 56 N = 75 
46.8% of response sample 
Clinical 
research groups 
N = 180 
49.7% of total population 
N = 127 N = 63 
39.4% of response sample 
Unknown N = 2 
0.5% of total population 
N = 2 - 
 
Table 41: Approached and responding health research groups 
 
The effect of non-response depends on the proportion of the population who do not respond and to the 
extent to which those not responding are biased, i.e. systematically different from the whole 
population (Fowler, 1993). Fowler argues that a generalisation that seems to hold for most mail 
surveys is that people who have a particular interest in the subject matter or the research itself are 
more likely to return mailed questionnaires than those who are less interested. This means that a 
survey may be biased significantly in the way it is related directly to the purpose of the research. In 
order to test whether there were significant differences between respondents and non-respondents 
dependent performance variables were compared. The performance of the research groups measured 
that responded was compared with the performance of the groups that did not respond.  
 
1. Number of SCI papers 
On the basis of data obtained from the ISI database, the numbers of papers (co-)authored by 
responding research group leaders that were published in international SCI scientific journals in 1999, 
2000 and 2001 were compared with those of non-respondents. The mean difference between the two 
groups is very small (24.35 vs. 24.83 publications) and the variance within both groups is large (SD 
24.49 and 24.82 respectively). Analysis of variance therefore shows a small and non-significant F-
value. It can be concluded that there is no significant difference in mean number of SCI papers 
published by respondents and non-respondents (see Table 432. 
 
2. NWO rating 
In addition, by using the electronic database Delfi, the NWO rating of the approached research group 
leaders was measured (Table 42). NWO rating was expressed on a 4-point scale. Three rating 
indicators were used with regard to NWO grants, NWO peers and information about NWO funding 
programmes. Table 43 shows that there is no significant difference for this variable between 
respondents and non-respondents.  
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3. Number of submitted NWO research proposals 
Finally, the number of submitted NWO research proposals received in competition for research grants 
from respondents were compared with those from non-respondents. A submitted research proposal 
was rated as valid if: (1) the name of the research group leader was mentioned in the research proposal 
as main applicant, fellow applicant, research leader or researcher and (2) the research proposal was 
entered in Delfi. Interestingly, those who participated in the study had submitted on average 
significantly (F=9.39**) more research proposals to NWO (mean 2.48) than those who did not 
participate (mean 1.63). This difference can be explained by the relatively high percentage of groups 
that did not submit any research proposal to NWO during the years 1999-2001. 43.8% of the non-
respondents did not submit research proposals to NWO, compared to 33.5% of the respondents. 
Probably, these non-respondents are group leaders who are not so much focused on basic health 
research. It may also indicate that these group leaders, after estimating their chances for NWO success, 
think that their research does not have the required quality level and innovativeness. In addition, NWO 
success percentages are generally low. Especially clinical research groups often search for alternative 
research funding agencies, as for example charity funds.  
 
 RESPONDENT 
N = 160 
NON-
RESPONDENT 
N = 222 
F VALUE 
Number of SCI papers 24.35 (24.49) 24.83 (24.82) 0.779 
NWO rating 3.12 (1.15) 2.92 (1.20) 2.466 
Number of submitted NWO research proposals  2.48 (3.38) 1.63 (2.39)     9.385** 
 
Table 42: Analysis of non-response  (analysis of variance) 
 
In conclusion, both the response rate and the main part of the non-response analyses suggest that the 
participating medical and health research groups can be regarded as representative of medical health 
research in Dutch universities and non-university institutes. In the next section the results found for 
para-clinical, pre-clinical and clinical research groups are presented. 
 
 
6.2 Results 
 
6.2.1 General information about respondents 
 
The average age of the respondents was 54 years (sd 6.4), and the majority were male (91%). On 
average, respondents had obtained their PhD about 20 years (sd 7.3) before this study was performed. 
79% of the respondents were working in a university setting and 21% in a non-university research 
institute. Writing and publishing scientific articles (93%), development of new knowledge (58%) and 
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training of young researchers (48%) were the most important goals of the research groups supervised 
by the respondents. 
 
 
6.2.2 Contingencies 
 
Table 43 compares the contingencies in para-clinical, pre-clinical and clinical research groups. It 
shows that, on average, 19 research staff members were working in a research group (SD 16.8). More 
time was allocated to research (F = 3.93; P<0.05) in pre-clinical research groups. As could be 
expected, more time was allocated to patient care (F = 8.71; P<0.01) in clinical research groups than 
in pre- and para-clinical research groups, which spend almost no time on patient care. No differences 
were found in time allocated to education (mean 1.7 on a 5-point scale) and supervision of PhD 
students (mean 2.4) among para-clinical, pre-clinical and clinical research groups. The heads of the 
para-clinical research groups had less (F = 3.19; P<0.05) research experience (21.3 years on average) 
than heads of pre-clinical and clinical research groups (25.5 and 23.6 years on average respectively). 
There is a misunderstanding among respondents with regard to the definition of research management. 
When research leaders were asked about their managerial experience, 42% indicated that they do not 
have any management experience. Interestingly, these respondents do not see leadership as a 
managerial task. The groups differed with regard to foreign research experience (χ2 = 9.84; P<0.01). 
Whereas leaders in pre-clinical and clinical research groups had been working in foreign countries for 
about two years, heads of para-clinical research groups generally lacked international experience68.  
                                                          
68
 Foreign research experience was measured as a quantitative measurement level (ratio scale). This variable is 
not normally distributed; for example 39% of the leaders do not have any foreign experience at all. Therefore we 
recoded foreign experience into a dummy variable with categories: no foreign experience (coded 0) and foreign 
experience (coded 1) and used this dummy in regression analyses. Recoding into a variable with three categories 
(trichomy): no foreign experience (coded 0), 1-2 years foreign experience (coded 1) and > 2 years experience 
(coded 3) shows the same results compared to the dummy. 
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CONTINGENCIES PARA-
CLINICAL 
(N = 19) 
PRE-
CLINICAL 
(N = 73) 
CLINICAL 
(N = 61) 
F VALUE 
Size (full-time equivalents, fte) 
Research staff   
 
18.7 (21.1) 
 
22.0 (19.8) 
 
17.3 (11.2) 
 
1.30 
Time allocation (5-point scale) 
Research 
Education 
Patient care 
Supervision of PhD students 
 
3.1 (1.1) 
2.1 (1.3) 
0.8 (1.5) 
2.4  (1.3) 
 
3.8 (2.1) 
1.7 (0.9) 
1.3 (1.5) 
2.6 (1.2) 
 
2.9 (1.3) 
1.5 (0.9) 
2.3 (1.9) 
2.3 (1.0) 
 
   3.93* 
2.44 
     8.71** 
1.04 
Age  (years) 
Research experience 
Management experience 
Foreign experience 
Supervising experience 
 
21.3 (7.6) 
7.1 (7.6) 
0.6 (1.2) 
12.5 (6.5) 
 
25.5 (6.6) 
5.7 (7.4) 
2.0 (3.2) 
13.0 (7.3) 
 
23.6 (7.0) 
5.7 (6.3) 
2.3 (4.5) 
11.2 (5.9) 
 
  3.19* 
0.30 
1.74 
1.18 
 
Table 43: Comparison of contingencies in para-clinical, pre-clinical and clinical research groups  
 
Table 44 shows that the staffing structure in para-clinical, pre-clinical and clinical groups is more or 
less the same. The leaders of research groups and senior staff together accounted for 48% (para-
clinical groups), 34% (pre-clinical groups) and 32% (clinical groups) of total staff, whilst junior staff 
accounted for 38% (para-clinical groups), 31% (pre-clinical groups) and 41% (clinical groups) of total 
staff. Not surprisingly, the staffing structure of research groups significantly differs (F = 8.37, P<0.01; 
χ2 = 31.67; P<0.01). Laboratory technician staff in para-clinical groups accounted for only 4% of total 
staff (mean 0.6 fte), compared to 28% (mean 5.9 fte) and 19% (mean 2.9 fte) in pre-clinical and 
clinical research groups. 
 
STAFFING STRUCTURE PARA-
CLINICAL 
(N = 19) 
PRE-
CLINICAL 
(N = 73) 
CLINICAL 
(N = 61) 
F VALUE 
Research leader (fte) 
Senior scientific staff (fte) 
PhD students (fte) 
Laboratory technician staff (fte) 
Technical support staff (fte) 
1.4 (1.0) 
 6.6 (10.1) 
6.4 (5.6) 
0.6 (1.1) 
1.8 (0.4) 
1.1 (0.9) 
6.0 (6.4) 
6.4 (5.2) 
5.9 (7.3) 
1.5 (3.9) 
1.2 (0.9) 
3.9 (3.0) 
6.4 (4.6) 
2.9 (3.8) 
1.3 (2.6) 
0.41 
2.50 
0.00 
     8.37** 
1.28 
 
Table 44: Comparison of staffing structure in para-clinical, pre-clinical and clinical research groups in 
fte  
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6.2.3 Research management  
 
Tables 45 and 46 compare the views and judgements of para-clinical, pre-clinical and clinical research 
leaders about research management items. Furthermore, research management activities of research 
leaders in para-clinical, pre-clinical and clinical research groups are shown in these tables.  
 
Internal control 
Medical and health research groups have serious problems in attracting qualified scientific staff such 
as PhD students, senior staff and laboratory technicians. About half of the respondents (52%) indicate 
that they are short-handed. This seems to be the main explanation of the problems that exist in 
carrying out health research69.  
In general, medical and health research leaders spend 20–25% of their time on internal management 
activities. No differences between leaders of para-clinical, pre-clinical and clinical leaders were found.  
In spite of these managerial tasks, research group leaders are, in general, still highly involved (mean 
4.1 on a 5-point scale) in medical and health research undertaken within their own research group. 
Internal research meetings are frequently organised by research leaders. Differences between para-
clinical, pre-clinical and clinical research groups are very small. Pre-clinical research groups organise, 
on average, more research meetings (mean 3.6, measured on a 5-point scale) than para-clinical (mean 
3.4) and clinical research groups (mean 3.5).  
Of the research leaders who responded, 80% organise meetings to discuss the long-term research 
policy of the group. Researchers participate in these discussions. In 96% of the research groups 
employees are asked to participate in these discussions. In addition, other researchers such as 
researchers employed in the same university or research institute (40%), researchers employed in the 
same research school (22%), researchers employed in a different university or research institute (11%) 
and foreign researchers (14%) are asked to participate in these discussions. No differences were found 
among the three types of medical and health research groups. 
In clinical research groups 36% of the communication between leaders and their research staff 
members goes directly via e-mail, telephone and personal talks. This percentage is significantly (F = 
5.75; P<0.01) higher than in pre-clinical (27.7%) research groups. 
In general, medical and health research leaders often offer their staff opportunities to develop their 
research skills (mean 2.6) and to work flexible hours (mean 2.2). In order to motivate research staff, 
special commendations are sometimes given (mean 1.7). The mean use of offering financial incentives 
to staff differs significantly (χ2 = 6.44; P<0.05) among research groups. Clinical research groups 
                                                          
69
 Research groups face problems and difficulties in conducting health research due to shortage of staff (52% of 
the respondents), equipment (33%), library services (28%), research materials (16%), data processing (12%) and 
laboratory room (6%). Compared to para-clinical and clinical research groups, pre-clinical research groups 
experience more deficiencies in laboratory room (χ2 = 7.2*) and library services (χ2  = 9.9**). 
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leaders less frequently give financial incentives (mean 1.3) than para-clinical (mean 1.5) and pre-
clinical research group leaders (mean 1.5). 
 
Not surprisingly, almost every medical and health research group (96%) uses internal job evaluations 
to evaluate their research staff members. 87% of the health research groups organise internal pre-
evaluations of research proposals before submission to external research funding agencies will take 
place. Pre-evaluation of research proposals is not only organised by research groups but also by 
medical faculties (69%), universities and non-university research institutes (56%). On average, more 
clinical groups (80%) seem to experience pre-evaluation of research proposals organised by medical 
faculties than para-clinical and pre-clinical research groups (71% and 61% respectively; χ2 = 5.5, n.s.).  
Group leaders think that internally organised pre-evaluation of research proposals will result in an 
increased opportunity to receive an external research grant (mean score 3.8, measured on a 5-point 
scale). Moreover, 88% of the medical and health research groups evaluate their research output 
internally. Evaluation of research output is also organised internally by medical faculties (82%), 
universities and non-university research institutes (69%). On average, fewer para-clinical groups 
experience internal evaluation of research output organised by medical faculties (68%) than pre-
clinical and clinical research groups (84% and 85% respectively). Internally organised research 
evaluations seem to be the most important type of evaluation for medical and health groups (mean 
importance 3.4).  
 
INTERNAL CONTROL PARA-
CLINICAL 
(N = 19) 
PRE-
CLINICAL 
(N = 73) 
CLINICAL 
(N = 61) 
F 
VALUE 
Resource control: personnel (5-point scale) 2.9 (1.4) 3.1 (1.0) 3.0 (0.9) 0.16 
Time spent on internal management activities (6-point scale) 2.6 (1.3) 2.3 (1.2) 2.2 (1.0) 0.89 
Research commitment (5-point scale) 4.1 (0.5) 4.1 (0.5) 4.1 (0.4) 0.04 
Communication  
Research meetings (5-point scale)  
Process of communication (percentage) 
 
3.4 (0.4) 
31.6 (12.7) 
 
3.6 (0.6) 
27.7 (15.0) 
 
3.5 (0.5) 
36.3 (14.2) 
 
1.32 
   5.75** 
Research policy planning (dichotomous) 90.0 (20.0) 80.0 (40.0) 80   (40) 1.48 
Rewards (3-point scale) 
Development of research skills  
Flexibility  
Special commendations  
Financial bonus system  
 
2.6 (0.2) 
2.4 (0.5) 
1.5 (0.7) 
1.5 (0.6) 
 
2.7 (0.3) 
2.2 (0.5) 
1.8 (0.7) 
1.5 (0.6) 
 
2.6 (0.3) 
2.1 (0.5) 
1.7 (0.7) 
1.3 (0.5) 
 
0.60 
2.05 
0.79 
2.94 
Internal organisation of research evaluations (dichotomous) 
Job evaluation   
Pre-evaluation of research proposals:  
Level of research group/department  
Level of faculty/research institute  
Level of university/research institute  
Evaluation of research output:  
Level of research group/department  
Level of faculty/research institute  
Level of university/research institute 
 
100.0% 
 
88.0% (33.0) 
71.0%  (47.0) 
65.0%  (49.0) 
 
84.0%  (37.0) 
68.0%  (48.0) 
58.0%  (51.0) 
 
93.2% 
 
91.0%  (40.0) 
61.0%  (49.0) 
56.0%  (50.0) 
 
86.0%  (35.0)  
84.0%  (37.0) 
73.0%  (45.0) 
 
98.4% 
 
93.0% (25.0) 
80.0% (41.0) 
60.0% (49.0) 
 
93.0%  (36.0) 
85.0%  (36.0) 
74.0%  (44.0) 
 
1.61 
 
2.35 
2.82 
0.79 
 
1.10 
1.48 
0.95 
Effectiveness of pre-evaluation of research proposals (5-point scale) 4.0 (0.5) 3.7 (1.1) 3.8 (0.9) 1.07 
Importance of internally organised research evaluations (5-point scale) 3.5 (1.1) 3.4 (0.8) 3.5 (0.7) 0.21 
 
Table 45: Comparison of internal control items in para-clinical, pre-clinical and clinical research 
groups (see 4.3.1 for a description of the measurement scales used) 
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External control 
Research leaders spend an average of 20–25 days per year on external research activities such as 
giving lectures, attending or organising conferences, participation in editorial boards of journals, 
participation in audit committees and participation in assessment committees. Compared to the amount 
of time allocated to internal management activities, medical and health research leaders on average 
allocate less time to external management activities (mean 1.4).  
Externally organised research evaluations such as DAG 1998 and the accreditation of research schools 
are considered less important than internally organised research evaluations. Medical and health 
researcher leaders indicate the importance of the DAG 1998 evaluation as neutral (mean importance of 
3.1). The (follow-up) accreditation of research schools is of minor importance (mean importance 2.8). 
This view on importance does not depend on organisational setting; the difference in importance of the 
DAG 1998 evaluation between leaders of university units and leaders of (non-university) institute 
units is not significant. Not surprisingly, collaboration with national and international research groups 
is very important for medical and health research groups (mean 7.0). Table 46 shows that, as expected, 
differences in importance of collaboration with ministries and semi-governmental organisations (F = 
10.92; P<0.01), collaboration with the clinic (F = 4.99; χ2 = 11.59; P<0.05) and collaboration with 
family doctors (F = 6.57; χ2 = 11.09; P<0.01) between research groups with a para-clinical, pre-clinical 
and clinical background are significant. Para-clinical research groups consider collaboration with 
ministries and semi-governmental organisations as reasonably important (mean 5.8). Pre-clinical and 
clinical research groups indicate collaboration with ministries and semi-governmental organisations as 
not important (mean importance 3.2). In addition, para-clinical research groups also find collaboration 
with general practioners relatively important (mean importance 4.7). This is significantly higher than 
in pre-clinical research groups, which indicates that collaboration with family doctors is a matter of 
minor importance (mean 2.2). Pre-clinical and clinical research groups that allocate more time to 
patient care (see Table 44) find collaboration with the clinic a matter of major concern (mean 
importance 7.2 and 8.2 respectively). This is significantly higher than for para-clinical research groups 
(mean importance 6.6).  
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EXTERNAL CONTROL PARA-
CLINICAL 
(N = 19) 
PRE-
CLINICAL 
(N = 73) 
CLINICAL 
(N = 61) 
F 
VALUE 
Time spent on external research activities (6-point scale) 2.3 (0.8) 2.3 (0.6) 2.3 (0.4) 0.68 
Time spent on external management activities (6-point scale) 1.4 (1.0) 1.6 (1.2) 1.4 (1.0) 0.69 
Importance of externally organised research evaluations (5-point scale) 
DAG evaluation 1998 
Research school evaluations 
 
 
3.2 (0.6) 
2.8 (1.1) 
 
 
3.1 (0.8) 
3.0 (0.8) 
 
 
3.0 (0.7) 
2.8 (1.0) 
 
 
0.94 
1.39 
Importance of collaboration (10-point scale) 
Research groups  
Ministries and semi-governmental organisations  
Pharmaceutical industries & firms  
Clinic  
Family doctor  
 
6.9 (1.6) 
5.8 (2.4) 
3.5 (2.3) 
6.6 (2.6) 
4.7 (3.1) 
 
7.1 (1.7) 
3.2 (2.2) 
4.7 (2.3) 
7.2 (2.2) 
2.2 (2.1) 
 
7.1 (1.3) 
3.2 (2.1) 
4.1 (2.3) 
8.2 (1.9) 
3.4 (3.1) 
 
0.15 
10.92** 
1.99 
   4.99** 
  6.57** 
 
Table 46: Comparison of external control items in para-clinical, pre-clinical and clinical research 
groups (see 4.3.1 for a description of the measurement scales used) 
 
 
6.2.4 Research performance 
 
The seven items measuring ‘research performance’ were compared among para-clinical, pre-clinical 
and clinical research groups.  
Whereas medical and health research leaders of para-clinical groups published an average of 13 SCI 
papers during the past three years, leaders of pre-clinical and clinical research groups published an 
average of 25 to 27 papers in SCI journals. This difference between the three groups is not significant 
due to the large standard deviations. Table 47 shows that most of the medical and health research 
groups are part of a main research theme that has been externally evaluated in the DAG 1998 as ‘very 
good’. However, it should be noted that only a few para-clinical research groups were involved in the 
externally organised DAG 1998 evaluation.  
The proportion of external funding is high in para-clinical, pre-clinical and clinical research groups; on 
average, 50% of the personnel and material resources stems from external funding. The number of 
grants applications submitted to and grants received from the NWO and NWO-Council for Medical 
and Health Research (MW-NWO) differs (but not significantly) between the three types of medical 
and health research groups. It seems that pre-clinical research groups submit, on average, more 
research proposals to NWO (3.1 proposals) and MW-NWO (1.0 proposal) than para-clinical (2.3 
NWO proposals, 0.3 MW-NWO proposals) and clinical research groups (1.8 NWO proposals, 0.6 
MW-NWO proposals). It is possible that pre-clinical research groups consider NWO and MW-NWO 
as a more important source of money for receive external research funding than para-clinical and 
clinical research groups. Finally, the average NWO rating of the research group leaders is high (3.1 
measured on 4-point scale). No significant differences among para-clinical, pre-clinical and clinical 
research groups were found. 
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RESEARCH PERFORMANCE PARA-CLINICAL 
(N = 19) 
PRE-CLINICAL 
(N = 73) 
CLINICAL 
(N = 61) 
F VALUE 
Research output 
SCI publications (number)   
DAG score (8-point scale) 
 
13.2 (10.6) 
5.5 (1.6) 
 
24.9 (21.8) 
6.1 (1.8) 
 
27.7 (29.1) 
5.9 (1.9) 
 
2.49 
0.46 
Research input  
External funding (percentage) 
Proposals to NWO (number) 
Proposals to MW-NWO (number) 
MW-NWO grants (number) 
NWO rating (4-point scale) 
 
51.5 (23.3) 
2.3 (2.4) 
0.3 (0.6) 
0.2 (0.4) 
3.3 (1.0) 
 
51.1 (21.9) 
3.1 (4.2) 
1.0 (1.5) 
0.6 (1.0) 
3.1 (1.2) 
 
50.5 (25.6) 
1.8 (2.1) 
0.6 (0.9) 
0.3 (0.7) 
3.0 (1.1) 
 
0.02 
2.34 
2.96 
2.71 
0.31 
 
Table 47: Comparison of research performance in para-clinical, pre-clinical and clinical research 
groups (see 4.3.1 for a description of the measurement scales used)70 
 
 
6.2.5 Bivariate correlations of variables 
 
In this section the results of three bivariate analyses are presented. First, the correlations between 
contingency variables and performance variables are reported. Second, the correlations between 
research management and performance variables are shown. Finally, the correlations between 
contingency variables and performance variables are given. Only significant correlations are presented 
in tables. Annexes 5-10 show detailed correlation matrices of the relevant variables.  
This section and the remaining ones in this chapter only discuss the results of analyses carried out for 
pre-clinical and clinical research groups. Unfortunately, it was not sensible to perform bivariate and 
multivariate analysis of the data of para-clinical groups. Only 13.8% of the response sample (N = 22) 
could be classified as para-clinical research groups. The size of this subgroup is relatively small, 
compared to the number of responding pre-clinical (N = 75) and clinical research groups (N = 63). In 
addition, among the respondents, only a few (5 or 6) para-clinical research groups were involved in the 
DAG 1998 assessment. Furthermore, it turned out that most of the leaders of para-clinical research 
groups had submitted hardly any research proposals to NWO and MW-NWO and had received hardly 
any grants from MW-NWO (see Table 48). For these reasons it was decided not to include para-
clinical research groups in the bivariate and multivariate analyses.  
 
 
 
 
                                                          
70
 Unfortunately, there is no information known about the amount of full-time equivalents (fte) that medical and 
health groups are spending to conduct medical and health research. Therefore the seven research performance 
measures cannot be corrected for the total research input. It should be noted that differences with regard to the 
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6.2.5.1 Bivariate correlations between contingencies and research performance 
 
Table 48 shows significant correlations between contingencies and the research performance of pre-
clinical and clinical research groups.  
 
Size  
In both pre-clinical and clinical research groups, group size correlates positively with each research 
performance measure. The size of pre-clinical research groups correlates positively with the number of 
NWO proposals submitted, the number of MW-NWO proposals submitted and number of MW-NWO 
grants received, while in clinical research groups size correlates positively with the number of SCI 
publications and the DAG 1998 score.     
 
Time allocation 
The time leaders allocated to research and clinical patient care shows an inverse relationship in pre-
clinical research groups. Time allocated to research correlates positively with the DAG 1998 score, the 
number of MW-NWO grants received and the NWO rating of the research leader. Time allocated to 
patient care correlates inversely with these three performance measures. Furthermore, time allocated to 
patient care correlates negatively with the amount of external research funding and the number of 
NWO research proposals submitted. The amount of time allocated to the supervision of PhD students 
in pre-clinical research groups is positively associated with the number of SCI publications, the DAG 
1998 score, the percentage of external research funding and the NWO rating of the research leader.  
 
Age 
The research management experience of pre-clinical research group leaders correlates negatively with 
their NWO rating. In pre-clinical groups, foreign experiences of the research leader are positively 
associated with the number of NWO and MW-NWO proposals submitted and the number of MW-
NWO grants received. In pre-clinical as well as clinical research groups, the foreign experience of the 
leader correlates positively with the number of SCI publications. The supervising experience of the 
medical and health group leader correlates negatively in pre-clinical groups, and positively in clinical 
research groups, with the number of MW-NWO grants received.  
 
Work setting 
Work setting (dummy; code 0= university setting; code 1= non-university institute) of pre-clinical 
research groups has a positive correlation with the DAG 1998 score and the amount of external 
                                                                                                                                                                                     
amount of fte spend on research between and within para-clinical, pre-clinical and clinical research groups are 
possible. 
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research funding. It correlates negatively with the number of SCI publications published during the 
years 1999-2001.  
 
In sum, it appears that there are both significant positive and negative correlations between 
contingencies and research performance (Table 48). In pre-clinical research groups significant 
correlations between contingencies and research performance are more prominent than in clinical 
research groups.  
 
 
PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
SCI publications + Time allocated to supervision of PhD students 
(0.31**) 
+ Foreign experience (0.24*) 
- Work setting (-0.27*) 
+ Size of research group (0.50**) 
+ Time allocated to research (0.42**) 
+ Foreign experience (0.31*) 
DAG score + Work setting (0.35*) 
+ Time allocated to research (0.67***) 
+ Time allocated to supervision (0.51***) 
- Time allocated to patient care (–0.63***) 
- Time allocated to education (–0.31*) 
+ Size of research group (0.36*) 
External research 
funding 
+ Time allocated to supervision of PhD students (0.27*) 
- Time allocated to patient care (–0.47***)  
+ Supervising experience (0.27*)  
NWO proposals  
submitted 
+ Size of research group (0.46***) 
- Time allocated to patient care (–0.26*)  
MW-NWO proposals 
submitted 
+ Size of research group (0.46**) 
 
MW-NWO grants 
received 
+ Size of research group (0.38***) 
+ Time allocated to research (0.27*) 
- Time allocated to patient care (–0.24*) 
- Research experience (–0.27*) 
- Supervising experience (-0.27*) 
+ Supervising experience (0.29*) 
NWO rating + Time allocated to research (0.30*) 
+ Time allocated to supervision of PhD students (0.29*) 
- Time allocated to patient care (–0.33*) 
- Management experience (–0.31*) 
 
 
Table 48: Significant correlations between contingencies and research performancei 
 
 
6.2.5.2 Bivariate correlations between managerial control and research performance 
 
Table 49 shows the significant correlations between the views and judgements of research leaders 
about research management items (internal and external control) and the research performance of both 
pre-clinical and clinical research groups. Furthermore, significant correlations between research 
management activities (internal and external control) undertaken by research leaders and the research 
performance of both pre-clinical and clinical research groups are shown in this table.  
 
Internal control  
 
Control of personnel resources 
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Table 49 shows that the extent to which pre-clinical research group leaders control their personnel (i.e. 
do not experience problems in securing qualified scientific staff) is positively associated with the 
number of MW-NWO proposals submitted.  
 
Time spent on internal managerial control 
In pre-clinical units, the time spent on internal managerial control is positively associated with both 
the percentage of external research funding received and the NWO rating. In clinical research groups a 
positive correlation was found between the amount of time allocated to internal managerial control and 
the number of MW-NWO grants received.  
 
Research commitment 
The involvement of pre-clinical research leaders in research activities within their own research groups 
shows a positive association with the number of SCI publications, the DAG 1998 score and the NWO 
rating. 
 
Communication 
The frequency of internally organised research meetings in pre-clinical research groups correlates 
positively with number of SCI publications and DAG 1998 score. In clinical research groups, the 
association between the frequency of internal research meetings and the number of SCI publications is 
only slightly positive.  
 
Research policy planning 
In pre-clinical research groups, discussion meetings about long-term research policy of the group are 
positively associated with the number of research proposals submitted to the NWO and the NWO 
rating.  
 
Rewards 
In pre-clinical research groups, the extent to which opportunities are offered to develop research skills 
correlates positively with the DAG 1998 score and the percentage of external research funding 
obtained, while in clinical research groups research skills correlate positively with the number of SCI 
publications. In pre-clinical research groups, the extent to which opportunities are offered to work 
flexible hours is positively associated with the number of NWO and MW-NWO proposals submitted. 
In contrast, in clinical groups the opportunity to work flexibly is negatively associated with the 
number of SCI publications. Special commendations given to motivate research staff show, in both 
pre-clinical and clinical research groups, positive correlations with the number of SCI publications and 
the amount of external research funding obtained. Furthermore, in pre-clinical groups a positive 
association is to be found with the number of NWO research proposals submitted. Finally, a positive 
 142  
correlation was found between the financial rewards offered in clinical groups and the number of SCI 
publications. 
 
Internally organised research evaluations 
The internally organised pre-evaluation of research proposals shows a positive association with the 
number of SCI publications in pre-clinical research groups. Pre-evaluations of research proposals that 
are organised on the level of universities and non-university research institutes show a positive 
correlation with the amount of external funding obtained by pre-clinical research groups. In contrast, 
in pre-clinical groups the correlation of the pre-evaluation of research proposals internally organised 
on a faculty level with the number of MW-NWO received grants is negative. The research leaders’ 
opinion that the internal organisation of pre-evaluations of research proposals is effective shows a 
positive association with the frequency of submission of NWO proposals in clinical research groups. 
There seems to be a positive association between the internal organisation of research output 
evaluations (organised on the level of both research groups and the faculty) and the amount of research 
funding obtained from external funding agencies.  
 
Importance of internally organised research evaluations 
The importance of internally organised research evaluations does not correlate significantly with the 
research performance of pre-clinical and clinical groups.  
 
 
PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
SCI publications + Special commendations (0.31*) 
+ Research commitment (0.26*) 
+ Research meetings (0.24*) 
+ Pre-evaluation research proposals organised on level 
of research group (0.24*) 
+ Research meetings (0.33*) 
+ Financial bonus system  (0.32*) 
- Flexibility (–0.31*) 
+ Research skills (0.27*) 
+ Special commendations (0.27*) 
DAG score + Research meetings (0.44**) 
+ Research commitment (0.43**) 
+ Research skills (0.31*) 
 
External research 
funding 
+ Pre-evaluation research proposals on the level of a 
university and a non-university research institute 
(0.41***) 
+ Special commendations (0.35**) 
+ Time spent on internal management activities (0.26*) 
+ Research skills (0.32*) 
+ Special commendations (0.42**) 
+ Internal evaluation of research output organised on a 
faculty level (0.34*) 
+ Internal evaluation of research output organised on  the 
level of research group (0.28*) 
 
NWO proposals  
submitted 
+ Special commendations (0.29*) 
+ Flexibility (0.28*) 
+ Research policy planning (0.25*) 
+ Effectiveness of pre-evaluations of research proposals 
(0.29*) 
 
MW-NWO 
proposals submitted 
+ Flexibility (0.26*) 
+ Resources for control of personnel (0.26*)  
MW-NWO grants 
received 
+ Pre-evaluation research proposals on the level of an 
faculty/research institute (-0.27*) 
+ Time spent on internal management activities (0.27*) 
NWO rating + Time spent on internal management activities 
(0.37**) 
+ Research policy planning (0.32**) 
+ Research commitment (0.27*) 
+ Internal evaluation of research output on level of 
faculty/research institute (0.25*) 
 
Table 49: Significant correlations between internal control and research performance 
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In sum, significant positive correlations are found between internal research management activities 
and research performance in both pre-clinical and clinical groups. In addition, significant positive 
correlations are found between the views and judgements of research leaders about internal research 
management items and the research performance of both pre-clinical and clinical research groups. 
 
External control  
Time spent on external research activities 
Table 50 shows that the amount of time leaders of pre-clinical groups spend on external research 
activities, correlates positively with the number of NWO proposals submitted. In clinical groups, a 
strong positive correlation is found between the time a research leader spends on external research 
activities and the number of SCI publications.  
 
Time spent on external managerial control 
The time pre-clinical research leaders spend on external managerial control shows a positive 
relationship with the percentage of external research funding obtained and the number of NWO 
research proposals submitted. In clinical research groups, the time research leaders spend on external 
management activities shows a positive association with the amount of external research funding 
obtained and the DAG 1998 score. 
 
Importance of externally organised research evaluations 
In pre-clinical research groups the importance of research school assessments correlates positively 
with the NWO rating (r = 0.25*).  
 
Importance of collaboration 
In pre-clinical research groups, the interest in collaboration with Ministries and semi-governmental 
organisations is negatively associated with the DAG 1998 score. In clinical research groups, by 
contrast, the interest in collaboration with Ministries and semi-governmental organisations correlates 
positively with the DAG 1998 score. In clinical groups, the interest in collaboration with 
pharmaceutical industries correlates positively with the DAG 1998 score and the percentage of 
external funding. In pre-clinical research groups, the interest in collaboration with the clinic is 
negatively associated with the DAG 1998 score and the amount of external funding. The interest of 
clinical groups in collaboration with the clinic is negatively associated with the NWO rating. Finally, 
in pre-clinical research groups, a negative association is shown between the interest in collaboration 
with family doctors and both the DAG 1998 score and the NWO rating.  
 
In sum, significant correlations are found between the views and judgements of research leaders about 
external collaboration and the research performance of both pre-clinical and clinical research groups. 
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It seems that the importance attached to collaboration with the clinic, general practitioners, Ministries 
and semi-governmental organisations correlate negatively with the research performance of pre-
clinical groups. In both pre-clinical and clinical research groups significant positive correlations are 
found between external research management activities and research performance. 
 
 
PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
SCI publications  + External research activities (0.47**) 
DAG score - Importance of collaborations with clinic (–0.35*) 
- Importance of collaborations with Ministries and 
semi-governmental organisations (–0.31*) 
- Importance of collaborations with family doctor  
(–0.30*) 
+ Importance of collaborations with pharmaceutical 
industries & firms (0.39*) 
+ Time for external managerial control (0.36*) 
+ Importance of collaborations with Ministries and semi-
governmental organisations (0.33*) 
External research 
funding 
+ Time spent on external managerial control  (0.37**) 
- Importance of collaboration with clinic (–0.27*) 
+ Time spent on external managerial control  (0.40**) 
+ Importance of collaboration with pharmaceutical 
industries/firms (0.29*) 
NWO proposals  
submitted 
+ Time spent on external managerial control  (0.32**) 
+ Time spent on external research activities (0.28*) 
 
MW-NWO 
proposals submitted 
 
 
MW-NWO grants 
received 
  
NWO rating - Importance of collaboration with family doctor  
(-0.26*) 
+ Importance of research school accreditation (0.25*) 
- Importance of collaboration with clinic (–0.26*) 
 
Table 50: Significant correlations between external control and research performance 
 
 
6.2.5.3 Bivariate correlations between contingencies and managerial control 
 
Contingencies, such as the size of the research group, the time that can be spent on research and the 
experience of the research leader, may influence the choice and the extent to which research 
management activities are organised and introduced in medical and health groups. Also, contingencies 
may influence the views and judgements of research leaders about both internal and external research 
management items. Table 51 presents significant correlations between the contingencies of both pre-
clinical and clinical research groups and research management items.   
 
Size 
The number of staff employed in health research groups is positively correlated with the time the 
research leader spends on external management activities and with the extent to which the research 
leader uses financial bonus systems to motivate employees. Furthermore, the size of clinical research 
groups shows a positive correlation with the time research leaders spend on external research activities 
and with the extent to which research leaders offer special commendations. In pre-clinical research 
groups a positive correlation is found between group size and the organisation of research policy 
meetings.  
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Time allocation 
In pre-clinical research groups, time allocation shows an inverse relationship with the importance of 
collaboration with family doctors, clinics and pharmaceutical industries/firms. If more time is 
allocated to research and the supervision of PhD students, the importance of collaboration between 
pre-clinical research groups and family doctors, clinics and pharmaceutical industries/firms is lower. If 
the emphasis is put on patient care, the importance of collaboration with family doctors, clinics and the 
pharmaceutical industry/firms is higher. Also, an inverse relationship in pre-clinical groups is found 
between time allocation (to research and patient care) and research commitment.   
Furthermore, the time pre-clinical research leaders allocate to research and supervision shows a 
positive correlation with the number of research meetings. In pre-clinical research, the time allocated 
to patient care shows negative correlations with the amount of time spent on both internal and external 
management activities and the extent to which opportunities are offered to staff members to develop 
their research skills. Negative correlations are also found in pre-clinical groups between the time 
allocated to research and the level of direct communication and between the amount of time allocated 
to the supervision of PhD students and the importance attached to internal research evaluations. 
In clinical research groups, time allocated to research and supervision is positively associated with the 
amount of time spent on internal management activities, the amount of time spent on external research 
activities and research commitment. In clinical research groups, in addition, time allocated to research 
shows a positive correlation with the research leaders’ opinion about the effectiveness of internal pre-
evaluation of research proposals. In clinical groups, time allocated to research correlates negatively, 
and time allocated to patient care positively, to the importance attached to collaboration with the 
clinic. Moreover, time allocated to patient care is negatively associated with the time spent on internal 
management activities and the extent to which staff are offered the opportunity to work flexibly. 
 
Age 
The research experience of pre-clinical leaders correlates negatively with the extent to which 
opportunities are offered to staff to work flexibly and with the importance attached to collaboration 
with pharmaceutical industries and firms. The management experience of pre-clinical leaders is 
positively associated with the importance attached to collaboration with family doctors and negatively 
with the number of research meetings organised in the responding groups. In clinical research groups, 
the management experience of research leaders seems to have a positive association with the personnel 
resource control and with the organisation of discussions of internal research policies. Table 51 shows 
that, in pre-clinical research groups, the foreign experience of leaders is positively associated with 
research commitment. In clinical research groups, the foreign experience of research leaders correlates 
positively with: 
– the time spent on external research activities 
– the extent to which opportunities are offered to develop research skills 
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– the extent to which special commendations are given to staff members, and  
– the importance attached to collaboration with pharmaceutical industries and firms.   
The experience of pre-clinical research leaders in supervising the research group is negatively 
associated with the extent to which financial bonus systems are used to stimulate staff. Also, a 
negative association is found with the importance attached to collaboration with pharmaceutical 
industries/firms, governmental agencies and family doctors. The experience of clinical leaders in 
supervising their research group show a positive correlation with the use of an internal evaluation of 
research output on the level of the group. 
 
Work setting  
The work setting is only correlated with research management items in pre-clinical research groups. It 
correlates positively with the organisation of pre-evaluation of research proposals on an organisational 
level, as well as with the opinion about the effectiveness of those evaluations as shown in Table 51. 
The work setting is also positively associated with the research commitment of pre-clinical leaders. 
Negative correlations are found between the work setting and two management activities (meetings 
about research policy and using of financial bonuses) and two managerial opinions about research 
collaboration. 
 
In sum, it is shown that contingencies have significant associations with views and judgements of 
research leaders about both internal and external research management items. Contingencies also have 
significant associations with the use of internal and external research management activities. In pre-
clinical research groups, positive correlations are found between contingencies and research 
management items except for the contingencies and research management items related to patient care. 
In clinical research groups, contingencies show mainly positive correlations with research 
management (both views/judgements and activities). In both types of research groups the amount of 
time allocated to patient care shows a negative correlation with research management 
views/judgements and activities.  
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PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
Staff members + Financial bonus system (0.34**) 
+ Research policy planning (0.27*) 
+ Time spent on external managerial control  (0.25*) 
+ Special commendations (0.37**) 
+ Time spent on external managerial control (0.32*) 
+ Time spent on external research activities (0.29*) 
+ Financial bonus system (0.28*) 
Work Setting + Pre-evaluation of research proposals on 
university/non-university institute level (0.39*) 
- Financial bonus system (-0.29*) 
- Importance of collaboration with family doctor (-
0.29*) 
+ Research commitment (0.28*) 
- Research policy planning (-0.28*) 
- Importance of collaboration with Ministries and semi-
governmental organisations (-0.27*) 
+ Effectiveness of pre-evaluations (0.27*) 
 
Time allocated to 
research 
+ Research commitment (0.45***) 
- Direct communication (-0.40**) 
+ Research meetings (0.29*) 
- Importance of collaboration with family doctor  
(-0.26*) 
- Importance of collaboration with clinic (-0.25*) 
+ Time spent on internal managerial control (0.35**) 
+ Time spent on external research activities (0.33*) 
+ Research commitment (0.29*) 
+ Effectiveness pre-evaluation proposals (0.26*) 
- Importance of collaboration with clinic (-0.26*) 
Time allocated to 
education 
+ Importance of collaboration with family doctor 
(0.31*) 
+ Financial bonus system (0.24*) 
- Importance of collaboration with clinic (-0.25*) 
+ Internal evaluation research output on faculty level 
(0.35*) 
Time allocated to 
patient care 
+ Importance of collaboration with Ministries and 
semi-governmental organisations (0.41***) 
- Time spent on internal managerial control (-0.37**) 
+ Importance of collaboration with clinic (0.34**) 
+ Importance of collaboration with family doctor 
(0.34**) 
- Research commitment (-0.33*) 
- Time spent on external managerial control (-0.29*) 
- Development of skills (-0.29*) 
+ Importance of collaboration with clinic (0.44**) 
-  Flexibility (-0.32*) 
- Time spent on internal managerial control  
(-0.35**) 
Time allocated to 
supervision 
+ Research commitment (0.47***) 
+ Time spent on internal managerial control (0.43***) 
- Importance of collaboration with Ministries and semi-
governmental organisations (-0.31*) 
+ Research meetings (0.27*) 
- Importance of collaboration with family doctor 
(–0.27*) 
- Importance of internal research evaluations (–0.25*) 
+ Time spent on internal managerial control (0.40**) 
+ Research commitment (0.37**) 
+ Time spent on external research activities (0.27*) 
Research experience - Importance of collaboration with pharmaceutical 
industries and firms (-0.26*) 
- Flexibility  (-0.24*) 
 
Management 
experience 
+ Importance of collaboration with family doctor 
(0.42**) 
- Research meetings (-0.29*) 
+ Resources control: personnel (0.43*) 
+ Special commendations (0.32*) 
Foreign experience - Importance of collaboration with clinic (-0.31*) 
+ Development of skills (0.28*) 
+ Control of personal resources (0.26*) 
+ Special commendations (0.24*) 
+ Importance of collaboration with clinic (0.37**) 
+ Importance of collaboration with research groups 
(0.28*) 
+ Time spent on external research activities (0.26*) 
Supervising 
experience 
+ Importance of collaboration with pharmaceutical 
industries & firms (–0.45***) 
- Importance of collaboration with Ministries and semi-
governmental organisations (–0.35**) 
- Financial bonus system (–0.33**) 
- Importance of collaboration with family doctor  
(–0.25*) 
+ Internal evaluation of research output on the level of 
group/department (0.39**) 
 
Table 51: Significant correlations between contingencies and research management items 
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6.2.6 Multivariate associations 
 
To explore the causal relationships between contingencies, research management and research 
performance in pre-clinical and clinical research groups (see Figure 11), stepwise multiple regression 
analysis was carried out.  
 
 
 
 
 
                                                    
 
 
 
 
 
 
Figure 11: The internal organisation of research groups 
 
A stepwise approach was chosen because of the exploratory character of this research question. The 
set of independent variables was not closely specified in the regression model. Furthermore, the set of 
independent variables was not essentially used in a confirmatory approach. A stepwise approach 
allows the researcher to examine the contribution of each independent variable to the regression model 
(Hair et al., 1998). Each variable was considered for inclusion prior to developing the equation. The 
independent variable (contingencies and research management items) with the greatest contribution 
was added first. Independent variables were then selected for inclusion based on their incremental 
contribution to the variables already present in the equation (Hair et al., 1998). The independent 
variables for which incremental F was not significant even at the 5% level were excluded. A series of 
stepwise regression (forward addition) analyses was carried out to determine the sets of predictors 
separately for each performance measure. The results are presented in Tables 53-59. R2 (adj) indicates 
the variance explained by the predictors.  
 
Validity  
Before stepwise regressions were conducted, the construct validity of outcome variables was assessed 
by using factor analysis (Principal Component Analysis, PCA). Table 52 shows that three factors, with 
a value greater than 1.00, were extracted. These three factors explain 74.45% of total variance. The 
PCA analysis revealed one factor of three items – the number of NWO proposals submitted, the 
number of MW-NWO proposals submitted and the number of MW-NWO grants obtained – reflecting 
the NWO activity of research groups (component 1). These three items can be reduced to one 
dimension. A one-dimensional index, ‘NWO activity’, was constructed and used in multivariate 
Contin-
gencies 
Manage-
ment 
activities 
Perfor-
mance 
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stepwise regression analysis. There are two items that load on more than one component. The variable 
‘DAG 1998 score’ has a low loading on both component 2 and component 3. The variable ‘NWO 
rating’ has a medium loading on both component 1 and component 2. In total 5 different variables 
were used in the stepwise regression analysis to measure research performance. 
 
 COMPONENT 1 
FACTOR 
LOADINGS 
COMPONENT 2 
FACTOR 
LOADINGS 
COMPONENT 3 
FACTOR 
LOADINGS 
Number of SCI publications 0.09 0.08 0.93 
DAG 1998 score 0.20 0.44 0.47 
External research funding 0.02 0.88 0.03 
Number of NWO proposals 
submitted 
0.78 0.38 0.14 
Number of MW-NWO 
proposals submitted 
0.94 0.12 0.07 
Number of MW-NWO grants 
obtained 
0.91 0.03 0.15 
NWO rating 0.45 0.62 0.09 
Explained variance 36.59 21.43 16.43 
 
Table 52: Factor loadings and variance explained after varimax rotation: results of a principal 
component analysis of seven items for research performance of all research groups 
 
Number of SCI publications 
Stepwise multiple regression analysis shows three predictors explaining about 27% of the variance in 
number of SCI publications (see Table 53) within pre-clinical research groups. The amount of time a 
research leader allocates to supervision of PhD students is the most important predictor (β = 0.36; 
P<0.001). Also special commendations given to research staff (β = 0.32; P<0.01) predict the number 
of SCI publications. Interestingly, the work setting71 of research groups has a negative relationship 
with the number of SCI publications (β = -0.38; P<0.001). This means that working in a non-
university institute has a negative relationship with the number of SCI publications that are published 
in these groups. This result may be explained by existing differences in publication strategies (e.g. 
Moed, 2000) between research groups. Open interviews that are conducted –in the earlier stages of this 
study- with experienced pre-clinical research leaders of non-university institutes showed that a number 
of Dutch medical and health non-university research institutes are stimulating researchers to focus on 
quality. They are encouraged to publish in highly renowned SCI journals within their medical subfield 
or to publish in interdisciplinary prestigious journals such as Nature, Science and Cell. As a 
                                                          
71
 Work or organisational setting (university versus institute) is used in this study as a contingency variable. In 
1995 Omta demonstrated that institutes judge elements of system control (constituted as an element of 
managerial control) e.g. effectiveness of personnel policy, adequacy of resources and administrative control 
more positively compared to universities.  
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consequence, the number of SCI publications of these research groups (quantity) may be relatively 
low compared to research groups that are not managed in this way.  
The step-wise regression reveals that 65% of the variance in the number of SCI publications within 
clinical research groups can be explained by seven predictors (Table 53). The three most important 
predictors are contingency variables: (1) the size of the research group (β = 0.44; P<0.001), (2) the 
amount of time allocated to research activities (β = 0.46; P<0.01) and (3) the amount of time allocated 
to patient care (β = 0.38; P<0.001). In addition to contingencies, four research management variables 
account for a fair amount of the variance in the variable in question. The first is the opinion of the 
clinical research group leaders about the importance of internal research assessments (β = –0.24; 
P<0.01). The second is the amount of time clinical research leaders spend on external research 
activities (β = 0.25; P<0.01). The third is the control of personnel resources (β = 0.18; P<0.05). The 
fourth research management variable is the frequency of internal research meetings (β = 0.17; 
P<0.05).  
 
RANKING OF PREDICTORS PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
1st rank Time allocated to supervision 
(β = 0.36***) 
Research staff 
(β = 0.44***) 
2nd rank Work setting 
(β = -0.38*) 
Time allocated to research 
(β = 0.46**) 
3rd rank Rewards: special commendations 
(β = 0.32*) 
Time allocated to patient care 
(β = 0.38***) 
4th rank – Importance internal research evaluations 
(β = –0.24**) 
5th rank – Time spent on external research activities 
(β = 0.25**) 
6th rank – Control of personnel resources 
(β = 0.178*) 
7th rank – Research meetings 
(β = 0.20*) 
R2 (adj) 0.27 0.65 
F ratio 9.57*** 17.12*** 
 
Table 53: Step-wise regression of contingency and research management variables on the number of 
SCI publications. *P<0.05; **P<0.01; ***P<0.001  
 
DAG 1998 score  
In pre-clinical groups, time allocated by a research leader to research and patient care are the most 
important predictors for the DAG 1998 score (see Table 54). Time allocated to research has a positive 
relationship with the DAG 1998 score. However, time allocated to patient care has a negative 
relationship with the DAG 1998 score. Furthermore, three research management variables have linear 
relationships with the DAG 1998 score. The number of research meetings shows a positive 
relationship (β = 0.29; P<0.01) with the DAG 1998 score: more research meetings will result in a 
higher DAG 1998 score. Research output evaluations internally organised by universities and non-
university research institutes also have a positive relationship with the DAG 1998 score (β = 0.24; 
P<0.01). Interestingly, research output evaluations organised by the research group itself show a 
negative relationship with the DAG 1998 score (β = –0.21*; P<0.05). The set of predictors explains 
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about 54% of the variance in the DAG 1998 score. In clinical groups, the set of predictors was 
comprised of indices reflecting the time that is spent on external management activities and the interest 
that is taken in collaboration with governmental agencies. These predictors together explain 22% of 
the variance in the DAG 1998 score. 
 
RANKING OF 
PREDICTORS 
PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
1st rank Time allocated to research 
(β = 0.28**) 
Time spent on external management activities 
(β = 0.39**) 
2nd rank Time allocated to patient care 
(β = –0.38***) 
Importance collaboration with pharmaceutical 
industries 
(β = 0.34***) 
3rd rank Research meetings 
(β = 0.29**) 
- 
4th rank Research output evaluations internally organised by 
universities and non-university research institutes 
(β = 0.24**) 
– 
5th rank Research output evaluations internally organised by 
research groups 
 (β = –0.21*) 
– 
R2 0.54 0.22 
F ratio 15.31*** 8.07*** 
 
Table 54: Step-wise regression of contingency and research management variables on the DAG 1998 
score. *P<0.05; **P<0.01; ***P<0.001 
 
External research funding 
Table 55 shows that if a pre-clinical research group leader allocates more time to patient care this will 
decrease the amount of external research funding obtained (β = –0.45; P<0.001). Moreover, the use of 
pre-evaluations of research proposals -before they are submitted to external funding agencies- that are 
internally organised by universities and non-university research institutes has a positive relationship 
with the percentage of external research funding obtained (β = 0.37; P<0.001). Also the extent to 
which special commendations are given to research staff is positively related to the percentage of 
external research funding. These three predictors together explain 42% of the variance in percentage of 
external research funding obtained. The set of external research funding predictors in clinical research 
groups, as presented in Table 55 by step-wise regression, comprises four management activities. 
Together they explain 33% of the variance.  
1. Amount of time clinical research leaders allocate to external management activities (β = 0.28; 
P<0.05); 
2. Extent to which special commendations are used to stimulate staff members (β = 0.31; P<0.01);  
3. Evaluation of research output internally organised by medical faculties (β = 0.35; P<0.01);  
4. Interest in collaboration with family doctors (β = 0.24; P<0.05). One possible explanation of this 
last result might be that family doctors, because they have access to their own extensive patient 
database, are easily able to select and find patients with particular diseases or syndromes.  
Collaboration between researchers and family doctors may contribute to solving sample-size problems 
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in study designs. Lastly, initiation and maintenance of collaboration with family doctors can be 
interpreted as an external research management activity. However, no significant correlation between 
time allocated to external management activities and interest in collaboration with family doctors has 
been found.  
 
RANKING OF 
PREDICTORS 
PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
1st rank Time allocated to patient care 
(β = –0.45***) 
Time spent on external management activities 
(β = 0.28*) 
2nd rank Pre-evaluations of research proposals internally 
organised by universities and non-university research 
institutes 
(β = 0.37***) 
Special commendations 
(β = 0.31**) 
3rd rank Special commendations 
(β = 0.25**) 
Pre-evaluations of research proposals internally 
organised by medical faculties  
(β = 0.35**) 
4th rank – Importance attached to collaboration with family 
doctors 
(β = 0.24*) 
R2 0.42 0.33 
F ratio 18.14*** 8.43*** 
 
Table 55: Step-wise regression of contingency and research management variables on the percentage 
of external research funding obtained. *P<0.05; **P<0.01; ***P<0.001 
 
NWO activity 
Table 56 shows that the set of predictors of Dutch research-council activity in pre-clinical groups 
consists of indices of contingencies and internal management activities. Four predictors explain 35% 
of the total variance. As shown in Table 56, the size of the pre-clinical research groups contributed 
most to the explained variance in Dutch research-council activity of research groups (β = 0.29; 
P<0.001). Other positive significant linear relations in order of importance are the time research 
leaders spend on external research activities (β = 0.23; P<0.05) and the extent to which flexibility in 
both working hours and work place (e.g. the possibility of working at home) is offered and used by 
leaders as a reward to motivate research staff (β = 0.20; P<0.05). Not surprisingly, the amount of time 
research leaders allocate to patient care (β = –0.19; P<0.05) shows a negative relationship with Dutch 
research-council activity.  
 
 153 
 
RANKING OF 
PREDICTORS 
PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
1st rank Research staff 
(β = 0.29***) 
Effectiveness of internally organised pre-
evaluation of research proposals 
(β = 0.27*) 
2nd rank Time allocated to patient care 
(β = –0.28*) 
 
3rd rank 
 
Time spent on external research activities 
(β = 0.23*) 
 
4th rank Rewards: flexibility 
(β = 0.20*) 
 
R2 0.35 0.06 
F ratio 10.52*** 4.69* 
 
Table 56: Step-wise regression of contingency and research management variables on NWO activity. 
*P<0.05; **P<0.01; ***P<0.001 
 
By using univariate analysis of variance it can be shown (Table 57) that pre-clinical research groups 
that organise pre-evaluations of research proposals and do not participate in pre-evaluations of 
proposals organised by medical faculties, submit more proposals to NWO and MW-NWO and also 
obtain more MW-NWO grants (mean Dutch research-council activity 3.20) than pre-clinical research 
groups not involved in pre-evaluations of proposals at all (Dutch research-council activity 1.11). 
Interestingly, pre-clinical research groups that not only organise pre-evaluations of proposals but also 
participate in pre-evaluations organised on a faculty level show almost the same Dutch research-
council activity (mean 1.18) as pre-clinical research groups not involved in pre-evaluations of 
proposals (mean 1.11). Apparently, involvement in pre-evaluations of proposals at both levels of 
organisation causes an additional barrier to undertaking Dutch research-council activity. For example 
pre-evaluations can result in inconsistency in evaluation scores, comments and suggestions to improve 
research proposals. Furthermore, pre-evaluation processes take time. To summarise, researchers can be 
discouraged from submitting research proposals. This process is further amplified given the fact that 
the Dutch research-council success percentage is already relatively low. 
 
PRE-EVALUATION OF RESEARCH PROPOSALS 
Research group level Medical faculty level  
NWO ACTIVITY (MEAN) N 
0 (No) 0 (No) 1.11 12 
1 (Yes) 0 (No) 3.20 15 
1 (yes) 1 (Yes) 1.18 41 
0 (No) 1 (Yes) – 0 
 
Table 57: Univariate analysis of variance with NWO activity as a dependent variable 
 
Table 56 indicates that there is only one variable that is related to Dutch research-council activity in 
clinical research groups: research leaders who think that internally organised pre-evaluations of 
research proposals are effective submit more proposals to both the NWO and the MW-NWO and 
obtain more MW-NWO research grants (β = 0.27; P<0.05). This predictor explains only 6% of the 
variance in Dutch research-council activity. Of more interest is the observation that, in the period 
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1999–2001, no less than 34% of responding clinical research groups did not submit research proposals 
to either the NWO or the MW-NWO. In order to investigate further the relation between 
contingencies, research management and Dutch research council activity in clinical research groups, a 
dummy variable was constructed. A dummy is used because the variable is not normally distributed 
(code 0= no Dutch research-council activity; code 1= any Dutch research-council activity). Table 58 
indicates that there are three management activities that are positively related to Dutch research-
council activity in clinical research groups: (1) stimulation of research staff by offering special 
commendations (β = 0.33; P<0.01); (2) participation in research output evaluations organised by 
medical faculties (β = 0.28; P<0.05) and (3) organisation of internal research policy meetings (β = 
0.26; P<0.05). The importance of collaboration with the clinic has a negative relationship with Dutch 
research council activity (β = -0.30*; P<0.05). These factors together explain 26% of the variance in 
Dutch research-council activity. The mission of the Dutch research council in the period 1999-2001 to 
stimulate mainly basic medical and health research can explain the negative relationship between 
collaboration with clinic practice and Dutch research-council activity. Also the criteria –mainly 
scientific quality- that were used in the selection process favoured the stimulation of pre-clinical 
research. 
 
RANKING OF PREDICTORS CLINICAL RESEARCH GROUPS 
1st rank Rewards: special commendations 
(β = 0.33**) 
2nd rank Research output evaluations internally organised by medical faculties 
(β = 0.28*) 
3rd rank 
 
Importance of collaboration with clinics 
(β = –0.30*) 
4th rank Research policy planning 
(β = 0.26*) 
R2 0.26 
F ratio 6.19*** 
 
Table 58: Step-wise regression of contingency and research management variables on NWO activity in 
clinical research groups. *P<0.05; **P<0.01; ***P<0.001 
 
NWO rating of research group leaders 
Table 59 indicates that four research management variables are related to the NWO rating of pre-
clinical research leaders: (1) the amount of time leaders spend on internal management activities (β = 
0.32**), (2) the organisation of internal research policy meetings (β = 0.50***), (3) participation in 
research output evaluations internally organised on the level of the medical faculties (β = –0.29*) and 
(4) direct communication between research group members (β = -0.23*). Furthermore, the 
management experience of the pre-clinical leader has a negative relationship with the NWO rating (β 
= –0.24*). These four research management variables and one contingency factor together explain 42% 
of the variance in the NWO rating. In clinical research groups, four research management variables 
have a relationship with the NWO rating of the leaders. The internal organisation of policy as well as 
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research meetings has a positive relationship with the NWO rating (β = 0.27*and β = 0.25* 
respectively). Furthermore, a positive relationship has been found with participation in research output 
evaluations organised by medical faculties (β = 0.27*). The most important predictor of the NWO 
rating of pre-clinical research group leaders seems to be the importance attached to collaboration with 
the clinic. The importance given to collaboration with the clinic has a negative relationship with the 
NWO rating of the research leader. The four factors together explain 26% of the variance in the NWO 
rating of clinical research group leaders (see Table 59 for an overview). 
 
RANKING OF 
PREDICTORS 
PRE-CLINICAL RESEARCH GROUPS CLINICAL RESEARCH GROUPS 
1st  rank Time spent on internal management activities 
(β = 0.32**) 
Importance of collaboration with clinic 
(β = –0.32**) 
2nd  rank Research policy planning 
(β = 0.50***) 
Research policy planning 
(β = 0.27*) 
3rd rank Research output evaluation internally organised by 
medical faculties  
(β = –0.29*) 
Research output evaluation internally organised 
by medical faculties  
 (β = 0.27*) 
4th rank Direct communication 
(β = –0.23*) 
Research meetings 
(β = 0.25*) 
5th rank Research commitment 
(β = 0.20*) 
- 
R2 0.42 0.26 
F ratio 9.64*** 5.03*** 
 
Table 59: Step-wise regression of contingency and research management variables on the NWO rating 
of research group leaders. *P<0.05; **P<0.01; ***P<0.001 
 
 
6.3 Concluding remarks 
 
We have analysed the relationship between experiences with and views of managerial control and the 
performance of Dutch medical research groups. Our empirical study shows that there is one internal 
research management activity which has a positive relationship with medical research performance in 
general. Offering honorable mentions to medical (both pre-clinical and clinical) research staff 
members, including non-financial prizes, in order to motivate them is positively correlated with the 
number of SCI publications, the percentage of externally obtained research funding and the NWO 
activity of research groups. In the regression analyses with contingencies and managerial control 
variables we found a positive linear relationship between special commendations and two medical 
research performance measures. It was found that the disciplinary setting, and classification into pre-
clinical and clinical research, affect the relationships between managerial control and performance. 
Interesting differences were found between pre-clinical and clinical research groups. Section 7.3 
presents and discusses these differences in more detail (see Table 62).  
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Patient care and performance 
As could be expected, the time allocated to research and the time allocated to patient care show an 
inverse relationship. Research leaders of pre-clinical groups spend significantly more time on research 
than research leaders of clinical groups. However, this extra time spent is not translated into better 
research performance. These results are in line with the work of Omta (1995) who found, in a study of 
medical scientific staff, that although scientific staff in pre-clinical units can spend twice as much time 
on research as staff in clinical units, this does not result in higher research quality or user 
effectiveness. In addition, we found negative linear relationships between the time pre-clinical 
research leaders spent on patient care and various research performance measures: the amount of 
research funding, NWO activity and the DAG 1998 score. Interestingly, in clinical research groups 
time that was spent on patient care had a positive linear relationship with the number of SCI 
publications72. An explanation for this unexpected finding is that working in clinical practice enlarges 
the possibilities of generating interesting and innovative research questions. In this respect the recent 
bibliometric study of research conducted at Dutch university medical centres (2004) should be 
mentioned. It shows that the number of publications of UMCs in clinical journals is relatively high. 
For instance the impact on general and internal medicine is quite impressive; the citation score is 
almost three times the international average.  
 
Reflection on research performance indicators used 
We experienced problems by using the DAG 1998 score as a research-group performance measure. 
First, research has been evaluated within the DAG 1998 procedure on the level of research themes. 
Research leaders were asked in the survey study to write down the overall DAG 1998 quality score of 
the research theme to which their groups belonged. It should be noted that a research theme consists of 
several (parts of) research groups. Therefore, (small) differences in DAG scores among research 
groups within a theme are possible, but not known. Second, factor analysis as presented in Table 54, 
showed that for the DAG 1998 there were only medium loads (0.44 and 0.47) on components 2 and 3 
and a low load (0.20) on component 1. This indicates that more than one component explains the 
variance of the variable, DAG 1998. Finally, the interview part of this thesis showed that both research 
leaders and research administrators reported negative views and experiences regarding the DAG 1998 
procedure. Consequently, the impact and implementation of DAG 1998 outcomes and 
recommendation were relatively low. In conclusion, the DAG 1998 score is less meaningful than 
generally assumed.  
                                                          
72
 In search for an explanation for this result we studied the combined effect of two factors (interaction effect). 
This means that the effect of one variable has to be shaded by the other variable. The positive effect of time 
allocated to patient care on the number of SCI publications might be valid for leaders who also spent some time 
on, for example, (internal/external) research activities. For research leaders who spent no time or too much time 
(in relation to the time allocated to patient care) on research activities, the effect would be absent or even 
negative. However, no significant effects of interactions were found.  
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In conclusion, five objective measures are used in this study to indicate research group performance. 
Although the technical and methodological problems involved with an indicator, for gathering and 
handling data and its relative use as a measure of research performance have been individually 
discussed and criticised by scholars, the simultaneous use of various measures as applied in this 
chapter provides a good assessment of research performance in medical and health groups. 
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CHAPTER 7: CONCLUSIONS AND DISCUSSION 
 
 
This thesis studied how Dutch medical and health research groups are affected by both internal and 
external evaluations and how (and in what way) they react to them. In addition, the study investigated 
whether research evaluations and other managerial control elements influence research- group 
performance.  
Although a number of scholars have studied the externally organised evaluation processes in the 
Netherlands, the effects and implications of these evaluations are hardly ever studied. In addition to 
external evaluations, we also reported information about internally organised research evaluations and 
their implications. They are interpreted as management activities. This approach is innovative; until 
now relatively little was known about internal research evaluations. In addition, empirical studies that 
described the relationship between managerial control and research performance omitted research 
evaluations from the scope of research. In this thesis research management, known contingency items, 
and research performance were studied together in one study. This is rarely done. Moreover, while 
empirical studies -which examined research performance- concentrated on only one or a few research 
management activities, managerial views, contingencies or personal characteristics of the scientist, this 
thesis was used to assess the relevance of the various factors known to influence research 
performance.  
This thesis used qualitative (interviews) and quantitative (questionnaire) techniques, as described in 
detail in chapter 3. It was organised in such a way that the first stages led to further definitions of the 
research area by finding out what was known about the topic and then developing more detailed 
questions about the topic for the main part of the empirical work. Both interview protocol and 
questionnaire were designed (including pre-testing) by obtaining in-depth information through 
interviews. Also literature was reviewed (see chapter 2). The response rate for the empirical 
management study was good. Together, this may inspire more confidence in the general validity of the 
findings. 
 
In this final chapter the general research questions, which were formulated in chapter 1 and presented 
in the empirical part of this thesis (chapter 4, 5 and 6), will be answered and discussed. The chapter 
ends with some implications for further research on the management of academic research. 
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Figure 12: Summary of medical and health research evaluations operating during the time when empirical data for this thesis was collected (2000-2002). 
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7.1 Medical and health research evaluations in the Netherlands 
 
Chapter 4 showed that medical and health research groups in the Netherlands have to deal with 
evaluation practices organised by various intermediary organisations in all phases of the research 
process. Furthermore, medical and health research groups in the Netherlands are subjected to internal 
research evaluations, as is shown in chapter 5. Different entities such as universities, non-university 
institutes and medical faculties organise such internal research evaluations. Also the majority of the 
research leaders interviewed conduct their own evaluations to control and stimulate their research 
input and research output. Research evaluations studied in this thesis have been summarised in Figure 12. 
This figure is based on Figure 6 (chapter 4, page 103) and Figure 9 (chapter 5, page 125). The arrows in 
this figure are described and explained in section 4.5 and section 5.3 of this thesis. This thesis reveals that 
some of the external research evaluation practices organised by intermediaries are copied and used in 
internal research evaluations by entities acting on the performance level. The organising bodies 
operating in the Dutch medical and health systems are subject to various changes in the way they 
interact, which in turn constantly influences the way  evaluations are made. For example, the DAG 
evaluation no longer exists in the form reported. 
 
We have seen that in all the research evaluation practices encountered in this study there is a 
traditional evaluation of scientific quality based on peer review. Peer review is a collective noun of 
different evaluation practices that uses peers. Chapters 4 and 5 showed that peers are asked in ex-ante, 
ex-post and incidental evaluations (such as RGO advices) to give comments and recommendations to 
improve research. If research proposals are pre-evaluated, advice about the possible external success 
percentages is also given.  
The protocol of evaluation practices differ, for example the use of peer review committees or 
individual peers. Questions which organizers have to deal with are for instance: how to select peers; 
how to compare the pro’s and cons of peer independence and expertise; who sets priorities and makes 
selections and takes final decisions and how is all this being performed? The selection of (anonymous) 
peers is one of the most important steps in the evaluation process. A peer must be competent to carry 
out the evaluation. In internal research evaluations direct colleagues or researchers who are employed 
within the same faculty or non-university research institutes indicate research performance. In external 
evaluations, peers must also be completely independent from the evaluation object involved. 
Consequently, only external peers are used. In internal evaluations external peers are rarely involved. 
In the evaluation of scientific quality of research peers are always scientists. 
Additionally, the question of societal quality, impact and relevance is becoming increasingly 
important, especially in externally organised research evaluations. However, Figure 13 shows that 
ZonMw is as yet the only intermediary that let peers indirectly evaluate the societal aspects of 
research. These proposals are submitted to societally relevant research programmes. Non-university 
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research institutes and universities that have been studied for this thesis do not use societal quality as a 
performance indicator (see Figure 13). Only one research institute, which has a clear mission to 
produce ‘useful’ knowledge and technology, deals with both scientific and societal aspects of medical 
and health research in their self-evaluations. Methodologies and indicators to measure the societal 
aspects of medical and health research are now being developed and tested in the Netherlands. Most of 
these experimental methodologies are quantitative evaluation tools that can be used in qualitative peer 
practices such as self-evaluations and external audits. This is not solely a Dutch concern; it is also 
being addressed in other countries. Lyall et al. (2004) for instance recently reported about the 
assessment methodology of end-user relevance in evaluating the output of biological (and agricultural) 
research organisations in the UK. Furthermore, societal aspects of research cannot be grafted onto the 
traditionally based peer review process. Because research activities are not only geared towards 
scientific colleagues, but also to other stakeholders, traditional peer review processes can be extended 
by including stakeholders, other than scientists, in the evaluation process of science. In that way, the 
Medical Committee of the KNAW has proposed the consultation of patient organisations, health-care 
institutions, policy-makers and research clients. The findings of the shift to extended peer review are 
in line with discussions in other Dutch studies, as for example the inclusion of lay jury73 in the 
evaluation process of research proposals organised by the Dutch Technology Foundation (van der 
Meulen and Rip, 2000). Finally, it may be possible that by consultating patient organisations, health-
care institutions, policy makers and research clients as suggested within the new national research 
evaluation system (see Figure 13 last column), the societal impact of research will become an 
increasingly important indicator in both internally and externally organised Dutch medical and health 
research evaluations. 
 
 
7.2 Implications of externally organised research evaluations  
 
In the medical and health sector, externally research evaluations are organised to fund research 
(ZonMw), to mark performance (ECOS), to inform about research (RGO, VSNU, RMW) and to direct 
research (RGO and ZonMw). The impact of externally organised evaluation procedures and outcomes 
on Dutch medical and health research differs. As shown in chapter 4, ZonMw evaluation practices and 
evaluation outcomes have a high impact. A few features of the evaluation procedures are borrowed 
and used in internally organised ex-ante evaluations. Also the winning MW-NWO grants are highly 
esteemed on the research performance level. In addition, ZonMw evaluation outcomes are used as a 
research performance indicator in internal resource (re)allocation processes. As reported in chapter 4, 
interviews about the accreditation of research schools showed that their impact has been reduced. The 
                                                          
73
 In this case, lay in the sense that they need not have any knowledge about the research domain of the research 
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strong increase in the number of research schools, which have obtained accreditation, seems to be the 
most important reason. Therefore, an accreditation is now no longer an indicator of performance. The 
interview and survey study as presented in chapter 4 has revealed that the DAG 1998 evaluation had 
little impact. 
 
Three different problems were identified within the evaluation procedure, which limited the use of 
DAG 1998 scores by research groups. First, evaluations units were not recognised. Second, 
communication (frequency and amount) between research level and evaluation organisers (RMW and 
VSNU) was unsatisfactory. Third, the evaluation procedure took so much time that evaluation 
outcomes and recommendations were outdated as soon as they were published. In conclusion, it 
appears that the impact of external evaluations sometimes changes over time due to, for example, 
adjustments in the evaluation procedure.  
 
Although attention to externally organised evaluations as well as knowledge accumulation in that area 
is extensive, none of the intermediary organisations ever conducted studies on the effects of external 
research evaluations. Consequently, intermediary organisations have little information on either 
positive or negative adjustments in internal work processes that are implemented as a response to the 
recommendations. In my opinion, this absence of follow-up studies is remarkable. It hampers 
communication between intermediaries and research institutes/groups. In this way it also fosters and 
increases the feeling of many researchers’ that dealing with external evaluations is an administrative 
and bureaucratic burden. It can be argued that replacing the set of external research evaluations by one 
system of external research evaluation may facilitate and enlarge our knowledge and information about 
its long-term effects. In addition, it would improve communication between researchers and 
intermediaries, as will be further discussed in 7.5. The UK has some experience with one system of 
research evaluation (Research Assessment Exercise, RAE). Since 1986 research has been periodically 
assessed (Garret-Jones and Aylward, 2000); outcomes have direct implications for the amount of 
governmental research funding. Due to the RAE, centres of excellences have been developed and the 
performance of research has increased. Half of the research groups have improved their evaluation 
score compared to previous assessments (van de Meent and van Vliet, 2005). However, the 
improvement of performance also has a reverse side as studied by the British parliamentary 
committee. The rearrangement of research groups by assigning weak researchers to strong groups 
without negatively influencing the final assessment score and buying up excellent professors from 
competitive groups in order to count the publications of the transferred professor in the next RAE, are 
two examples of strategic games that are regularly played (van de Meent and van Vliet, 2005).
                                                                                                                                                                                     
proposal. 
 163 
 
Intermediary level Performance level New national 
evaluation 
system 
 
 
 
 
 
 
 
Research indicators 
ZonMw RMW/ 
VSNU 
ECOS University Non-
university 
research 
institute 
Medical faculty Research 
group 
KNAW/VSNU/
NWO and 
performance 
level74 
Financial resources X X X X X X X  
Hunan resources X X X    X X 
I
n
p
u
t
 
Research themes X X X X X X X  
Research management  X X     X 
Collaboration  X X      
T
h
r
o
u
g
h
p
u
t
 
Training   X      
Publications X X X X X X X X 
Citations    X X X X X 
Dissertations    X X X X  
Presentations       X  
Awards X        
Innovation X X      X 
Patents     X X  X 
O
u
t
p
u
t
 
Societal impact X       X 
 
Figure 13: Summary of research indicators used in Dutch medical and health research evaluations during the time empirical data for this thesis were being 
collected (2000-2002). 
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Nowadays the RAE is a controversial but still functioning system within the UK. In conclusion, by 
taking the UK experiences into account, I would recommend the Dutch government and intermediaries 
frequently and adequately to assess the new national evaluation protocol and practices. These 
assessments will restrict the strategic games could be played. By doing so, the impact of these games 
would be kept to a minimum. Assessing the evaluation practices could result in (re)adjustment of the 
rules of national evaluation procedure. However, one should be aware that a system of rules will 
always in some way influence to some extent the behaviour of researchers. Strategic behaviour (also 
called goal shifting) is part of the game. However, I think that strategic games will have less impact in 
the Netherlands than in the UK, because the Dutch internal and external research evaluations are 
nowadays linked within one system.  
 
 
7.3 Implications of internally organized research evaluations  
 
The purpose of internally developed research evaluation practices is to assess staff members, research 
proposals and research output.  
Research leaders generally evaluate staff members once a year. These job evaluations serve multiple 
purposes. They are not only used to assess staff but also to improve conditions in order to stimulate 
(individual) research performance. Specific evaluation practices to stimulate PhD students have been 
developed by a number of medical faculties and non-university research institutes.  
Research proposals are generally pre-evaluated before they are submitted to external funding agencies. 
Pre-evaluations introduced by medical faculties and non-university institutes are organised by steering 
committees. Specific procedures for PhD research proposals have been developed. Which research 
proposals are pre-evaluated, varies between the faculties. It generally depends upon the proposal type 
(personal or programme grant) and the funding agency. Interestingly, non-university research 
institutes pre-evaluate any research proposal that is written. Their procedures are, compared to the 
ones that are used by medical faculties, more detailed. Furthermore, both research boards and research 
management teams are highly involved in pre-evaluations. Research groups also generally organise 
pre-evaluations of proposals. Evaluation outcomes are intended to assure performance. Research 
output evaluations are also prevalent. As shown in Figure 14, the number of publications and their SCI 
impact are the most frequently used indicators. However, the complexity of output evaluation 
practices varies between the medical faculties and non-university research institutes. Three types -
none, restricted and extensive output evaluation practices- have been distinguished (see figure 11 in 
Chapter 5). The boundaries between them are not clear and sharp. From the interviews with research 
managers, it can be concluded that one evaluation type may gradually develop into another evaluation 
type over time.  
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Research output evaluations, which are internally organised, have a high impact on Dutch medical and 
health research. The majority of the responding medical and health research leaders have positive 
views about the outcome of internal research evaluations. They attach high value to evaluation 
outcome. In addition, research groups generally implement the recommendations that are given by 
peers. On faculty and institute level, boards use outcome to formulate and adjust their research 
strategy and profile. In addition, outcome is frequently used to re-adjust, develop, and (financially) 
stimulate local research programmes. These empirical results are in line with a study conducted by the 
American Sociological Association (2003). They found a few universities that use evaluation reports 
of departmental productivity to identify ‘excellent’ or potentially ‘excellent’ programmes and to 
justify the steering of additional resources to those departments.  
 
 
7.4 Research management and performance of pre-clinical and clinical research groups 
 
As shown in Figure 14 research throughput is only evaluated at the intermediary level. Improvement 
of research management, including leadership, to help research organisations, units and individual 
researchers to arrive at better decisions about future research, management and policy have recently 
become a new government goal. This renewed attention to research management results in an 
intensification of planning and managerial control within and outside academic research groups. We 
therefore analysed managerial control in chapter 6 of this thesis and studied its effects on the research 
performance of academic medical and health groups. The empirical study showed that there is only 
one internal research management activity which has a positive relationship with medical research 
performance in general. Offering special commendations to medical (both pre-clinical and clinical) 
research staff members, including non-financial prizes, in order to motivate them is positively 
correlated with the number of SCI publications, the percentage of externally obtained research funding 
and the NWO activity of research groups. In the regression analyses of contingencies and managerial 
control variables we found a positive linear relationship between special commendations and two 
medical research performance measures. These results are in line with suggestions by McKeachie 
(1979) and Omta (1997) who both argue that (immaterial) incentives reflect the competence achieved, 
and may stimulate staff and research groups to perform better.  
 
The impact of the disciplinary setting is also studied in chapter 6 in order to assess whether such 
effects on performance are uniform.  It was found that the disciplinary setting, the classification into 
pre-clinical and clinical research, has an impact on the relationships between managerial control and 
performance. As presented in Table 60, four differences have been found between pre-clinical and 
clinical research groups.  
 166  
First, in clinical groups three internal management tools –organisation of research output evaluations; 
research policy meetings and research meetings- are important in predicting research performance. In 
pre-clinical groups the organisation of various internal research management activities shows 
relationships with particular research performance measures. No homogeneity was found among 
research management tools. In conclusion, managerial choices of leaders result in differences between 
performances measures. Different styles of research management are required to enable researchers to 
score well on the various research goals.  
Second, the relationship between the time allocated to external research management activities and 
research performance is different for the two groups. In pre-clinical groups time allocated to external 
research management activities is important for obtaining research council involvement while in 
clinical groups time spent on these activities is important for predicting the number of SCI 
publications, and the DAG 1998 score. Third, views of pre-clinical leaders about the importance of 
collaboration with medical stakeholders are not linearly related to the research performance measures 
used in this study. In clinical groups, the collaboration with medical stakeholders generates 
relationships with different performance measures.  
Finally, we have seen that contingencies are important predictors of research performance especially 
in pre-clinical groups. In clinical groups contingencies such as size and time allocation are the only 
important variables in getting papers published in SCI journals. Contingencies in these groups are not 
significantly correlated with performance measures concerning external research funding. 
Subsequently, no linear relationships were found.  
 
In sum, it appears that the chosen subdivision of different types of research groups is a fruitful way of 
shedding light on the complex world of research management and research group performance. This 
study indicates that medical and health groups are different. Perhaps, this differentiation can, to some 
extent, be explained by the differences between pre-clinical and clinical research groups (as presented 
in Table 4 with regard to dependency on external financial resources. Unfortunately, we were not able 
to study the effects of managerial control on research performance in para-clinical research groups 
because a number of indicators were insufficient for measuring para-clinical research performance. 
For example, it turned out that most (72%) para-clinical research group leaders did not submit research 
proposals to the CMHR. Consequently, only a few groups received grants from the CMHR. 
Furthermore, only 23% of para-clinical research groups were assessed in the DAG 1998 evaluation. 
The number of para-clinical groups became too small to perform correlation and regression analyses. 
Additional in-depth and qualitative research is needed to analyse managerial control and its 
relationships with the research performance of para-clinical groups. 
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Table 60 
Linear relationships between managerial control, contingencies and research performance of medical and health research groups: a summary 
a. pre-clinical groups 
 SCI Publications External funding NWO activity NWO rating DAG 1998 score 
+ Rewards: special 
commendations 
+ Rewards: special commendations + Rewards: flexibility + Time to internal management + Research meetings 
 + Pre-evaluations of research proposals  - Research output evaluation  +&- Research output evaluations 
   + Research commitment  
   + Research policy planning  
Internal control 
   - Direct communication  
External control   + Time spent on external research 
activities 
  
+ Time for supervision - Time for patient care - Time for patient care  -Time for patient care Contingencies 
- Work setting  + Size  + Time to research 
 
b. clinical groups 
 SCI Publications External funding NWO activity NWO rating DAG 1998 score 
+ Research meetings + Rewards: special commendations + Rewards: special commendations + Research meetings  
+ Control of personnel resources + Research output evaluations + Research output evaluations  
+ Research policy planning  
Internal control 
- Importance internal research 
evaluations 
+ Research output evaluations 
 
 
+ Research policy planning 
  
External control + Time for external research 
activities 
+ Time for external managerial 
control 
- Importance of collaboration with clinic -Importance of collaboration with 
clinic 
+ Time for external management 
control 
  + Importance of collaboration with 
family doctors 
  + Importance of collaboration 
with pharmaceutical industries 
+ Size     Contingencies 
+ Time for research     
 + Time for patient care     
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7.5 Discussion and some suggestions for further research 
 
In this final section the possible contribution that the empirical results could make to management 
practice will be evaluated. Fruitful directions for further research and complementary follow up 
studies will be indicated and supported with literature.  
 
An understanding of the determinants of medical and health research performance is a prerequisite for 
designing effective micro as well as macro research policy. It may give health research leaders and 
administrators tools to attract motivated individuals as well as to achieve organisational and project 
goals. Furthermore health research leaders and administrators may be stimulated to improve and 
control research group performance. This thesis revealed that different management actions may be 
advised for achieving a good overall group performance. Research leaders are recommended to 
compose their management team of staff members who have different tasks and also use different 
management styles. A challenge for future research is to gather data from junior and senior research 
staff members to get a more complete picture about the functioning of medical and health research 
groups (see the dotted line in figure 13). This future approach allows us to study the implications of 
managerial initiatives of research leaders such as for example the effects of leadership style. Over the 
years many authors have emphasised the style of leadership as an important determinant for obtaining 
performance. Studies have emphasised the importance of participative or consultative leadership in 
research groups (e.g. Pineau and Levy-Leboyer, 1983). Also positive relationships are found between 
transformational leadership and outcome variables of research project groups (e.g. Keller, 1995). 
However, studies concentrating on leadership and performance leave scope for other managerial 
control elements. We did some preliminary research (Heijnen, 2002) and found that transformational 
leadership has positive correlations with both the affective and the career-oriented commitment of 
medical staff members. Commitment has positive relationships with the functioning –measured by 
achievement orientation, competitiveness and persistence- of medical staff members. Also the culture 
and climate of research groups could be studied within future approaches. Although several scholars 
describe group culture and climate, studies focusing on the relationship between culture, climate and 
academic performance are rather limited. Within one decade, only two studies were published. Hurley 
(1995) studied the relationship between culture and innovative productivity in research groups. Once it 
has been established that the group has reliable structural properties, the innovativeness of the culture 
of this group may have a significant positive effect on innovative productivity. Personal and career 
development, and participative decision making explained 22% of the variation in the innovativeness 
of groups. In another study West and colleagues (1998) reported a relationship between the 
organisational climate and the excellence of departments, and vice versa. The strongest influences 
were indicated by the dimensions: ‘degree of formalisation’, ‘support for career development’ and 
‘support for innovation’. We recently studied the effects of organisational culture and climate on the 
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performance of medical PhD students. A positive correlation between rule orientation and impact 
scores was found, suggesting that relatively low levels of autonomy may contribute to a researchers’ 
productivity (Geerling et al., 2005). In future research a longitudinal study design is to be preferred. 
This might enable us to study the proposition that managerial activities and views actually enhance 
group performance and are not only initiated by leaders as a result of good performance. To assess the 
long-term effects of managerial activities within research groups, performance measures need to be 
measured at several points in time. Moreover, as we demonstrated in this study different performance 
measures show conflicting lessons for management.  
 
The study of research staff members will also contribute to explaining how research group 
performance depends on the interaction between the leader and staff members, the so-called intra-
group dynamics. Information about the internal social structure of research groups is essential for 
solving this research problem. Questions are for example: Are research management activities aimed 
at the group as a whole or at some staff members in particular? How does the group allocate tasks? 
What are the roles of staff members and research group leaders? Although research leaders and staff 
members have distinctive roles, it is essential -in improving research performance- that they develop 
some kind of mutual understanding in which both functions regard themselves as being representative 
of the research group. For example Shrum, Compalov and Genuth (2001) found that the organisation 
of interaction between structural components, such as research teams, is important. It is interesting to 
study these intra-group dynamics in the medical and health setting. Are there -in addition to 
differences in goals, activities and research management- also differences in intra-group dynamics 
between pre-clinical and clinical groups?  
 
The issue of research management is still highly debated. This is also the case in the Dutch public 
media. Although most (90%) Dutch professors are generally satisfied with their jobs, they complain 
about low salaries, spending too much time on managerial tasks and unbearable bureaucracy (Broer, 
2004). According to Borst (2004), these problems are generated by detailed government rules and the 
centralised way of managing universities by full-time managers who have limited knowledge about 
research and education practices. Borst proposes the ‘meewerkend voorman’ model to solve this last 
problem. Research leaders should combine their part-time management job with running their own lab 
as is customary in the United States. Capable full-time research managers should assist research 
leaders, but should not be charged with making final decisions. In the case of research groups, this 
thesis showed that both internal and external managerial control has a positive impact on performance. 
Managing a research group actively makes a difference. However, an excellent researcher does not 
make an excellent group. I agree with Borst that an excellent creative leader supported by an 
enthusiastic research manager together could manage a research group. In my opinion, this research 
manager should not only accomplish administrative tasks (as suggested by Borst), but should also 
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coordinate research. He or she should be valued as an equal interlocutor and sparring partner for the 
research leader. That is why the research manager should have a university degree. For example a 
medical and health research group should seek a person who has a PhD in a relevant social science 
(e.g. science and technology studies or innovation processes) and a background in medicine or medical 
biology. Knowledge about and experience with evaluation systems is also necessary. As has been 
shown (e.g. van der Meulen, 1992; Omta, 1995; Spaapen, 1995, Wouters, 1999 and this thesis) 
research management and evaluation is a new but distinct sub-discipline within the social sciences.  
By using their particular skills research leaders and managers should define their own designated tasks 
and responsibilities. Generally, research leaders should focus on brainstorming and the elaboration of 
innovative research ideas, research communication, supervision and training of researchers. Research 
managers should have knowledge about and seek for opportunities concerning research funding, 
collaboration, training (including research schools) and research exchange. They also support the 
organisation of research evaluations and the implementation of evaluation outcomes and 
recommendations. Finally, they organise and coordinate internal research activities such as seminars 
and lectures. Research managers work at institutional level in a research institute or in an academic 
medical centre. Depending on the group size, research managers can support and coordinate a number 
of groups. 
 
This thesis also showed that the introduction of the new national evaluation system –as developed by 
intermediaries and described in outline in chapter 4- for publicly funded research is a positive 
development for researchers. It will lower the administrative burden of procedures by linking external 
evaluations to internal ones. Furthermore, it will decrease researchers’ work load because input and 
output data will not only be stored in an internal information system, which should be updated on an 
annual basis, but will also be presented to peers once-only in a standardised way. Another advantage is 
that it will improve communication among researchers because they will be able to ask colleagues for 
advice about the organisation and execution of self-evaluation. Finally, the introduction of the new 
research evaluation system will be an incentive for research leaders to improve further their internal 
evaluation system and the steering of research. As a consequence, the national comparability between 
medical and health research sub-disciplines, as presented in former national (DAG) evaluations, has 
disappeared. This is not harmful because, as described in this thesis, both research leaders and 
administrators reported many problems with the disciplinary evaluation procedure as well as with 
evaluation outcomes. Furthermore, the interactions between clinical and pre-clinical disciplines have 
strongly improved over the years. On the one hand, the increasing belief among medical and health 
researchers in the existence of a research continuum (‘from bench to bedside’) has reduced the 
importance of sharp boundaries between the disciplines. On the other hand, this thesis shows that the 
medical and health sector is also not (yet) a coherent entity. It is conceivable that particular (clinical?) 
sub-disciplines attach value to evaluation and comparability on a national level. In this respect, the 
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recently accomplished bibliometric analysis of research conducted within Dutch university medical 
centres should be mentioned (Nederlandse Federatie van Universitair Medische Centra, 2004a). A 
comparison of the mean citation score of each UMC with the global citation score has indicated the 
ten most productive disciplines for each university medical centre. Oncology, cardiovascular diseases, 
biochemistry, molecular biology and haematology are disciplines that are prominently present in every 
UMC. Consequently, it is possible to compare these disciplines nationally.  
 
The outcomes of this thesis are also of interest to health policymakers. The replacement of the external 
set of research evaluations by one system of external research assurance and the establishment of 
permanent internal evaluation of research reduces the participation and roles of intermediaries. 
However, in the first few years after introduction, intermediary organisations are essential for 
supporting and assisting researchers by putting the new evaluation system into practice. The 
establishment of Quality Assurance Netherlands Universities (QANU) in 2004 to support universities 
in the organisation of external assessments of research programmes and to advise on ways of 
improving internal quality assurance is a good development. However it should be kept in mind that 
university boards still have the primary responsibility for making choices with regard to evaluations of 
their institutes. Also the new role of the KNAW in developing knowledge about methodological issues 
concerning quality assurance (see KNAW, NWO and VSNU, 2001) and organising a meta-evaluation 
on the new evaluation process and its outcome (see VSNU, NWO and KNAW, 2003) is another good 
development. Finally, the accreditation and follow-up accreditation of research schools should be 
discussed. It could be hypothesized that the accreditation of research courses –instead of the 
accreditation of research schools– would be a logical future step within the framework of the 
accreditation of the Bachelors and Masters education systems.  With regard to external input 
evaluations, the current approach of policymakers for enhancing research performance and stimulating 
new developments in research is to have groups develop detailed project proposals and to let these be 
judged by peers. In such procedures, limited attention is paid to managerial experience. Moreover, a 
strong emphasis on controlling and allocating scarce resources might lead to the neglect of the effects 
of organisational factors on the results achieved. Our results point to the need to develop a more 
specific set of assessment instruments for medical and health research. Also broadening incentives to 
include the public recognition of research work beyond direct funding might influence research 
direction and performance. 
 
Finally, it would be interesting to study the relationship between managerial control and performance 
in other academic research fields. Can we identify managerial control variables, for example, special 
commendations and non-financial prizes, or others such as exposure in the media or discussions with 
users, which will stimulate the performance of academic research groups in general? And which 
managerial control variables are context-dependent? We believe that most parts of our questionnaire 
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are readily applicable to research activities in other fields. For example the concepts that together 
constitute the construct of managerial control refer to general processes such as control over 
personnel, resources and research processes and to communication and exchange with the 
environment of the research group. However, the questionnaire should also include specific questions 
concerning the chosen research field. To interpret the data well, detailed knowledge about the 
background, traditions and development within the chosen research field is required. A combination of 
qualitative (interviews) and quantitative (questionnaire) techniques is also recommended in future 
approaches.   
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KORTE  NEDERLANDSE SAMENVATTING 
 
Het proefschrift ‘Op zoek naar kwaliteit: onderzoeksmanagement in de Nederlandse publieke 
gezondheidssector’ geeft inzicht in de onderzoeksbeoordelingen waarmee academische 
onderzoeksgroepen werkzaam in de Nederlandse gezondheidssector te maken krijgen. Daarnaast zijn 
de effecten en implicaties van onderzoeksbeoordelingen onderzocht. Tenslotte is onderzoek gedaan 
naar de invloed van onderzoeksbeoordelingen en (andere) interne onderzoeksmanagement activiteiten 
op de performance van onderzoeksgroepen. Het onderzoek is uitgevoerd in de periode 1999-2004 en 
heeft een exploratief karakter. Data zijn verzameld met behulp van zowel kwalitatieve (interviews) als 
kwantitatieve (vragenlijst) technieken. In deze korte Nederlandse samenvatting zullen de opbrengsten 
van het proefschrift worden belicht. 
 
Beoordeling van Nederlands gezondheidsonderzoek 
Uit interviews met beleidsmedewerkers en onderzoeksleiders aangevuld met literatuur onderzoek 
wordt duidelijk dat onderzoeksgroepen te maken krijgen met verschillende soorten 
onderzoeksbeoordelingen in alle fases van het onderzoeksproces.  
Externe beoordelingen van onderzoek worden in de regel uitgevoerd en/of gecoördineerd door 
intermediaire organisaties. Intermediaire organisaties zijn organisaties of onderdelen van organisaties 
die zowel gelieerd zijn aan de overheid als aan de wetenschappelijke gemeenschap. Voorbeelden zijn: 
(1) ZonMw, een fusieorganisatie van Zorgonderzoek Nederland (ZON) en Medische Wetenschappen 
NWO (NWO-MW). Deze organisatie is verantwoordelijk voor het stimuleren van 
gezondheidsonderzoek, dat zich uitstrekt van fundamenteel onderzoek tot uitvoeringsprojecten in de 
praktijk. (2) de Raad voor de Medische Wetenschappen van de KNAW (RMW-KNAW) tot voor kort 
verantwoordelijk voor het uitbrengen van het Discipline Advies Geneeskunde. Dit was een 
vijfjaarlijkse beoordeling van al het gezondheidsonderzoek dat binnen medische faculteiten/clusters en 
para-universitaire instituten had plaatsgevonden. (3) De Vereniging van Samenwerkende Nederlandse 
Universiteiten (VSNU), organisator van beoordelingen van de universitaire onderzoeksprogramma’s 
met behulp van internationale visitatie commissies. In het kader van het gezondheidsonderzoek heeft 
men vooral in de beoordeling van 1998 nauw samengewerkt met de KNAW. (4) Raad voor 
Gezondheidsonderzoek, geeft advies aan ministeries over prioriteiten in het gezondheidsonderzoek en 
de technologieontwikkeling in deze sector, evenals de daarbij behorende  infrastructuur. (5) 
Erkenningscommissie Onderzoekscholen, een zelfstandige commissie verbonden aan de KNAW en 
verantwoordelijk voor de erkenning en hererkenning van onderzoekscholen.  
Onderzoeksleiders werkzaam in de gezondheidssector geven aan dat het onderzoek ook binnen de 
eigen organisatie wordt beoordeeld. Deze beoordelingen worden georganiseerd door universiteiten, 
medische faculteiten en onderzoeksinstituten. Daarnaast organiseren veel onderzoeksgroepen zelf ook 
beoordelingen om zo de gewenste onderzoeksprestaties te bereiken. Zo worden onderzoeksvoorstellen 
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intern op verschillende organisatieniveaus beoordeeld voordat indiening bij externe financiers 
plaatsvindt. Ook zijn er speciale procedures voor PhD onderzoeksvoorstellen ontwikkeld. Welke 
onderzoeksvoorstellen worden beoordeeld verschilt en hangt af van het type onderzoeksvoorstel en 
onderzoeksfinancier. Ook de onderzoeksoutput wordt op verschillende organisatie niveaus intern 
beoordeeld. De complexiteit van de beoordelingsprocedures verschilt sterk. Het aantal publicaties en 
de SCI impact zijn de meest gehanteerde indicatoren in de interne output beoordelingen. 
De bovengenoemde externe  en interne onderzoeksbeoordelingen zijn allen (in meer of mindere mate) 
gebaseerd op peer review. Peers geven commentaar op voorgesteld en uitgevoerd onderzoek, 
daarnaast geven zij aanbevelingen om onderzoek te verbeteren. Bij het beoordelen van 
onderzoeksvoorstellen geven peers daarnaast ook nog advies over de mogelijke financieringskans. De 
inhoud van het protocol verschilt per onderzoeksbeoordeling. De selectie van peers, de afweging van 
de onafhankelijkheid en deskundigheid van peers, de toepassing van wederhoor, het gebruik van de 
rankingsmethode en de afweging om kwantitatieve gegevens te verzamelen en te gebruiken in het 
beoordelingsproces zijn enkele onderwerpen die in het protocol vermeld worden.  
In interne onderzoeksbeoordeling worden directe collega’s en/of onderzoekers werkzaam in dezelfde 
instelling gevraagd als peers. Externe beoordelingen maken gebruik van peers die volkomen 
onafhankelijk zijn van het te beoordelen evaluatie object. Bij het beoordelen van wetenschappelijke 
kwaliteit van onderzoek zijn peers altijd wetenschappers.  
De maatschappelijke kwaliteit en impact van gezondheidsonderzoek wordt in Nederland steeds 
belangrijker gevonden, vooral binnen externe onderzoeksbeoordelingen. Methodes en indicatoren om 
maatschappelijke aspecten van gezondheidsonderzoek te meten worden momenteel ontwikkeld. Dit 
zijn voornamelijk kwantitatieve tools die gebruikt kunnen worden binnen zelfevaluaties en externe 
audits. Daarnaast zijn er (KNAW) voorstellen gedaan om het traditionele peer review proces uit te 
breiden met stakeholders zoals patiënten organisaties.     
In de praktijk blijkt dat de afstemming in de vorm van planning, uitvoering en informatievraag tussen 
de externe onderzoeksbeoordelingen minimaal is. Dit is opmerkelijk en draagt bij aan een hoge 
beoordelingslast per onderzoekseenheid. Dit komt onder meer tot uitdrukking in veelvuldige 
verzoeken aan onderzoekers om informatie voor externe beoordelingen te leveren, vaak juist weer net 
in een andere vorm. Om deze problemen te minimaliseren heeft de werkgroep Kwaliteitszorg 
Wetenschappelijk Onderzoek in 1999 een nieuw beoordelingsysteem voor academisch onderzoek 
ontwikkeld. Dit is verder uitgewerkt en heeft in 2003 geleid tot de publicatie van het standaard 
evaluatie protocol. Het evaluatieprotocol verbindt de externe met de interne kwaliteitszorg met het 
doel de bureaucratisering te verminderen. Onderzoeksgroepen initiëren zelfevaluaties om zodoende de 
aansturing van onderzoeksinstituten te verbeteren. Tevens zijn de zelfevaluaties het startpunt voor 
zesjaarlijkse externe evaluaties. De externe evaluaties zijn bedoeld onderzoeksorganisaties, managers 
en individuele onderzoekers te helpen om (betere) beslissingen te nemen over de onderzoeksplannen, 
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onderzoeksmanagement en –beleid. Anno 2006 wordt dit evaluatie protocol in elk universitair 
medisch centrum gebruikt. 
 
Implicaties van beoordelingen van gezondheidsonderzoek 
Nu een overzicht is gegeven van de beoordelingen waar onderzoeksgroepen mee te maken krijgen is 
het interessant te onderzoeken welke impact de beoordelingen hebben op het gezondheidsonderzoek.  
Hiertoe zijn open interviews gehouden met onderzoeksleiders, onderzoeksmanagers werkzaam op 
facultair niveau en beleidsmedewerkers werkzaam bij intermediaire organisaties. Deze interviews 
laten zien dat de impact van extern georganiseerde onderzoeksbeoordelingen sterk verschillen. De 
beoordeling van onderzoeksvoorstellen door ZonMw heeft veel impact op het gezondheidsonderzoek. 
Aspecten van de ZonMw beoordelingsprocedures zijn overgenomen en gebruikt zijn in interne ex-ante 
onderzoeksbeoordelingen. Ook het verkrijgen van een ZonMw subsidie staat hoog aangeschreven in 
het onderzoeksveld. Bovendien worden de ZonMw beoordelingsuitkomsten in sommige medische 
faculteiten gebruikt als indicator bij de verdeling van interne onderzoeksbudgetten. De impact van de 
accreditatie van onderzoekscholen is de laatste jaren sterk afgenomen, vooral door de sterke toename 
in het aantal dat accreditatie verkregen heeft. Ook het Discipline Advies Geneeskunde heeft weinig 
impact op het onderzoeksveld gehad. Onderzoeksgroepen ondervonden problemen met de evaluatie 
procedure, zoals de geringe communicatie met de organisatoren. Ook nam de evaluatie procedure 
zoveel tijd in beslag dat de uitkomsten verouderd waren op het moment dat de resultaten openbaar 
werden gemaakt. De intermediaire organisaties die in deze studies onderzocht zijn hebben zelf geen 
(follow-up) onderzoek gedaan naar de effecten en impact van hun onderzoeksbeoordeling(en) op het 
veld. Dit is opmerkelijk gezien de veelvuldige aandacht voor beoordelingen en de grote hoeveelheid 
kennis die is en nog wordt verzameld. Het ontbreken van follow-up studies doet de communicatie 
tussen de intermediaire en onderzoekers geen goed. Het versterkt het gevoel te maken te hebben met 
een bureaucratische en administratieve last. Het nieuwe evaluatie protocol dat de interne met de 
externe kwaliteitszorg verbindt zal in de toekomst informatie en kennis genereren over de lange 
termijn effecten van onderzoeksbeoordelingen. Hierdoor zal ook de communicatie tussen 
intermediairen en onderzoekers versterkt worden.  
Interviews en survey uitkomsten laten zien dat interne output evaluaties veel impact hebben op het 
Nederlandse gezondheidsonderzoek. In de meeste medische faculteiten en onderzoeksinstituten 
hebben interne evaluatie uitkomsten en aanbevelingen directe implicaties voor het lokale 
onderzoeksbeleid. Interne evaluatie resultaten worden gebruikt bij het formuleren en aanpassen van 
het onderzoeksprofiel en de onderzoekstrategie. Bovendien worden de resultaten gebruikt bij het 
ontwikkelen, sturen en (financieel) stimuleren van locale onderzoeksprogramma’s. In twee medische 
faculteiten wordt op basis van de uitkomsten van interne onderzoeksbeoordelingen een gedeelte van 
het onderzoeksgeld verdeeld. De meeste onderzoeksleiders zijn positief over de uitkomsten van 
interne onderzoeksbeoordelingen. Ze hechten veel waarde aan de evaluatie uitkomsten. Over het 
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algemeen implementeren de meeste onderzoeksleiders de aanbevelingen die peers aanreiken. De mate 
waarin evaluatie uitkomsten en aanbevelingen geïmplementeerd zijn in de onderzoeksgroep wordt 
regelmatig gebruikt als indicator in een volgende onderzoeksoutput evaluatie. 
 
Onderzoeksmanagement van gezondheidsonderzoek  
Een voorwaarde voor het ontwerpen van effectief onderzoeksbeleid, op zowel micro als macro niveau, 
is het hebben van inzicht in de determinanten van performance. Dit geeft onderzoeksleiders en 
beleidsmedewerkers tools om gemotiveerde onderzoekers aan te trekken en om organisatie en project 
doelen te behalen. Bovendien worden zij zo gestimuleerd om de performance van de onderzoeksgroep 
te controleren en te verbeteren. Ook is de relatie tussen het hanteren van managementactiviteiten/visies 
en performance van groepen onderzocht. Een vragenlijst is door 160 onderzoeksleiders werkzaam in 
het gezondheidsonderzoek beantwoord. De kwantitatieve studie laat zien dat een onderzoeksklimaat 
waarin waardering wordt uitgesproken en zichtbaar wordt gemaakt door middel van het verstrekken 
van eervolle vermeldingen en niet-financiële prijzen als stimulans voor onderzoekers een positieve 
relatie heeft met drie performance maten (aantal SCI publicaties, percentage extern verkregen 
onderzoeksfinanciering en mate van NWO activiteit). De invloed van disciplinaire achtergrond is ook 
onderzocht. De gereageerde onderzoeksgroepen zijn onderverdeeld in twee categorieën, te weten pre-
klinische en klinische groepen. Uit onderzoek blijkt dat de disciplinaire achtergrond impact heeft op 
de relatie tussen (intern en extern) onderzoeksmanagement en de performance van groepen. Er zijn 
vier verschillen gevonden tussen pre-klinische en klinische groepen. Tabel 61 geeft een samenvattend 
overzicht.  
1. In klinische groepen hebben drie management activiteiten, te weten het organiseren van output 
evaluaties, onderzoeksbijeenkomsten en discussies over onderzoeksbeleid, een positieve relatie met 
performance. Echter in pre-klinische groepen leiden de management keuzes die onderzoeksleiders 
maken tot verschillen tussen performance maten. Het verdient dan ook de aanbeveling verschillende 
management stijlen te hanteren om zodoende een onderzoeksgroep op verscheidene performance 
maten goed te doen scoren. Onderzoeksleiders worden dan ook geadviseerd om hun stafleden 
verschillende taken te geven en elk een andere management stijl te hanteren.  
2. De relatie tussen de tijd die de onderzoeksleider besteed aan externe management activiteiten en 
performance is verschillend voor de twee soorten onderzoeksgroepen. In pre-klinische groepen is 
extern onderzoeksmanagement belangrijk bij het indienen van ZonMw en NWO 
onderzoeksvoorstellen en het verkrijgen van grants. In klinische groepen is tijdsbesteding aan extern 
onderzoeksmanagement belangrijk bij het voorspellen van SCI publicaties en de hoogte van de DAG 
1998 score. 
3. De meningen van pre-klinische onderzoeksleiders met betrekking tot het belang van samenwerking 
met medische stakeholders zijn niet lineair gerelateerd aan de onderzoeksperformance maten die 
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gebruikt zijn in deze studie. In klinische groepen bestaat er wel een (zowel positieve als negatieve) 
lineaire relatie met verschillende performance maten.  
4. Tenslotte heeft de disciplinaire achtergrond ook invloed op de relatie tussen contingentie factoren 
en de performance van groepen. Contingentie variabelen zijn vooral in pre-klinische 
onderzoeksgroepen belangrijke predicatoren voor performance.  
 
Vervolg onderzoek 
Om een compleet plaatje te krijgen van het functioneren van onderzoeksgroepen (werkzaam in de 
gezondheidsector) is het belangrijk data te verzamelen van zowel junior als senior stafleden. Deze 
aanpak stelt ons ook in staat de gevolgen de management initiatieven van onderzoeksleiders op de 
performance van groepen te onderzoeken. Onderzoek naar het effect van leiderschapstijlen en 
onderzoek naar de cultuur en het klimaat van onderzoeksgroepen zijn enkele voorbeelden.  
Het betrekken van stafleden in het onderzoek zal ook inzicht geven in de interactie tussen de 
onderzoeksleider en stafleden. Interessant is om te onderzoeken wat de invloed van deze interactie op 
de groepsperformance is. 
In vervolg onderzoek zal een longitudinale aanpak gekozen worden. Dit stelt ons in staat de hypothese 
dat management activiteiten en visies met betrekking tot onderzoeksmanagement daadwerkelijk de 
performance van onderzoeksgroepen verhogen en niet geïnitieerd worden door onderzoeksleiders als 
gevolg van goede performance. Om de lange termijn effecten van management activiteiten te 
bestuderen dient groepsperformance op meerdere momenten in tijd te worden gemeten. 
Tenslotte is het interessant de relatie tussen het hanteren van managementactiviteiten/visies en 
performance ook in andere academische sectoren te onderzoeken. Bestaan er management variabelen 
die de performance van academische onderzoeksgroepen in het algemeen stimuleren? Het verstrekken 
van eervolle vermeldingen en niet-financiële prijzen door onderzoeksleiders, het bediscussiëren van 
onderzoek met gebruikers en de mate van publiciteit in de media of zijn enkele voorbeelden die nader 
onderzocht kunnen worden. 
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Tabel 61 
Lineaire relaties tussen onderzoeksmanagement, contingenties en performance maten van academische groepen werkzaam in de gezondheidsector  
a. pre-klinische groepen 
 SCI Publicaties Externe financiering NWO activiteit Status bij NWO  DAG 1998 score 
+ eervolle vermeldingen en 
niet-financiële prijzen 
+ eervolle vermeldingen en niet-
financiële prijzen 
+ flexibele werkuren + tijd aan intern 
onderzoeksmanagement 
+ organiseren van 
onderzoeksbijeenkomsten 
 + beoordelen van 
onderzoeksvoorstellen 
 - beoordelen van 
onderzoeksoutput  
+&- beoordelen van  
onderzoeksoutput 
   + betrokkenheid bij onderzoek  
   + organiseren van 
bijeenkomsten over 
onderzoeksbeleid 
 
Interne 
onderzoeksmangement 
variabelen 
   - Directe communicatie  
Externe 
onderzoeksmanagement 
variabelen 
  + tijd aan externe 
onderzoeksactiviteiten 
  
+ tijd aan begeleiding van 
onderzoekers 
- tijd aan patiëntenzorg - tijd aan patiëntenzorg  - tijd aan patiëntenzorg Contingentie variabelen 
- werkomgeving  + Groepsgrootte  + tijd aan onderzoek 
 
b. klinische groepen 
 SCI Publicaties Externe financiering NWO activiteit Status bij NWO DAG 1998 score 
+ organiseren van 
onderzoeksbijeenkomsten 
+ eervolle vermeldingen en niet-
financiële prijzen 
+ eervolle vermeldingen en niet-
financiële prijzen 
+ organiseren van 
onderzoeksbijeenkomsten 
 
+ voldoende personeel + beoordelen van 
onderzoeksoutput 
+ beoordelen van 
onderzoeksoutput 
 
+ organiseren van 
bijeenkomsten over 
onderzoeksbeleid 
 
Interne 
onderzoeksmanagement 
variabelen 
- belangrijkheid van interne 
onderzoeksevaluaties 
+ beoordelen van 
onderzoeksoutput 
 
 
+ organiseren van bijeenkomsten 
over onderzoeksbeleid 
  
Externe 
onderzoeksmanagement 
variabelen 
+ tijd aan externe 
onderzoeksactiviteiten 
+ tijd aan externe management 
activiteiten 
- belangrijkheid van samenwerking 
met de kliniek 
- belangrijkheid van 
samenwerking met de kliniek 
+ tijd aan externe 
management activiteiten 
  + belangrijkheid van 
samenwerking met huisartsen 
  + belangrijkheid van 
samenwerking met 
farmaceutische industrie 
+ groepsgrootte     Contingentie variabelen 
+ tijd aan onderzoek     
 + tijd aan patiëntenzorg     
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ANNEX 1 
 
Interview question list 
 
Depending on the interview partners, different questions were asked and different topics were 
discussed. Interviews with representatives of intermediary organisations and research 
administrators generally consisted of three parts: a first introductory part, a second part about the 
research evaluations used and a third part dealing with the effects of the evaluations. Interviews 
with research leaders generally consisted of five parts: an introductory part, a part about research 
funding, an explorative part about research management issues and, finally, a fourth and a fifth 
part dealing with internally and externally organised research evaluations respectively.  
 
I. Representatives of intermediary organisations 
General questions: 
• What are the goals and functions of the intermediary organisation? 
• What is the area of attention of the intermediary organisation? 
• When was the intermediary organisation established? 
• Why was the intermediary organisation established? 
• What is your current position within the intermediary organisation? 
• How long have you been working for the intermediary organisation? 
• How is the concept ‘research quality’ defined within the intermediary organisation? 
 
Research evaluations 
Present research evaluations: 
• In which phases of the research process (input, throughput and/or output) has the health 
research been evaluated? 
• What (kind of) procedures were used in the evaluation of health research? 
• What criteria and indicators were used in the evaluation of health research? 
• What are the most important indicators or criteria in the evaluation of health research? 
• Do the evaluation procedures used distinguish scientific quality from societal quality? If so, 
does the intermediary organisation use separate procedures, protocols and indicators? 
• In evaluating research, to what extent does the intermediary organisation take the outcomes 
and results of previous research evaluations into account? 
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Changes and developments in research evaluations: 
• What changes or developments have recently taken place in research evaluation procedures 
(for example, changes in criteria, indicators, frequency, evaluation unit)? 
• What are the reasons for these changes or developments? 
• What is the opinion of the intermediary organisation about the developments that have 
recently taken place in the evaluation of health care research? 
• What changes or developments in evaluation procedures of health research will take place in 
the near future? 
 
Impact 
• What, from the point of view of the intermediary organisation, are the implications of the 
procedures used in evaluating health research for health research groups in the Netherlands? 
• What, from your point of view of the intermediary organisation, are the implications of the 
results and outcomes of health research evaluations for health research groups in the 
Netherlands? 
 
II. Research administrators 
General questions: 
• What is your current position within the organisation? 
• How long have you been working for the organisation? 
• How is the faculty or research organisation structured? 
• How is the research budget allocated to the research groups? 
• How is the concept ‘research quality’ defined within the organisation? 
 
Research evaluations 
Present research evaluations: 
• In which phases of the research process (input, throughput and/or output) is health research 
evaluated? 
• What procedures and protocols are used in the evaluation of health research? 
• What criteria and indicators are used in the evaluation of health research? 
• What is the most important indicator or criterion in the evaluation of health research? 
• Do the evaluation procedures used distinguish scientific quality from societal quality? If so, 
does the faculty or research organisation use separate procedures, protocols and/or indicators? 
Changes and developments in research evaluations: 
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• What changes or developments in the evaluation procedures of health research will take place 
in the near future? 
• What are the reasons for these changes or developments? 
Impact of internally organised research evaluations: 
• How did the faculty or research organisation respond to the outcomes of the Discipline 
Report on medical and Health Sciences Research in the Netherlands 1998 (DAG 1998)? 
• What decisions have been made as a result of the DAG 1998? 
• How important were other external research evaluations such as evaluations of research 
schools, evaluation of NWO and/or ZON research proposals and bibliometric analysis in this 
decision-making process? 
• How could research groups themselves implement the results and recommendations of the 
DAG 1998? 
 
Impact 
• In what way(s) does the faculty or research organisation communicate with research groups? 
• Has the faculty or research organisation some direct or indirect influence on the direction and 
quality of health research (conducted within research groups)? 
 
Future research 
• Are you willing to assist me in preparing future research by collecting the names and 
addresses of research groups? 
 
III. Research leaders 
General questions 
• Which type of medical and health research (fundamental, strategic and applied) is conducted 
within the research group? 
• In which different medical disciplines can your research group be placed? 
• What is the size (number of employees in fte) of your research group? 
• How many research staff are employed relative to the number of administrative staff? 
• How could you formulate the mission of your research group? 
• Could you name the two most important scientific journals you read to keep informed about 
recent developments? 
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• Could you name the two most important scientific journals in which your research group 
publish articles? 
• Could you mention the most important national and international research meeting (e.g. 
conference, symposium) in your research area? 
 
Research funding 
• From which of the following external research funding agencies does your research group 
obtain funding: NWO (including ZON), KNAW, charity funds, firms and industries, 
European funds, other external funding agencies? 
• What criteria are used in selecting external funding agencies? 
• Have opportunities for receiving external research funding recently changed (in the case of 
your research group)?  
 
Research management  
• Could you indicate whether research management issues given below could influence 
research quality? 
– staffing policy 
– collaborations 
– scientific strategy 
– consistency of research topics 
– flow of PhD students and other scientific staff to other research groups 
– participation in a research school 
 
Internally organised research evaluations  
• Do you evaluate research staff (e.g. job assessments)?  
• Are research proposals pre-assessed in your research group before submission to external 
funding agencies? 
– What procedures and protocols are used in pre-evaluation of research proposals? 
– What criteria and indicators are used in pre-evaluation of research proposals? 
• Is research output evaluated in your research group? 
– What procedures and protocols are used in the pre-evaluation of research proposals? 
– What criteria and indicators are used in pre-pre-evaluation of research proposals? 
• In what other internally organised research evaluations does your group participate? 
– Research output evaluations organised by the medical faculty  
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– Research output evaluations organised by the university or non-university research 
institute 
– Pre-evaluations of research proposals organised by the medical faculty  
– Pre-evaluations of research proposals organised by the university or non-university 
research institute 
• How, in general, are the results and recommendations of internally organised research 
evaluations implemented? 
 
Externally organised research evaluations  
• In what other externally organised research evaluations does your group participate? 
– Discipline Report on medical and Health Sciences Research in the Netherlands 1998 
– Accreditation of a research school 
– Research output evaluation of research schools 
• How, in general, are the results and recommendations of these externally organised research 
evaluations implemented? 
 
Views on the importance of research evaluations 
• Which research evaluation is the most important? 
• Which research evaluation is the least important? 
• Has the realisation that ‘research quality is of vital importance’ increased, decreased or not 
changed during the past few years? 
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ANNEX 2 
 
Abbreviations 
 
AHCI   Arts and Humanities Citation Index 
ALIFI   Amsterdam-Leiden Institute For Immunology 
AMC   Amsterdam Medical Centre 
ANOVA  One-way Analysis of Variance 
ECOS   Commission for the Recognition of Research Schools  
EMC   Erasmus Medical Centre 
CBF   Dutch Central Bureau for Fund-raising 
CDAG   Dutch Committee for Disciplinary Research 
CI   Citation Indices 
COS   Cooperating Sector Council 
CWTS   Centre for Science and Technology Studies  
DMW-VSNU  Association of universities in the Netherlands, Council for medical  
faculties in the Netherlands 
DAG   Discipline Report on medical and Health Sciences Research 
ECOS   Commission for the Recognition of Research Schools 
EU   European Union 
FTE   Full-Time Equivalent 
FMWV   Federation of Biomedical Scientific Societies  
GCP   Good Clinical Practice 
GDP   Gross Domestic Product 
GLP   Good Laboratory Practice 
GMC   Groningen Medical Centre 
GMP   Good Manufacturing Practice 
KNAW    Royal Netherlands Academy of Arts and Sciences 
KWO   Workgroup on Quality Assurance of Scientific Research 
IAC   International Assessment Committee 
IF   Impact Factor 
ISI   Institute for Scientific Information 
LUMC   Leiden University Medical Center 
MSCI   Material Science Citation Index 
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NCI   Neuroscience Citation Index 
NFU   Netherlands Federation of University Medical Centers 
NIVEL   Netherlands Institute for Health Services Research  
NWO   Netherlands Organization for Scientific Research 
MW-NWO Department of Medical Sciences of the Netherlands Organisation for 
Scientific Research  
NOD   Dutch Research Data base 
OECD    Organization for Economic Co-operation and Development 
PCA   Principal Component Analysis 
PIONIER  Personal Impulse for Research Groups with Ideas for Excellent Research 
QANU   Quality Assurance for Netherlands Universities  
R&D   Research and Development 
RAE   Research Assessment Exercise 
RB   Research Board 
REPP   Research Embedment and Performance Profile 
RGO   Advisory Council on Health Research 
RIVM   National Institute of Public Health and the Environment 
RMW Council for Medical Sciences (Royal Netherlands Academy of Arts and 
Sciences) 
SCI   Science Citation Index 
SQRP   Societal Quality Research Profile 
SSCI   Social Science Citation Index 
TNO   Netherlands Organization for Applied Scientific Research  
TQM   Total Quality Management 
UK   United Kingdom 
UMC   Utrecht Medical Centre 
UMCN   University Medical Centre Nijmegen 
US   United States 
VFI   Dutch Association of Fund-raising Organizations 
VSNU   Association of Universities in the Netherlands 
VUMC   Vrije Universiteit Medical Centre 
ZON Netherlands Organisation for Health Care Research and Development 
Council  
ZonMw  Netherlands Organisation for Health Research and Development 
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ANNEX 3 
 
List of persons interviewed  
 
Ark, G. van   NWO-MW     18-04-2000 
Benneker, H.    Advisory Council on Health Research 28-03-2000 
Bickerstaffe, R.    Solvay Pharmaceuticals   06-05-1999 
Collijn, D.   Maastricht University   01-11-2000 
Cools, A.   University of Nijmegen   29-01-2001 
Coppens, M.   VSNU     09-03-2000 
Daha, M.R.   Research School ALIFI   26-02-1999 
Deen, K.    KNAW Council for Medical Sciences 11-05-2000 
Dijk, F. van     University of Amsterdam   22-03-2001   
Egberink, G.   University of Nijmegen   14-02-2001 
Festen, C.   Erasmus University Rotterdam  27-10-2000 
Groenewegen, P.P.  NIVEL      14-03-2001 
Guttinger, V.   TNO, Prevention and Health   15-05-2001 
Haan, P. de   Vrije Universiteit Amsterdam  13-03-2001 
Havekes, L.    TNO, Prevention and Health   19-03-2001  
Joling, W.   ZON     12-04-2000 
Klasen, E.C.   NWO-MW    23-04-1999/11-05-1999 
Kukenheim, R.   Leiden University   03-11-2000  
Kraal, G.   Research School ALIFI   02-03-1999 
Meulen, B.J.R. van der  University of Twente   08-04-1999 
Miedema, F.    Sanquin     24-02-1999 
Neefjes, J.   Netherlands Cancer Institute  26-01-2001 
Nicholson, N.V.   Organon     28-04-1999 
Nieboer, H.   TNO Nutrition and Food Research  29-04-1999 
Oostra, B.   Erasmus University Rotterdam  12-01-2001  
Plasterk, R.   Netherlands Cancer Institute  09-06-1999 
Poppema, S.    University of Groningen   23-04-2001 
Raan, A.J.R. van   Leiden University   06-04-1999 
Roseboom, H.    Solvay Pharmaceuticals   06-05-1999 
Ruitenberg, E.C   Sanquin     08-03-1999/11-08-1999 
Sanderman, R.   University of Groningen   23-04-2001 
Schlotter, R.    Utrecht University   06-04-2001 
Schuitemaker, H.   Sanquin     22-10-2000 
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Smeenk, J.W.   ECOS/ Sanquin    15-02-2000/21-03-2001  
van Steijn, F. van   VSNU     09-03-2000 
Stukart, M.   KNAW Council for Medical Sciences 11-02-2000 
Tanke, H.   Leiden University    28-06-2001 
Thiens, T.   University of Nijmegen   14-02-2001 
Timmerman, H.   Vrije Universiteit Amsterdam  04-03-1999 
Visschedijk-Brinkman, M.  TNO Nutrition and Food Research  29-04-1999 
Visser, C.   Vrije Universiteit Amsterdam   17-05-2001 
Vos, E.    Netherlands Cancer Institute  23-10-2000 
Voest, E.    Utrecht University   21-03-2001  
Wagstaff, J.   Maastricht University   19-01-2001 
Zegers, B.   Research School Infection and Immunity 03-03-1999 
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ANNEX 4 
 
Questionnaire 
 
SECTION I: RESPONDENT INFORMATION 
 
Please indicate your sex:        1 o Male 
2 o Female 
Question 1. What is your year of birth?      19— 
 
Question 2a. In what year did you obtain your PhD?     19— 
 
Question 2b. How many years of experience do you have in health research?   ---years 
 
Question 2c. How many years of foreign health research experience do you have? ---years 
 
Question 2d. Did you ever hold a management position?     
1 o No 
 2 o Yes ---years 
 
Question 3. Please indicate your workplace:     
1 o University  
2 o Non-university research institute  
 
Question 4a. How frequently does the composition of your research group change in time? 
1 o The composition of the research group has been stable for several years 
2 o The composition of the research group has been stable for at least one year 
3 o The composition of research groups changes every 6 months 
4 o The composition of the research group changes frequently 
 
Question 4b. Does your research group conduct more than one research project at the same time? 
1 o Yes 
 2 o No 
 
Question 4c: Are you the only research leader of your research group? 
1 o Yes 
 2 o No, I share the leadership with others 
 
Question 4d: How long have you been directing this research group?   ---years 
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SECTION II: GENERAL QUESTIONS FOR THE RESEARCH GROUP 
 
Question 5a. In which of these areas can your research group be placed? (Please tick all suitable answers) 
1 o Cell biology and developmental biology  15 o medical technology 
2 o Genetics     16 o Pharmacology and toxicology 
3 o Bio-informatics and epidemiology  17 o Endocrinology 
4 o Immunology     18 o Metabolism 
5 o Microbiology     19 o Basal neurology 
6 o Virology     20 o Neurology 
7 o Oncogenesis     21 o Psychiatry 
8 o Cardiovascular system    22 o Medical psychology 
9 o Haematology    23 o Environment, work and health 
10 o Nephrology     24 o Gerontology and geriatrics 
11 o Respiration     25 o Youth and health 
12 o Dermatology    26 o Social medicine 
13 o Musculoskeletal disorders   27 o General practice 
14 o Gastroenterology and hepatology  28 o Public health 
 
Question 5b. Which of the areas mentioned in question 5a is most important in characterising your research 
group? (Please tick the most appropriate answer)    ---------- 
 
Question 5c. On which part of health research does your research group mainly concentrate? (Maximum of 
two answers are allowed) 
1 o Subcellular level    4 o Pathological process 
2 o Cell level     5 o Patients 
3 o Organ level     6 o Public health/health care system 
 
Question 5d. Please describe the proportion of research conducted by your research group that you 
characterise as multidisciplinary.  
1 o 0–20%     4 o 61–80% 
2 o 21–40%     5 o 81–100% 
3 o 41–60%     
 
Question 6a. Please indicate below the number of employees (fte) in your research group (including 
yourself). 
 PERMANENT 
APPOINTMENT 
TEMPORARY 
APPOINTMENT 
Professors   
Senior scientific staff    
PhD students   
Laboratory technical staff   
Technical support staff   
Other scientific staff   
 
Question 6b. How many staff are working under your leadership in the research group?  --- fte 
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Question 7a. Please indicate the three most important aims of your research group. 
1 o Scientific publications   7 o Development of new products 
2 o Exploitation of knowledge   8 o New collegiate interaction 
3 o Development of methodology   9 o Knowledge transfer to users 
4 o Training of young researchers   10 o Collection of empirical material 
5 o Development of research abilities  11 o Gaining international contacts 
6 o Development of new knowledge  12 o Receiving research funding 
 
Question 7b. What is your attitude towards the following statements about the outcomes of research 
conducted in your research group? 
Never Rarely Sometimes Often Always 
Research results in Dutch publications   o o o o o 
Research results in international publications  o o o o o 
Research results in clinical medical applications  o o o o o 
(e.g. development and improvement of medicine or treatment) 
Research results in general medical applications  o o o o o 
 
Question 8. Please indicate (by circling a figure) your attitude towards the following statements about 
choosing new research topics 
Not  Neutral  Very  
Important            Important 
Connection with my previous research   1 2 3 4 5 
Continuation of research themes in my discipline  1 2 3 4 5 
Connection with internationally important research themes 1 2 3 4 5 
Theoretically challenged and innovative research themes 1 2 3 4 5 
Possibility of testing totally new research themes   1 2 3 4 5  
Interest and possibilities for young researchers  1 2 3 4 5 
Practicability of research by young researchers  1 2 3 4 5  
The guarantee that PhDs will be obtained   1 2 3 4 5 
Opinion of colleagues in the Netherlands   1 2 3 4 5 
Opinion of foreign colleagues       1 2 3 4 5 
Spearheads of Dutch research programmes   1 2 3 4 5 
Spearheads of European research programmes  1 2 3 4 5 
Possibility of applying research to Dutch health care  1 2 3 4 5 
Possibility of obtaining visibility in top journals  1 2 3 4 5 
(e.g. Nature, Science, Lancet) 
Use of available or new lab equipment   1 2 3 4 5 
 
Question 9. Please indicate whether research conducted by your research group is part of the core business 
of your faculty or research institute. 
1 o Yes 
 2 o No 
 3 o Do not know 
 
Question 10a. Please indicate below how much time your research group spends on average on: 
Research o 1–20% o 21–40% o 41–60% o 61–80% o 81–100%  
Education o 1–20% o 21–40% o 41–60% o 61–80% o 81–100%  
Patient care  o 1–20% o 21–40% o 41–60% o 61–80% o 81–100%  
 
 204  
Question 10b. Please indicate below how much time you spend on average on: 
     None 1–10% 11–20% 21–30% 31–40% 41–50% 51–100% 
Laboratory experiments and analyses o  o o o o o o 
Education    o  o o o o o o 
Patient care    o  o o o o o o 
Supervision (PhD students)  o  o o o o o o  
Internal research management  o  o o o o o o 
External research management  o  o o o o o o 
Other research activities   o  o o o o o o 
 
Question 11. What is your opinion on the following general statements about research involvement? 
Dis-  Dis- Neither Agree Agree   
Agree agree agree  partly fully 
fully partly nor disagree 
1. I feel more like a researcher than like a manager  o o o o o 
2. I feel still involved in research conducted   o o o o o 
by my research group 
3. I’m still well informed about recent developments  o o o o o 
taking place in my research area 
4. I keep up with the specialist literature   o o o o o 
5. By generating new ideas I still contribute to research o o o o o 
conducted by my research group 
6. I’m intensively involved in more research project(s) o o o o o 
conducted by my research group 
7. I regularly attend research meetings organised in  o o o o o 
my research group 
8. I regularly publish as first author in international journals o o o o o 
9. My staff think of me as a highly skilled scientist  o o o o o 
10. I’m acting as oracle in solving research problems  o o o o o 
 
Question 12. Please indicate below the most important articles your research group has published in the 
past five years 
Journal ----------   Journal -----------    Journal ---------- 
Year ----------   Year -----------   Year ---------- 
 
 
SECTION III: RESEARCH FUNDING 
 
Question 13. Please indicate the (average) yearly research budget of your research group (in Dutch 
guilders). 
1 o 1.000.000–2.000.000   3 o 5.000.000–10.000.000 
2 o 2.000.000–5.000.000   4 o more than 10.000.000 
 
Question 14. Please indicate the proportion of your research group’s funds that come from: 
University    -----------%  Ministries  -----------%  
Research institute   -----------%  Charity funds  -----------% 
Research Council NWO   -----------%  Firms/industry  -----------% 
Research Council ZON   -----------%  European funds  -----------% 
Royal Netherlands Academy  -----------%  Others   -----------% 
of Arts and Sciences   
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Question 15. This question concerns your research group. Compared to five years ago: 
De- Not  In- Don’t 
creased changed creased know 
1. The amount of money received from the first flow has    o o o o 
2. The amount of money received from NWO has    o o o o 
3. The number of submitted research proposals to NWO has   o o o o 
4. The amount of money received from charity funds has  o o o o 
5. The number of submitted research proposals to charity funds has o o o o 
6. The amount of money received from Dutch ministries has  o o o o 
7. The number of submitted research proposals to EU funds has o o o o 
8. The amount of money received from EU funds has  o o o o 
9. The amount of money received from firms, industries   o o o o 
and health insurers has   
 
Please think about the last time your research group submitted a research proposal to NWO (research 
questions 16-19). 
Research question 16. Please indicate the result of the evaluation of the research proposal.   
1 o Rejected in pre-evaluation 
2 o Accepted in pre-evaluation, rejected in evaluation 
3 o Accepted 
4 o I have never submitted a research proposal to NWO 
 
Research question 171. To what extent were you informed about the evaluation procedures? 
Please indicate your response by circling a figure 
To a large extent 1-2-3-4-5 to a small extent 
 
Research question 181. The following items refer to the procedures used to evaluate a research proposal 
submitted. To what extent: 
1. Have you been able to express your views and feelings  To a large extent 1-2-3-4-5 to a small extent 
during the procedure?  
2. Have you had influence on the evaluation outcome?  To a large extent 1-2-3-4-5 to a small extent 
3. Has the evaluation been applied consistently?  To a large extent 1-2-3-4-5 to a small extent 
4. Has the evaluation been free of bias?    To a large extent 1-2-3-4-5 to a small extent 
5. Has the evaluation been based on accurate information?  To a large extent 1-2-3-4-5 to a small extent 
6. Has the evaluation upheld ethical and moral standards?  To a large extent 1-2-3-4-5 to a small extent 
 
Research question 191. The following items refer to the outcome of the evaluation of a research proposal. 
To what extent: 
1. Does the outcome reflect the effort you have put into  To a large extent 1-2-3-4-5 to a small extent 
the proposal?    
2. Is the outcome appropriate in the light of   To a large extent 1-2-3-4-5 to a small extent  
the work you have completed?      
3. Does the outcome reflect your contribution to   To a large extent 1-2-3-4-5 to a small extent 
the research field? 
4. Is the outcome justified given your performance?  To a large extent 1-2-3-4-5 to a small extent 
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SECTION IV: RESEARCH MANAGEMENT 
 
Question 20. Please indicate whether you have had problems in securing qualified scientific staff. 
Never Rarely Sometimes Often Always Not ap- 
plicable  
Professors     o o o o o o 
Senior scientific staff    o o o o o o 
PhD students      o o o o o o 
Laboratory technician staff   o o o o o o 
Technical support staff    o o o o o o 
Other scientific staff    o o o o o o 
 
Question 21a. What efforts does the research group make to secure qualified scientific staff? 
1. ----------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------ 
2. ----------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------ 
3. ----------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------ 
 
Question 21b. Are the efforts mentioned in question 21a also made by your university or research institute? 
1 o Never 
2 o Rarely 
3 o Sometimes 
4 o Often 
5 o Always 
 
Question 22a. Please indicate to what extent the research group offers rewards to their employees. 
Never       Sometimes Often 
To take (inter)national courses and education    o o o 
To attend (inter)national conferences     o o o 
To gain experience in foreign research groups    o o o 
To supervise master and PhD students     o o o 
To receive financial bonuses      o o o 
To work at home        o o o 
To work flexible hours      o o o 
To receive special commendations or prizes     o o o 
 
Question 22b. Are the efforts mentioned in question 22a also made by your university or research institute? 
1 o Never 
2 o Rarely 
3 o Sometimes 
4 o Often 
5 o Always 
 
Question 23. Please indicate whether researchers are assessed by job assessments.  
1 o Yes 
2 o No 
 
Question 24. How often are job assessments done in your research group? 
1 o Once every 6 months 
2 o Once a year 
3 o Once every 2 years 
4 o Once every 5 years 
Question 25. What are the goals of job assessments in your research group? 
1 o To evaluate researcher output  
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2 o To present possibilities for developing researcher  skills 
3 o To make yearly appointments with the researcher 
4 o To reflect upon leadership received from the researcher 
5 o To develop a relationship between the researcher and the supervisor 
 
Question 26. Please indicate the frequency of meetings held (within the research group) to discuss 
research? 
Never Once a Twice  Once a Once a  
year a year   month week 
Discussions about literature    o o o o o 
Progress meetings about current research projects  o o o o o 
Research presentations     o o o o o 
Discussions about (conference) papers   o o o o o 
Discussions about research proposals   o o o o o 
Other research meetings………………….   o o o o o 
 
Question 27. Please indicate what activities are organised in your research group (Please tick all suitable 
answers) 
1 o Lunches 
2 o Drinks 
3 o Retreats 
4 o Other activities……………….. 
 
Question 28. To what extent do you use different means of communication?  
1 o E-mail 
2 o Telephone 
3 o Memorandum 
4 o Intranet 
5 o Personal, with appointment 
6 o Personal, without appointment 
 
Question 29a. Please indicate whether your research group organises discussion meetings about research 
policy plans. 
1 o Yes 
2 o No, please go to question 29d 
 
Question 29b. Which staff participate in discussions about research policy plans? (Please tick all suitable 
answers) 
1 o Researchers employed in ‘own’ research group 
2 o Researchers employed in the same university or research institute 
3 o Researchers employed in the same research school 
4 o Researchers employed in a different university or research institute 
5 o Foreign researchers  
 
Question 29c. Why does your research group organise discussion about research policy plans? 
 
---------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------- 
 
Question 29d. Does the group’s research policy plan form a part of the main points of the research policy 
plan formulated for the whole faculty or research institute? 
 1 o Yes 
2 o No 
3 o Not applicable 
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Question 30. Please indicate whether your research group is facing problems/difficulties in conducting 
research due to: (Please tick all suitable answers) 
1 o Equipment 
2 o Research material 
3 o Data processing 
4 o Laboratory room 
5 o Library services 
6 o Personnel 
7 o Other infrastructure conditions-------------------- 
 
Question 31. How many working days (1 working day is equivalent to 8 hours) per year do you spend on 
average on external activities? 
None 1–10  11–20  21–30  31–40  41–50   >  
days days days days days 50 days 
1. Working visits   o o o o o o o 
2. Supervision of PhD students employed  o o o o o o o 
outside your research group 
3. Presentation of lectures  o o o o o o o 
4. Attending symposia and conferences o o o o o o o 
5. Organising symposia and conferences o o o o o o o 
6. Participation in editorial boards of  o o o o o o o 
       scientific journals 
7. Participation in assessment committees o o o o o o o 
8. Participation in audit committees o o o o o o o 
 
Questions 32. Please indicate (with mark between 1, absolutely unimportant to 10, essential) how important 
collaboration is with: 
1. Members of a research school   Mark ---------- 
2. Dutch research groups    Mark ---------- 
3. International research groups   Mark ---------- 
4. Semi-government institutes   Mark ---------- 
5. Pharmaceutical industries   Mark ---------- 
6. Firms     Mark ---------- 
7. Clinics     Mark ---------- 
8. Family doctors    Mark ---------- 
9. Ministries     Mark ---------- 
 
Question 32b. What, from the point of view of your research group, are the three most important goals of 
scientific collaboration? 
1 o Scientific publications   7 o Development of new products 
2 o Exploitation of knowledge   8 o New collegiate interaction 
3 o Development of methodology   9 o Knowledge transfer to users 
4 o Training of young researchers   10 o Collection of empirical material 
5 o Development of research abilities  11 o Gaining international contacts 
6 o Development of new knowledge  12 o Receiving research funding 
 
 
 209 
SECTION V: INTERNAL RESEARCH EVALUATIONS 
 
Question 33a. Please indicate whether research proposals are pre-assessed internally before submission to 
external funding agencies. 
1 o No -> Please go to question 35b 
2 o Yes, at the level of my research group 
3 o Yes, at the level of the faculty or research institute (part of university) 
3 o Yes, at the level of the university or research institute 
 
Question 33b. What research proposals are pre-assessed? 
---------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------- 
--------------------------------------------------------------------------------------------------------------------- 
 
Question 34. Please indicate the judges of pre-assessments of research proposals. (Please tick all suitable 
answers) 
Research group level 
1 o Researchers employed in ‘own’ research group 
2 o Researchers employed in the same university or research institute 
4 o Researchers employed in the Netherlands 
5 o Foreign researchers  
6 o Other judge(s) 
7 o Not applicable 
 
Medical faculty level  
1 o Researchers employed in ‘own’ research group 
2 o Researchers employed in the same university or research institute 
3 o Researchers employed in the Netherlands 
4 o Foreign researchers  
5 o Other judge(s) 
6 o Not applicable 
 
University or non-university research institute level 
1 o Researchers employed in ‘own’ research group 
2 o Researchers employed in the same university or research institute 
3 o Researchers employed in the Netherlands 
4 o Foreign researchers  
5 o Other judge(s) 
6 o Not applicable 
 
Question 35. What is your opinion on the following statements about the pre-assessment of research 
proposals? 
Dis-  Dis- Neither Agree Agree   
Agree agree agree  partly fully 
fully partly nor  
disagree 
1. Researchers are not obliged to incorporate any    o o o o o 
comments and suggestions received from judges 
2. Researcher leader decides whether research proposals  o o o o o 
are submitted 
3. Faculty/research institute must have the opportunity o o o o o 
to select and submit research proposals to external  
funding agencies 
4. Internal pre-assessments of research proposals   o o o o o 
generally result in major changes to receiving external funding 
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Question 36. Please indicate whether the research output of your group is evaluated internally. (Please tick 
all suitable answers) 
1 o Yes, at the level of my research group 
2 o Yes, at the level of the medical faculty  
3 o Yes, at the level of the university or non-university research institute 
4 o No -> please go to question 43 
 
Question 37. Please indicate the judges of internally organised research output evaluation(s). (Please tick 
all suitable answers) 
Research group level 
1 o Researchers employed in ‘own’ research group 
2 o Researchers employed in the same university or research institute 
3 o Researchers employed in the Netherlands 
4 o Foreign researchers  
5 o Other judge(s) 
6 o Not applicable 
 
Medical faculty level  
1 o Researchers employed in ‘own’ research group 
2 o Researchers employed in the same university or research institute 
3 o Researchers employed in the Netherlands 
4 o Foreign researchers  
5 o Other judge(s) 
6 o Not applicable 
 
University or non-university research institute level 
1 o Researchers employed in ‘own’ research group 
2 o Researchers employed in the same university or research institute 
3 o Researchers employed in the Netherlands 
4 o Foreign researchers  
5 o Other judge(s) 
6 o Not applicable 
 
Question 38. Please indicate the frequency of internally organised research output evaluation(s). (Please 
tick all suitable answers) 
Research group level 
1 o Once every 3–5 years 
2 o Once every 2–3 years 
3 o Once a year 
4 o Not applicable 
 
Medical faculty level  
1 o Once every 3–5 years 
2 o Once every 2–3 years 
3 o Once a year 
4 o Not applicable 
 
University or non-university research institute level 
1 o Once every 3–5 years 
2 o Once every 2–3 years 
3 o Once a year 
4 o Not applicable 
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Question 39. Please indicate which of the following criteria or indicators are used in internally organised 
research output evaluation(s). (Please tick all suitable answers) 
Research group level 
1 o Number of publications 
2 o Impact factors of SCI journals 
3 o Citation analysis 
4 o Benchmark 
5 o External research funding received 
6 o Number of dissertations 
7 o Number of presentations 
8 o Not applicable 
 
Medical faculty level 
1 o Number of publications 
2 o Impact factors of SCI journals 
3 o Citation analysis 
4 o Benchmark 
5 o External research funding received 
6 o Number of dissertations 
7 o Number of presentations 
8 o Not applicable 
 
University or non-university research institute level 
1 o Number of publications 
2 o Impact factors of SCI journals 
3 o Citation analysis 
4 o Benchmark 
5 o External research funding received 
6 o Number of dissertations 
7 o Number of presentations 
8 o Not applicable 
 
Question 40. Please indicate the goals of the internally organised research output evaluation(s).  
Research group level 
--------------------------------------------------------------------------------------------------------------------- 
--------------------------------------------------------------------------------------------------------------------- 
Medical faculty level 
--------------------------------------------------------------------------------------------------------------------- 
--------------------------------------------------------------------------------------------------------------------- 
University or non-university research institute level 
--------------------------------------------------------------------------------------------------------------------- 
--------------------------------------------------------------------------------------------------------------------- 
 
Question 41a. How are you experiencing the results and recommendations of internally organised research 
output evaluation(s) in general? 
Very  Neutral  Not  
useful              Useful 
1 2 3 4 5 
 
Question 41b. Please indicate whether the results and recommendations of internally organised research 
output evaluation(s) are  incorporated?   
Very  Neutral  Not  
intensively   intensively 
1 2 3 4 5 
 
Question 42. Please indicate whether the incorporation of recommendations from internally organised 
research evaluations are tested in subsequent research evaluations. 
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1 o Never    
2 o Rarely 
3 o Sometimes 
4 o Often 
5 o Always 
 
 
SECTION V: EXTERNAL RESEARCH EVALUATIONS 
 
Question 43. Please indicate whether your research group is involved in externally organised research 
output evaluations. (Please tick all suitable answers) 
1 o Discipline assessment of medical and health research in the Netherlands 
2 o Evaluations of a research school 
3 o Other externally organised research evaluation(s) 
  
Question 44. Please indicate the result of your research theme evaluation in the national discipline 
assessment of medical and health research in 1998? 
1 o Poor (score 1) 
2 o Unsatisfactory (score 2) 
3 o Satisfactory (score 3) 
4 o Good (score 4) 
5 o Good to very good (score 5) 
6 o Very good (score 6) 
7 o Very good to excellent (score 7) 
8 o Excellent (score 8) 
9 o Not assessed in the national discipline assessment of medical and health  
research in 1998  
 
Question 45. Please indicate to what extent the score of your research theme, in the national discipline 
assessment of medical and health research of 1998, corresponds to your own estimation? 
1 o Score is lower than my own estimation 
2 o Score corresponds to my own estimation 
3 o Score is higher than my own estimation 
4 o Don’t know 
 
Question 46. To what extent were you informed about the procedures used in the national discipline 
assessment of medical and health research of 1998? Please indicate your response by circling a figure 
To a large extent 1-2-3-4-5 to a small extent 
 
Question 47a. How are you experiencing the results and recommendations of the national discipline 
assessment of medical and health research of 1998? 
Very  Neutral  Not  
useful              useful 
1 2 3 4 5 
 
Question 47b. How are you experiencing the results and recommendations of research school evaluations in 
general? 
Very  Neutral  Not  
useful              useful 
1 2 3 4 5 
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Question 47c. Please indicate whether the results and recommendations of the national discipline 
assessment of medical and health research of 1998 are incorporated?   
Very  Neutral  Not  
intensively             intensively 
1 2 3 4 5 
 
Question 47d. Please indicate whether the results and recommendations of the research school evaluations 
are incorporated in general?   
Very  Neutral  Not  
intensively             intensively 
1 2 3 4 5 
 
Question 48. What is your opinion about the following general statements about the national discipline 
assessment of medical and health research of 1998 
Dis-  Dis- Neither Agree Agree   
agree agree agree  partly fully 
fully partly nor  
disagree 
1. The results and recommendations are relevant because o o o o o 
research is judged on actual value 
2. The results and recommendations are not relevant  o o o o o 
because research is not assessed at the group level 
3. The results and recommendations are not relevant  o o o o o 
because the research assessed is not up to date 
4. The results and recommendations are not relevant  o o o o o 
because in my opinion inappropriate criteria are used 
5. I attach higher value to results of internal evaluations o o o o o 
6. I support the replacement of national discipline   o o o o o 
assessment of medical and health research by a  
new external research evaluation protocol, consisting of  
self-evaluation and periodical external evaluations 
 
Question 49. Please indicate if you agree with the statement: ‘The evaluation of the social quality of 
research will stimulate researchers not only to perform well from a scientific but also from societal point of 
view’. 
1 o Yes 
2 o No 
3 o Don’t know 
 
Notes: 
1 Questions 17 and 18 are after Colquitt (2001) 
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ANNEX 5 
 
Correlation matrix of research performance measures 
 
SCI publications DAG score 1998 External funding Proposals NWO Proposals CMHR CMHR grants NWO rating NWO activities 
 
SCI publications    
 
DAG score 1998 Pre-clin 0.10               
  Clinical 0.26  
  
External funding Pre-clin 0.12 Pre-clin 0.33* 
  Clinical -0.03 Clinical 0.22 
 
Proposals NWO Pre-clin 0.29* Pre-clin 0.23 Pre-clin 0.24*   
  Clinical 0.21 Clinical 0.32* Clinical 0.26 
 
Proposals CMHR Pre-clin 0.23 Pre-clin 0.18 Pre-clin 0.20 Pre-clin 0.82*** 
  Clinical 0.06 Clinical 0.21 Clinical 0.18 Clinical 0.78*** 
 
CMHR grants Pre-clin 0.22 Pre-clin 0.23 Pre-clin 0.19 Pre-clin 0.71*** Pre-clin 0.91*** 
  Clinical 0.16 Clinical 0.35* Clinical 0.08 Clinical 0.50*** Clinical 0.75*** 
 
NWO rating Pre-clin 0.25* Pre-clin 0.34* Pre-clin 0.20 Pre-clin 0.52*** Pre-clin 0.48*** Pre-clin 0.45*** 
  Clinical 0.22 Clinical 0.26 Clinical 0.31* Clinical 0.58*** Clinical 0.47*** Clinical 0.29* 
 
NWO activities Pre-clin 0.28* Pre-clin 0.23 Pre-clin 0.24 Pre-clin 0.97*** Pre-clin 0.93*** Pre-clin 0.85*** Pre-clin 0.53*** 
  Clinical 0.18 Clinical 0.32* Clinical 0.23 Clinical 0.95*** Clinical 0.92*** Clinical 0.73*** Clinical 0.55***  
  
*p < 05; **p <.01; ***p <0.001 
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ANNEX 6 
 
Correlation matrix of contingencies with research performance  
 
 
 
SCI 
publications 
DAG score External 
funding 
Proposals 
NWO 
Proposals 
CMHR 
CMHR grants NWO rating NWO 
activities 
NWO 
activities 
dummy 
Size 
 Research staff                      
Pre-clin 
Clinical
0.06 
0.50*** 
0.03 
0.36* 
0.22 
0.13 
0.46*** 
0.05 
0.46*** 
0.00 
0.38*** 
0.15 
0.18 
0.11 
0.48*** 
0.06 
 
0.11 
Work setting  Pre-clin 
Clinical 
-0.27* 
-0.12 
0.35* 
0.17 
0.36** 
0.23 
-0.09 
0.07 
-0.05 
0.01 
-0.01 
-0.01 
0.04 
-0.09 
-0.07 
0.03 
 
0.07 
 
Pre-clin 
Clinical 
 
0.02 
0.42*** 
 
0.67*** 
0.08 
 
0.18 
-0.10 
 
0.13 
0.14 
 
0.22 
0.07 
 
0.27* 
0.09 
 
0.30* 
0.06 
 
0.17 
0.13 
 
 
0.03 
Pre-clin 
Clinical 
0.05 
0.08 
-0.31* 
-0.07 
-0.10 
-0.19 
-0.11 
-0.22 
-0.17 
-0.10 
-0.16 
-0.02 
-0.07 
-0.03 
-0.17 
-0.16 
 
-0.01 
Pre-clin 
Clinical 
0.05 
0.12 
-0.63*** 
-0.24 
-0.47*** 
-0.05 
-0.26* 
-0.05 
-0.22 
0.03 
-0.24* 
0.00 
-0.33** 
0.04 
-0.28* 
-0.02 
 
0.02 
Time allocation 
                        Research 
 
Education 
 
Patient care 
 
Supervision of PhD 
students 
Pre-clin 
Clinical 
0.31* 
0.12 
0.51*** 
0.11 
0.27* 
0.07 
0.18 
0.16 
0.19 
-0.07 
0.22 
0.04 
0.29* 
-0.02 
0.19 
0.09 
 
0.05 
 
Pre-clin 
Clinical 
 
0.12 
0.19 
 
0.08 
-0.08 
 
-0.14 
0.04 
 
-0.13 
-0.08 
 
-0.23 
-0.06 
 
-0.27* 
-0.07 
 
-0.15 
0.03 
 
-0.18 
-0.08 
 
 
0.02 
Pre-clin 
Clinical 
-0.05 
-0.19 
-0.26 
-0.20 
-0.21 
-0.07 
-0.20 
-0.17 
-0.20 
-0.11 
-0.23 
-0.17 
-0.31** 
-0.07 
-0.20 
-0.17 
 
-0.20 
Pre-clin 
Clinical 
0.24* 
0.31* 
0.18 
-0.02 
0.03 
0.07 
0.17 
0.15 
0.07 
0.12 
0.03 
0.22 
0.13 
-0.09 
0.13 
0.18 
 
-0.02 
Age 
Research experience 
 
 
Management experience 
 
Foreign Experience 
 
Supervising experience 
Pre-clin 
Clinical 
0.20 
0.18 
0.02 
0.15 
-0.02 
0.27* 
-0.09 
0.10 
-0.23 
0.15 
-0.27* 
0.29* 
0.00 
0.18 
-0.17 
0.17 
 
0.18 
 
*p < 05; **p <.01; ***p <0.001 
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ANNEX 7 
 
Correlation matrix of internal control with research performance  
 
 
 
SCI 
publications 
DAG score 
1998 
External 
funding 
Proposals 
NWO 
Proposals 
CMHR 
CMHR grants NWO 
rating 
NWO 
activities 
NWO 
activities 
dummy 
Control of personal 
resources  
Pre-clin      
Clinical 
0.18 
-0.09 
-0.02 
0.01 
0.15 
0.03 
0.18 
0.02 
 0.26* 
0.01 
0.25 
0.21 
0.23 
-0.01 
0.22 
0.04 
 
-0.01 
Research commitment Pre-clin      
Clinical 
  0.26* 
0.10 
 0.43** 
0.00 
0.14 
0.07 
0.10 
0.09 
0.11 
0.09 
0.16 
0.01 
  0.27* 
-0.02 
0.11 
0.08 
 
0.09 
Time spent on internal 
managerial control 
Pre-clin 
Clinical 
0.12 
0.05 
0.25 
-0.04 
  0.26* 
0.04 
0.21 
0.23 
0.20 
0.15 
0.23 
 0.27* 
     0.37** 
0.17 
0.24* 
0.24 
 
0.16 
Pre-clin 
Clinical 
0.24* 
0.33* 
0.44** 
0.00 
-0.01 
0.12 
0.04 
0.13 
0.03 
0.20 
0.13 
0.17 
0.10 
0.22 
0.04 
0.17 
 
0.20 
Communication 
Research meetings 
 
Direct communication 
Pre-clin 
Clinical 
-0.02 
-0.06 
-0.09 
-0.13 
-0.06 
-0.06 
0.09 
0.00 
0.04 
0.06 
-0.05 
0.10 
-0.21 
0.09 
0.07 
0.04 
 
0.03 
Pre-clin 
Clinical 
0.05 
 0.27* 
 0.31* 
0.20 
 0.32* 
0.14 
0.17 
0.23 
0.05 
0.09 
0.07 
0.08 
0.23 
0.15 
0.11 
0.18 
 
0.18 
Pre-clin 
Clinical 
0.06 
-0.31* 
0.01 
-0.14 
0.22 
-0.13 
  0.28* 
-0.15 
  0.26* 
-0.11 
0.17 
-0.16 
0.15 
-0.18 
0.28* 
-0.16 
 
-0.23 
Pre-clin 
Clinical 
 0.31* 
 0.29* 
0.12 
0.24 
    0.35** 
    0.42** 
  0.29* 
0.10 
0.19 
0.00 
0.18 
-0.09 
0.14 
0.17 
0.27* 
0.04 
 
0.31* 
Rewards  
Development of research 
skills  
 
Flexibility 
 
Special commendations 
 
Financial bonus system 
Pre-clin 
Clinical 
0.02 
 0.32* 
0.03 
-0.02 
-0.07 
0.19 
0.23 
0.08 
0.18 
-0.07 
0.15 
0.04 
-0.04 
0.23 
0.23 
0.04 
 
0.15 
Research policy 
planning 
Pre-clin 
Clinical 
0.09 
-0.03 
-0.07 
0.10 
0.14 
-0.03 
  0.25* 
0.08 
0.20 
0.19 
0.15 
0.19 
   0.32** 
0.22 
0.24* 
0.14 
 
0.18 
Job evaluation 
 
Pre-clin 
Clinical 
-0.01 
-0.05 
0.06 
 
0.03 
-0.06 
-0.23 
0.05 
-0.18 
0.09 
-0.11 
0.06 
-0.11 
-0.11 
-0.21 
0.07 
 
-0.10 
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Pre-clin 
Clinical 
 
0.24* 
0.06 
 
-0.01 
-0.11 
 
0.08 
0.02 
 
0.15 
0.07 
 
0.10 
0.10 
 
0.00 
0.03 
 
0.07 
0.12 
 
0.10 
0.08 
 
 
-0.05 
Pre-clin 
Clinical 
-0.01 
0.21 
-0.23 
0.22 
0.03 
-0.01 
-0.23 
0.02 
-0.16 
0.09 
-0.27* 
0.10 
-0.16 
0.16 
-0.25* 
0.06 
 
0.08 
Pre-evaluation research 
proposals 
Group/Department 
 
Medical Faculty 
 
University / Non-
university institute 
 
Pre-clin 
Clinic 
 
-0.10 
0.03 
 
-0.05 
-0.20 
 
0.41*** 
0.01 
 
-0.05 
0.09 
 
0.11 
0.13 
 
0.07 
0.05 
 
-0.04 
0.11 
 
-0.01 
0.11 
 
 
0.07 
 
Pre-clin 
Clinical 
 
0.02 
0.08 
 
-0.25 
0.10 
 
-0.07 
0.28* 
 
-0.09 
0.07 
 
-0.11 
0.10 
 
-0.15 
0.03 
 
-0.22 
0.12 
 
-0.10 
0.08 
 
 
0.08 
Pre-clin 
Clinical 
0.05 
0.04 
-0.25 
0.22 
0.06 
0.34* 
0.02 
0.23 
-0.05 
0.23 
-0.10 
0.13 
-0.17 
0.25* 
-0.01 
0.23 
 
0.28* 
Research output 
evaluation  
Group/Department 
 
Medical Faculty 
 
University/Non-
university institute 
Pre-clin 
Clinical 
0.07 
-0.03 
0.16 
-0.06 
0.14 
0.17 
0.02 
0.05 
0.00 
0.03 
-0.08 
0.12 
-0.10 
0.25 
0.01 
0.07 
 
0.27* 
Effectiveness of 
pre-evaluations 
Pre-clin 
Clinical 
0.02 
0.09 
-0.08 
0.06 
0.06 
0.18 
-0.04 
  0.29* 
-0.07 
0.21 
0.02 
0.16 
-0.05 
-0.03 
-0.05 
0.27* 
 
0.10 
Importance of internal 
research evaluations 
Pre-clin 
Clinical 
0.11 
-0.20 
-0.16 
0.16 
-0.04 
0.11 
0.00 
-0.08 
0.00 
-0.14 
-0.05 
-0.21 
0.03 
-0.13 
0.01 
-0.13 
 
 
-0.07 
 
*p < 05; **p <.01; ***p <0.001 
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ANNEX 8 
 
Correlation matrix of external control with research performance  
 
 
SCI 
publications 
DAG score 
1998 
External 
funding 
Proposals 
NWO 
Proposals 
CMHR 
CMHR grants NWO rating NWO 
activities 
NWO 
activities 
dummy 
Time spent on external 
research activities 
Pre-clin  
Clinical 
0.16 
   0.47** 
0.02 
0.12 
0.03 
0.19 
 0.28* 
0.13 
0.16 
-0.07 
0.18 
-0.02 
0.12 
0.10 
0.25* 
0.06 
 
0.23 
Time spent on external 
managerial control 
Pre-clin 
Clinical 
0.17 
-0.02 
0.27 
0.36* 
    0.37** 
   0.40** 
   0.32** 
0.11 
0.19 
0.09 
0.10 
0.10 
0.22 
0.02 
0.31* 
0.12 
 
0.18 
 
Pre-clin 
Clinical 
 
-0.14 
-0.12 
 
-0.21 
-0.25 
 
-0.11 
-0.02 
 
-0.13 
-0.13 
 
-0.07 
-0.04 
 
0.06 
-0.14 
 
-0.04 
-0.21 
 
-0.05 
-0.12 
 
 
-0.18 
Importance of external 
research evaluations 
DAG evaluations 1998 
 
Research school 
evaluation 
Pre-clin 
Clinical 
-0.14 
0.08 
-0.01 
-0.15 
0.10 
0.05 
0.12 
0.11 
0.00 
0.17 
0.08 
0.24 
  0.25* 
-0.19 
0.09 
0.16 
 
-0.04 
Importance of 
collaboration 
Research groups 
 
Pre-clin 
Clinical 
 
0.10 
-0.08 
 
 -0.08 
-0.01 
 
-0.06 
0.07 
 
-0.02 
-0.23 
 
0.01 
-0.10 
 
0.08 
-0.01 
 
0.09 
-0.17 
 
0.00 
-0.17 
 
 
-0.14 
Ministries and semi-
governmental 
organisations 
 
Pre-clin 
Clinical 
 
0.02 
0.08 
 
-0.31* 
0.33* 
 
-0.10 
-0.10 
 
-0.13 
-0.04 
 
-0.07 
-0.05 
 
-0.08 
-0.03 
 
-0.22 
0.10 
 
-0.10 
-0.05 
 
 
0.09 
Pharmaceutical industries 
& firms 
 
 
Pre-clin 
Clinical 
 
0.01 
0.08 
 
-0.13 
0.39* 
 
-0.05 
0.29* 
 
-0.07 
-0.08 
 
0.02 
-0.11 
 
0.07 
-0.12 
 
0.01 
-0.04 
 
-0.03 
-0.11 
 
 
0.06 
Clinic 
 
Pre-clin 
Clinical 
0.05 
0.10 
-0.35* 
-0.21 
-0.27* 
-0.13 
-0.19 
-0.13 
-0.08 
-0.08 
-0.03 
-0.13 
-0.21 
-0.26* 
-0.15 
-0.13 
 
-0.27* 
Family doctor Pre-clin 
Clinical 
0.03 
0.06 
-0.30* 
0.11 
-0.21 
0.15 
-0.12 
-0.02 
-0.05 
0.00 
-0.05 
-0.02 
-0.26* 
0.18 
-0.08 
0.01 
 
0.17 
 
*p < 05; **p <.01; ***
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ANNEX 9 
 
Correlation matrix of contingencies with internal control  
 
 
 
Size Work 
setting 
Time to 
research 
Time to 
education 
Time to 
patient 
care 
Time to 
supervision 
Research 
experience 
Management 
experience 
Foreign 
experience 
Supervising 
experience 
Control of personal 
resources 
Pre-clin      
Clinical 
0.23 
0.03 
0.14 
0.12 
0.15 
0.23 
-0.19 
-0.06 
-0.05 
0.05 
0.23 
0.20 
-0.18 
0.08 
-0.11 
0.43* 
0.26* 
-0.02 
-0.08 
0.08 
Research 
commitment 
Pre-clin      
Clinical 
-0.22 
-0.17 
0.28* 
0.19 
0.45*** 
0.29* 
-0.10 
-0.11 
-0.33** 
-0.09 
0.47*** 
0.37** 
0.08 
0.14 
-0.07 
-0.24 
0.19 
0.13 
0.17 
0.10 
Time spent on 
internal managerial 
control  
Pre-clim     
Clinical 
0.18 
0.22 
0.14 
-0.01 
0.19 
0.35** 
-0.17 
-0.02 
-0.37*** 
-0.35** 
0.43*** 
0.40** 
0.00 
-0.14 
-0.01 
-0.11 
0.08 
0.08 
0.03 
000 
Pre-clin 
Clinical 
-0.16 
0.15 
0.13 
-0.06 
0.29* 
0.09 
-0.07 
0.12 
-0.08 
0.06 
0.27* 
0.12 
-0.14 
-0.01 
-0.29* 
-0.14 
-0.12 
0.08 
-0.03 
0.07 
Communication 
Research meetings 
 
Direct communication 
Pre-clin    
Clinical 
0.11 
-0.01 
-0.14 
-0.18 
-0.40*** 
-0.12 
-0.13 
0.03 
0.14 
0.16 
-0.14 
-0.06 
0.05 
0.08 
0.21 
0.26 
-0.15 
0.05 
-0.10 
-0.20 
 
Pre-clin 
Clinical 
 
0.05 
0.22 
 
0.07 
0.06 
 
0.13 
0.14 
 
0.02 
0.14 
 
-0.29* 
-0.12 
 
0.05 
0.18 
 
-0.07 
0.12 
 
-0.18 
-0.04 
 
0.28* 
0.27* 
 
0.01 
0.13 
Pre-clin 
Clinical 
0.13 
-0.19 
0.04 
-0.04 
0.09 
0.17 
0.10 
0.12 
-0.03 
-0.32* 
-0.12 
0.07 
-0.24* 
-0.06 
-0.06 
0.05 
0.24* 
0.08 
-0.16 
-0.09 
Pre-clin 
Clinical 
0.14 
0.37** 
0.11 
0.07 
0.01 
-0.04 
-0.06 
0.03 
-0.01 
0.18 
0.03 
0.03 
-0.07 
0.17 
0.07 
-0.14 
0.07 
0.22 
0.01 
0.11 
Rewards 
Development skills  
 
Flexibility 
 
Special 
commendations 
 
Financial bonus 
system 
 
Pre-clin 
Clinical 
 
0.34** 
0.28* 
 
-0.29* 
-0.03 
 
-0.06 
-0.02 
 
0.24* 
-0.01 
 
0.15 
0.05 
 
-0.14 
-0.03 
 
-0.16 
0.05 
 
0.01 
-0.01 
 
0.05 
0.20 
 
-0.33** 
0.07 
Research policy 
planning 
Pre-clin 
Clinical 
0.27* 
0.11 
-0.28* 
-0.12 
-0.04 
0.11 
0.06 
0.23 
-0.05 
-0.09 
-0.17 
-0.01 
-0.03 
0.04 
-0.14 
0.27* 
-0.04 
0.14 
-0.03 
-0.13 
Job evaluation 
 
Pre-clin 
Clinical 
0.00 
0.10 
0.03 
0.04 
0.00 
-0.11 
-0.08 
-0.07 
0.04 
-0.12 
-0.05 
0.04 
0.04 
-0.23 
0.02 
0.10 
-0.04 
-0.12 
0.09 
0.03 
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Pre-clin 
Clinical 
 
0.15 
-0.15 
 
-0.06 
0.09 
 
0.12 
0.20 
 
-0.01 
-0.07 
 
0.14 
-0.17 
 
0.08 
-0.07 
 
0.07 
0.08 
 
-0.14 
0.16 
 
0.05 
0.03 
 
0.17 
0.15 
Pre-clin 
Clinical 
-0.03 
0.04 
-0.03 
0.07 
-0.04 
-0.10 
0.03 
-0.09 
0.19 
0.17 
-0.12 
-0.07 
-0.11 
0.17 
-0.01 
0.03 
-0.02 
-0.02 
0.02 
0.09 
Pre-evaluation of 
research proposals 
Group/Department 
 
Medical Faculty 
 
University / Non-
university institute 
 
Pre-clin 
Clinic 
 
0.18 
-0.18 
 
0.39** 
0.07 
 
0.21 
0.10 
 
-0.22 
-0.03 
 
0.03 
0.16 
 
0.06 
-0.07 
 
-0.16 
0.08 
 
-0.09 
0.16 
 
-0.12 
-0.05 
 
-0.07 
-0.04 
 
Pre-clin 
Clinical 
 
-0.08 
0.11 
 
-0.05 
0.11 
 
-0.08 
0.09 
 
0.23 
0.01 
 
0.22 
-0.06 
 
-0.05 
-0.14 
 
0.01 
0.22 
 
-0.02 
0.00 
 
0.04 
0.17 
 
0.05 
  0.39** 
Pre-clin 
Clinical 
0.08 
0.06 
-0.17 
-0.08 
-0.20 
0.13 
0.12 
0.35** 
0.18 
-0.06 
-0.22 
-0.08 
-0.09 
0.09 
0.00 
-0.01 
0.07 
0.00 
-0.10 
0.23 
Research output 
evaluation  
Group/Department 
 
Medical Faculty 
 
University/Non-
university institute 
Pre-clin 
Clinical 
0.18 
-0.03 
 
0.07 
0.02 
0.02 
0.15 
-0.13 
0.01 
0.21 
0.03 
-0.09 
0.17 
0.08 
-0.11 
-0.01 
0.04 
-0.09 
0.14 
-0.10 
-0.25 
Effectiveness of 
pre-evaluations 
Pre-clin 
Clinical 
-0.14 
-0.18 
0.27* 
0.16 
0.09 
0.26* 
-0.16 
-0.06 
0.03 
-0.07 
0.05 
0.13 
0.17 
-0.08 
-0.05 
0.02 
0.19 
0.17 
0.21 
0.21 
Importance of 
internal research 
evaluations 
Pre-clin 
Clinical 
0.03 
0.08 
0.03 
0.11 
-0.18 
-0.05 
-0.17 
0.01 
0.10 
0.01 
-0.25* 
0.12 
0.00 
0.02 
0.05 
-0.09 
0.19 
0.07 
-0.01 
-0.07 
 
*p < 05; **p <.01; ***p <0.001 
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Correlation matrix of contingencies with external control  
 
 
 
Size Work 
setting 
Time to 
research 
Time to 
education 
Time to 
patient 
care 
Time to 
supervision 
Research 
experience 
Management 
experience 
Foreign 
experience 
Supervising 
experience 
Time spent on external 
research activities 
Pre-clin      
Clinical 
0.10 
0.29* 
-0.18 
-0.07 
0.14 
0.33* 
0.13 
0.09 
0.19 
-0.05 
-0.06 
0.27* 
-0.02 
0.13 
-0.13 
-0.21 
0.08 
0.26* 
-0.01 
0.01 
Time spent on external 
managerial control 
Pre-clin      
Clinical 
0.25* 
0.32* 
0.08 
0.17 
0.07 
-0.01 
-0.13 
-0.01 
-0.29* 
-0.25 
0.12 
0.01 
0.10 
0.24 
-0.19 
-0.02 
-0.01 
0.17 
-0.01 
0.16 
Importance of external 
research evaluations 
DAG evaluation 1998 
 
Research school 
evaluations 
 
Pre-clin     
Clinical 
 
Pre-clin     
Clinical 
 
0.04 
-0.22 
 
-0.09 
-0.07 
 
-0.14 
-0.03 
 
0.14 
0.12 
 
-0.19 
-0.16 
 
0.13 
-0.06 
 
0.17 
0.03 
 
-0.04 
-0.24 
 
0.03 
0.06 
 
-0.11 
0.02 
 
0.12 
-0.04 
 
0.13 
0.16 
 
-0.08 
0.05 
 
-0.23 
0.05 
 
0.03 
-0.07 
 
-0.16 
0.10 
 
-0.24 
0.01 
 
0.18 
0.08 
 
0.05 
0.12 
 
-0.07 
0.31 
 
Pre-clin    
Clinical 
 
-0.12 
0.09 
 
-0.14 
0.00 
 
-0.13 
-0.12 
 
0.00 
-0.04 
 
0.07 
0.04 
 
-0.15 
-0.03 
 
-0.12 
0.02 
 
-0.03 
0.03 
 
-0.11 
0.28* 
 
-0.10 
0.06 
 
Pre-clin     
Clinical 
 
0.15 
0.15 
 
-0.27* 
0.05 
 
-0.22 
-0.01 
 
0.05 
0.18 
 
0.41*** 
-0.06 
 
-0.31* 
0.19 
 
-0.08 
-0.19 
 
0.22 
0.10 
 
-0.15 
-0.06 
 
-0.35** 
-0.22 
 
Pre-clin     
Clinical 
 
0.07 
0.16 
 
-0.06 
0.14 
 
0.09 
0.02 
 
0.23 
-0.05 
 
0.23 
0.09 
 
-0.19 
-0.12 
 
-0.26* 
-0.02 
 
-0.04 
0.08 
 
-0.16 
0.37** 
 
-0.45*** 
0.10 
Pre-clin     
Clinical 
0.06 
-0.22 
-0.23 
0.00 
-0.25* 
-0.26* 
-0.25* 
0.03 
0.34** 
0.44*** 
-0.23 
-0.25 
-0.04 
0.08 
0.16 
0.22 
-0.31* 
0.24 
-0.15 
-0.15 
Importance of 
collaboration 
Research groups 
 
Ministries and semi-
governmental 
organisations 
 
Pharmaceutical 
industries & firms 
 
Clinic 
 
Family doctor 
Pre-clin     
Clinical 
0.08 
0.03 
-0.29* 
0.04 
-0.26* 
-0.25 
0.31* 
0.24 
0.34** 
-0.09 
-0.27* 
0.19 
0.06 
-0.24 
0.42** 
0.07 
-0.08 
-0.22 
-0.25* 
-0.08 
 
 
*p < 05; **p <.01; ***p <0.001 
 222  
DANKWOORD 
 
Allereerst bedank ik alle respondenten (wetenschappers en beleidsmedewerkers) die bereid waren 
mee te werken en hun inzichten en kennis met mij wilden delen aan dit onderzoek. Zonder jullie 
geen empirisch materiaal en dus geen proefschrift. 
 
Mijn complimenten aan mijn (co)promotoren. Peter, jouw enthousiasme zorgde ervoor dat ik het 
aandurfde om te beginnen aan een promotie traject. Bedankt dat je me deze mogelijkheid hebt 
gegeven. Je bent een echte ideeën generator en hebt de gave om opmerkingen te kunnen plaatsen 
die de kern van de zaak raken  (als ik weer eens een zijweg was ingeslagen). Ik heb de afgelopen 
jaren enorm veel van je geleerd. Jij hebt mij veel ruimte en vrijheid gelaten om binnen het project 
mijn eigen weg te gaan. Ook stimuleerde je me om verder dan alleen het onderzoeksproject te 
kijken. Veel dank daarvoor! Eduard, bedankt voor je enthousiasme, betrokkenheid, steun en 
vertrouwen in mij. Ondanks je overvolle agenda wist je toch altijd weer tijd vrij te maken voor 
efficiënte besprekingen, eerst in de stationsrestauratie van Leiden (onder het genot van een koffie 
verkeerd), later in je eigen kamer in het LUMC. De sfeer tijdens de besprekingen was altijd 
ontspannen. Jouw streven naar helderheid en duidelijkheid hielp mij ‘to-the-point’ te blijven. Ik 
hoop dat je trots kan zijn op het eindproduct! Dick, zonder jou zou er heel wat minder 
kwantitatief materiaal in het proefschrift zijn gekomen. Bedankt dat jij, halverwege het 
promotietraject, in de begeleidingscommissie wilde stappen. Je hebt me rondgeleid in de SPSS 
wereld en ik kon altijd bij je terecht als ik weer eens was vastgelopen in de data. Ik waardeer je 
wetenschappelijke nauwkeurigheid en precisie, ook al maakte dit mij wel eens ongeduldig. Jouw 
kritische blik op de concepten van hoofdstukken heeft zeker geresulteerd in kwaliteitsverbetering! 
Kortom, een sociale wetenschapper, een psycholoog en een medicus als begeleiders -op het eerste 
gezicht een lastige combinatie- jullie inhoudelijk inbreng was divers, maar juist omdat jullie 
elkaar aanvulden vormden we samen een uitstekend team!  
 
Het onderzoek zoals beschreven in dit proefschrift was niet mogelijk geweest zonder verdere 
financiële steun van NWO. Hierbij wil ik ook ZonMw bedanken voor de unieke kans die ze me 
boden om praktijkervaring op te doen. Ook bij het kwantitatieve gedeelte in het promotie 
onderzoek kon ik rekenen op jullie hulp. Daarnaast vond ik het heel leuk om de uiteindelijke 
resultaten van het kwantitatieve gedeelte te hebben mogen presenteren tijdens het zogenaamde 
‘broodje NWO’. Tenslotte Team 1 bedankt voor jullie interesse in mijn onderzoek en de 
interessante discussies! 
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De leden van de begeleidingscommissie bedank ik voor de tijd die ze gestoken hebben in het 
lezen van conceptstukken en het geven van kritisch commentaar. Helen Richardson wil ik 
bedanken voor de Engelse correcties. 
 
De eerste twee jaar is het onderzoek uitgevoerd in de MAWIN groep. Hierbij wil ik mijn oud-
MAWIN collega’s bedanken voor de interesse in mijn onderzoek, de fijne samenwerking in 
onderwijsprojecten, en de gezellige sfeer. Veel dank gaat uit naar de afdeling Bestuur en 
Organisatie die mij halverwege het promotietraject de mogelijkheid gaf om mijn project  verder 
uit te voeren en af te ronden. De overstap van Exacte Wetenschappen naar de Sociale 
Wetenschappen was niet altijd makkelijk, we spraken een andere taal. Toch heb ik het gevoel een 
van jullie te zijn geworden, ik wil dan ook mijn Strategie en Organisatie collega’s bedanken voor 
jullie interesse in mijn onderzoek en de inspirerende discussies. Ook mede promovendi van de 
afdelingen Bestuur en Organisatie, Communicatiewetenschap en Politicologie: bedankt voor de 
discussies over het wel-en-wee van het AIO-schap en het sociale netwerk. Ik denk met veel 
plezier terug aan de gezellige etentjes in de Bodega (de gamba’s!) en de summerschools in Essex.  
 
Scriptiestudenten Anna, Maaike en Swi-Fan: het was erg leuk en inspirerend om met jullie te 
werken, heel veel succes in jullie loopbanen! Ook Carlo wil ik bedanken voor invoeren van 
geretourneerde vragenlijsten in SPSS, jij hebt me veel werk uit handen genomen!  
 
Ook een dank je wel aan de dames van het AIO clubje. Ik heb veel gehad aan onze besprekingen 
en discussies. Bedankt voor het begrip, de steun, de interesse en het commentaar op mijn 
concepten.  
 
Pap en mam: bedankt voor de mogelijkheid en vrijheid die jullie me gegeven hebben om me te 
ontwikkelen en ontplooien. Mijn vriendinnen, vrienden en (schoon)familieleden bedank ik voor 
de fijne open gesprekken, gezellige etentjes en sportieve uitjes. Jullie steun en peptalks hebben 
mij goed gedaan!  
 
Mijn laatste woord van dank gaat uit naar Jim. Jij bent de rots in de branding, mijn uitlaatklep, 
mijn luisterend oor. Bij jou kan ik mijn hart uit storten, jij blijft altijd rustig en kalm. Jouw geloof 
in mij heeft me enorm gestimuleerd dit proefschrift af te ronden.  
 
Utrecht, Oktober 2006 
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OVER DE AUTEUR 
 
Inge van der Weijden werd op 22 september 1976 geboren te Heemstede. In 1994 behaalde zij 
haar VWO diploma en begon aan de Vrije Universiteit met de studie Medische Biologie. Ze koos 
voor de afstudeerrichting beleid en management. In  1998  heeft ze als afstudeeropdracht (onder 
leiding van voormalig directeur prof. Joost Ruitenberg) bij het Centraal Laboratorium van de 
Bloedtransfusiedienst (tegenwoordig Sanquin) het functioneren van het stakeholdersmodel 
geëvalueerd. Met de analyse van dit managementsysteem voor medisch wetenschappelijk 
onderzoek is de fascinatie voor onderzoeksmanagement en evaluatie ontstaan. In 1999 studeerde 
zij af en begon als junior onderzoeker bij de afdeling MAWIN (faculteit Exacte Wetenschappen) 
aan de Vrije Universiteit met een verkenning van het promotie onderwerp. In 2000 ontving zij 
een subsidie van NWO om gedurende een periode van drie jaar empirisch onderzoek te 
verrichten. In 2001 heeft zij 5 maanden praktijk ervaring opgedaan bij NWO Medische 
Wetenschappen (tegenwoordig CMHR). Ze werkte als programmasecretaris divisie 
orgaansystemen en heeft mogen ervaren hoe het beoordelingsproces van onderzoeksvoorstellen in 
de praktijk plaatsvond. Eind 2001 maakte ze de overstap naar de afdeling Bestuur en Organisatie 
(faculteit Sociale Wetenschappen) om in nabijheid van haar co-promotoren en in een inspirerend 
onderzoeksklimaat verder aan het promotie onderzoek te werken. Daarnaast was zij eindredacteur 
van het tijdschrift Wetenschap Technologie en Samenleving (2000-2002) en behartigde ze op 
facultair niveau de belangen van promovendi (2002). Na afloop van haar aanstelling in 2004 heeft 
zij een jaar als programmasecretaris in het ZonMw Open Programma gewerkt. In 2005 was ze 
werkzaam als research fellow bij de afdeling Bestuur en Organisatie en in het voorjaar van 2006 
als docent bij de afdeling Methoden en Technieken aan de Vrije Universiteit. Vanaf oktober 2006 
werkt ze als onderzoeker bij het Rathenau Instituut aan het Science System Assessment 
programma. 
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